Hits from PDB	Structure Title	EC number
102L	HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME	3.2.1.17
103L	HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME	3.2.1.17
104L	HOW AMINO-ACID INSERTIONS ARE ALLOWED IN AN ALPHA-HELIX OF T4 LYSOZYME	3.2.1.17
107L	STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME	3.2.1.17
108L	STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME	3.2.1.17
109L	STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME	3.2.1.17
110L	STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME	3.2.1.17
111L	STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME	3.2.1.17
112L	STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME	3.2.1.17
113L	STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME	3.2.1.17
114L	STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME	3.2.1.17
115L	STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME	3.2.1.17
117E	THE R78K AND D117E ACTIVE SITE VARIANTS OF SACCHAROMYCES CEREVISIAE SOLUBLE INORGANIC PYROPHOSPHATASE: STRUCTURAL STUDIES AND MECHANISTIC IMPLICATIONS	3.6.1.1
118L	THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
119L	THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
11BA	BINDING OF A SUBSTRATE ANALOGUE TO A DOMAIN SWAPPING PROTEIN IN THE COMPLEX OF BOVINE SEMINAL RIBONUCLEASE WITH URIDYLYL-2',5'-ADENOSINE	3.1.27.5 4.6.1.18
11BG	A POTENTIAL ALLOSTERIC SUBSITE GENERATED BY DOMAIN SWAPPING IN BOVINE SEMINAL RIBONUCLEASE	3.1.27.5 4.6.1.18
120L	THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
121P	STRUKTUR UND GUANOSINTRIPHOSPHAT-HYDROLYSEMECHANISMUS DES C-TERMINAL VERKUERZTEN MENSCHLICHEN KREBSPROTEINS P21-H-RAS	3.6.5.2
122L	THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
123L	THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
125L	THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
126L	THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
127L	THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
128L	THE ENERGETIC COST AND THE STRUCTURAL CONSEQUENCES OF BURYING A HYDROXYL GROUP WITHIN THE CORE OF A PROTEIN DETERMINED FROM ALA TO SER AND VAL TO THR SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
129L	STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED BY RELAXATION OF STRAIN AND BY IMPROVED HYDROGEN BONDING VIA BOUND SOLVENT	3.2.1.17
130L	STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED BY RELAXATION OF STRAIN AND BY IMPROVED HYDROGEN BONDING VIA BOUND SOLVENT	3.2.1.17
131L	STRUCTURES OF RANDOMLY GENERATED MUTANTS OF T4 LYSOZYME SHOW THAT PROTEIN STABILITY CAN BE ENHANCED BY RELAXATION OF STRAIN AND BY IMPROVED HYDROGEN BONDING VIA BOUND SOLVENT	3.2.1.17
132L	STRUCTURAL CONSEQUENCES OF REDUCTIVE METHYLATION OF LYSINE RESIDUES IN HEN EGG WHITE LYSOZYME: AN X-RAY ANALYSIS AT 1.8 ANGSTROMS RESOLUTION	3.2.1.17
133L	ROLE OF ARG 115 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME. X-RAY STRUCTURE OF HIS 115 AND GLU 115 MUTANTS	3.2.1.17
134L	ROLE OF ARG 115 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME. X-RAY STRUCTURE OF HIS 115 AND GLU 115 MUTANTS	3.2.1.17
135L	X-RAY STRUCTURE OF MONOCLINIC TURKEY EGG LYSOZYME AT 1.3 ANGSTROMS RESOLUTION	3.2.1.17
137L	STRUCTURAL BASIS OF AMINO ACID ALPHA HELIX PROPENSITY	3.2.1.17
138L	RAPID CRYSTALLIZATION OF T4 LYSOZYME BY INTERMOLECULAR DISULFIDE CROSSLINKING	3.2.1.17
139L	RAPID CRYSTALLIZATION OF T4 LYSOZYME BY INTERMOLECULAR DISULFIDE CROSSLINKING	3.2.1.17
140L	ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME	3.2.1.17
141L	ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME	3.2.1.17
142L	ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME	3.2.1.17
143L	ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME	3.2.1.17
144L	ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME	3.2.1.17
145L	ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME	3.2.1.17
146L	ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME	3.2.1.17
147L	ROLE OF BACKBONE FLEXIBILITY IN THE ACCOMMODATION OF VARIANTS THAT REPACK THE CORE OF T4 LYSOZYME	3.2.1.17
148L	A COVALENT ENZYME-SUBSTRATE INTERMEDIATE WITH SACCHARIDE DISTORTION IN A MUTANT T4 LYSOZYME	3.2.1.17
149L	CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
150L	CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
151L	CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
152L	CONSERVATION OF SOLVENT-BINDING SITES IN 10 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
153L	THE REFINED STRUCTURES OF GOOSE LYSOZYME AND ITS COMPLEX WITH A BOUND TRISACCHARIDE SHOW THAT THE GOOSE-TYPE LYSOZYMES LACK A CATALYTIC ASPARTATE"	3.2.1.17
154L	THE REFINED STRUCTURES OF GOOSE LYSOZYME AND ITS COMPLEX WITH A BOUND TRISACCHARIDE SHOW THAT THE GOOSE-TYPE LYSOZYMES LACK A CATALYTIC ASPARTATE"	3.2.1.17
155L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
156L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
157L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
158L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
159L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
160L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
161L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
162L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
163L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
164L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
165L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
166L	CONTROL OF ENZYME ACTIVITY BY AN ENGINEERED DISULFIDE BOND	3.2.1.17
167L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
168L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
169L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
170L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
171L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
172L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
173L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
174L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
175L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
176L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
177L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
178L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
180L	PROTEIN FLEXIBILITY AND ADAPTABILITY SEEN IN 25 CRYSTAL FORMS OF T4 LYSOZYME	3.2.1.17
181L	SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY	3.2.1.17
182L	SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY	3.2.1.17
183L	SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY	3.2.1.17
184L	SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY	3.2.1.17
185L	SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY	3.2.1.17
186L	SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY	3.2.1.17
187L	SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY	3.2.1.17
188L	SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY	3.2.1.17
189L	ENHANCEMENT OF PROTEIN STABILITY BY THE COMBINATION OF POINT MUTATIONS IN T4 LYSOZYME IS ADDITIVE	3.2.1.17
190L	A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS	3.2.1.17
191L	A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS	3.2.1.17
192L	A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS	3.2.1.17
193L	THE 1.33 A STRUCTURE OF TETRAGONAL HEN EGG WHITE LYSOZYME	3.2.1.17
194L	THE 1.40 A STRUCTURE OF SPACEHAB-01 HEN EGG WHITE LYSOZYME	3.2.1.17
195L	THERMODYNAMIC AND STRUCTURAL COMPENSATION IN SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME"	3.2.1.17
196L	THERMODYNAMIC AND STRUCTURAL COMPENSATION IN SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME"	3.2.1.17
197L	THERMODYNAMIC AND STRUCTURAL COMPENSATION IN SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME"	3.2.1.17
198L	THERMODYNAMIC AND STRUCTURAL COMPENSATION IN SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME"	3.2.1.17
199L	THERMODYNAMIC AND STRUCTURAL COMPENSATION IN SIZE-SWITCH" CORE-REPACKING VARIANTS OF T4 LYSOZYME"	3.2.1.17
1A0H	THE X-RAY CRYSTAL STRUCTURE OF PPACK-MEIZOTHROMBIN DESF1: KRINGLE/THROMBIN AND CARBOHYDRATE/KRINGLE/THROMBIN INTERACTIONS AND LOCATION OF THE LINKER CHAIN	3.4.21.5
1A0J	CRYSTAL STRUCTURE OF A NON-PSYCHROPHILIC TRYPSIN FROM A COLD-ADAPTED FISH SPECIES.	3.4.21.4
1A0L	HUMAN BETA-TRYPTASE: A RING-LIKE TETRAMER WITH ACTIVE SITES FACING A CENTRAL PORE	3.4.21.59
1A16	AMINOPEPTIDASE P FROM E. COLI WITH THE INHIBITOR PRO-LEU	3.4.11.9
1A17	TETRATRICOPEPTIDE REPEATS OF PROTEIN PHOSPHATASE 5	3.1.3.16
1A1Q	HEPATITIS C VIRUS NS3 PROTEINASE	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1A1R	HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1A1V	HEPATITIS C VIRUS NS3 HELICASE DOMAIN COMPLEXED WITH SINGLE STRANDED SDNA	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1A2A	AGKISTROTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS	3.1.1.4
1A2B	HUMAN RHOA COMPLEXED WITH GTP ANALOGUE	3.6.5.2
1A2C	STRUCTURE OF THROMBIN INHIBITED BY AERUGINOSIN298-A FROM A BLUE-GREEN ALGA	3.4.21.5
1A2O	STRUCTURAL BASIS FOR METHYLESTERASE CHEB REGULATION BY A PHOSPHORYLATION-ACTIVATED DOMAIN	3.1.1.61 3.5.1.44
1A2P	BARNASE WILDTYPE STRUCTURE AT 1.5 ANGSTROMS RESOLUTION	3.1.27
1A2Q	SUBTILISIN BPN' MUTANT 7186	3.4.21.62
1A2T	STAPHYLOCOCCAL NUCLEASE, B-MERCAPTOETHANOL DISULFIDE TO V23C VARIANT	3.1.31.1
1A2U	STAPHYLOCOCCAL NUCLEASE, V23C VARIANT, COMPLEX WITH 1-N-BUTANE THIOL AND 3',5'-THYMIDINE DIPHOSPHATE	3.1.31.1
1A2W	CRYSTAL STRUCTURE OF A 3D DOMAIN-SWAPPED DIMER OF BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1A2Z	PYRROLIDONE CARBOXYL PEPTIDASE FROM THERMOCOCCUS LITORALIS	3.4.19.3
1A30	HIV-1 PROTEASE COMPLEXED WITH A TRIPEPTIDE INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1A39	HUMICOLA INSOLENS ENDOCELLULASE EGI S37W, P39W DOUBLE-MUTANT	3.2.1.4
1A3B	COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG1	3.4.21.5
1A3D	PHOSPHOLIPASE A2 (PLA2) FROM NAJA NAJA VENOM	3.1.1.4
1A3E	COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG2	3.4.21.5
1A3F	PHOSPHOLIPASE A2 (PLA2) FROM NAJA NAJA VENOM	3.1.1.4
1A3H	ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHERANS AT 1.6A RESOLUTION	3.2.1.4
1A3T	STAPHYLOCOCCAL NUCLEASE, V23C VARIANT, COMPLEX WITH 2-FLUOROETHANE THIOL AND 3',5'-THYMIDINE DIPHOSPHATE	3.1.31.1
1A3U	STAPHYLOCOCCAL NUCLEASE, CYCLOHEXANE THIOL DISULFIDE TO V23C VARIANT	3.1.31.1
1A3V	STAPHYLOCOCCAL NUCLEASE, CYCLOPENTANE THIOL DISULFIDE TO V23C VARIANT	3.1.31.1
1A43	STRUCTURE OF THE HIV-1 CAPSID PROTEIN DIMERIZATION DOMAIN AT 2.6A RESOLUTION	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1A46	THROMBIN COMPLEXED WITH HIRUGEN AND A BETA-STRAND MIMETIC INHIBITOR	3.4.21.5
1A4G	INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR	3.2.1.18
1A4I	HUMAN TETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE	1.5.1.5 3.5.4.9 6.3.4.3
1A4L	ADA STRUCTURE COMPLEXED WITH DEOXYCOFORMYCIN AT PH 7.0	3.5.4.4
1A4M	ADA STRUCTURE COMPLEXED WITH PURINE RIBOSIDE AT PH 7.0	3.5.4.4
1A4Q	INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH DIHYDROPYRAN-PHENETHYL-PROPYL-CARBOXAMIDE	3.2.1.18
1A4R	G12V MUTANT OF HUMAN PLACENTAL CDC42 GTPASE IN THE GDP FORM	3.6.5.2
1A4W	CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE-CONTAINING INHIBITORS: PROBES OF THE S1' BINDING SITE	3.4.21.5
1A5G	HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN	3.4.21.5
1A5H	CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE	3.4.21.68
1A5I	CATALYTIC DOMAIN OF VAMPIRE BAT (DESMODUS ROTUNDUS) SALIVA PLASMINOGEN ACTIVATOR IN COMPLEX WITH EGR-CMK (GLU-GLY-ARG CHLOROMETHYL KETONE)	3.4.21.68
1A5K	K217E VARIANT OF KLEBSIELLA AEROGENES UREASE	3.5.1.5
1A5L	K217C VARIANT OF KLEBSIELLA AEROGENES UREASE	3.5.1.5
1A5M	K217A VARIANT OF KLEBSIELLA AEROGENES UREASE	3.5.1.5
1A5N	K217A VARIANT OF KLEBSIELLA AEROGENES UREASE, CHEMICALLY RESCUED BY FORMATE AND NICKEL	3.5.1.5
1A5O	K217C VARIANT OF KLEBSIELLA AEROGENES UREASE, CHEMICALLY RESCUED BY FORMATE AND NICKEL	3.5.1.5
1A5P	C[40,95]A VARIANT OF BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1A5Q	P93A VARIANT OF BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1A5V	ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 AND MN CATION	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
1A5W	ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
1A5X	ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
1A5Y	PROTEIN TYROSINE PHOSPHATASE 1B CYSTEINYL-PHOSPHATE INTERMEDIATE	3.1.3.48
1A61	THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR	3.4.21.5
1A62	CRYSTAL STRUCTURE OF THE RNA-BINDING DOMAIN OF THE TRANSCRIPTIONAL TERMINATOR PROTEIN RHO	3.6.4
1A63	THE NMR STRUCTURE OF THE RNA BINDING DOMAIN OF E.COLI RHO FACTOR SUGGESTS POSSIBLE RNA-PROTEIN INTERACTIONS, 10 STRUCTURES	3.6.4
1A6F	RNASE P PROTEIN FROM BACILLUS SUBTILIS	3.1.26.5
1A6Q	CRYSTAL STRUCTURE OF THE PROTEIN SERINE/THREONINE PHOSPHATASE 2C AT 2 A RESOLUTION	3.1.3.16
1A6R	GAL6 (YEAST BLEOMYCIN HYDROLASE) MUTANT C73A	3.4.22 3.4.22.40
1A6S	M-DOMAIN FROM GAG POLYPROTEIN OF ROUS SARCOMA VIRUS, NMR, 20 STRUCTURES	3.4.23
1A73	INTRON-ENCODED ENDONUCLEASE I-PPOI COMPLEXED WITH DNA	3.1
1A74	I-PPOL HOMING ENDONUCLEASE/DNA COMPLEX	3.1
1A76	FLAP ENDONUCLEASE-1 FROM METHANOCOCCUS JANNASCHII	3.1
1A77	FLAP ENDONUCLEASE-1 FROM METHANOCOCCUS JANNASCHII	3.1
1A7A	STRUCTURE OF HUMAN PLACENTAL S-ADENOSYLHOMOCYSTEINE HYDROLASE: DETERMINATION OF A 30 SELENIUM ATOM SUBSTRUCTURE FROM DATA AT A SINGLE WAVELENGTH	3.3.1.1
1A7T	METALLO-BETA-LACTAMASE WITH MES	3.5.2.6
1A85	MMP8 WITH MALONIC AND ASPARAGINE BASED INHIBITOR	3.4.24.34
1A86	MMP8 WITH MALONIC AND ASPARTIC ACID BASED INHIBITOR	3.4.24.34
1A8D	TETANUS TOXIN C FRAGMENT	3.4.24.68
1A8G	HIV-1 PROTEASE IN COMPLEX WITH SDZ283-910	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1A8K	CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVED CA-P2 SUBSTRATE: INTERACTIONS WITH FREQUENTLY OCCURRING GLUTAMIC ACID RESIDUE AT P2' POSITION OF SUBSTRATES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1A8O	HIV CAPSID C-TERMINAL DOMAIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1A8R	GTP CYCLOHYDROLASE I (H112S MUTANT) IN COMPLEX WITH GTP	3.5.4.16
1A8T	METALLO-BETA-LACTAMASE IN COMPLEX WITH L-159,061	3.5.2.6
1A8V	STRUCTURE OF THE RNA-BINDING DOMAIN OF THE RHO TRANSCRIPTION TERMINATOR	3.6.4
1A94	STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1A9M	G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AA9	HUMAN C-HA-RAS(1-171)(DOT)GDP, NMR, MINIMIZED AVERAGE STRUCTURE	3.6.5.2
1AAF	NUCLEOCAPSID ZINC FINGERS DETECTED IN RETROVIRUSES: EXAFS STUDIES ON INTACT VIRUSES AND THE SOLUTION-STATE STRUCTURE OF THE NUCLEOCAPSID PROTEIN FROM HIV-1	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AAQ	HYDROXYETHYLENE ISOSTERE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE: STRUCTURE-ACTIVITY ANALYSIS USING ENZYME KINETICS, X-RAY CRYSTALLOGRAPHY, AND INFECTED T-CELL ASSAYS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AAX	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH TWO BIS(PARA-PHOSPHOPHENYL)METHANE (BPPM) MOLECULES	3.1.3.48
1AB9	CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN	3.4.21.1
1ABI	STRUCTURE OF THE HIRULOG 3-THROMBIN COMPLEX AND NATURE OF THE S' SUBSITES OF SUBSTRATES AND INHIBITORS	3.4.21.5
1ABJ	STRUCTURE OF THE HIRULOG 3-THROMBIN COMPLEX AND NATURE OF THE S' SUBSITES OF SUBSTRATES AND INHIBITORS	3.4.21.5
1ABR	CRYSTAL STRUCTURE OF ABRIN-A	3.2.2.22
1AC0	GLUCOAMYLASE, GRANULAR STARCH-BINDING DOMAIN COMPLEX WITH CYCLODEXTRIN, NMR, MINIMIZED AVERAGE STRUCTURE	3.2.1.3
1AC5	CRYSTAL STRUCTURE OF KEX1(DELTA)P, A PROHORMONE-PROCESSING CARBOXYPEPTIDASE FROM SACCHAROMYCES CEREVISIAE	3.4.16.6
1ACB	CRYSTAL AND MOLECULAR STRUCTURE OF THE BOVINE ALPHA-CHYMOTRYPSIN-EGLIN C COMPLEX AT 2.0 ANGSTROMS RESOLUTION	3.4.21.1
1ACJ	QUATERNARY LIGAND BINDING TO AROMATIC RESIDUES IN THE ACTIVE-SITE GORGE OF ACETYLCHOLINESTERASE	3.1.1.7
1ACL	QUATERNARY LIGAND BINDING TO AROMATIC RESIDUES IN THE ACTIVE-SITE GORGE OF ACETYLCHOLINESTERASE	3.1.1.7
1ACZ	GLUCOAMYLASE, GRANULAR STARCH-BINDING DOMAIN COMPLEX WITH CYCLODEXTRIN, NMR, 5 STRUCTURES	3.2.1.3
1AD8	COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY	3.4.21.5
1ADD	A PRE-TRANSITION STATE MIMIC OF AN ENZYME: X-RAY STRUCTURE OF ADENOSINE DEAMINASE WITH BOUND 1-DEAZA-ADENOSINE AND ZINC-ACTIVATED WATER	3.5.4.4
1AE7	NOTEXIN, A PRESYNAPTIC NEUROTOXIC PHOSPHOLIPASE A2	3.1.1.4
1AE8	HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D-PHE-PRO-AZALYS-ONP	3.4.21.5
1AE9	STRUCTURE OF THE LAMBDA INTEGRASE CATALYTIC CORE	2.7.7 3.1
1AEC	CRYSTAL STRUCTURE OF ACTINIDIN-E-64 COMPLEX+	3.4.22.14
1AEX	STAPHYLOCOCCAL NUCLEASE, METHANE THIOL DISULFIDE TO V23C VARIANT	3.1.31.1
1AF0	SERRATIA PROTEASE IN COMPLEX WITH INHIBITOR	3.4.24.40
1AF2	CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE COMPLEXED WITH URIDINE	3.5.4.5
1AF4	CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG IN ANHYDROUS DIOXANE	3.4.21.62
1AF5	GROUP I MOBILE INTRON ENDONUCLEASE	3.1
1AF9	TETANUS NEUROTOXIN C FRAGMENT	3.4.24.68
1AFE	HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO-AZALYS-ONP	3.4.21.5
1AFK	CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5'-DIPHOSPHOADENOSINE-3'-PHOSPHATE	3.1.27.5 4.6.1.18
1AFL	RIBONUCLEASE A IN COMPLEX WITH 5'-DIPHOSPHOADENOSINE 2'-PHOSPHATE AT 1.7 ANGSTROM RESOLUTION	3.1.27.5 4.6.1.18
1AFQ	CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR	3.4.21.1
1AFU	STRUCTURE OF RIBONUCLEASE A AT 2.0 ANGSTROMS FROM MONOCLINIC CRYSTALS	3.1.27.5 4.6.1.18
1AFV	HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AGI	CRYSTAL STRUCTURE OF BOVINE ANGIOGENIN AT 1.5 ANGSTROMS RESOLUTION	3.1.27
1AGJ	EPIDERMOLYTIC TOXIN A FROM STAPHYLOCOCCUS AUREUS	3.4.21
1AGM	REFINED STRUCTURE FOR THE COMPLEX OF ACARBOSE WITH GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100 TO 2.4 ANGSTROMS RESOLUTION	3.2.1.3
1AGP	THREE-DIMENSIONAL STRUCTURES AND PROPERTIES OF A TRANSFORMING AND A NONTRANSFORMING GLY-12 MUTANT OF P21-H-RAS	3.6.5.2
1AGX	REFINED CRYSTAL STRUCTURE OF ACINETOBACTER GLUTAMINASIFICANS GLUTAMINASE-ASPARAGINASE	3.5.1.1 3.5.1.38
1AGY	THE 1.15 ANGSTROM REFINED STRUCTURE OF FUSARIUM SOLANI PISI CUTINASE	3.1.1 3.1.1.74
1AH2	SERINE PROTEASE PB92 FROM BACILLUS ALCALOPHILUS, NMR, 18 STRUCTURES	3.4.21
1AH7	PHOSPHOLIPASE C FROM BACILLUS CEREUS	3.1.4.3
1AHA	THE N-GLYCOSIDASE MECHANISM OF RIBOSOME-INACTIVATING PROTEINS IMPLIED BY CRYSTAL STRUCTURES OF ALPHA-MOMORCHARIN	3.2.2.22
1AHB	THE N-GLYCOSIDASE MECHANISM OF RIBOSOME-INACTIVATING PROTEINS IMPLIED BY CRYSTAL STRUCTURES OF ALPHA-MOMORCHARIN	3.2.2.22
1AHC	THE N-GLYCOSIDASE MECHANISM OF RIBOSOME-INACTIVATING PROTEINS IMPLIED BY CRYSTAL STRUCTURES OF ALPHA-MOMORCHARIN	3.2.2.22
1AHT	CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND P-AMIDINOPHENYLPYRUVATE AT 1.6 ANGSTROMS RESOLUTION	3.4.21.5
1AI4	PENICILLIN ACYLASE COMPLEXED WITH 3,4-DIHYDROXYPHENYLACETIC ACID	3.5.1.11
1AI5	PENICILLIN ACYLASE COMPLEXED WITH M-NITROPHENYLACETIC ACID	3.5.1.11
1AI6	PENICILLIN ACYLASE WITH P-HYDROXYPHENYLACETIC ACID	3.5.1.11
1AI7	PENICILLIN ACYLASE COMPLEXED WITH PHENOL	3.5.1.11
1AI8	HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROMPG	3.4.21.5
1AID	STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AIH	CATALYTIC DOMAIN OF BACTERIOPHAGE HP1 INTEGRASE	2.7.7 3.1
1AIM	CRUZAIN INHIBITED BY BENZOYL-TYROSINE-ALANINE-FLUOROMETHYLKETONE	3.4.22 3.4.22.51
1AIW	NMR STRUCTURES OF THE CELLULOSE-BINDING DOMAIN OF THE ENDOGLUCANASE Z FROM ERWINIA CHRYSANTHEMI, 23 STRUCTURES	3.2.1.4
1AIX	HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROVAL	3.4.21.5
1AJA	THREE-DIMENSIONAL STRUCTURE OF THE D153G MUTANT OF E. COLI ALKALINE PHOSPHATASE: A MUTANT WITH WEAKER MAGNESIUM BINDING AND INCREASED CATALYTIC ACTIVITY	3.1.3.1
1AJB	THREE-DIMENSIONAL STRUCTURE OF THE D153G MUTANT OF E. COLI ALKALINE PHOSPHATASE: A MUTANT WITH WEAKER MAGNESIUM BINDING AND INCREASED CATALYTIC ACTIVITY	3.1.3.1
1AJC	THREE-DIMENSIONAL STRUCTURE OF THE D153G MUTANT OF E. COLI ALKALINE PHOSPHATASE: A MUTANT WITH WEAKER MAGNESIUM BINDING AND INCREASED CATALYTIC ACTIVITY	3.1.3.1
1AJD	THREE-DIMENSIONAL STRUCTURE OF THE D153G MUTANT OF E. COLI ALKALINE PHOSPHATASE: A MUTANT WITH WEAKER MAGNESIUM BINDING AND INCREASED CATALYTIC ACTIVITY	3.1.3.1
1AJE	CDC42 FROM HUMAN, NMR, 20 STRUCTURES	3.6.5.2
1AJK	CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-84	3.2.1.73
1AJN	PENICILLIN ACYLASE COMPLEXED WITH P-NITROPHENYLACETIC ACID	3.5.1.11
1AJO	CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-127	3.2.1.73
1AJP	PENICILLIN ACYLASE COMPLEXED WITH 2,5-DIHYDROXYPHENYLACETIC ACID	3.5.1.11
1AJQ	PENICILLIN ACYLASE COMPLEXED WITH THIOPHENEACETIC ACID	3.5.1.11
1AJV	HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AJX	HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AK0	P1 NUCLEASE IN COMPLEX WITH A SUBSTRATE ANALOG	3.1.30.1
1AK9	SUBTILISIN MUTANT 8321	3.4.21.62
1AKI	THE STRUCTURE OF THE ORTHORHOMBIC FORM OF HEN EGG-WHITE LYSOZYME AT 1.5 ANGSTROMS RESOLUTION	3.2.1.17
1AKL	ALKALINE PROTEASE FROM PSEUDOMONAS AERUGINOSA IFO3080	3.4.24.40
1AKN	STRUCTURE OF BILE-SALT ACTIVATED LIPASE	3.1.1.3 3.1.1.13 3.1.1.6
1AKO	EXONUCLEASE III FROM ESCHERICHIA COLI	3.1.11.2
1AKS	CRYSTAL STRUCTURE OF THE FIRST ACTIVE AUTOLYSATE FORM OF THE PORCINE ALPHA TRYPSIN	3.4.21.4
1AKZ	HUMAN URACIL-DNA GLYCOSYLASE	3.2.2 3.2.2.27
1ALH	KINETICS AND CRYSTAL STRUCTURE OF A MUTANT E. COLI ALKALINE PHOSPHATASE (ASP-369-->ASN): A MECHANISM INVOLVING ONE ZINC PER ACTIVE SITE	3.1.3.1
1ALI	ALKALINE PHOSPHATASE MUTANT (H412N)	3.1.3.1
1ALJ	ALKALINE PHOSPHATASE MUTANT (H412N)	3.1.3.1
1ALK	REACTION MECHANISM OF ALKALINE PHOSPHATASE BASED ON CRYSTAL STRUCTURES. TWO METAL ION CATALYSIS	3.1.3.1
1ALN	CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE COMPLEXED WITH 3-DEAZACYTIDINE	3.5.4.5
1ALQ	CIRCULARLY PERMUTED BETA-LACTAMASE FROM STAPHYLOCOCCUS AUREUS PC1	3.5.2.6
1AM5	THE CRYSTAL STRUCTURE AND PROPOSED AMINO ACID SEQUENCE OF A PEPSIN FROM ATLANTIC COD (GADUS MORHUA)	3.4.23.1 3.4.23
1AM7	LYSOZYME FROM BACTERIOPHAGE LAMBDA	3.2.1.17 4.2.2
1AMH	UNCOMPLEXED RAT TRYPSIN MUTANT WITH ASP 189 REPLACED WITH SER (D189S)	3.4.21.4
1AMN	TRANSITION STATE ANALOG: ACETYLCHOLINESTERASE COMPLEXED WITH M-(N,N,N-TRIMETHYLAMMONIO)TRIFLUOROACETOPHENONE	3.1.1.7
1AMP	CRYSTAL STRUCTURE OF AEROMONAS PROTEOLYTICA AMINOPEPTIDASE: A PROTOTYPICAL MEMBER OF THE CO-CATALYTIC ZINC ENZYME FAMILY	3.4.11.10
1AMY	CRYSTAL AND MOLECULAR STRUCTURE OF BARLEY ALPHA-AMYLASE	3.2.1.1
1AN0	CDC42HS-GDP COMPLEX	3.6.5.2
1AN1	LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX	3.4.21.4
1ANB	ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY GLU	3.4.21.4
1ANC	ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY LYS	3.4.21.4
1AND	ANIONIC TRYPSIN MUTANT WITH ARG 96 REPLACED BY HIS	3.4.21.4
1ANE	ANIONIC TRYPSIN WILD TYPE	3.4.21.4
1ANG	CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FROM RIBONUCLEASE	3.1.27
1ANI	ALKALINE PHOSPHATASE (D153H, K328H)	3.1.3.1
1ANJ	ALKALINE PHOSPHATASE (K328H)	3.1.3.1
1AO5	MOUSE GLANDULAR KALLIKREIN-13 (PRORENIN CONVERTING ENZYME)	3.4.21.35 3.4.21.119
1AOD	PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C FROM LISTERIA MONOCYTOGENES	3.1.4.10 4.6.1.13
1AOK	VIPOXIN COMPLEX	3.1.1.4
1APA	X-RAY STRUCTURE OF A POKEWEED ANTIVIRAL PROTEIN, CODED BY A NEW GENOMIC CLONE, AT 0.23 NM RESOLUTION. A MODEL STRUCTURE PROVIDES A SUITABLE ELECTROSTATIC FIELD FOR SUBSTRATE BINDING.	3.2.2.22
1APO	THREE-DIMENSIONAL STRUCTURE OF THE APO FORM OF THE N-TERMINAL EGF-LIKE MODULE OF BLOOD COAGULATION FACTOR X AS DETERMINED BY NMR SPECTROSCOPY AND SIMULATED FOLDING	3.4.21.6
1APQ	STRUCTURE OF THE EGF-LIKE MODULE OF HUMAN C1R, NMR, 19 STRUCTURES	3.4.21.41
1APS	THREE-DIMENSIONAL STRUCTURE OF ACYLPHOSPHATASE. REFINEMENT AND STRUCTURE ANALYSIS	3.6.1.7
1APT	CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION	3.4.23.20
1APU	CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION	3.4.23.20
1APV	CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES	3.4.23.20
1APW	CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES	3.4.23.20
1APY	HUMAN ASPARTYLGLUCOSAMINIDASE	3.5.1.26
1APZ	HUMAN ASPARTYLGLUCOSAMINIDASE COMPLEX WITH REACTION PRODUCT	3.5.1.26
1AQ0	BARLEY 1,3-1,4-BETA-GLUCANASE IN MONOCLINIC SPACE GROUP	3.2.1.73
1AQ6	STRUCTURE OF L-2-HALOACID DEHALOGENASE FROM XANTHOBACTER AUTOTROPHICUS	3.8.1.2
1AQ7	TRYPSIN WITH INHIBITOR AERUGINOSIN 98-B	3.4.21.4
1AQH	ALPHA-AMYLASE FROM ALTEROMONAS HALOPLANCTIS	3.2.1.1
1AQL	CRYSTAL STRUCTURE OF BOVINE BILE-SALT ACTIVATED LIPASE COMPLEXED WITH TAUROCHOLATE	3.1.1.13 3.1.1.3 3.1.1.6
1AQM	ALPHA-AMYLASE FROM ALTEROMONAS HALOPLANCTIS COMPLEXED WITH TRIS	3.2.1.1
1AQN	SUBTILISIN MUTANT 8324	3.4.21.62
1AQP	RIBONUCLEASE A COPPER COMPLEX	3.1.27.5 4.6.1.18
1AQZ	CRYSTAL STRUCTURE OF A HIGHLY SPECIFIC ASPERGILLUS RIBOTOXIN, RESTRICTOCIN	3.1.27
1ARB	THE PRIMARY STRUCTURE AND STRUCTURAL CHARACTERISTICS OF ACHROMOBACTER LYTICUS PROTEASE I, A LYSINE-SPECIFIC SERINE PROTEASE	3.4.21.50
1ARC	THE PRIMARY STRUCTURE AND STRUCTURAL CHARACTERISTICS OF ACHROMOBACTER LYTICUS PROTEASE I, A LYSINE-SPECIFIC SERINE PROTEASE	3.4.21.50
1ARL	CARBOXYPEPTIDASE A WITH ZN REMOVED	3.4.17.1
1ARM	CARBOXYPEPTIDASE A WITH ZN REPLACED BY HG	3.4.17.1
1ARO	T7 RNA POLYMERASE COMPLEXED WITH T7 LYSOZYME	3.5.1.28
1AST	STRUCTURE OF ASTACIN AND IMPLICATIONS FOR ACTIVATION OF ASTACINS AND ZINC-LIGATION OF COLLAGENASES	3.4.24.21
1ASU	AVIAN SARCOMA VIRUS INTEGRASE CATALYTIC CORE DOMAIN CRYSTALLIZED FROM 2% PEG 400, 2M AMMONIUM SULFATE, HEPES PH 7.5	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
1ASV	AVIAN SARCOMA VIRUS INTEGRASE CATALYTIC CORE DOMAIN	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
1ASW	AVIAN SARCOMA VIRUS INTEGRASE CATALYTIC CORE DOMAIN CRYSTALLIZED FROM 20% PEG 4000, 10% ISOPROPANOL, HEPES PH 7.5 USING SELENOMETHIONINE SUBSTITUTED PROTEIN; DATA COLLECTED AT-165 DEGREES C	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
1AT3	HERPES SIMPLEX VIRUS TYPE II PROTEASE	3.4.21.97
1AT5	HEN EGG WHITE LYSOZYME WITH A SUCCINIMIDE RESIDUE	3.2.1.17
1AT6	HEN EGG WHITE LYSOZYME WITH A ISOASPARTATE RESIDUE	3.2.1.17
1ATK	CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR E-64	3.4.22.38
1ATL	STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE, ATROLYSIN C (FORM-D)	3.4.24.42
1ATR	THREONINE 204 OF THE CHAPERONE PROTEIN HSC70 INFLUENCES THE STRUCTURE OF THE ACTIVE SITE BUT IS NOT ESSENTIAL FOR ATP HYDROLYSIS	3.6.1.3
1ATS	THREONINE 204 OF THE CHAPERONE PROTEIN HSC70 INFLUENCES THE STRUCTURE OF THE ACTIVE SITE BUT IS NOT ESSENTIAL FOR ATP HYDROLYSIS	3.6.1.3
1AU0	CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC DIACYLAMINOMETHYL KETONE INHIBITOR	3.4.22.38
1AU2	CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PROPANONE INHIBITOR	3.4.22.38
1AU3	CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINONE INHIBITOR	3.4.22.38
1AU4	CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINONE INHIBITOR	3.4.22.38
1AU8	HUMAN CATHEPSIN G	3.4.21.20
1AU9	SUBTILISIN BPN' MUTANT 8324 IN CITRATE	3.4.21.62
1AUG	CRYSTAL STRUCTURE OF THE PYROGLUTAMYL PEPTIDASE I FROM BACILLUS AMYLOLIQUEFACIENS	3.4.19.3
1AUI	HUMAN CALCINEURIN HETERODIMER	3.1.3.16
1AUJ	BOVINE TRYPSIN COMPLEXED TO META-CYANO-BENZYLIC INHIBITOR	3.4.21.4
1AUK	HUMAN ARYLSULFATASE A	3.1.6.8
1AUM	HIV CAPSID C-TERMINAL DOMAIN (CAC146)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AUO	CARBOXYLESTERASE FROM PSEUDOMONAS FLUORESCENS	3.1.1.1
1AUR	PMSF-INHIBITED CARBOXYLESTERASE FROM PSEUDOMONAS FLUORESCENS	3.1.1.1
1AUT	HUMAN ACTIVATED PROTEIN C	3.4.21.69
1AV5	PKCI-SUBSTRATE ANALOG	3
1AV7	SUBTILISIN CARLSBERG L-NAPHTHYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX	3.4.21.62
1AVA	AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED	3.2.1.1
1AVF	ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH	3.4.23.3
1AVG	THROMBIN INHIBITOR FROM TRIATOMA PALLIDIPENNIS	3.4.21.5
1AVP	STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEINASE WITH ITS 11 AMINO ACID COFACTOR	3.4.22.39
1AVQ	TOROIDAL STRUCTURE OF LAMBDA EXONUCLEASE DETERMINED AT 2.4 ANGSTROMS	3.1.11.3
1AVT	SUBTILISIN CARLSBERG D-PARA-CHLOROPHENYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX	3.4.21.62
1AVW	COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, ORTHORHOMBIC CRYSTAL FORM	3.4.21.4
1AVX	COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, TETRAGONAL CRYSTAL FORM	3.4.21.4
1AWB	HUMAN MYO-INOSITOL MONOPHOSPHATASE IN COMPLEX WITH D-INOSITOL-1-PHOSPHATE AND CALCIUM	3.1.3.25 3.1.3.94
1AWF	NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT	3.4.21.5
1AWH	NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT	3.4.21.5
1AWZ	3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR SPECTROSCOPY, 30 STRUCTURES	3.1.27
1AX9	ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, LAUE DATA	3.1.1.7
1AXA	ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AXB	TEM-1 BETA-LACTAMASE FROM ESCHERICHIA COLI INHIBITED WITH AN ACYLATION TRANSITION STATE ANALOG	3.5.2.6
1AXK	ENGINEERED BACILLUS BIFUNCTIONAL ENZYME GLUXYN-1	3.2.1.73 3.2.1.8
1AY6	THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF	3.4.21.5
1AY7	RIBONUCLEASE SA COMPLEX WITH BARSTAR	3.1.27.3 4.6.1.24
1AY9	WILD-TYPE UMUD' FROM E. COLI	3.4.21
1AYA	CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO-TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE	3.1.3.48
1AYB	CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO-TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE	3.1.3.48
1AYC	CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO-TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE	3.1.3.48
1AYD	CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO-TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE	3.1.3.48
1AYE	HUMAN PROCARBOXYPEPTIDASE A2	3.4.17.15
1AYK	INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, 30 STRUCTURES	3.4.24.7
1AYM	HUMAN RHINOVIRUS 16 COAT PROTEIN AT HIGH RESOLUTION	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1AYN	HUMAN RHINOVIRUS 16 COAT PROTEIN	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1AYP	A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT	3.1.1.4
1AYU	CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC BISCARBOHYDRAZIDE INHIBITOR	3.4.22.38
1AYV	CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT THIAZOLHYDRAZIDE INHIBITOR	3.4.22.38
1AYW	CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT BENZYLOXYBENZOYLCARBOHYDRAZIDE INHIBITOR	3.4.22.38
1AYX	CRYSTAL STRUCTURE OF GLUCOAMYLASE FROM SACCHAROMYCOPSIS FIBULIGERA AT 1.7 ANGSTROMS	3.2.1.3
1AYY	GLYCOSYLASPARAGINASE	3.5.1.26
1AZ0	ECORV ENDONUCLEASE/DNA COMPLEX	3.1.21.4
1AZ3	ECORV ENDONUCLEASE, UNLIGANDED, FORM B	3.1.21.4
1AZ4	ECORV ENDONUCLEASE, UNLIGANDED, FORM B, T93A MUTANT	3.1.21.4
1AZ5	UNLIGANDED SIV PROTEASE STRUCTURE IN AN OPEN" CONFORMATION"	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1AZ6	THREE-DIMENSIONAL STRUCTURES OF THREE ENGINEERED CELLULOSE-BINDING DOMAINS OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI, NMR, 23 STRUCTURES	3.2.1.91
1AZ8	BOVINE TRYPSIN COMPLEXED TO BIS-PHENYLAMIDINE INHIBITOR	3.4.21.4
1AZF	CHICKEN EGG WHITE LYSOZYME CRYSTAL GROWN IN BROMIDE SOLUTION	3.2.1.17
1AZH	THREE-DIMENSIONAL STRUCTURES OF THREE ENGINEERED CELLULOSE-BINDING DOMAINS OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI, NMR, 14 STRUCTURES	3.2.1.91
1AZK	THREE-DIMENSIONAL STRUCTURES OF THREE ENGINEERED CELLULOSE-BINDING DOMAINS OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI, NMR, 19 STRUCTURES	3.2.1.91
1AZW	PROLINE IMINOPEPTIDASE FROM XANTHOMONAS CAMPESTRIS PV. CITRI	3.4.11.5
1AZZ	FIDDLER CRAB COLLAGENASE COMPLEXED TO ECOTIN	3.4.21.32
1B0A	5,10, METHYLENE-TETRAHYDROPHOLATE DEHYDROGENASE/CYCLOHYDROLASE FROM E COLI.	1.5.1.5 3.5.4.9
1B0D	STRUCTURAL EFFECTS OF MONOVALENT ANIONS ON POLYMORPHIC LYSOZYME CRYSTALS	3.2.1.17
1B0E	CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH MDL 101,146	3.4.21.36
1B0F	CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146	3.4.21.37
1B0I	ALPHA-AMYLASE FROM ALTEROMONAS HALOPLANCTIS	3.2.1.1
1B0L	RECOMBINANT HUMAN DIFERRIC LACTOFERRIN	3.4.21
1B11	STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH TL-3-093	3.4.23.16 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 3.6.1.23 2.7.7 3.1
1B12	CRYSTAL STRUCTURE OF TYPE 1 SIGNAL PEPTIDASE FROM ESCHERICHIA COLI IN COMPLEX WITH A BETA-LACTAM INHIBITOR	3.4.21.89
1B1E	CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Q	3.1.27
1B1I	CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN	3.1.27
1B1J	CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A.	3.1.27
1B1X	STRUCTURE OF DIFERRIC MARE LACTOFERRIN AT 2.62A RESOLUTION	3.4.21
1B1Y	SEVENFOLD MUTANT OF BARLEY BETA-AMYLASE	3.2.1.2
1B20	DELETION OF A BURIED SALT-BRIDGE IN BARNASE	3.1.27.3 3.1.27
1B21	DELETION OF A BURIED SALT BRIDGE IN BARNASE	3.1.27.3 3.1.27
1B24	I-DMOI, INTRON-ENCODED ENDONUCLEASE	3.1
1B27	STRUCTURAL RESPONSE TO MUTATION AT A PROTEIN-PROTEIN INTERFACE	3.1.27.3 3.1.27
1B2I	KRINGLE 2 DOMAIN OF HUMAN PLASMINOGEN: NMR SOLUTION STRUCTURE OF TRANS-4-AMINOMETHYLCYCLOHEXANE-1-CARBOXYLIC ACID (AMCHA) COMPLEX	3.4.21.7
1B2K	STRUCTURAL EFFECTS OF MONOVALENT ANIONS ON POLYMORPHIC LYSOZYME CRYSTALS	3.2.1.17
1B2M	THREE-DIMENSIONAL STRUCTURE OF RIBONULCEASE T1 COMPLEXED WITH AN ISOSTERIC PHOSPHONATE ANALOGUE OF GPU: ALTERNATE SUBSTRATE BINDING MODES AND CATALYSIS.	3.1.27.3 4.6.1.24
1B2S	STRUCTURAL RESPONSE TO MUTATION AT A PROTEIN-PROTEIN INTERFACE	3.1.27.3 3.1.27
1B2U	STRUCTURAL RESPONSE TO MUTATION AT A PROTEIN-PROTEIN INTERFACE	3.1.27.3 3.1.27
1B2X	BARNASE WILDTYPE STRUCTURE AT PH 7.5 FROM A CRYO_COOLED CRYSTAL AT 100K	3.1.27.3 3.1.27
1B2Y	STRUCTURE OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THE CARBOHYDRATE INHIBITOR ACARBOSE	3.2.1.1
1B2Z	DELETION OF A BURIED SALT BRIDGE IN BARNASE	3.1.27.3 3.1.27
1B30	XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH 1,2-(4-DEOXY-BETA-L-THREO-HEX-4-ENOPYRANOSYLURONIC ACID)-BETA-1,4-XYLOTRIOSE)	3.2.1.8
1B31	XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, NATIVE WITH PEG200 AS CRYOPROTECTANT	3.2.1.8
1B3D	STROMELYSIN-1	3.4.24.17
1B3R	RAT LIVER S-ADENOSYLHOMOCYSTEIN HYDROLASE	3.3.1.1
1B3S	STRUCTURAL RESPONSE TO MUTATION AT A PROTEIN-PROTEIN INTERFACE	3.1.27.3 3.1.27
1B3V	XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOSE	3.2.1.8
1B3W	XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOBIOSE	3.2.1.8
1B3X	XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOTRIOSE	3.2.1.8
1B3Y	XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOTETRAOSE	3.2.1.8
1B3Z	XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOPENTAOSE	3.2.1.8
1B43	FEN-1 FROM P. FURIOSUS	3.1
1B4O	NMR STUDY OF SSO7D MUTANT (F31A) MINIMIZED AVERAGE STRUCTURE	3.1.27
1B4W	BASIC PHOSPHOLIPASE A2 FROM AGKISTRODON HALYS PALLAS-IMPLICATIONS FOR ITS ASSOCIATION AND ANTICOAGULANT ACTIVITIES BY X-RAY CRYSTALLOGRAPHY	3.1.1.4
1B59	COMPLEX OF HUMAN METHIONINE AMINOPEPTIDASE-2 COMPLEXED WITH OVALICIN	3.4.11.18
1B5F	NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.	3.4.23
1B5G	HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN	3.4.21.5
1B5U	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANT	3.2.1.17
1B5V	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS	3.2.1.17
1B5W	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS	3.2.1.17
1B5X	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS	3.2.1.17
1B5Y	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS	3.2.1.17
1B5Z	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS	3.2.1.17
1B65	STRUCTURE OF L-AMINOPEPTIDASE D-ALA-ESTERASE/AMIDASE FROM OCHROBACTRUM ANTHROPI, A PROTOTYPE FOR THE SERINE AMINOPEPTIDASES, REVEALS A NEW VARIANT AMONG THE NTN HYDROLASE FOLD	3.4.11.19
1B6A	HUMAN METHIONINE AMINOPEPTIDASE 2 COMPLEXED WITH TNP-470	3.4.11.18
1B6G	HALOALKANE DEHALOGENASE AT PH 5.0 CONTAINING CHLORIDE	3.8.1.5
1B6I	T4 LYSOZYME MUTANT WITH CYS 54 REPLACED BY THR, CYS 97 REPLACED BY ALA, THR 21 REPLACED BY CYS AND LYS 124 REPLACED BY CYS (C54T,C97A,T21C,K124C)	3.2.1.17
1B6J	HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1B6K	HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1B6L	HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1B6M	HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1B6P	HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1B6V	CRYSTAL STRUCTURE OF A HYBRID BETWEEN RIBONUCLEASE A AND BOVINE SEMINAL RIBONUCLEASE	3.1.27.5 4.6.1.18
1B78	STRUCTURE-BASED IDENTIFICATION OF THE BIOCHEMICAL FUNCTION OF A HYPOTHETICAL PROTEIN FROM METHANOCOCCUS JANNASCHII:MJ0226	3.6.1.66
1B79	N-TERMINAL DOMAIN OF DNA REPLICATION PROTEIN DNAB	3.6.1 3.6.4.12
1B7E	TRANSPOSASE INHIBITOR	3.1
1B7L	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES	3.2.1.17
1B7M	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES	3.2.1.17
1B7N	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES	3.2.1.17
1B7O	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES	3.2.1.17
1B7P	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES	3.2.1.17
1B7Q	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES	3.2.1.17
1B7R	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES	3.2.1.17
1B7S	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES	3.2.1.17
1B7U	STRUCTURE OF MARE APOLACTOFERRIN: THE N AND C LOBES ARE IN THE CLOSED FORM	3.4.21
1B7X	STRUCTURE OF HUMAN ALPHA-THROMBIN Y225I MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE	3.4.21.5
1B7Z	STRUCTURE OF OXALATE SUBSTITUTED DIFERRIC MARE LACTOFERRIN FROM COLOSTRUM	3.4.21
1B8J	ALKALINE PHOSPHATASE COMPLEXED WITH VANADATE	3.1.3.1
1B8Y	X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLICATIONS FOR INHIBITOR SELECTIVITY	3.4.24.17
1B90	BACILLUS CEREUS BETA-AMYLASE APO FORM	3.2.1.2
1B92	MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1B94	RESTRICTION ENDONUCLEASE ECORV WITH CALCIUM	3.1.21.4
1B95	ANALYSIS OF A MUTATIONAL HOT-SPOT IN THE ECORV RESTRICTION ENDONUCLEASE: A CATALYTIC ROLE FOR A MAIN CHAIN CARBONYL GROUP	3.1.21.4
1B96	ANALYSIS OF A MUTATIONAL HOT-SPOT IN THE ECORV RESTRICTION ENDONUCLEASE: A CATALYTIC ROLE FOR A MAIN CHAIN CARBONYL GROUP	3.1.21.4
1B97	ANALYSIS OF A MUTATIONAL HOT-SPOT IN THE ECORV RESTRICTION ENDONUCLEASE: A CATALYTIC ROLE FOR A MAIN CHAIN CARBONYL GROUP	3.1.21.4
1B9D	MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1B9F	MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1B9S	NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE	3.2.1.18
1B9T	NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE	3.2.1.18
1B9V	NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN TEH ACTIVE SITE	3.2.1.18
1B9Z	BACILLUS CEREUS BETA-AMYLASE COMPLEXED WITH MALTOSE	3.2.1.2
1BA0	HEAT-SHOCK COGNATE 70KD PROTEIN 44KD ATPASE N-TERMINAL 1NGE 3	3.6.1.3
1BA1	HEAT-SHOCK COGNATE 70KD PROTEIN 44KD ATPASE N-TERMINAL MUTANT WITH CYS 17 REPLACED BY LYS	3.6.1.3
1BA8	THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES	3.4.21.5
1BAG	ALPHA-AMYLASE FROM BACILLUS SUBTILIS COMPLEXED WITH MALTOPENTAOSE	3.2.1.1
1BAI	CRYSTAL STRUCTURE OF ROUS SARCOMA VIRUS PROTEASE IN COMPLEX WITH INHIBITOR	3.4.23
1BAJ	HIV-1 CAPSID PROTEIN C-TERMINAL FRAGMENT PLUS GAG P2 DOMAIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BAM	STRUCTURE OF RESTRICTION ENDONUCLEASE BAMHI PHASED AT 1.95 ANGSTROMS RESOLUTION BY MAD ANALYSIS	3.1.21.4
1BAN	THE CONTRIBUTION OF BURIED HYDROGEN BONDS TO PROTEIN STABILITY: THE CRYSTAL STRUCTURES OF TWO BARNASE MUTANTS	3.1.27
1BAO	THE CONTRIBUTION OF BURIED HYDROGEN BONDS TO PROTEIN STABILITY: THE CRYSTAL STRUCTURES OF TWO BARNASE MUTANTS	3.1.27
1BAV	CARBOXYPEPTIDASE A COMPLEXED WITH 2-BENZYL-3-IODO-PROPANOIC ACID (BIP)	3.4.17.1
1BB0	THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES	3.4.21.5
1BB3	HUMAN LYSOZYME MUTANT A96L	3.2.1.17
1BB4	HUMAN LYSOZYME DOUBLE MUTANT A96L, W109H	3.2.1.17
1BB5	HUMAN LYSOZYME MUTANT A96L COMPLEXED WITH CHITOTRIOSE	3.2.1.17
1BB6	LYSOZYME COMPLEX WITH 4-METHYL-UMBELLIFERYL CHITOTRIOSE	3.2.1.17
1BB7	LYSOZYME COMPLEX WITH 4-METHYL-UMBELLIFERYL CHITOBIOSE	3.2.1.17
1BBC	STRUCTURE OF RECOMBINANT HUMAN RHEUMATOID ARTHRITIC SYNOVIAL FLUID PHOSPHOLIPASE A2 AT 2.2 ANGSTROMS RESOLUTION	3.1.1.4
1BBR	THE STRUCTURE OF RESIDUES 7-16 OF THE A ALPHA CHAIN OF HUMAN FIBRINOGEN BOUND TO BOVINE THROMBIN AT 2.3 ANGSTROMS RESOLUTION	3.4.21.5
1BBS	X-RAY ANALYSES OF PEPTIDE INHIBITOR COMPLEXES DEFINE THE STRUCTURAL BASIS OF SPECIFICITY FOR HUMAN AND MOUSE RENINS	3.4.23.15
1BBY	DNA-BINDING DOMAIN FROM HUMAN RAP30, NMR, MINIMIZED AVERAGE	3.6.4.12
1BC2	ZN-DEPENDENT METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS	3.5.2.6
1BC4	THE SOLUTION STRUCTURE OF A CYTOTOXIC RIBONUCLEASE FROM THE OOCYTES OF RANA CATESBEIANA (BULLFROG), NMR, 15 STRUCTURES	3.1.27.5 3.1.27
1BCI	C2 DOMAIN OF CYTOSOLIC PHOSPHOLIPASE A2, NMR, MINIMIZED AVERAGE STRUCTURE	3.1.1.4 3.1.1.5
1BCM	BACTERIOPHAGE MU TRANSPOSASE CORE DOMAIN WITH 2 MONOMERS PER ASYMMETRIC UNIT	3.1.22 6.5.1
1BCO	BACTERIOPHAGE MU TRANSPOSASE CORE DOMAIN	3.1.22 6.5.1
1BCR	COMPLEX OF THE WHEAT SERINE CARBOXYPEPTIDASE, CPDW-II, WITH THE MICROBIAL PEPTIDE ALDEHYDE INHIBITOR, ANTIPAIN, AND ARGININE AT ROOM TEMPERATURE	3.4.16.6
1BCS	COMPLEX OF THE WHEAT SERINE CARBOXYPEPTIDASE, CPDW-II, WITH THE MICROBIAL PEPTIDE ALDEHYDE INHIBITOR, CHYMOSTATIN, AND ARGININE AT 100 DEGREES KELVIN	3.4.16.6
1BCU	ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN	3.4.21.5
1BCX	MUTATIONAL AND CRYSTALLOGRAPHIC ANALYSES OF THE ACTIVE SITE RESIDUES OF THE BACILLUS CIRCULANS XYLANASE	3.2.1.8
1BDA	CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE)	3.4.21.68
1BDL	HIV-1 (2:31-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BDQ	HIV-1 (2:31-37, 47, 82) PROTEASE COMPLEXED WITH INHIBITOR SB203386	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BDR	HIV-1 (2: 31, 33-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BDX	E. COLI DNA HELICASE RUVA WITH BOUND DNA HOLLIDAY JUNCTION, ALPHA CARBONS AND PHOSPHATE ATOMS ONLY	3.6.4.12
1BE0	HALOALKANE DEHALOGENASE AT PH 5.0 CONTAINING ACETIC ACID	3.8.1.5
1BE6	TRANS-CINNAMOYL-SUBTILISIN IN ANHYDROUS ACETONITRILE	3.4.21.62
1BE8	TRANS-CINNAMOYL-SUBTILISIN IN WATER	3.4.21.62
1BEE	HALOALKANE DEHALOGENASE MUTANT WITH TRP 175 REPLACED BY TYR	3.8.1.5
1BEL	HYDROLASE PHOSPHORIC DIESTER, RNA	3.1.27.5 4.6.1.18
1BEV	BOVINE ENTEROVIRUS VG-5-27	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1BEZ	HALOALKANE DEHALOGENASE MUTANT WITH TRP 175 REPLACED BY TYR AT PH 5	3.8.1.5
1BF2	STRUCTURE OF PSEUDOMONAS ISOAMYLASE	3.2.1.68
1BF9	N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES	3.4.21.21
1BFK	CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG IN 40% ACETONITRILE	3.4.21.62
1BFN	BETA-AMYLASE/BETA-CYCLODEXTRIN COMPLEX	3.2.1.2
1BFU	SUBTILISIN CARLSBERG IN 20% DIOXANE	3.4.21.62
1BG4	XYLANASE FROM PENICILLIUM SIMPLICISSIMUM	3.2.1.8
1BG9	BARLEY ALPHA-AMYLASE WITH SUBSTRATE ANALOGUE ACARBOSE	3.2.1.1
1BGA	BETA-GLUCOSIDASE A FROM BACILLUS POLYMYXA	3.2.1.21
1BGB	ECORV ENDONUCLEASE COMPLEX WITH 5'-CGGGATATCCC DNA	3.1.21.4
1BGG	GLUCOSIDASE A FROM BACILLUS POLYMYXA COMPLEXED WITH GLUCONATE	3.2.1.21
1BGI	ORTHORHOMBIC LYSOZYME CRYSTALLIZED AT HIGH TEMPERATURE (310K)	3.2.1.17
1BGO	CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PEPTIDOMIMETIC INHIBITOR	3.4.22.38
1BGS	RECOGNITION BETWEEN A BACTERIAL RIBONUCLEASE, BARNASE, AND ITS NATURAL INHIBITOR, BARSTAR	3.1.27
1BH6	SUBTILISIN DY IN COMPLEX WITH THE SYNTHETIC INHIBITOR N-BENZYLOXYCARBONYL-ALA-PRO-PHE-CHLOROMETHYL KETONE	3.4.21.62
1BHE	POLYGALACTURONASE FROM ERWINIA CAROTOVORA SSP. CAROTOVORA	3.2.1.15
1BHG	HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION	3.2.1.31
1BHL	CACODYLATED CATALYTIC DOMAIN OF HIV-1 INTEGRASE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BHM	RESTRICTION ENDONUCLEASE BAMHI COMPLEX WITH DNA	3.1.21.4
1BHX	X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE INHIBITOR SDZ 229-357	3.4.21.5
1BHZ	LOW TEMPERATURE MIDDLE RESOLUTION STRUCTURE OF HEN EGG WHITE LYSOZYME FROM MASC DATA	3.2.1.17
1BI4	CATALYTIC DOMAIN OF HIV-1 INTEGRASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BIF	6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE BIFUNCTIONAL ENZYME COMPLEXED WITH ATP-G-S AND PHOSPHATE	2.7.1.105 3.1.3.46
1BIL	CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS	3.4.23.15
1BIM	CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS	3.4.23.15
1BIO	HUMAN COMPLEMENT FACTOR D IN COMPLEX WITH ISATOIC ANHYDRIDE INHIBITOR	3.4.21.46
1BIR	RIBONUCLEASE T1, PHE 100 TO ALA MUTANT COMPLEXED WITH 2' GMP	3.1.27.3 4.6.1.24
1BIS	HIV-1 INTEGRASE CORE DOMAIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BIT	THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN A SECOND CRYSTAL FORM	3.4.21.4
1BIU	HIV-1 INTEGRASE CORE DOMAIN COMPLEXED WITH MG++	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BIW	DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS	3.4.24.17
1BIX	THE CRYSTAL STRUCTURE OF THE HUMAN DNA REPAIR ENDONUCLEASE HAP1 SUGGESTS THE RECOGNITION OF EXTRA-HELICAL DEOXYRIBOSE AT DNA ABASIC SITES	4.2.99.18 3.1
1BIY	STRUCTURE OF DIFERRIC BUFFALO LACTOFERRIN	3.4.21
1BIZ	HIV-1 INTEGRASE CORE DOMAIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BJI	THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH THE GLAXO 6-CARBOXAMIDE SIALIC ACID ANALOGUE GR217029	3.2.1.18
1BJJ	AGKISTRODOTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS	3.1.1.4
1BJR	COMPLEX FORMED BETWEEN PROTEOLYTICALLY GENERATED LACTOFERRIN FRAGMENT AND PROTEINASE K	3.4.21.64
1BJU	BETA-TRYPSIN COMPLEXED WITH ACPU	3.4.21.4
1BJV	BETA-TRYPSIN COMPLEXED WITH APPU	3.4.21.4
1BK1	ENDO-1,4-BETA-XYLANASE C	3.2.1.8
1BK4	CRYSTAL STRUCTURE OF RABBIT LIVER FRUCTOSE-1,6-BISPHOSPHATASE AT 2.3 ANGSTROM RESOLUTION	3.1.3.11
1BK7	RIBONUCLEASE MC1 FROM THE SEEDS OF BITTER GOURD	3.1.27.1 4.6.1.19
1BK9	PHOSPHOLIPASE A2 MODIFIED BY PBPB	3.1.1.4
1BKA	OXALATE-SUBSTITUTED DIFERRIC LACTOFERRIN	3.4.21
1BKC	CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE)	3.4.24.86
1BKD	COMPLEX OF HUMAN H-RAS WITH HUMAN SOS-1	3.6.5.2
1BL3	CATALYTIC DOMAIN OF HIV-1 INTEGRASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BLC	INHIBITION OF BETA-LACTAMASE BY CLAVULANATE: TRAPPED INTERMEDIATES IN CRYOCRYSTALLOGRAPHIC STUDIES	3.5.2.6
1BLF	STRUCTURE OF DIFERRIC BOVINE LACTOFERRIN AT 2.8 ANGSTROMS RESOLUTION	3.4.21
1BLH	STRUCTURE OF A PHOSPHONATE-INHIBITED BETA-LACTAMASE. AN ANALOG OF THE TETRAHEDRAL TRANSITION STATE(SLASH)INTERMEDIATE OF BETA-LACTAM HYDROLYSIS	3.5.2.6
1BLI	BACILLUS LICHENIFORMIS ALPHA-AMYLASE	3.2.1.1
1BLL	X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE STRUCTURE OF BOVINE LENS LEUCINE AMINOPEPTIDASE COMPLEXED WITH AMASTATIN: FORMULATION OF A CATALYTIC MECHANISM FEATURING A GEM-DIOLATE TRANSITION STATE	3.4.11.1 3.4.13.23 3.4.11.5
1BLP	STRUCTURAL BASIS FOR THE INACTIVATION OF THE P54 MUTANT OF BETA-LACTAMASE FROM STAPHYLOCOCCUS AUREUS PC1	3.5.2.6
1BLS	CRYSTALLOGRAPHIC STRUCTURE OF A PHOSPHONATE DERIVATIVE OF THE ENTEROBACTER CLOACAE P99 CEPHALOSPORINASE: MECHANISTIC INTERPRETATION OF A BETA-LACTAMASE TRANSITION STATE ANALOG	3.5.2.6
1BM6	SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 COMPLEXED TO A POTENT NON-PEPTIDIC INHIBITOR, NMR, 20 STRUCTURES	3.4.24.17
1BMA	BENZYL METHYL AMINIMIDE INHIBITOR COMPLEXED TO PORCINE PANCREATIC ELASTASE	3.4.21.36
1BMC	STRUCTURE OF A ZINC METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS	3.5.2.6
1BML	COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE	3.4.21.7
1BMM	HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R*,R*)]-4-[(AMINOIMINOMETHYL)AMINO]-N-[[1-[3-HYDROXY-2-[(2-NAPHTHALENYLSULFONYL)AMINO]-1-OXOPROPYL]-2-PYRROLIDINYL] METHYL]BUTANAMIDE (BMS-186282)	3.4.21.5
1BMN	HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R*,R*)]-1-(AMINOIMINOMETHYL)-N-[[1-[N-[(2-NAPHTHALENYLSULFONYL)-L-SERYL]-PYRROLIDINYL]METHYL]-3-PIPERIDENECARBOXAMIDE (BMS-189090)	3.4.21.5
1BMQ	CRYSTAL STRUCTURE OF THE COMPLEX OF INTERLEUKIN-1BETA CONVERTING ENZYME (ICE) WITH A PEPTIDE BASED INHIBITOR, (3S )-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L-PROLYL }AMINO)-4-OXOBUTANAMIDE	3.4.22.36
1BN5	HUMAN METHIONINE AMINOPEPTIDASE 2	3.4.11.18
1BN6	HALOALKANE DEHALOGENASE FROM A RHODOCOCCUS SPECIES	3.8.1.5
1BN7	HALOALKANE DEHALOGENASE FROM A RHODOCOCCUS SPECIES	3.8.1.5
1BNE	BARNASE A43C/S80C DISULFIDE MUTANT	3.1.27
1BNF	BARNASE T70C/S92C DISULFIDE MUTANT	3.1.27
1BNG	BARNASE S85C/H102C DISULFIDE MUTANT	3.1.27
1BNI	BARNASE WILDTYPE STRUCTURE AT PH 6.0	3.1.27
1BNJ	BARNASE WILDTYPE STRUCTURE AT PH 9.0	3.1.27
1BNK	HUMAN 3-METHYLADENINE DNA GLYCOSYLASE COMPLEXED TO DNA	3.2.2.21
1BNR	BARNASE	3.1.27
1BNS	STRUCTURAL STUDIES OF BARNASE MUTANTS	3.1.27
1BOA	HUMAN METHIONINE AMINOPEPTIDASE 2 COMPLEXED WITH ANGIOGENESIS INHIBITOR FUMAGILLIN	3.4.11.18
1BOL	THE CRYSTAL STRUCTURE OF RIBONUCLEASE RH FROM RHIZOPUS NIVEUS AT 2.0 A RESOLUTION	3.1.27.1 4.6.1.19
1BOQ	PRO REGION C-TERMINUS: PROTEASE ACTIVE SITE INTERACTIONS ARE CRITICAL IN CATALYZING THE FOLDING OF ALPHA-LYTIC PROTEASE	3.4.21.12
1BOX	N39S MUTANT OF RNASE SA FROM STREPTOMYCES AUREOFACIENS	3.1.27.3 4.6.1.24
1BP2	STRUCTURE OF BOVINE PANCREATIC PHOSPHOLIPASE A2 AT 1.7 ANGSTROMS RESOLUTION	3.1.1.4
1BP4	USE OF PAPAIN AS A MODEL FOR THE STRUCTURE-BASED DESIGN OF CATHEPSIN K INHIBITORS. CRYSTAL STRUCTURES OF TWO PAPAIN INHIBITOR COMPLEXES DEMONSTRATE BINDING TO S'-SUBSITES.	3.4.22.2
1BPL	GLYCOSYLTRANSFERASE	3.2.1.1
1BPM	DIFFERENTIATION AND IDENTIFICATION OF THE TWO CATALYTIC METAL BINDING SITES IN BOVINE LENS LEUCINE AMINOPEPTIDASE BY X-RAY CRYSTALLOGRAPHY	3.4.11.1 3.4.13.23 3.4.11.5
1BPN	DIFFERENTIATION AND IDENTIFICATION OF THE TWO CATALYTIC METAL BINDING SITES IN BOVINE LENS LEUCINE AMINOPEPTIDASE BY X-RAY CRYSTALLOGRAPHY	3.4.11.1 3.4.13.23 3.4.11.5
1BPQ	PHOSPHOLIPASE A2 ENGINEERING. X-RAY STRUCTURAL AND FUNCTIONAL EVIDENCE FOR THE INTERACTION OF LYSINE-56 WITH SUBSTRATES	3.1.1.4
1BQB	AUREOLYSIN, STAPHYLOCOCCUS AUREUS METALLOPROTEINASE	3.4.24.27 3.4.24.29
1BQC	BETA-MANNANASE FROM THERMOMONOSPORA FUSCA	3.2.1.78
1BQI	USE OF PAPAIN AS A MODEL FOR THE STRUCTURE-BASED DESIGN OF CATHEPSIN K INHIBITORS. CRYSTAL STRUCTURES OF TWO PAPAIN INHIBITOR COMPLEXES DEMONSTRATE BINDING TO S'-SUBSITES.	3.4.22.2
1BQM	HIV-1 RT/HBY 097	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BQN	TYR 188 LEU HIV-1 RT/HBY 097	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BQO	DISCOVERY OF POTENT, ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS	3.4.24.17
1BQQ	CRYSTAL STRUCTURE OF THE MT1-MMP--TIMP-2 COMPLEX	3.4.24 3.4.24.80
1BQY	PLASMINOGEN ACTIVATOR (TSV-PA) FROM SNAKE VENOM	3.4.21
1BR5	RICIN A CHAIN (RECOMBINANT) COMPLEX WITH NEOPTERIN	3.2.2.22
1BR6	RICIN A CHAIN (RECOMBINANT) COMPLEX WITH PTEROIC ACID	3.2.2.22
1BRA	RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN	3.4.21.4
1BRC	RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN	3.4.21.4
1BRG	CRYSTALLOGRAPHIC ANALYSIS OF PHE->LEU SUBSTITUTION IN THE HYDROPHOBIC CORE OF BARNASE	3.1.27
1BRH	BARNASE MUTANT WITH LEU 14 REPLACED BY ALA	3.1.27
1BRI	BARNASE MUTANT WITH ILE 76 REPLACED BY ALA	3.1.27
1BRJ	BARNASE MUTANT WITH ILE 88 REPLACED BY ALA	3.1.27
1BRK	BARNASE MUTANT WITH ILE 96 REPLACED BY ALA	3.1.27
1BRS	PROTEIN-PROTEIN RECOGNITION: CRYSTAL STRUCTURAL ANALYSIS OF A BARNASE-BARSTAR COMPLEX AT 2.0-A RESOLUTION	3.1.27
1BRU	STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH THE ELASTASE INHIBITOR GR143783	3.4.21.71
1BRY	BRYODIN TYPE I RIP	3.2.2.22
1BS4	PEPTIDE DEFORMYLASE AS ZN2+ CONTAINING FORM (NATIVE) IN COMPLEX WITH INHIBITOR POLYETHYLENE GLYCOL	3.5.1.31 3.5.1.88
1BS5	PEPTIDE DEFORMYLASE AS ZN2+ CONTAINING FORM	3.5.1.31 3.5.1.88
1BS6	PEPTIDE DEFORMYLASE AS NI2+ CONTAINING FORM IN COMPLEX WITH TRIPEPTIDE MET-ALA-SER	3.5.1.31 3.5.1.88
1BS7	PEPTIDE DEFORMYLASE AS NI2+ CONTAINING FORM	3.5.1.31 3.5.1.88
1BS8	PEPTIDE DEFORMYLASE AS ZN2+ CONTAINING FORM IN COMPLEX WITH TRIPEPTIDE MET-ALA-SER	3.5.1.31 3.5.1.88
1BS9	ACETYLXYLAN ESTERASE FROM P. PURPUROGENUM REFINED AT 1.10 ANGSTROMS	3.1.1.6 3.1.1.72
1BSC	CRYSTAL STRUCTURAL ANALYSIS OF MUTATIONS IN THE HYDROPHOBIC CORES OF BARNASE	3.1.27
1BSD	CRYSTAL STRUCTURAL ANALYSIS OF MUTATIONS IN THE HYDROPHOBIC CORES OF BARNASE	3.1.27
1BSE	CRYSTAL STRUCTURAL ANALYSIS OF MUTATIONS IN THE HYDROPHOBIC CORES OF BARNASE	3.1.27
1BSG	BETA-LACTAMASE FROM STREPTOMYCES ALBUS G	3.5.2.6
1BSI	HUMAN PANCREATIC ALPHA-AMYLASE FROM PICHIA PASTORIS, GLYCOSYLATED PROTEIN	3.2.1.1
1BSJ	COBALT DEFORMYLASE INHIBITOR COMPLEX FROM E.COLI	3.5.1.27 3.5.1.88
1BSK	ZINC DEFORMYLASE INHIBITOR COMPLEX FROM E.COLI	3.5.1.27 3.5.1.88
1BSS	ECORV-T93A/DNA/CA2+	3.1.21.4
1BSU	STRUCTURAL AND ENERGETIC ORIGINS OF INDIRECT READOUT IN SITE-SPECIFIC DNA CLEAVAGE BY A RESTRICTION ENDONUCLEASE	3.1.21.4
1BSW	ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 7.5	3.4.24
1BSZ	PEPTIDE DEFORMYLASE AS FE2+ CONTAINING FORM (NATIVE) IN COMPLEX WITH INHIBITOR POLYETHYLENE GLYCOL	3.5.1.31 3.5.1.88
1BT5	CRYSTAL STRUCTURE OF THE IMIPENEM INHIBITED TEM-1 BETA-LACTAMASE FROM ESCHERICHIA COLI	3.5.2.6
1BT7	THE SOLUTION NMR STRUCTURE OF THE N-TERMINAL PROTEASE DOMAIN OF THE HEPATITIS C VIRUS (HCV) NS3-PROTEIN, FROM BK STRAIN, 20 STRUCTURES	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1BTC	THREE-DIMENSIONAL STRUCTURE OF SOYBEAN BETA-AMYLASE DETERMINED AT 3.0 ANGSTROMS RESOLUTION: PRELIMINARY CHAIN TRACING OF THE COMPLEX WITH ALPHA-CYCLODEXTRIN	3.2.1.2
1BTH	STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR	3.4.21.5
1BTL	CRYSTAL STRUCTURE OF ESCHERICHIA COLI TEM1 BETA-LACTAMASE AT 1.8 ANGSTROMS RESOLUTION	3.5.2.6
1BTP	UNIQUE BINDING OF A NOVEL SYNTHETIC INHIBITOR, N-[3-[4-[4-(AMIDINOPHENOXY)-CARBONYL]PHENYL]-2-METHYL-2-PROPENOYL]-N-ALLYLGLYCINE METHANESULFONATE TO BOVINE TRYPSIN, REVEALED BY THE CRYSTAL STRUCTURE OF THE COMPLEX	3.4.21.4
1BTU	PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4R)-1-TOLUENESULPHONYL-3-ETHYL-AZETIDIN-2-ONE-4-CARBOXYLIC ACID	3.4.21.36
1BTW	EPISELECTION: NOVEL KI ~NANOMOLAR INHIBITORS OF SERINE PROTEASES SELECTED BY BINDING OR CHEMISTRY ON AN ENZYME SURFACE	3.4.21.4
1BTX	EPISELECTION: NOVEL KI ~NANOMOLAR INHIBITORS OF SERINE PROTEASES SELECTED BY BINDING OR CHEMISTRY ON AN ENZYME SURFACE	3.4.21.4
1BTY	CRYSTAL STRUCTURE OF BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE	3.4.21.4
1BTZ	EPISELECTION: NOVEL KI ~NANOMOLAR INHIBITORS OF SERINE PROTEASES SELECTED BY BINDING OR CHEMISTRY ON AN ENZYME SURFACE	3.4.21.4
1BU4	RIBONUCLEASE 1 COMPLEX WITH 2'GMP	3.1.27.3 4.6.1.24
1BU8	RAT PANCREATIC LIPASE RELATED PROTEIN 2	3.1.1.3 3.1.1.26
1BUA	STRUCTURAL AND ENERGETIC ORIGINS OF INDIRECT READOUT IN SITE-SPECIFIC DNA CLEAVAGE BY A RESTRICTION ENDONUCLEASE	3.1.21.4
1BUD	ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 5.0	3.4.24
1BUE	NMC-A CARBAPENEMASE FROM ENTEROBACTER CLOACAE	3.5.2.6
1BUI	STRUCTURE OF THE TERNARY MICROPLASMIN-STAPHYLOKINASE-MICROPLASMIN COMPLEX: A PROTEINASE-COFACTOR-SUBSTRATE COMPLEX IN ACTION	3.4.21.7
1BUJ	STRUCTURE OF BINASE IN SOLUTION	3.1.27
1BUL	6ALPHA-(HYDROXYPROPYL)PENICILLANATE ACYLATED ON NMC-A BETA-LACTAMASE FROM ENTEROBACTER CLOACAE	3.5.2.6
1BUN	STRUCTURE OF BETA2-BUNGAROTOXIN: POTASSIUM CHANNEL BINDING BY KUNITZ MODULES AND TARGETED PHOSPHOLIPASE ACTION	3.1.1.4
1BUV	CRYSTAL STRUCTURE OF THE MT1-MMP-TIMP-2 COMPLEX	3.4.24.80
1BV7	COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA AMIDES WITH BROAD SPECIFICITIES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BV9	HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BVE	HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BVG	HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BVH	SOLUTION STRUCTURE OF A LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE	3.1.3.2 3.1.3.48
1BVI	RIBONUCLEASE T1 (WILDTYPE) COMPLEXED WITH 2'GMP	3.1.27.3 4.6.1.24
1BVM	SOLUTION NMR STRUCTURE OF BOVINE PANCREATIC PHOSPHOLIPASE A2, 20 STRUCTURES	3.1.1.4
1BVN	PIG PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THE PROTEINACEOUS INHIBITOR TENDAMISTAT	3.2.1.1
1BVQ	THREE-DIMENSIONAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE FROM PSEUDOMONAS SP. STRAIN CBS-3.	3.8.1.6 3.1.2.23
1BVS	RUVA COMPLEXED TO A HOLLIDAY JUNCTION.	3.6.4.12
1BVT	METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS 569/H/9	3.5.2.6
1BVV	SUGAR RING DISTORTION IN THE GLYCOSYL-ENZYME INTERMEDIATE OF A FAMILY G/11 XYLANASE	3.2.1.8
1BVW	CELLOBIOHYDROLASE II (CEL6A) FROM HUMICOLA INSOLENS	3.2.1.91
1BVX	THE 1.8 A STRUCTURE OF GEL GROWN TETRAGONAL HEN EGG WHITE LYSOZYME	3.2.1.17
1BVZ	ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R-47	3.2.1.135
1BWA	HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BWB	HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF DUPONT PHARMACEUTICALS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1BWH	THE 1.8 A STRUCTURE OF GROUND CONTROL GROWN TETRAGONAL HEN EGG WHITE LYSOZYME	3.2.1.17
1BWI	THE 1.8 A STRUCTURE OF MICROBATCH OIL DROP GROWN TETRAGONAL HEN EGG WHITE LYSOZYME	3.2.1.17
1BWJ	THE 1.8 A STRUCTURE OF MICROGRAVITY GROWN TETRAGONAL HEN EGG WHITE LYSOZYME	3.2.1.17
1BWP	PROBING THE SUBSTRATE SPECIFICITY OF THE INTRACELLULAR BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE	3.1.1.47
1BWQ	PROBING THE SUBSTRATE SPECIFICITY OF THE INTRACELLULAR BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE	3.1.1.47
1BWR	PROBING THE SUBSTRATE SPECIFICITY OF THE INTRACELLULAR BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE	3.1.1.47
1BXO	ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL CYCLO[(2S)-2-[[(1R)-1-(N-(L-N-(3-METHYLBUTANOYL)VALYL-L-ASPARTYL)AMINO)-3-METHYLBUT YL] HYDROXYPHOSPHINYLOXY]-3-(3-AMINOMETHYL) PHENYLPROPANOATE	3.4.23.20
1BXQ	ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR.	3.4.23.20
1BY8	THE CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN K	3.4.22.38
1BYA	CRYSTAL STRUCTURES OF SOYBEAN BETA-AMYLASE REACTED WITH BETA-MALTOSE AND MALTAL: ACTIVE SITE COMPONENTS AND THEIR APPARENT ROLE IN CATALYSIS	3.2.1.2
1BYB	CRYSTAL STRUCTURES OF SOYBEAN BETA-AMYLASE REACTED WITH BETA-MALTOSE AND MALTAL: ACTIVE SITE COMPONENTS AND THEIR APPARENT ROLE IN CATALYSIS	3.2.1.2
1BYC	CRYSTAL STRUCTURES OF SOYBEAN BETA-AMYLASE REACTED WITH BETA-MALTOSE AND MALTAL: ACTIVE SITE COMPONENTS AND THEIR APPARENT ROLE IN CATALYSIS	3.2.1.2
1BYD	CRYSTAL STRUCTURES OF SOYBEAN BETA-AMYLASE REACTED WITH BETA-MALTOSE AND MALTAL: ACTIVE SITE COMPONENTS AND THEIR APPARENT ROLE IN CATALYSIS	3.2.1.2
1BYH	MOLECULAR AND ACTIVE-SITE STRUCTURE OF A BACILLUS (1-3,1-4)-BETA-GLUCANASE	3.2.1.73
1BZA	BETA-LACTAMASE TOHO-1 FROM ESCHERICHIA COLI TUH12191	3.5.2.6
1BZC	HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH TPI	3.1.3.48
1BZH	CYCLIC PEPTIDE INHIBITOR OF HUMAN PTP1B	3.1.3.48
1BZJ	HUMAN PTP1B COMPLEXED WITH TPICOOH	3.1.3.48
1BZQ	COMPLEX OF A DROMEDARY SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A	3.1.27.5 4.6.1.18
1BZS	CRYSTAL STRUCTURE OF MMP8 COMPLEXED WITH HMR2909	3.4.24.34
1BZX	THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR	3.4.21.4
1C0B	BOVINE PANCREATIC RIBONUCLEASE A DESICCATED FOR 2.5 DAYS	3.1.27.5 4.6.1.18
1C0C	BOVINE PANCREATIC RIBONUCLEASE A DESICCATED FOR 4.0 DAYS	3.1.27.5 4.6.1.18
1C0E	ACTIVE SITE S19A MUTANT OF BOVINE HEART PHOSPHOTYROSYL PHOSPHATASE	3.1.3.2 3.1.3.48
1C0M	CRYSTAL STRUCTURE OF RSV TWO-DOMAIN INTEGRASE	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
1C0T	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1C0U	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1C10	CRYSTAL STRUCTURE OF HEW LYSOZYME UNDER PRESSURE OF XENON (8 BAR)	3.2.1.17
1C1A	CRYSTAL STRUCTURE OF RSV TWO-DOMAIN INTEGRASE	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
1C1B	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA-186	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1C1C	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-6123	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1C1J	STRUCTURE OF CADMIUM-SUBSTITUTED PHOSPHOLIPASE A2 FROM AGKISTRONDON HALYS PALLAS AT 2.8 ANGSTROMS RESOLUTION	3.1.1.4
1C1M	PORCINE ELASTASE UNDER XENON PRESSURE (8 BAR)	3.4.21.36
1C1N	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C1O	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C1P	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C1Q	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C1R	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C1S	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C1T	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C1U	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.5
1C1V	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.5
1C1W	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.5
1C1Y	CRYSTAL STRUCTURE OF RAP.GMPPNP IN COMPLEX WITH THE RAS-BINDING-DOMAIN OF C-RAF1 KINASE (RAFRBD).	3.6.5.2
1C21	E. COLI METHIONINE AMINOPEPTIDASE: METHIONINE COMPLEX	3.4.11.18
1C22	E. COLI METHIONINE AMINOPEPTIDASE: TRIFLUOROMETHIONINE COMPLEX	3.4.11.18
1C23	E. COLI METHIONINE AMINOPEPTIDASE: METHIONINE PHOSPHONATE COMPLEX	3.4.11.18
1C24	E. COLI METHIONINE AMINOPEPTIDASE: METHIONINE PHOSPHINATE COMPLEX	3.4.11.18
1C25	HUMAN CDC25A CATALYTIC DOMAIN	3.1.3.48
1C27	E. COLI METHIONINE AMINOPEPTIDASE:NORLEUCINE PHOSPHONATE COMPLEX	3.4.11.18
1C2B	ELECTROPHORUS ELECTRICUS ACETYLCHOLINESTERASE	3.1.1.7
1C2D	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2E	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2F	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2G	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2H	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2I	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2J	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2K	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2L	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2M	RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES	3.4.21.4
1C2P	HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
1C3B	AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR, BENZO(B)THIOPHENE-2-BORONIC ACID (BZB)	3.5.2.6
1C3F	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, D130N MUTANT	3.2.1.96
1C3I	HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812	3.4.24.17
1C3L	SUBTILISIN-CARLSBERG COMPLEXED WITH XENON (8 BAR)	3.4.21.62
1C43	MUTANT HUMAN LYSOZYME WITH FOREIGN N-TERMINAL RESIDUES	3.2.1.17
1C45	MUTANT HUMAN LYSOZYME WITH FOREIGN N-TERMINAL RESIDUES	3.2.1.17
1C46	MUTANT HUMAN LYSOZYME WITH FOREIGN N-TERMINAL RESIDUES	3.2.1.17
1C4U	SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.	3.4.21.5
1C4V	SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.	3.4.21.5
1C4X	2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDROLASE (BPHD) FROM RHODOCOCCUS SP. STRAIN RHA1	3.7.1.8
1C4Y	SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS	3.4.21.5
1C54	SOLUTION STRUCTURE OF RIBONUCLEASE SA	3.1.27.3 4.6.1.24
1C5H	HYDROGEN BONDING AND CATALYSIS: AN UNEXPECTED EXPLANATION FOR HOW A SINGLE AMINO ACID SUBSTITUTION CAN CHANGE THE PH OPTIMUM OF A GLYCOSIDASE	3.2.1.8
1C5I	HYDROGEN BONDING AND CATALYSIS: AN UNEXPECTED EXPLANATION FOR HOW A SINGLE AMINO ACID SUBSTITUTION CAN CHANGE THE PH OPTIMUM OF A GLYCOSIDASE	3.2.1.8
1C5L	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.5
1C5M	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.6
1C5N	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.5
1C5O	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.5
1C5P	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.4
1C5Q	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.4
1C5R	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.4
1C5S	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.4
1C5T	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.4
1C5U	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.4
1C5V	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.4
1C5W	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
1C5X	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
1C5Y	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
1C5Z	STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
1C60	T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM ARGON	3.2.1.17
1C61	T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM KRYPTON	3.2.1.17
1C62	T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM XENON	3.2.1.17
1C63	T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM ARGON	3.2.1.17
1C64	T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM KRYPTON	3.2.1.17
1C65	T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM XENON	3.2.1.17
1C66	T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM ARGON	3.2.1.17
1C67	T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM KRYPTON	3.2.1.17
1C68	T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM XENON	3.2.1.17
1C69	T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM ARGON	3.2.1.17
1C6A	T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM KRYPTON	3.2.1.17
1C6B	T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM XENON	3.2.1.17
1C6C	T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM ARGON	3.2.1.17
1C6D	T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM KRYPTON	3.2.1.17
1C6E	T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 2 ATM XENON	3.2.1.17
1C6F	T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 32 ATM ARGON	3.2.1.17
1C6G	T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM KRYPTON	3.2.1.17
1C6H	T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM XENON	3.2.1.17
1C6I	T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM ARGON	3.2.1.17
1C6J	T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM KRYPTON	3.2.1.17
1C6K	T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM XENON	3.2.1.17
1C6L	T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM ARGON	3.2.1.17
1C6M	T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM KRYPTON	3.2.1.17
1C6N	T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM XENON	3.2.1.17
1C6P	T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM ARGON	3.2.1.17
1C6Q	T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM KRYPTON	3.2.1.17
1C6T	T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM XENON	3.2.1.17
1C6V	SIV INTEGRASE (CATALYTIC DOMAIN + DNA BIDING DOMAIN COMPRISING RESIDUES 50-293) MUTANT WITH PHE 185 REPLACED BY HIS (F185H)	2.7.7.49 3.1.13.2 3.1.26.13
1C6X	ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.	3.4.24
1C6Y	ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.	3.4.24
1C6Z	ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.	3.4.24
1C70	ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.	3.4.23
1C74	STRUCTURE OF THE DOUBLE MUTANT (K53,56M) OF PHOSPHOLIPASE A2	3.1.1.4
1C76	STAPHYLOKINASE (SAK) MONOMER	3.4.24.29
1C77	STAPHYLOKINASE (SAK) DIMER	3.4.24.29
1C78	STAPHYLOKINASE (SAK) DIMER	3.4.24.29
1C79	STAPHYLOKINASE (SAK) DIMER	3.4.24.29
1C7I	THERMOPHYLIC PNB ESTERASE	3.1.1
1C7J	PNB ESTERASE 56C8	3.1.1
1C7K	CRYSTAL STRUCTURE OF THE ZINC PROTEASE	3.4.24 3.4.24.77
1C7P	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME WITH FOUR EXTRA RESIDUES (EAEA) AT THE N-TERMINAL	3.2.1.17
1C7S	BETA-N-ACETYLHEXOSAMINIDASE MUTANT D539A COMPLEXED WITH DI-N-ACETYL-BETA-D-GLUCOSAMINE (CHITOBIASE)	3.2.1.52
1C7T	BETA-N-ACETYLHEXOSAMINIDASE MUTANT E540D COMPLEXED WITH DI-N ACETYL-D-GLUCOSAMINE (CHITOBIASE)	3.2.1.52
1C7Y	E.COLI RUVA-HOLLIDAY JUNCTION COMPLEX	3.6.4.12
1C7Z	REGULATORY COMPLEX OF FRUCTOSE-2,6-BISPHOSPHATASE	3.1.3.46 2.7.1.105
1C80	REGULATORY COMPLEX OF FRUCTOSE-2,6-BISPHOSPHATASE	3.1.3.46 2.7.1.105
1C81	MICHAELIS COMPLEX OF FRUCTOSE-2,6-BISPHOSPHATASE	3.1.3.46 2.7.1.105
1C83	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID	3.1.3.48
1C84	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXLIC ACID	3.1.3.48
1C85	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO)-BENZOIC ACID	3.1.3.48
1C86	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (R47V,D48N) COMPLEXED WITH 2-(OXALYL-AMINO-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID	3.1.3.48
1C87	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID	3.1.3.48
1C88	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO)-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID	3.1.3.48
1C8B	CRYSTAL STRUCTURE OF A NOVEL GERMINATION PROTEASE FROM SPORES OF BACILLUS MEGATERIUM: STRUCTURAL REARRANGEMENTS AND ZYMOGEN ACTIVATION	3.4.99 3.4.24.78
1C8M	REFINED CRYSTAL STRUCTURE OF HUMAN RHINOVIRUS 16 COMPLEXED WITH VP63843 (PLECONARIL), AN ANTI-PICORNAVIRAL DRUG CURRENTLY IN CLINICAL TRIALS	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1C8Q	STRUCTURE SOLUTION AND REFINEMENT OF THE RECOMBINANT HUMAN SALIVARY AMYLASE	3.2.1.1
1C8T	HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812	3.4.24.17
1C8U	CRYSTAL STRUCTURE OF THE E.COLI THIOESTERASE II, A HOMOLOGUE OF THE HUMAN NEF-BINDING ENZYME	3.1.2 3.1.2.20
1C8X	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, D130E MUTANT	3.2.1.96
1C8Y	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, D130A MUTANT	3.2.1.96
1C90	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, E132Q MUTANT	3.2.1.96
1C91	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, E132D	3.2.1.96
1C92	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, E132A MUTANT	3.2.1.96
1C93	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, D130N/E132Q DOUBLE MUTANT	3.2.1.96
1C9F	NMR STRUCTURE OF THE CAD DOMAIN OF CASPASE-ACTIVATED DNASE	3
1C9J	BACILLUS LENTUS SUBTILISIN K27R/N87S/V104Y/N123S/T274A VARIANT	3.4.21.62
1C9M	BACILLUS LENTUS SUBTILSIN (SER 87) N76D/S103A/V104I	3.4.21.62
1C9N	BACILLUS LENTUS SUBSTILISIN VARIANT (SER 87) K27R/V104Y/N123S/T274A	3.4.21.62
1C9P	COMPLEX OF BDELLASTASIN WITH PORCINE TRYPSIN	3.4.21.4
1C9T	COMPLEX OF BDELLASTASIN WITH BOVINE TRYPSIN	3.4.21.4
1C9V	H12A VARIANT OF RIBONUCLEASE A	3.1.27.5 4.6.1.18
1CA0	BOVINE CHYMOTRYPSIN COMPLEXED TO APPI	3.4.21.1
1CA1	ALPHA-TOXIN FROM CLOSTRIDIUM PERFRINGENS	3.1.4.3
1CA8	THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES	3.4.21.5
1CAQ	X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY	3.4.24.17
1CB2	CELLOBIOHYDROLASE II, CATALYTIC DOMAIN, MUTANT Y169F	3.2.1.91
1CB5	HUMAN BLEOMYCIN HYDROLASE.	3.4.22 3.4.22.40
1CB6	STRUCTURE OF HUMAN APOLACTOFERRIN AT 2.0 A RESOLUTION.	3.4.21
1CBG	THE CRYSTAL STRUCTURE OF A CYANOGENIC BETA-GLUCOSIDASE FROM WHITE CLOVER (TRIFOLIUM REPENS L.), A FAMILY 1 GLYCOSYL-HYDROLASE	3.2.1.21
1CBH	DETERMINATION OF THE THREE-DIMENSIONAL STRUCTURE OF THE C-TERMINAL DOMAIN OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI. A STUDY USING NUCLEAR MAGNETIC RESONANCE AND HYBRID DISTANCE GEOMETRY-DYNAMICAL SIMULATED ANNEALING	3.2.1.91
1CBW	BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI	3.4.21.1
1CBX	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CARBOXYPEPTIDASE A AND THE BIPRODUCT ANALOG INHIBITOR L-BENZYLSUCCINATE AT 2.0 ANGSTROMS RESOLUTION	3.4.17.1
1CC0	CRYSTAL STRUCTURE OF THE RHOA.GDP-RHOGDI COMPLEX	3.6.5.2
1CCF	HOW AN EPIDERMAL GROWTH FACTOR (EGF)-LIKE DOMAIN BINDS CALCIUM-HIGH RESOLUTION NMR STRUCTURE OF THE CALCIUM FORM OF THE NH2-TERMINAL EGF-LIKE DOMAIN IN COAGULATION FACTOR X	3.4.21.6
1CD5	GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI, T CONFORMER	3.5.99.6
1CE2	STRUCTURE OF DIFERRIC BUFFALO LACTOFERRIN AT 2.5A RESOLUTION	3.4.21
1CE5	BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE	3.4.21.4
1CE7	MISTLETOE LECTIN I FROM VISCUM ALBUM	3.2.2.22
1CEA	THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WITH EACA (EPSILON-AMINOCAPROIC ACID)	3.4.21.7
1CEB	THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WITH AMCHA (TRANS-4-AMINOMETHYLCYCLOHEXANE-1-CARBOXYLIC ACID)	3.4.21.7
1CEC	A COMMON PROTEIN FOLD AND SIMILAR ACTIVE SITE IN TWO DISTINCT FAMILIES OF BETA-GLYCANASES	3.2.1.4
1CEE	SOLUTION STRUCTURE OF CDC42 IN COMPLEX WITH THE GTPASE BINDING DOMAIN OF WASP	3.6.5.2
1CEF	CEFOTAXIME COMPLEXED WITH THE STREPTOMYCES R61 DD-PEPTIDASE	3.4.16.4
1CEG	CEPHALOTHIN COMPLEXED WITH DD-PEPTIDASE	3.4.16.4
1CEH	STRUCTURE AND FUNCTION OF THE CATALYTIC SITE MUTANT ASP99ASN OF PHOSPHOLIPASE A2: ABSENCE OF CONSERVED STRUCTURAL WATER	3.1.1.4
1CEL	THE THREE-DIMENSIONAL CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI	3.2.1.91
1CEM	ENDOGLUCANASE A (CELA) CATALYTIC CORE, RESIDUES 33-395	3.2.1.4
1CEN	CELLULASE (CELC) MUTANT WITH GLU 140 REPLACED BY GLN COMPLEXED WITH CELLOHEXAOSE	3.2.1.4
1CEO	CELLULASE (CELC) MUTANT WITH GLU 140 REPLACED BY GLN	3.2.1.4
1CEV	ARGINASE FROM BACILLUS CALDOVELOX, NATIVE STRUCTURE AT PH 5.6	3.5.3.1
1CEX	STRUCTURE OF CUTINASE	3.1.1 3.1.1.74
1CF4	CDC42/ACK GTPASE-BINDING DOMAIN COMPLEX	3.6.5.2
1CF5	BETA-MOMORCHARIN STRUCTURE AT 2.55 A	3.2.2.22
1CFH	STRUCTURE OF THE METAL-FREE GAMMA-CARBOXYGLUTAMIC ACID-RICH MEMBRANE BINDING REGION OF FACTOR IX BY TWO-DIMENSIONAL NMR SPECTROSCOPY	3.4.21.22
1CFI	NMR STRUCTURE OF CALCIUM ION-BOUND GAMMA-CARBOXY-GLUTAMIC ACID-RICH DOMAIN OF FACTOR IX	3.4.21.22
1CFJ	METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH O-ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN)	3.1.1.7
1CFR	CRYSTAL STRUCTURE OF CITROBACTER FREUNDII RESTRICTION ENDONUCLEASE CFR10I AT 2.15 ANGSTROMS RESOLUTION.	3.1.21.4
1CFZ	HYDROGENASE MATURATING ENDOPEPTIDASE HYBD FROM E. COLI	3.4 3.4.23
1CG2	CARBOXYPEPTIDASE G2	3.4.17.11
1CGE	CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF	3.4.24.7
1CGF	CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF	3.4.24.7
1CGH	HUMAN CATHEPSIN G	3.4.21.20
1CGI	THREE-DIMENSIONAL STRUCTURE OF THE COMPLEXES BETWEEN BOVINE CHYMOTRYPSINOGEN*A AND TWO RECOMBINANT VARIANTS OF HUMAN PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL-TYPE)	3.4.21.1
1CGJ	THREE-DIMENSIONAL STRUCTURE OF THE COMPLEXES BETWEEN BOVINE CHYMOTRYPSINOGEN*A AND TWO RECOMBINANT VARIANTS OF HUMAN PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL-TYPE)	3.4.21.1
1CGL	STRUCTURE OF THE CATALYTIC DOMAIN OF FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR	3.4.24.7
1CH0	RNASE T1 VARIANT WITH ALTERED GUANINE BINDING SEGMENT	3.1.27.3 4.6.1.24
1CHD	CHEB METHYLESTERASE DOMAIN	3.1.1.61 3.5.1.44
1CHG	CHYMOTRYPSINOGEN,2.5 ANGSTROMS CRYSTAL STRUCTURE, COMPARISON WITH ALPHA-CHYMOTRYPSIN,AND IMPLICATIONS FOR ZYMOGEN ACTIVATION	3.4.21.1
1CHK	STREPTOMYCES N174 CHITOSANASE PH5.5 298K	3.2.1.132
1CHM	ENZYMATIC MECHANISM OF CREATINE AMIDINOHYDROLASE AS DEDUCED FROM CRYSTAL STRUCTURES	3.5.3.3
1CHO	CRYSTAL AND MOLECULAR STRUCTURES OF THE COMPLEX OF ALPHA-*CHYMOTRYPSIN WITH ITS INHIBITOR TURKEY OVOMUCOID THIRD DOMAIN AT 1.8 ANGSTROMS RESOLUTION	3.4.21.1
1CI8	ESTERASE ESTB FROM BURKHOLDERIA GLADIOLI: AN ESTERASE WITH (BETA)-LACTAMASE FOLD.	3.1.1.1 3.1.1
1CI9	DFP-INHIBITED ESTERASE ESTB FROM BURKHOLDERIA GLADIOLI	3.1.1.1 3.1.1
1CIJ	HALOALKANE DEHALOGENASE SOAKED WITH HIGH CONCENTRATION OF BROMIDE	3.8.1.5
1CIZ	X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY	3.4.24.17
1CJ6	T11A MUTANT HUMAN LYSOZYME	3.2.1.17
1CJ7	T11V MUTANT HUMAN LYSOZYME	3.2.1.17
1CJ8	T40A MUTANT HUMAN LYSOZYME	3.2.1.17
1CJ9	T40V MUTANT HUMAN LYSOZYME	3.2.1.17
1CJL	CRYSTAL STRUCTURE OF A CYSTEINE PROTEASE PROFORM	3.4.22.15
1CJY	HUMAN CYTOSOLIC PHOSPHOLIPASE A2	3.1.1.4 3.1.1.5
1CK3	N276D MUTANT OF ESCHERICHIA COLI TEM-1 BETA-LACTAMASE	3.5.2.6
1CK7	GELATINASE A (FULL-LENGTH)	3.4.24.24
1CKC	T43A MUTANT HUMAN LYSOZYME	3.2.1.17
1CKD	T43V MUTANT HUMAN LYSOZYME	3.2.1.17
1CKF	T52A MUTANT HUMAN LYSOZYME	3.2.1.17
1CKG	T52V MUTANT HUMAN LYSOZYME	3.2.1.17
1CKH	T70V MUTANT HUMAN LYSOZYME	3.2.1.17
1CKQ	PRE-TRANSITION STATE ECO RI ENDONUCLEASE/COGNATE DNA (TCGCGAATTCGCG) COMPLEX	3.1.21.4
1CL5	CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA	3.1.1.4
1CL8	A PRE-TRANSITION STATE ECO RI ENDONUCLEASE/COGNATE DNA (TCGCGAPTTCGCG) COMPLEX WITH DNA BASE ANALOG PURINE (P)	3.1.21.4
1CLC	THREE-DIMENSIONAL STRUCTURE OF ENDOGLUCANASE D AT 1.9 ANGSTROMS RESOLUTION	3.2.1.4
1CLE	STRUCTURE OF UNCOMPLEXED AND LINOLEATE-BOUND CANDIDA CYLINDRACEA CHOLESTEROL ESTERASE	3.1.1.3
1CLP	CRYSTAL STRUCTURE OF A CALCIUM-INDEPENDENT PHOSPHOLIPASELIKE MYOTOXIC PROTEIN FROM BOTHROPS ASPER VENOM	3.1.1.4
1CLQ	CRYSTAL STRUCTURE OF A REPLICATION FORK DNA POLYMERASE EDITING COMPLEX AT 2.7 A RESOLUTION	2.7.7.7 3.1.11
1CLU	H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA,GAMMA-IMIDO-GTP	3.6.5.2
1CLV	YELLOW MEAL WORM ALPHA-AMYLASE IN COMPLEX WITH THE AMARANTH ALPHA-AMYLASE INHIBITOR	3.2.1.1
1CLW	TAILSPIKE PROTEIN FROM PHAGE P22, V331A MUTANT	3.2.1
1CLX	CATALYTIC CORE OF XYLANASE A	3.2.1.8
1CMS	THE THREE-DIMENSIONAL STRUCTURE OF RECOMBINANT BOVINE CHYMOSIN AT 2.3 ANGSTROMS RESOLUTION	3.4.23.4
1CMV	HUMAN CYTOMEGALOVIRUS PROTEASE	3.4.21 3.4.21.97
1CMX	STRUCTURAL BASIS FOR THE SPECIFICITY OF UBIQUITIN C-TERMINAL HYDROLASES	3.1.2.15
1CNM	ENHANCEMENT OF CATALYTIC EFFICIENCY OF PROTEINASE K THROUGH EXPOSURE TO ANHYDROUS ORGANIC SOLVENT AT 70 DEGREES CELSIUS	3.4.21.64
1CNQ	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH FRUCTOSE-6-PHOSPHATE AND ZINC IONS	3.1.3.11
1CNS	CRYSTAL STRUCTURE OF CHITINASE AT 1.91A RESOLUTION	3.2.1.14
1COV	COXSACKIEVIRUS B3 COAT PROTEIN	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1CP3	CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC	3.4.22 3.4.22.56
1CP6	1-BUTANEBORONIC ACID BINDING TO AEROMONAS PROTEOLYTICA AMINOPEPTIDASE	3.4.11.10
1CP7	AMINOPEPTIDASE FROM STREPTOMYCES GRISEUS	3.4.11 3.4.11.24
1CPB	STRUCTURE OF CARBOXYPEPTIDASE B AT 2.8 ANGSTROMS RESOLUTION	3.4.17.2
1CPJ	CRYSTAL STRUCTURES OF RECOMBINANT RAT CATHEPSIN B AND A CATHEPSIN B-INHIBITOR COMPLEX: IMPLICATIONS FOR STRUCTURE-BASED INHIBITOR DESIGN	3.4.22.1
1CPM	NATIVE-LIKE IN VIVO FOLDING OF A CIRCULARLY PERMUTED JELLYROLL PROTEIN SHOWN BY CRYSTAL STRUCTURE ANALYSIS	3.2.1.73
1CPN	NATIVE-LIKE IN VIVO FOLDING OF A CIRCULARLY PERMUTED JELLYROLL PROTEIN SHOWN BY CRYSTAL STRUCTURE ANALYSIS	3.2.1.73
1CPS	STRUCTURAL COMPARISON OF SULFODIIMINE AND SULFONAMIDE INHIBITORS IN THEIR COMPLEXES WITH ZINC ENZYMES	3.4.17.1
1CPU	SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT	3.2.1.1
1CPX	BETA FORM OF CARBOXYPEPTIDASE A (RESIDUES 3-307) FROM BOVINE PANCREAS IN AN ORTHORHOMBIC CRYSTAL FORM WITH TWO ZINC IONS IN THE ACTIVE SITE.	3.4.17.1
1CPY	SITE-DIRECTED MUTAGENESIS ON (SERINE) CARBOXYPEPTIDASE Y FROM YEAST. THE SIGNIFICANCE OF THR 60 AND MET 398 IN HYDROLYSIS AND AMINOLYSIS REACTIONS	3.4.16.5
1CQD	THE 2.1 ANGSTROM STRUCTURE OF A CYSTEINE PROTEASE WITH PROLINE SPECIFICITY FROM GINGER RHIZOME, ZINGIBER OFFICINALE	3.4.22.67
1CQQ	TYPE 2 RHINOVIRUS 3C PROTEASE WITH AG7088 INHIBITOR	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1CQR	CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTION	3.4.24.17
1CQW	NAI COCRYSTALLISED WITH HALOALKANE DEHALOGENASE FROM A RHODOCOCCUS SPECIES	3.8.1.5
1CQY	STARCH BINDING DOMAIN OF BACILLUS CEREUS BETA-AMYLASE	3.2.1.2
1CR0	CRYSTAL STRUCTURE OF THE HELICASE DOMAIN OF THE GENE4 PROTEIN OF BACTERIOPHAGE T7	2.7.7 3.6.4.12
1CR1	CRYSTAL STRUCTURE OF THE HELICASE DOMAIN OF THE GENE 4 PROTEIN OF BACTERIOPHAGE T7: COMPLEX WITH DTTP	2.7.7 3.6.4.12
1CR2	CRYSTAL STRUCTURE OF THE HELICASE DOMAIN OF THE GENE 4 PROTEIN OF BACTERIOPHAGE T7: COMPLEX WITH DATP	2.7.7 3.6.4.12
1CR4	CRYSTAL STRUCTURE OF THE HELICASE DOMAIN OF THE GENE 4 PROTEIN OF BACTERIOPHAGE T7: COMPLEX WITH DTDP	2.7.7 3.6.4.12
1CRL	INSIGHTS INTO INTERFACIAL ACTIVATION FROM AN 'OPEN' STRUCTURE OF CANDIDA RUGOSA LIPASE	3.1.1.3
1CRP	THE SOLUTION STRUCTURE AND DYNAMICS OF RAS P21. GDP DETERMINED BY HETERONUCLEAR THREE AND FOUR DIMENSIONAL NMR SPECTROSCOPY	3.6.5.2
1CRQ	THE SOLUTION STRUCTURE AND DYNAMICS OF RAS P21. GDP DETERMINED BY HETERONUCLEAR THREE AND FOUR DIMENSIONAL NMR SPECTROSCOPY	3.6.5.2
1CS8	CRYSTAL STRUCTURE OF PROCATHEPSIN L	3.4.22.15
1CSB	CRYSTAL STRUCTURE OF CATHEPSIN B INHIBITED WITH CA030 AT 2.1 ANGSTROMS RESOLUTION: A BASIS FOR THE DESIGN OF SPECIFIC EPOXYSUCCINYL INHIBITORS	3.4.22.1
1CSE	THE HIGH-RESOLUTION X-RAY CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN SUBTILISIN CARLSBERG AND EGLIN C, AN ELASTASE INHIBITOR FROM THE LEECH HIRUDO MEDICINALIS. STRUCTURAL ANALYSIS, SUBTILISIN STRUCTURE AND INTERFACE GEOMETRY	3.4.21.62
1CSJ	CRYSTAL STRUCTURE OF THE RNA-DEPENDENT RNA POLYMERASE OF HEPATITIS C VIRUS	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
1CSO	CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-ILE18I IN COMPLEX WITH SGPB	3.4.21.81
1CT0	CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-SER18I IN COMPLEX WITH SGPB	3.4.21.81
1CT2	CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-THR18I IN COMPLEX WITH SGPB	3.4.21.81
1CT4	CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-VAL18I IN COMPLEX WITH SGPB	3.4.21.81
1CTE	CRYSTAL STRUCTURES OF RECOMBINANT RAT CATHEPSIN B AND A CATHEPSIN B-INHIBITOR COMPLEX: IMPLICATIONS FOR STRUCTURE-BASED INHIBITOR DESIGN	3.4.22.1
1CTN	CRYSTAL STRUCTURE OF A BACTERIAL CHITINASE AT 2.3 ANGSTROMS RESOLUTION	3.2.1.14
1CTQ	STRUCTURE OF P21RAS IN COMPLEX WITH GPPNHP AT 100 K	3.6.5.2
1CTT	TRANSITION-STATE SELECTIVITY FOR A SINGLE OH GROUP DURING CATALYSIS BY CYTIDINE DEAMINASE	3.5.4.5
1CTU	TRANSITION-STATE SELECTIVITY FOR A SINGLE OH GROUP DURING CATALYSIS BY CYTIDINE DEAMINASE	3.5.4.5
1CTW	T4 LYSOZYME MUTANT I78A	3.2.1.17
1CU0	T4 LYSOZYME MUTANT I78M	3.2.1.17
1CU1	CRYSTAL STRUCTURE OF AN ENZYME COMPLEX FROM HEPATITIS C VIRUS	3.4.21 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1CU2	T4 LYSOZYME MUTANT L84M	3.2.1.17
1CU3	T4 LYSOZYME MUTANT V87M	3.2.1.17
1CU5	T4 LYSOZYME MUTANT L91M	3.2.1.17
1CU6	T4 LYSOZYME MUTANT L91A	3.2.1.17
1CUA	CUTINASE, N172K MUTANT	3.1.1.3 3.1.1.74
1CUB	CUTINASE, N172K, R196D MUTANT, MONOCLINIC CRYSTAL FORM	3.1.1.3 3.1.1.74
1CUC	CUTINASE, N172K, R196D MUTANT, ORTHORHOMBIC CRYSTAL FORM	3.1.1.3 3.1.1.74
1CUD	CUTINASE, N172K, R196D MUTANT, MONOCLINIC CRYSTAL FORM WITH THREE MOLECULES PER ASYMMETRIC UNIT	3.1.1.3 3.1.1.74
1CUE	CUTINASE, Q121L MUTANT	3.1.1.3 3.1.1.74
1CUF	CUTINASE, R156L MUTANT	3.1.1.3 3.1.1.74
1CUG	CUTINASE, R17E, N172K MUTANT	3.1.1.3 3.1.1.74
1CUH	CUTINASE, R196E MUTANT	3.1.1.3 3.1.1.74
1CUI	CUTINASE, S120A MUTANT	3.1.1.3 3.1.1.74
1CUJ	CUTINASE, S120C MUTANT	3.1.1.3 3.1.1.74
1CUK	ESCHERICHIA COLI RUVA PROTEIN AT PH 4.9 AND ROOM TEMPERATURE	3.6.4.12
1CUP	METHIONINE CORE MUTANT OF T4 LYSOZYME	3.2.1.17
1CUQ	T4 LYSOZYME MUTANT V103M	3.2.1.17
1CUS	FUSARIUM SOLANI CUTINASE IS A LIPOLYTIC ENZYME WITH A CATALYTIC SERINE ACCESSIBLE TO SOLVENT	3.1.1 3.1.1.74
1CUU	CUTINASE, A199C MUTANT	3.1.1.3 3.1.1.74
1CUV	CUTINASE, A85F MUTANT	3.1.1.3 3.1.1.74
1CUW	CUTINASE, G82A, A85F, V184I, A185L, L189F MUTANT	3.1.1.3 3.1.1.74
1CUX	CUTINASE, L114Y MUTANT	3.1.1.3 3.1.1.74
1CUY	CUTINASE, L189F MUTANT	3.1.1.3 3.1.1.74
1CUZ	CUTINASE, L81G, L182G MUTANT	3.1.1.3 3.1.1.74
1CV0	T4 LYSOZYME MUTANT F104M	3.2.1.17
1CV1	T4 LYSOZYME MUTANT V111M	3.2.1.17
1CV2	HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 AT 1.6 A RESOLUTION	3.8.1.5
1CV3	T4 LYSOZYME MUTANT L121M	3.2.1.17
1CV4	T4 LYSOZYME MUTANT L118M	3.2.1.17
1CV5	T4 LYSOZYME MUTANT L133M	3.2.1.17
1CV6	T4 LYSOZYME MUTANT V149M	3.2.1.17
1CV8	STAPHOPAIN, CYSTEINE PROTEINASE FROM STAPHYLOCOCCUS AUREUS V8	3.4.22 3.4.22.48
1CVI	CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE	3.1.3.2 3.1.3.5
1CVK	T4 LYSOZYME MUTANT L118A	3.2.1.17
1CVL	CRYSTAL STRUCTURE OF BACTERIAL LIPASE FROM CHROMOBACTERIUM VISCOSUM ATCC 6918	3.1.1.3
1CVM	CADMIUM INHIBITED CRYSTAL STRUCTURE OF PHYTASE FROM BACILLUS AMYLOLIQUEFACIENS	3.1.3.8
1CVR	CRYSTAL STRUCTURE OF THE ARG SPECIFIC CYSTEINE PROTEINASE GINGIPAIN R (RGPB)	3.4.22.37
1CVW	CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR VIIA (DES-GLA)	3.4.21.21
1CVZ	CRYSTAL STRUCTURE ANALYSIS OF PAPAIN WITH CLIK148(CATHEPSIN L SPECIFIC INHIBITOR)	3.4.22.2
1CW0	CRYSTAL STRUCTURE ANALYSIS OF VERY SHORT PATCH REPAIR (VSR) ENDONUCLEASE IN COMPLEX WITH A DUPLEX DNA	3.1
1CWR	HUMAN CDC25B CATALYTIC DOMAIN WITHOUT ION IN CATALYTIC SITE	3.1.3.48
1CWS	HUMAN CDC25B CATALYTIC DOMAIN WITH TUNGSTATE	3.1.3.48
1CWT	HUMAN CDC25B CATALYTIC DOMAIN WITH METHYL MERCURY	3.1.3.48
1CX1	SECOND N-TERMINAL CELLULOSE-BINDING DOMAIN FROM CELLULOMONAS FIMI BETA-1,4-GLUCANASE C, NMR, 22 STRUCTURES	3.2.1.4
1CX6	T4 LYSOZYME SUBSTITUTED WITH SELENOMETHIONINE	3.2.1.17
1CX7	T4 LYSOZYME METHIONINE CORE MUTANT	3.2.1.17
1CXQ	ATOMIC RESOLUTION ASV INTEGRASE CORE DOMAIN FROM AMMONIUM SULFATE	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
1CXU	1.42A RESOLUTION ASV INTEGRASE CORE DOMAIN FROM CITRATE	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
1CXV	STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13)	3.4.24
1CXW	THE SECOND TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2	3.4.24.24
1CXZ	CRYSTAL STRUCTURE OF HUMAN RHOA COMPLEXED WITH THE EFFECTOR DOMAIN OF THE PROTEIN KINASE PKN/PRK1	3.6.5.2
1CYQ	INTRON ENCODED HOMING ENDONUCLEASE I-PPOI (H98A)/DNA HOMING SITE COMPLEX	3.1
1CZ0	INTRON ENCODED HOMING ENDONUCLEASE I-PPOI/DNA COMPLEX LACKING CATALYTIC METAL ION	3.1
1CZ1	EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS AT 1.85 A RESOLUTION	3.2.1.58 2.4.1
1CZ9	ATOMIC RESOLUTION ASV INTEGRASE CORE DOMAIN (D64N) FROM CITRATE	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
1CZB	ATOMIC RESOLUTION ASV INTEGRASE CORE DOMAIN FROM HEPES	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
1CZF	ENDO-POLYGALACTURONASE II FROM ASPERGILLUS NIGER	3.2.1.15
1CZI	CHYMOSIN COMPLEX WITH THE INHIBITOR CP-113972	3.4.23.4
1D02	CRYSTAL STRUCTURE OF MUNI RESTRICTION ENDONUCLEASE IN COMPLEX WITH COGNATE DNA	3.1.21.4
1D07	HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 WITH 1,3-PROPANEDIOL, A PRODUCT OF DEBROMIDATION OF DIBROMPROPANE, AT 2.0A RESOLUTION	3.8.1.5
1D0E	CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
1D0H	THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH N-ACETYL-GALACTOSAMINE	3.4.24.68
1D1D	NMR SOLUTION STRUCTURE OF THE CAPSID PROTEIN FROM ROUS SARCOMA VIRUS	3.4.23
1D1P	CRYSTAL STRUCTURE OF A YEAST LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LTP1)	3.1.3.48 3.1.3.2
1D1Q	CRYSTAL STRUCTURE OF A YEAST LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LTP1) COMPLEXED WITH THE SUBSTRATE PNPP	3.1.3.48 3.1.3.2
1D1U	USE OF AN N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE TO FACILITATE CRYSTALLIZATION AND ANALYSIS OF A PSEUDO-16-MER DNA MOLECULE CONTAINING G-A MISPAIRS	2.7.7.7 3.4.23 2.7.7.49 3.1.26.4 2.7.7 3.1
1D2A	CRYSTAL STRUCTURE OF A YEAST LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LTP1) COMPLEXED WITH THE ACTIVATOR ADENINE	3.1.3.48 3.1.3.2
1D2I	CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE BGLII COMPLEXED WITH DNA 16-MER	3.1.21.4
1D2K	C. IMMITIS CHITINASE 1 AT 2.2 ANGSTROMS RESOLUTION	3.2.1.14
1D2N	D2 DOMAIN OF N-ETHYLMALEIMIDE-SENSITIVE FUSION PROTEIN	3.6.4.6
1D2T	CRYSTAL STRUCTURE OF ACID PHOSPHATASE FROM ESCHERICHIA BLATTAE	3.1.3.2
1D2W	N-TERMINAL DOMAIN CORE METHIONINE MUTATION	3.2.1.17
1D2Y	N-TERMINAL DOMAIN CORE METHIONINE MUTATION	3.2.1.17
1D3D	CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZOTHIOPHENE INHIBITOR 4	3.4.21.5
1D3F	N-TERMINAL DOMAIN CORE METHIONINE MUTATION	3.2.1.17
1D3J	N-TERMINAL DOMAIN CORE METHIONINE MUTATION	3.2.1.17
1D3M	METHIONINE CORE MUTATION	3.2.1.17
1D3N	METHIONINE CORE MUTATION	3.2.1.17
1D3P	CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 3	3.4.21.5
1D3Q	CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 2	3.4.21.5
1D3T	CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 1	3.4.21.5
1D3V	CRYSTAL STRUCTURE OF THE BINUCLEAR MANGANESE METALLOENZYME ARGINASE COMPLEXED WITH 2(S)-AMINO-6-BORONOHEXANOIC ACID, AN L-ARGININE ANALOG	3.5.3.1
1D4F	CRYSTAL STRUCTURE OF RECOMBINANT RAT-LIVER D244E MUTANT S-ADENOSYLHOMOCYSTEINE HYDROLASE	3.3.1.1
1D4H	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1D4I	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1D4J	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1D4K	HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR	3.4.23.16
1D4L	HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR	3.4.23.16
1D4M	THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1D4P	CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5-AMIDINOINDOLE-4-BENZYLPIPERIDINE INHIBITOR	3.4.21.5
1D4S	HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1D4Y	HIV-1 PROTEASE TRIPLE MUTANT/TIPRANAVIR COMPLEX	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1D5G	SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E COMPLEXED WITH A PEPTIDE	3.1.3.48
1D5J	CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR.	3.4.24.17
1D5R	CRYSTAL STRUCTURE OF THE PTEN TUMOR SUPPRESSOR	3.1.3.48 3.1.3.16 3.1.3.67
1D6A	STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN COMPLEXED WITH GUANINE	3.2.2.22
1D6P	HUMAN LYSOZYME L63 MUTANT LABELLED WITH 2',3'-EPOXYPROPYL N,N'-DIACETYLCHITOBIOSE	3.2.1.17
1D6Q	HUMAN LYSOZYME E102 MUTANT LABELLED WITH 2',3'-EPOXYPROPYL GLYCOSIDE OF N-ACETYLLACTOSAMINE	3.2.1.17
1D6R	CRYSTAL STRUCTURE OF CANCER CHEMOPREVENTIVE BOWMAN-BIRK INHIBITOR IN TERNARY COMPLEX WITH BOVINE TRYPSIN AT 2.3 A RESOLUTION. STRUCTURAL BASIS OF JANUS-FACED SERINE PROTEASE INHIBITOR SPECIFICITY	3.4.21.4
1D6T	RNASE P PROTEIN FROM STAPHYLOCOCCUS AUREUS	3.1.26.5
1D6W	STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON-ELECTROPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1	3.4.21.5
1D7X	CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR.	3.4.24.17
1D8B	NMR STRUCTURE OF THE HRDC DOMAIN FROM SACCHAROMYCES CEREVISIAE RECQ HELICASE	3.6.4.12
1D8F	CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR.	3.4.24.17
1D8H	X-RAY CRYSTAL STRUCTURE OF YEAST RNA TRIPHOSPHATASE IN COMPLEX WITH SULFATE AND MANGANESE IONS.	3.1.3.33
1D8I	X-RAY CRYSTAL STRUCTURE OF YEAST RNA TRIPHOSPHATASE IN COMPLEX WITH A SULFATE ION.	3.1.3.33
1D8L	E. COLI HOLLIDAY JUNCTION BINDING PROTEIN RUVA NH2 REGION LACKING DOMAIN III	3.6.4.12
1D8M	CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE-BASED INHIBITOR	3.4.24.17
1D8V	THE RESTRAINED AND MINIMIZED AVERAGE NMR STRUCTURE OF MAP30.	3.2.2.22
1D9I	STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON-ELECTOPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1	3.4.21.5
1D9Q	OXIDIZED PEA FRUCTOSE-1,6-BISPHOSPHATASE FORM 1	3.1.3.11
1D9U	BACTERIOPHAGE LAMBDA LYSOZYME COMPLEXED WITH A CHITOHEXASACHARIDE	3.2.1.17 4.2.2
1D9W	BACTERIOPHAGE T4 LYSOZYME MUTANT	3.2.1.17
1DAN	COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR	3.4.21.21
1DAQ	SOLUTION STRUCTURE OF THE TYPE I DOCKERIN DOMAIN FROM THE CLOSTRIDIUM THERMOCELLUM CELLULOSOME (MINIMIZED AVERAGE STRUCTURE)	3.2.1.4 3.2.1.176
1DAV	SOLUTION STRUCTURE OF THE TYPE I DOCKERIN DOMAIN FROM THE CLOSTRIDIUM THERMOCELLUM CELLULOSOME (20 STRUCTURES)	3.2.1.4 3.2.1.176
1DAZ	STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1DB4	HUMAN S-PLA2 IN COMPLEX WITH INDOLE 8	3.1.1.4
1DB5	HUMAN S-PLA2 IN COMPLEX WITH INDOLE 6	3.1.1.4
1DBI	CRYSTAL STRUCTURE OF A THERMOSTABLE SERINE PROTEASE	3.4.21
1DBZ	C153S MUTANT OF PEA FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
1DC1	RESTRICTION ENZYME BSOBI/DNA COMPLEX STRUCTURE: ENCIRCLEMENT OF THE DNA AND HISTIDINE-CATALYZED HYDROLYSIS WITHIN A CANONICAL RESTRICTION ENZYME FOLD	3.1.21.4
1DCU	REDOX SIGNALING IN THE CHLOROPLAST: STRUCTURE OF OXIDIZED PEA FRUCTOSE-1,6-BISPHOSPHATE PHOSPHATASE	3.1.3.11
1DCY	CRYSTAL STRUCTURE OF HUMAN S-PLA2 IN COMPLEX WITH INDOLE 3 ACTIVE SITE INHIBITOR	3.1.1.4
1DD6	IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A MERCAPTOCARBOXYLATE INHIBITOR	3.5.2.6
1DDJ	CRYSTAL STRUCTURE OF HUMAN PLASMINOGEN CATALYTIC DOMAIN	3.4.21.7
1DDK	CRYSTAL STRUCTURE OF IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA	3.5.2.6
1DE3	SOLUTION STRUCTURE OF THE CYTOTOXIC RIBONUCLEASE ALPHA-SARCIN	3.1.27.10 4.6.1.23
1DE8	HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE-1 (APE1) BOUND TO ABASIC DNA	4.2.99.18 3.1
1DE9	HUMAN APE1 ENDONUCLEASE WITH BOUND ABASIC DNA AND MN2+ ION	4.2.99.18 3.1
1DEA	STRUCTURE AND CATALYTIC MECHANISM OF GLUCOSAMINE 6-PHOSPHATE DEAMINASE FROM ESCHERICHIA COLI AT 2.1 ANGSTROMS RESOLUTION	3.5.99.6
1DEF	PEPTIDE DEFORMYLASE CATALYTIC CORE (RESIDUES 1-147), NMR, 9 STRUCTURES	3.5.1.31 3.5.1.88
1DEO	RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.55 A RESOLUTION WITH SO4 IN THE ACTIVE SITE	3.1.1.86
1DET	RIBONUCLEASE T1 CARBOXYMETHYLATED AT GLU 58 IN COMPLEX WITH 2'GMP	3.1.27.3 4.6.1.24
1DEU	CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN X: A CYSTEINE PROTEASE WITH THE PROREGION COVALENTLY LINKED TO THE ACTIVE SITE CYSTEINE	3.4.18.1
1DEW	CRYSTAL STRUCTURE OF HUMAN APE1 BOUND TO ABASIC DNA	4.2.99.18 3.1
1DEX	RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.9 A RESOLUTION	3.1.1.86
1DF0	CRYSTAL STRUCTURE OF M-CALPAIN	3.4.22.53
1DFA	CRYSTAL STRUCTURE OF PI-SCEI IN C2 SPACE GROUP	7.1.2.2 3.1
1DFF	PEPTIDE DEFORMYLASE	3.5.1.31 3.5.1.88
1DFJ	RIBONUCLEASE INHIBITOR COMPLEXED WITH RIBONUCLEASE A	3.1.27.5 4.6.1.18
1DFM	CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE BGLII COMPLEXED WITH DNA 16-MER	3.1.21.4
1DFP	FACTOR D INHIBITED BY DIISOPROPYL FLUOROPHOSPHATE	3.4.21.46
1DFQ	THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH SIALIC ACID	3.4.24.68
1DG3	STRUCTURE OF HUMAN GUANYLATE BINDING PROTEIN-1 IN NUCLEOTIDE FREE FORM	3.6.5
1DG9	CRYSTAL STRUCTURE OF BOVINE LOW MOLECULAR WEIGHT PTPASE COMPLEXED WITH HEPES	3.1.3.48 3.1.3.2
1DGI	CRYO-EM STRUCTURE OF HUMAN POLIOVIRUS(SEROTYPE 1)COMPLEXED WITH THREE DOMAIN CD155	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1DHK	STRUCTURE OF PORCINE PANCREATIC ALPHA-AMYLASE	3.2.1.1
1DI3	ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME	3.2.1.17
1DI4	ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME	3.2.1.17
1DI5	ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME	3.2.1.17
1DIA	HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE COMPLEXED WITH NADP AND INHIBITOR LY249543	1.5.1.5 3.5.4.9 6.3.4.3
1DIB	HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE COMPLEXED WITH NADP AND INHIBITOR LY345899	1.5.1.5 3.5.4.9 6.3.4.3
1DIC	STRUCTURE OF 3,4-DICHLOROISOCOUMARIN-INHIBITED FACTOR D	3.4.21.46
1DIF	HIV-1 PROTEASE IN COMPLEX WITH A DIFLUOROKETONE CONTAINING INHIBITOR A79285	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1DIG	HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE COMPLEXED WITH NADP AND INHIBITOR LY374571	1.5.1.5 3.5.4.9 6.3.4.3
1DIL	SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH APANA AND EPANA INHIBITORS	3.2.1.18
1DIM	SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH EPANA INHIBITOR	3.2.1.18
1DIN	DIENELACTONE HYDROLASE AT 2.8 ANGSTROMS	3.1.1.45
1DIT	COMPLEX OF A DIVALENT INHIBITOR WITH THROMBIN	3.4.21.5
1DIW	THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH GALACTOSE	3.4.24.68
1DIX	CRYSTAL STRUCTURE OF RNASE LE	3.1.27.1 4.6.1.19
1DIZ	CRYSTAL STRUCTURE OF E. COLI 3-METHYLADENINE DNA GLYCOSYLASE (ALKA) COMPLEXED WITH DNA	3.2.2.21
1DJA	STRUCTURE OF BETA-LACTAMASE PRECURSOR, K73H MUTANT, AT 298K	3.5.2.6
1DJB	STRUCTURE OF BETA-LACTAMASE PRECURSOR, S70A MUTANT, AT 298K	3.5.2.6
1DJC	STRUCTURE OF BETA-LACTAMASE PRECURSOR, S70A MUTANT, AT 120K	3.5.2.6
1DJG	PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH LANTHANUM	3.1.4.11
1DJH	PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH BARIUM	3.1.4.11
1DJI	PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM	3.1.4.11
1DJO	CRYSTAL STRUCTURE OF PSEUDOMONAS 7A GLUTAMINASE-ASPARAGINASE WITH THE INHIBITOR DONV COVALENTLY BOUND IN THE ACTIVE SITE	3.5.1.38
1DJP	CRYSTAL STRUCTURE OF PSEUDOMONAS 7A GLUTAMINASE-ASPARAGINASE WITH THE INHIBITOR DON COVALENTLY BOUND IN THE ACTIVE SITE	3.5.1.38
1DJW	PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-1,2-CYCLIC-MONOPHOSPHONATE	3.1.4.11
1DJX	PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-1,4,5-TRISPHOSPHATE	3.1.4.11
1DJY	PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2,4,5-TRISPHOSPHATE	3.1.4.11
1DJZ	PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-4,5-BISPHOSPHATE	3.1.4.11
1DK4	CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE	3.1.3.25 3.1.3.11
1DKI	CRYSTAL STRUCTURE OF THE ZYMOGEN FORM OF STREPTOCOCCAL PYROGENIC EXOTOXIN B ACTIVE SITE (C47S) MUTANT	3.4.22.10
1DKJ	BOBWHITE QUAIL LYSOZYME	3.2.1.17
1DKK	BOBWHITE QUAIL LYSOZYME WITH NITRATE	3.2.1.17
1DKL	CRYSTAL STRUCTURE OF ESCHERICHIA COLI PHYTASE AT PH 4.5 (NO LIGAND BOUND)	3.1.3.2 3.1.3.26
1DKM	CRYSTAL STRUCTURE OF ESCHERICHIA COLI PHYTASE AT PH 6.6 WITH HG2+ CATION ACTING AS AN INTERMOLECULAR BRIDGE	3.1.3.2 3.1.3.26
1DKN	CRYSTAL STRUCTURE OF ESCHERICHIA COLI PHYTASE AT PH 5.0 WITH HG2+ CATION ACTING AS AN INTERMOLECULAR BRIDGE	3.1.3.2 3.1.3.26
1DKO	CRYSTAL STRUCTURE OF TUNGSTATE COMPLEX OF ESCHERICHIA COLI PHYTASE AT PH 6.6 WITH TUNGSTATE BOUND AT THE ACTIVE SITE AND WITH HG2+ CATION ACTING AS AN INTERMOLECULAR BRIDGE	3.1.3.2 3.1.3.26
1DKP	CRYSTAL STRUCTURE OF PHYTATE COMPLEX OF ESCHERICHIA COLI PHYTASE AT PH 6.6. PHYTATE IS BOUND WITH ITS 3-PHOSPHATE IN THE ACTIVE SITE. HG2+ CATION ACTS AS AN INTERMOLECULAR BRIDGE	3.1.3.2 3.1.3.26
1DKQ	CRYSTAL STRUCTURE OF PHYTATE COMPLEX ESCHERICHIA COLI PHYTASE AT PH 5.0. PHYTATE IS BOUND WITH ITS 3-PHOSPHATE IN THE ACTIVE SITE. HG2+ CATION ACTS AS AN INTERMOLECULAR BRIDGE	3.1.3.2 3.1.3.26
1DL2	CRYSTAL STRUCTURE OF CLASS I ALPHA-1,2-MANNOSIDASE FROM SACCHAROMYCES CEREVISIAE AT 1.54 ANGSTROM RESOLUTION	3.2.1.113
1DLE	FACTOR B SERINE PROTEASE DOMAIN	3.4.21.47
1DLK	CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR	3.4.21.1
1DLL	THE HC FRAGEMENT OF TETANUS TOXIN COMPLEXED WITH LACTOSE	3.4.24.68
1DLO	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1DM0	SHIGA TOXIN	3.2.2.22
1DM4	SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16)	3.4.21.5
1DMP	STRUCTURE OF HIV-1 PROTEASE COMPLEX	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1DMT	STRUCTURE OF HUMAN NEUTRAL ENDOPEPTIDASE COMPLEXED WITH PHOSPHORAMIDON	3.4.24.11
1DMU	CRYSTAL STRUCTURE OF THE RESTRICTION ENDONUCLEASE BGLI (E.C.3.1.21.4) BOUND TO ITS DNA RECOGNITION SEQUENCE	3.1.21.4
1DNK	THE X-RAY STRUCTURE OF THE DNASE I-D(GGTATACC)2 COMPLEX AT 2.3 ANGSTROMS RESOLUTION	3.1.21.1
1DOA	STRUCTURE OF THE RHO FAMILY GTP-BINDING PROTEIN CDC42 IN COMPLEX WITH THE MULTIFUNCTIONAL REGULATOR RHOGDI	3.6.5.2
1DOG	REFINED STRUCTURE FOR THE COMPLEX OF 1-DEOXYNOJIRIMYCIN WITH GLUCOAMYLASE FROM (ASPERGILLUS AWAMORI) VAR. X100 TO 2.4 ANGSTROMS RESOLUTION	3.2.1.3
1DOJ	CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN*RWJ-51438 COMPLEX AT 1.7 A	3.4.21.5
1DP5	THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR	3.4.23.25
1DPF	CRYSTAL STRUCTURE OF A MG-FREE FORM OF RHOA COMPLEXED WITH GDP	3.6.5.2
1DPJ	THE STRUCTURE OF PROTEINASE A COMPLEXED WITH IA3 PEPTIDE INHIBITOR	3.4.23.25
1DPM	THREE-DIMENSIONAL STRUCTURE OF THE ZINC-CONTAINING PHOSPHOTRIESTERASE WITH BOUND SUBSTRATE ANALOG DIETHYL 4-METHYLBENZYLPHOSPHONATE	3.1.8.1
1DPO	STRUCTURE OF RAT TRYPSIN	3.4.21.4
1DPW	STRUCTURE OF HEN EGG-WHITE LYSOZYME IN COMPLEX WITH MPD	3.2.1.17
1DPX	STRUCTURE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
1DPY	THREE-DIMENSIONAL STRUCTURE OF A NOVEL PHOSPHOLIPASE A2 FROM INDIAN COMMON KRAIT AT 2.45 A RESOLUTION	3.1.1.4
1DQ3	CRYSTAL STRUCTURE OF AN ARCHAEAL INTEIN-ENCODED HOMING ENDONUCLEASE PI-PFUI	1.17.4.1 3.1
1DS2	CRYSTAL STRUCTURE OF SGPB:OMTKY3-COO-LEU18I	3.4.21.81
1DSN	D60S N-TERMINAL LOBE HUMAN LACTOFERRIN	3.4.21
1DST	MUTANT OF FACTOR D WITH ENHANCED CATALYTIC ACTIVITY	3.4.21.46
1DSU	HUMAN FACTOR D, COMPLEMENT ACTIVATING ENZYME	3.4.21.46
1DT2	CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN B	3.4.21
1DT3	THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE	3.1.1.3
1DT5	THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE	3.1.1.3
1DTD	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE LEECH CARBOXYPEPTIDASE INHIBITOR AND THE HUMAN CARBOXYPEPTIDASE A2 (LCI-CPA2)	3.4.15.1 3.4.17.15
1DTE	THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE	3.1.1.3
1DTH	METALLOPROTEASE	3.4.24.42
1DTQ	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-1 (PETT131A94)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1DTT	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 (PETT130A94)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1DTZ	STRUCTURE OF CAMEL APO-LACTOFERRIN DEMONSTRATES ITS DUAL ROLE IN SEQUESTERING AND TRANSPORTING FERRIC IONS SIMULTANEOUSLY:CRYSTAL STRUCTURE OF CAMEL APO-LACTOFERRIN AT 2.6A RESOLUTION.	3.4.21
1DU4	THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE OTHER STRUCTURE DETAILS	3.1.1.3
1DUA	CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN A	3.4.21
1DUC	EIAV DUTPASE DUDP/STRONTIUM COMPLEX	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1DUD	DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDE HYDROLASE (D-UTPASE) COMPLEXED WITH THE SUBSTRATE ANALOGUE DEOXYURIDINE 5'-DIPHOSPHATE (D-UDP)	3.6.1.23
1DUE	CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN A S195A MUTANT	3.4.21
1DUI	SUBTILISIN BPN' FROM BACILLUS AMYLOLIQUEFACIENS, CRYSTAL GROWTH MUTANT	3.4.21.62
1DUN	EIAV DUTPASE NATIVE	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1DUP	DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDO HYDROLASE (D-UTPASE)	3.6.1.23
1DUT	FIV DUTP PYROPHOSPHATASE	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1DVA	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA	3.4.21.21
1DW6	STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1DWA	STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 1: STRUCTURE PRIOR TO IRRADIATION	3.2.1.147
1DWB	CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTIVE SITE-DIRECTED INHIBITORS	3.4.21.5
1DWC	CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTIVE SITE-DIRECTED INHIBITORS	3.4.21.5
1DWD	CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTIVE SITE-DIRECTED INHIBITORS	3.4.21.5
1DWE	CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTIVE SITE-DIRECTED INHIBITORS	3.4.21.5
1DWF	STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 2: STRUCTURE AFTER IRRADIATION WITH 9.1*10E15 PHOTONS/MM2	3.2.1.147
1DWG	STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL: PART 3 STRUCTURE AFTER IRRADIATION WITH 18.2*10E15 PHOTONS/MM2.	3.2.1.147
1DWH	STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 4: STRUCTURE AFTER IRRADIATION WITH 27.2*10E15 PHOTONS/MM2	3.2.1.147
1DWI	STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 5: STRUCTURE AFTER IRRADIATION WITH 54.0*10E15 PHOTONS/MM2	3.2.1.147
1DWJ	STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. REFINED PART 6: STRUCTURE AFTER A RADIATION DOSE OF 54*10E15 PHOTONS/MM2	3.2.1.147
1DX4	ACHE FROM DROSOPHILA MELANOGASTER COMPLEX WITH TACRINE DERIVATIVE 9-(3-PHENYLMETHYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	3.1.1.7
1DX5	CRYSTAL STRUCTURE OF THE THROMBIN-THROMBOMODULIN COMPLEX	3.4.21.5
1DX6	STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-GALANTHAMINE AT 2.3A RESOLUTION	3.1.1.7
1DXJ	STRUCTURE OF THE CHITINASE FROM JACK BEAN	3.2.1.14
1DXK	METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS 569/H/9 C168S MUTANT	3.5.2.6
1DXP	INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (APO STRUCTURE)	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1DY4	CBH1 IN COMPLEX WITH S-PROPRANOLOL	3.2.1.91
1DY5	DEAMIDATED DERIVATIVE OF BOVINE PANCREATIC RIBONUCLEASE	3.1.27.5 4.6.1.18
1DY6	STRUCTURE OF THE IMIPENEM-HYDROLYZING BETA-LACTAMASE SME-1	3.5.2.6
1DY8	INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR II)	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1DY9	INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR I)	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1DYA	DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1DYB	DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1DYC	DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1DYD	DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1DYE	DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1DYF	DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1DYG	DETERMINATION OF ALPHA-HELIX PROPENSITY WITHIN THE CONTEXT OF A FOLDED PROTEIN: SITES 44 AND 131 IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1DYL	9 ANGSTROM RESOLUTION CRYO-EM RECONSTRUCTION STRUCTURE OF SEMLIKI FOREST VIRUS (SFV) AND FITTING OF THE CAPSID PROTEIN STRUCTURE IN THE EM DENSITY	3.4.21.90
1DYM	HUMICOLA INSOLENS ENDOCELLULASE CEL7B (EG 1) E197A MUTANT	3.2.1.4
1DYN	CRYSTAL STRUCTURE AT 2.2 ANGSTROMS RESOLUTION OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM HUMAN DYNAMIN	3.6.5.5
1DYO	XYLAN-BINDING DOMAIN FROM CBM 22, FORMALLY X6B DOMAIN	3.2.1.8
1DYP	1,3-ALPHA-1,4-BETA-D-GALACTOSE-4-SULFATE-3,6-ANHYDRO-D-GALACTOSE 4 GALACTOHYDROLASE	3.2.1.83
1DYS	ENDOGLUCANASE CEL6B FROM HUMICOLA INSOLENS	3.2.1.4
1DYT	X-RAY CRYSTAL STRUCTURE OF ECP (RNASE 3) AT 1.75 A	3.1.27
1DZA	3-D STRUCTURE OF A HP-RNASE	3.1.27.5 4.6.1.18
1E0A	CDC42 COMPLEXED WITH THE GTPASE BINDING DOMAIN OF P21 ACTIVATED KINASE	3.6.5.2
1E0E	N-TERMINAL ZINC-BINDING HHCC DOMAIN OF HIV-2 INTEGRASE	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1E0F	CRYSTAL STRUCTURE OF THE HUMAN ALPHA-THROMBIN-HAEMADIN COMPLEX: AN EXOSITE II-BINDING INHIBITOR	3.4.21.5
1E0J	GP4D HELICASE FROM PHAGE T7 ADPNP COMPLEX	2.7.7 3.6.4.12
1E0K	GP4D HELICASE FROM PHAGE T7	2.7.7 3.6.4.12
1E0V	XYLANASE 10A FROM SREPTOMYCES LIVIDANS. CELLOBIOSYL-ENZYME INTERMEDIATE AT 1.7 A	3.2.1.8
1E0W	XYLANASE 10A FROM SREPTOMYCES LIVIDANS. NATIVE STRUCTURE AT 1.2 ANGSTROM RESOLUTION	3.2.1.8
1E0X	XYLANASE 10A FROM SREPTOMYCES LIVIDANS. XYLOBIOSYL-ENZYME INTERMEDIATE AT 1.65 A	3.2.1.8
1E1A	CRYSTAL STRUCTURE OF DFPASE FROM LOLIGO VULGARIS	3.1.8.2
1E1E	CRYSTAL STRUCTURE OF A MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE	3.2.1.21 3.2.1.182
1E1F	CRYSTAL STRUCTURE OF A MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE IN COMPLEX WITH P-NITROPHENYL-BETA-D-THIOGLUCOSIDE	3.2.1.21 3.2.1.182
1E1H	CRYSTAL STRUCTURE OF RECOMBINANT BOTULINUM NEUROTOXIN TYPE A LIGHT CHAIN, SELF-INHIBITING ZN ENDOPEPTIDASE.	3.4.24.69
1E1Z	CRYSTAL STRUCTURE OF AN ARYLSULFATASE A MUTANT C69S	3.1.6.8
1E21	RIBONUCLEASE 1 DES1-7 CRYSTAL STRUCTURE AT 1.9A	3.1.27.5 4.6.1.18
1E25	THE HIGH RESOLUTION STRUCTURE OF PER-1 CLASS A BETA-LACTAMASE	3.5.2.6
1E2S	CRYSTAL STRUCTURE OF AN ARYLSULFATASE A MUTANT C69A	3.1.6.8
1E32	STRUCTURE OF THE N-TERMINAL DOMAIN AND THE D1 AAA DOMAIN OF MEMBRANE FUSION ATPASE P97	3.6.4.6
1E33	CRYSTAL STRUCTURE OF AN ARYLSULFATASE A MUTANT P426L	3.1.6.8
1E34	PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA- TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID) PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR ONE MINUTE	3.4.21.36
1E35	PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-TOLUENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR TWO MINUTES	3.4.21.36
1E36	PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE	3.4.21.36
1E37	PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR 1 MINUTE	3.4.21.36
1E38	PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR 2 MINUTES	3.4.21.36
1E3A	A SLOW PROCESSING PRECURSOR PENICILLIN ACYLASE FROM ESCHERICHIA COLI	3.5.1.11
1E3C	CRYSTAL STRUCTURE OF AN ARYLSULFATASE A MUTANT C69S SOAKED IN SYNTHETIC SUBSTRATE	3.1.6.8
1E3Q	TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH BW284C51	3.1.1.7
1E3U	MAD STRUCTURE OF OXA10 CLASS D BETA-LACTAMASE	3.5.2.6
1E3X	NATIVE STRUCTURE OF CHIMAERIC AMYLASE FROM B. AMYLOLIQUEFACIENS AND B. LICHENIFORMIS AT 1.92A	3.2.1.1
1E3Z	ACARBOSE COMPLEX OF CHIMAERIC AMYLASE FROM B. AMYLOLIQUEFACIENS AND B. LICHENIFORMIS AT 1.93A	3.2.1.1
1E40	TRIS/MALTOTRIOSE COMPLEX OF CHIMAERIC AMYLASE FROM B. AMYLOLIQUEFACIENS AND B. LICHENIFORMIS AT 2.2A	3.2.1.1
1E43	NATIVE STRUCTURE OF CHIMAERIC AMYLASE FROM B. AMYLOLIQUEFACIENS AND B. LICHENIFORMIS AT 1.7A	3.2.1.1
1E4D	STRUCTURE OF OXA10 BETA-LACTAMASE AT PH 8.3	3.5.2.6
1E4I	2-DEOXY-2-FLUORO-BETA-D-GLUCOSYL/ENZYME INTERMEDIATE COMPLEX OF THE BETA-GLUCOSIDASE FROM BACILLUS POLYMYXA	3.2.1.21
1E4L	CRYSTAL STRUCTURE OF THE INACTIVE MUTANT MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE ZM GLU191ASP	3.2.1.21 3.2.1.182
1E4M	MYROSINASE FROM SINAPIS ALBA	3.2.1.147
1E4N	CRYSTAL STRUCTURE OF THE INACTIVE MUTANT MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE ZMGLUE191D IN COMPLEX WITH THE NATURAL AGLYCONE DIMBOA	3.2.1.21 3.2.1.182
1E55	CRYSTAL STRUCTURE OF THE INACTIVE MUTANT MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE ZMGLUE191D IN COMPLEX WITH THE COMPETITIVE INHIBITOR DHURRIN	3.2.1.21 3.2.1.182
1E56	CRYSTAL STRUCTURE OF THE INACTIVE MUTANT MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE ZMGLUE191D IN COMPLEX WITH THE NATURAL SUBSTRATE DIMBOA-BETA-D-GLUCOSIDE	3.2.1.21 3.2.1.182
1E5B	INTERNAL XYLAN BINDING DOMAIN FROM C. FIMI XYN10A, R262G MUTANT	3.2.1.8 3.5.1
1E5C	INTERNAL XYLAN BINDING DOMAIN FROM C. FIMI XYN10A, R262G MUTANT	3.2.1.8 3.5.1
1E5J	ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE TETRAGONAL CRYSTAL FORM IN COMPLEX WITH METHYL-4II-S-ALPHA-CELLOBIOSYL-4II-THIO-BETA-CELLOBIOSIDE	3.2.1.4
1E5N	E246C MUTANT OF P FLUORESCENS SUBSP. CELLULOSA XYLANASE A IN COMPLEX WITH XYLOPENTAOSE	3.2.1.8
1E5O	ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2	3.4.23.23 3.4.23.22
1E5T	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT	3.4.21.26
1E66	STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-HUPRINE X AT 2.1A RESOLUTION	3.1.1.7
1E6A	FLUORIDE-INHIBITED SUBSTRATE COMPLEX OF SACCHAROMYCES CEREVISIAE INORGANIC PYROPHOSPHATASE	3.6.1.1
1E6N	CHITINASE B FROM SERRATIA MARCESCENS INACTIVE MUTANT E144Q IN COMPLEX WITH N-ACETYLGLUCOSAMINE-PENTAMER	3.2.1.14
1E6Q	MYROSINASE FROM SINAPIS ALBA WITH THE BOUND TRANSITION STATE ANALOGUE GLUCO-TETRAZOLE	3.2.3.1 3.2.1.147
1E6S	MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE	3.2.1.147
1E6X	MYROSINASE FROM SINAPIS ALBA WITH A BOUND TRANSITION STATE ANALOGUE,D-GLUCONO-1,5-LACTONE	3.2.3.1 3.2.1.147
1E6Z	CHITINASE B FROM SERRATIA MARCESCENS WILDTYPE IN COMPLEX WITH CATALYTIC INTERMEDIATE	3.2.1.14
1E70	2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA	3.2.1.147
1E71	MYROSINASE FROM SINAPIS ALBA WITH BOUND ASCORBATE	3.2.1.147
1E72	MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE OR ASCORBATE	3.2.3.1 3.2.1.147
1E73	2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA WITH BOUND L-ASCORBATE	3.2.1.147
1E7D	ENDONUCLEASE VII (ENDOVII) FFROM PHAGE T4	3.1.22.4 3.1
1E7L	ENDONUCLEASE VII (ENDOVII) N62D MUTANT FROM PHAGE T4	3.1.22.4 3.1
1E80	ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD56133	3.4.23.23 3.4.23.22
1E81	ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD61395	3.4.23.23 3.4.23.22
1E82	ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD59601	3.4.23.23 3.4.23.22
1E8L	NMR SOLUTION STRUCTURE OF HEN LYSOZYME	3.2.1.17
1E8M	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH INHIBITOR	3.4.21.26
1E8N	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH PEPTIDE	3.4.21.26
1E8P	CHARACTERISATION OF THE CELLULOSE DOCKING DOMAIN FROM PIROMYCES EQUI	3.2.1.4
1E8Q	CHARACTERISATION OF THE CELLULOSE DOCKING DOMAIN FROM PIROMYCES EQUI	3.2.1.4
1E8R	SOLUTION STRUCTURE OF TYPE X CBD	3.2.1.8
1E8T	STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE	3.2.1.18
1E8U	STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE	3.2.1.18
1E8V	STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE	3.2.1.18
1E94	HSLV-HSLU FROM E.COLI	3.4.25.2
1E96	STRUCTURE OF THE RAC/P67PHOX COMPLEX	3.6.5.2
1E9G	STRUCTURE OF INORGANIC PYROPHOSPHATASE	3.6.1.1
1E9K	THE STRUCTURE OF THE RACK1 INTERACTION SITES LOCATED WITHIN THE UNIQUE N-TERMINAL REGION OF THE CAMP-SPECIFIC PHOSPHODIESTERASE, PDE4D5.	3.1.4.53
1E9L	THE CRYSTAL STRUCTURE OF NOVEL MAMMALIAN LECTIN YM1 SUGGESTS A SACCHARIDE BINDING SITE	3.2.1.52
1E9N	A SECOND DIVALENT METAL ION IN THE ACTIVE SITE OF A NEW CRYSTAL FORM OF HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE, APE1, AND ITS IMPLICATIONS FOR THE CATALYTIC MECHANISM	4.2.99.18 3.1
1E9Y	CRYSTAL STRUCTURE OF HELICOBACTER PYLORI UREASE IN COMPLEX WITH ACETOHYDROXAMIC ACID	3.5.1.5
1E9Z	CRYSTAL STRUCTURE OF HELICOBACTER PYLORI UREASE	3.5.1.5
1EA5	NATIVE ACETYLCHOLINESTERASE (E.C. 3.1.1.7) FROM TORPEDO CALIFORNICA AT 1.8A RESOLUTION	3.1.1.7
1EA6	N-TERMINAL 40KDA FRAGMENT OF NHPMS2 COMPLEXED WITH ADP	3.1
1EA9	CYCLOMALTODEXTRINASE	3.2.1.54
1EAG	SECRETED ASPARTIC PROTEINASE (SAP2) FROM CANDIDA ALBICANS COMPLEXED WITH A70450	3.4.23.24
1EAH	PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1EAI	COMPLEX OF ASCARIS CHYMOTRPSIN/ELASTASE INHIBITOR WITH PORCINE ELASTASE	3.4.21.36
1EAK	CATALYTIC DOMAIN OF PROMMP-2 E404Q MUTANT	3.4.24.24
1EAS	NONPEPTIDIC INHIBITORS OF HUMAN LEUKOCYTE ELASTASE. 3. DESIGN, SYNTHESIS, X-RAY CRYSTALLOGRAPHIC ANALYSIS, AND STRUCTURE-ACTIVITY RELATIONSHIPS FOR A SERIES OF ORALLY ACTIVE 3-AMINO-6-PHENYLPYRIDIN-2-ONE TRIFLUOROMETHYL KETONES	3.4.21.36
1EAT	NONPEPTIDIC INHIBITORS OF HUMAN LEUKOCYTE ELASTASE. 5. DESIGN, SYNTHESIS, AND X-RAY CRYSTALLOGRAPHY OF A SERIES OF ORALLY ACTIVE 5-AMINO-PYRIMIDIN-6-ONE-CONTAINING TRIFLUOROMETHYLKETONES	3.4.21.36
1EAU	NONPEPTIDIC INHIBITORS OF HUMAN LEUKOCYTE ELASTASE. 6. DESIGN OF A POTENT, INTRATRACHEALLY ACTIVE, PYRIDONE-BASED TRIFLUOROMETHYL KETONE	3.4.21.36
1EAW	CRYSTAL STRUCTURE OF THE MTSP1 (MATRIPTASE)-BPTI (APROTININ) COMPLEX	3.4.21 3.4.21.109
1EAX	CRYSTAL STRUCTURE OF MTSP1 (MATRIPTASE)	3.4.21 3.4.21.109
1EB2	TRYPSIN INHIBITOR COMPLEX (BPO)	3.4.21.4
1EB6	DEUTEROLYSIN FROM ASPERGILLUS ORYZAE	3.4.24.39
1EBK	STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EBM	CRYSTAL STRUCTURE OF THE HUMAN 8-OXOGUANINE GLYCOSYLASE (HOGG1) BOUND TO A SUBSTRATE OLIGONUCLEOTIDE	3.2.2 4.2.99.18
1EBW	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EBY	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EBZ	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EC0	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EC1	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EC2	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EC3	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1ECE	ACIDOTHERMUS CELLULOLYTICUS ENDOCELLULASE E1 CATALYTIC DOMAIN IN COMPLEX WITH A CELLOTETRAOSE	3.2.1.4
1ECV	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 5-IODO-2-(OXALYL-AMINO)-BENZOIC ACID	3.1.3.48
1ECW	CRYSTAL STRUCTURE OF SIMIAN IMMUNODEFICIENCY VIRUS MATRIX ANTIGEN (SIV MA) AT 293K.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1ED1	CRYSTAL STRUCTURE OF SIMIAN IMMUNODEFICIENCY VIRUS MATRIX ANTIGEN (SIV MA) AT 100K.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1ED7	SOLUTION STRUCTURE OF THE CHITIN-BINDING DOMAIN OF BACILLUS CIRCULANS WL-12 CHITINASE A1	3.2.1.14
1ED8	STRUCTURE OF E. COLI ALKALINE PHOSPHATASE INHIBITED BY THE INORGANIC PHOSPHATE AT 1.75A RESOLUTION	3.1.3.1
1ED9	STRUCTURE OF E. COLI ALKALINE PHOSPHATASE WITHOUT THE INORGANIC PHOSPHATE AT 1.75A RESOLUTION	3.1.3.1
1EDB	CRYSTALLOGRAPHIC AND FLUORESCENCE STUDIES OF THE INTERACTION OF HALOALKANE DEHALOGENASE WITH HALIDE IONS: STUDIES WITH HALIDE COMPOUNDS REVEAL A HALIDE BINDING SITE IN THE ACTIVE SITE	3.8.1.5
1EDD	CRYSTALLOGRAPHIC AND FLUORESCENCE STUDIES OF THE INTERACTION OF HALOALKANE DEHALOGENASE WITH HALIDE IONS: STUDIES WITH HALIDE COMPOUNDS REVEAL A HALIDE BINDING SITE IN THE ACTIVE SITE	3.8.1.5
1EDE	REFINED X-RAY STRUCTURES OF HALOALKANE DEHALOGENASE AT PH 6.2 AND PH 8.2 AND IMPLICATIONS FOR THE REACTION MECHANISM	3.8.1.5
1EDG	SINGLE CRYSTAL STRUCTURE DETERMINATION OF THE CATALYTIC DOMAIN OF CELCCA CARRIED OUT AT 15 DEGREE C	3.2.1.4
1EDM	EPIDERMAL GROWTH FACTOR-LIKE DOMAIN FROM HUMAN FACTOR IX	3.4.21.22
1EDQ	CRYSTAL STRUCTURE OF CHITINASE A FROM S. MARCESCENS AT 1.55 ANGSTROMS	3.2.1.14
1EDT	CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H AT 1.9 ANGSTROMS RESOLUTION: ACTIVE SITE GEOMETRY AND SUBSTRATE RECOGNITION	3.2.1.96
1EE3	CADMIUM-SUBSTITUTED BOVINE PANCREATIC CARBOXYPEPTIDASE A (ALFA-FORM) AT PH 7.5 AND 2 MM CHLORIDE IN MONOCLINIC CRYSTAL FORM	3.4.17.1
1EE8	CRYSTAL STRUCTURE OF MUTM (FPG) PROTEIN FROM THERMUS THERMOPHILUS HB8	3.2.2.23 4.2.99.18
1EEA	ACETYLCHOLINESTERASE	3.1.1.7
1EED	X-RAY CRYSTALLOGRAPHIC ANALYSIS OF INHIBITION OF ENDOTHIAPEPSIN BY CYCLOHEXYL RENIN INHIBITORS	3.4.23.22
1EEN	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-D-A-D-BPA-PTYR-L-I-P-Q-Q-G	3.1.3.48
1EEO	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-E-L-E-F-PTYR-M-D-Y-E-NH2	3.1.3.48
1EES	SOLUTION STRUCTURE OF CDC42HS COMPLEXED WITH A PEPTIDE DERIVED FROM P-21 ACTIVATED KINASE, NMR, 20 STRUCTURES	3.6.5.2
1EET	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EF0	CRYSTAL STRUCTURE OF PI-SCEI MINIPRECURSOR	7.1.2.2 3.1
1EF2	CRYSTAL STRUCTURE OF MANGANESE-SUBSTITUTED KLEBSIELLA AEROGENES UREASE	3.5.1.5
1EF7	CRYSTAL STRUCTURE OF HUMAN CATHEPSIN X	3.4.18.1
1EG1	ENDOGLUCANASE I FROM TRICHODERMA REESEI	3.2.1.4
1EGN	CELLOBIOHYDROLASE CEL7A (E223S, A224H, L225V, T226A, D262G) MUTANT	3.2.1.91
1EGQ	ENHANCEMENT OF ENZYME ACTIVITY THROUGH THREE-PHASE PARTITIONING: CRYSTAL STRUCTURE OF A MODIFIED SERINE PROTEINASE AT 1.5 A RESOLUTION	3.4.21.64
1EGZ	CELLULASE CEL5 FROM ERWINIA CHRYSANTHEMI, A FAMILY GH 5-2 ENZYME	3.2.1.4
1EH3	R210K N-TERMINAL LOBE HUMAN LACTOFERRIN	3.4.21
1EH5	CRYSTAL STRUCTURE OF PALMITOYL PROTEIN THIOESTERASE 1 COMPLEXED WITH PALMITATE	3.1.2.22
1EH9	CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS GLYCOSYLTREHALOSE TREHALOHYDROLASE	3.2.1.1 3.2.1.141
1EHA	CRYSTAL STRUCTURE OF GLYCOSYLTREHALOSE TREHALOHYDROLASE FROM SULFOLOBUS SOLFATARICUS	3.2.1.1 3.2.1.141
1EHN	CRYSTAL STRUCTURE OF CHITINASE A MUTANT E315Q COMPLEXED WITH OCTA-N-ACETYLCHITOOCTAOSE (NAG)8.	3.2.1.14
1EHY	X-RAY STRUCTURE OF THE EPOXIDE HYDROLASE FROM AGROBACTERIUM RADIOBACTER AD1	3.3.2.10 3.3.2.3
1EI5	CRYSTAL STRUCTURE OF A D-AMINOPEPTIDASE FROM OCHROBACTRUM ANTHROPI	3.4.11.19
1EI6	CRYSTAL STRUCTURE OF PHOSPHONOACETATE HYDROLASE COMPLEXED WITH PHOSPHONOFORMATE	3.11.1.2
1EI9	CRYSTAL STRUCTURE OF PALMITOYL PROTEIN THIOESTERASE 1	3.1.2.22
1EIB	CRYSTAL STRUCTURE OF CHITINASE A MUTANT D313A COMPLEXED WITH OCTA-N-ACETYLCHITOOCTAOSE (NAG)8.	3.2.1.14
1EIC	CRYSTAL STRUCTURE OF F120A MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1EID	CRYSTAL STRUCTURE OF F120G MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1EIE	CRYSTAL STRUCTURE OF F120W MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1EIN	THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE	3.1.1.3
1EJA	STRUCTURE OF PORCINE TRYPSIN COMPLEXED WITH BDELLASTASIN, AN ANTISTASIN-TYPE INHIBITOR	3.4.21.4
1EJM	CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN	3.4.21.4
1EJN	UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN INHIBITOR COMPLEX	3.4.21.73
1EJR	CRYSTAL STRUCTURE OF THE D221A VARIANT OF KLEBSIELLA AEROGENES UREASE	3.5.1.5
1EJS	CRYSTAL STRUCTURE OF THE H219N VARIANT OF KLEBSIELLA AEROGENES UREASE	3.5.1.5
1EJT	CRYSTAL STRUCTURE OF THE H219Q VARIANT OF KLEBSIELLA AEROGENES UREASE	3.5.1.5
1EJU	CRYSTAL STRUCTURE OF THE H320N VARIANT OF KLEBSIELLA AEROGENES UREASE	3.5.1.5
1EJV	CRYSTAL STRUCTURE OF THE H320Q VARIANT OF KLEBSIELLA AEROGENES UREASE	3.5.1.5
1EJW	CRYSTAL STRUCTURE OF WILD-TYPE KLEBSIELLA AEROGENES UREASE AT 298K	3.5.1.5
1EJX	CRYSTAL STRUCTURE OF WILD-TYPE KLEBSIELLA AEROGENES UREASE AT 100K	3.5.1.5
1EKB	THE SERINE PROTEASE DOMAIN OF ENTEROPEPTIDASE BOUND TO INHIBITOR VAL-ASP-ASP-ASP-ASP-LYS-CHLOROMETHANE	3.4.21.9
1EKE	CRYSTAL STRUCTURE OF CLASS II RIBONUCLEASE H (RNASE HII) WITH MES LIGAND	3.1.26.4
1EL1	X-RAY CRYSTAL STRUCTURE ANALYSIS OF CANINE MILK LYSOZYME (HOLO-TYPE)	3.2.1.17
1ELA	ANALOGOUS INHIBITORS OF ELASTASE DO NOT ALWAYS BIND ANALOGOUSLY	3.4.21.36
1ELB	ANALOGOUS INHIBITORS OF ELASTASE DO NOT ALWAYS BIND ANALOGOUSLY	3.4.21.36
1ELC	ANALOGOUS INHIBITORS OF ELASTASE DO NOT ALWAYS BIND ANALOGOUSLY	3.4.21.36
1ELD	STRUCTURAL ANALYSIS OF THE ACTIVE SITE OF PORCINE PANCREATIC ELASTASE BASED ON THE X-RAY CRYSTAL STRUCTURES OF COMPLEXES WITH TRIFLUOROACETYL-DIPEPTIDE-ANILIDE INHIBITORS	3.4.21.36
1ELE	STRUCTURAL ANALYSIS OF THE ACTIVE SITE OF PORCINE PANCREATIC ELASTASE BASED ON THE X-RAY CRYSTAL STRUCTURES OF COMPLEXES WITH TRIFLUOROACETYL-DIPEPTIDE-ANILIDE INHIBITORS	3.4.21.36
1ELF	NATURE OF THE INACTIVATION OF ELASTASE BY N-PEPTIDYL-O-AROYL HYDROXYLAMINE AS A FUNCTION OF PH	3.4.21.36
1ELG	NATURE OF THE INACTIVATION OF ELASTASE BY N-PEPTIDYL-O-AROYL HYDROXYLAMINE AS A FUNCTION OF PH	3.4.21.36
1ELL	CADMIUM-SUBSTITUTED BOVINE PANCREATIC CARBOXYPEPTIDASE A (ALFA-FORM) AT PH 7.5 AND 0.25 M CHLORIDE IN MONOCLINIC CRYSTAL FORM.	3.4.17.1
1ELM	CADMIUM-SUBSTITUTED BOVINE PACREATIC CARBOXYPEPTIDASE A (ALFA-FORM) AT PH 5.5 AND 2 MM CHLORIDE IN MONOCLINIC CRYSTAL FORM.	3.4.17.1
1ELT	STRUCTURE OF NATIVE PANCREATIC ELASTASE FROM NORTH ATLANTIC SALMON AT 1.61 ANGSTROMS RESOLUTION	3.4.21.36
1ELV	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COMPLEMENT C1S PROTEASE	3.4.21.42
1ELX	E. COLI ALKALINE PHOSPHATASE MUTANT (S102A)	3.1.3.1
1ELY	E. COLI ALKALINE PHOSPHATASE MUTANT (S102C)	3.1.3.1
1ELZ	E. COLI ALKALINE PHOSPHATASE MUTANT (S102G)	3.1.3.1
1EM9	ROUS SARCOMA VIRUS CAPSID PROTEIN: N-TERMINAL DOMAIN	3.4.23
1EMH	CRYSTAL STRUCTURE OF HUMAN URACIL-DNA GLYCOSYLASE BOUND TO UNCLEAVED SUBSTRATE-CONTAINING DNA	3.2.2.3 3.2.2.27
1EMJ	URACIL-DNA GLYCOSYLASE BOUND TO DNA CONTAINING A 4'-THIO-2'DEOXYURIDINE ANALOG PRODUCT	3.2.2.3 3.2.2.27
1EMS	CRYSTAL STRUCTURE OF THE C. ELEGANS NITFHIT PROTEIN	3.6.1.29 3.5
1EN2	UDA TETRASACCHARIDE COMPLEX. CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ, A SUPERANTIGEN PRESENTED BY MHC MOLECULES OF CLASS I AND CLASS II	3.2.1.14
1EN7	ENDONUCLEASE VII (ENDOVII) FROM PHAGE T4	3.1.22.4 3.1
1ENA	CRYSTAL STRUCTURES OF THE BINARY CA2+ AND PDTP COMPLEXES AND THE TERNARY COMPLEX OF THE ASP 21->GLU MUTANT OF STAPHYLOCOCCAL NUCLEASE. IMPLICATIONS FOR CATALYSIS AND LIGAND BINDING	3.1.31.1
1ENC	CRYSTAL STRUCTURES OF THE BINARY CA2+ AND PDTP COMPLEXES AND THE TERNARY COMPLEX OF THE ASP 21->GLU MUTANT OF STAPHYLOCOCCAL NUCLEASE. IMPLICATIONS FOR CATALYSIS AND LIGAND BINDING	3.1.31.1
1ENI	CRYSTAL STRUCTURE OF A PYRIMIDINE DIMER SPECIFIC EXCISION REPAIR ENZYME FROM BACTERIOPHAGE T4: REFINEMENT AT 1.45 ANGSTROMS AND X-RAY ANALYSIS OF THE THREE ACTIVE SITE MUTANTS	3.1.25.1 3.2.2.17 4.2.99.18
1ENJ	CRYSTAL STRUCTURE OF A PYRIMIDINE DIMER SPECIFIC EXCISION REPAIR ENZYME FROM BACTERIOPHAGE T4: REFINEMENT AT 1.45 ANGSTROMS AND X-RAY ANALYSIS OF THE THREE ACTIVE SITE MUTANTS	3.1.25.1 3.2.2.17 4.2.99.18
1ENK	CRYSTAL STRUCTURE OF A PYRIMIDINE DIMER SPECIFIC EXCISION REPAIR ENZYME FROM BACTERIOPHAGE T4: REFINEMENT AT 1.45 ANGSTROMS AND X-RAY ANALYSIS OF THE THREE ACTIVE SITE MUTANTS	3.1.25.1 3.2.2.17 4.2.99.18
1ENM	UDA TRISACCHARIDE COMPLEX. CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ, A SUPERANTIGEN PRESENTED BY MHC MOLECULES OF CLASS I AND CLASS II	3.2.1.14
1ENT	X-RAY ANALYSES OF ASPARTIC PROTEINASES. THE THREE-DIMENSIONAL STRUCTURE AT 2.1 ANGSTROMS RESOLUTION OF ENDOTHIAPEPSIN	3.4.23.22
1ENX	STRUCTURAL COMPARISON OF TWO MAJOR ENDO-1,4-BETA-XYLANASES FROM TRICHODREMA REESEI	3.2.1.8
1EO3	INHIBITION OF ECORV ENDONUCLEASE BY DEOXYRIBO-3'-S-PHOSPHOROTHIOLATES: A HIGH RESOLUTION X-RAY CRYSTALLOGRAPHIC STUDY	3.1.21.4
1EO4	ECORV BOUND TO MN2+ AND COGNATE DNA CONTAINING A 3'S SUBSTITION AT THE CLEAVAGE SITE	3.1.21.4
1EOI	CRYSTAL STRUCTURE OF ACID PHOSPHATASE FROM ESCHERICHIA BLATTAE COMPLEXED WITH THE TRANSITION STATE ANALOG MOLYBDATE	3.1.3.2
1EOJ	DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES	3.4.21.5
1EOK	CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F3	3.2.1.96
1EOL	DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES	3.4.21.5
1EOM	CRYSTAL STRUCTURE OF THE COMPLEX OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F3 WITH A BIANTENNARY COMPLEX OCTASACCHARIDE	3.2.1.96
1EON	ECORV BOUND TO 3'-S-PHOSPHOROTHIOLATE DNA AND CA2+	3.1.21.4
1EOO	ECORV BOUND TO COGNATE DNA	3.1.21.4
1EOP	ECORV BOUND TO COGNATE DNA	3.1.21.4
1EOQ	ROUS SARCOMA VIRUS CAPSID PROTEIN: C-TERMINAL DOMAIN	3.4.23
1EOS	CRYSTAL STRUCTURE OF RIBONUCLEASE A COMPLEXED WITH URIDYLYL(2',5')GUANOSINE (PRODUCTIVE BINDING)	3.1.27.5 4.6.1.18
1EOW	CRYSTAL STRUCTURE OF RIBONUCLEASE A COMPLEXED WITH URIDYLYL(2',5')GUANOSINE (NON-PRODUCTIVE BINDING)	3.1.27.5 4.6.1.18
1EP4	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S-1153	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EP5	CRYSTAL STRUCTURE OF THE CONSERVED CORE DOMAIN OF VENEZUALAN EQUINE ENCEPHALITIS CAPSID PROTEIN	3.4.21 3.4.21.90
1EP6	CRYSTAL STRUCTURE OF THE CONSERVED CORE DOMAIN OF VENEZUALAN EQUINE ENCEPHALITIS CAPSID PROTEIN	3.4.21 3.4.21.90
1EPL	A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA	3.4.23.22
1EPM	A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA	3.4.23.22
1EPN	A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA	3.4.23.22
1EPO	ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH CP-81,282 (MOR PHE NLE CHF NME)	3.4.23.22
1EPP	ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-130,693 (MAS PHE LYS+MTF STA MBA)	3.4.23.22
1EPQ	ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-133,450 (SOT PHE GLY+SCC GCL)	3.4.23.22
1EPR	ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-135,040	3.4.23.22
1EPT	REFINED 1.8 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF PORCINE EPSILON-TRYPSIN	3.4.21.4
1EPW	CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B	3.4.24.69
1EPY	T4 LYSOZYME MUTANT, T21H/C54T/C97A/Q141H/T142H	3.2.1.17
1EQ4	CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME	3.2.1.17
1EQ5	CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME	3.2.1.17
1EQ9	CRYSTAL STRUCTURE OF FIRE ANT CHYMOTRYPSIN COMPLEXED TO PMSF	3.4.21.1
1EQC	EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS IN COMPLEX WITH CASTANOSPERMINE AT 1.85 A	3.2.1.58 2.4.1
1EQE	CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME	3.2.1.17
1EQP	EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS	3.2.1.58 2.4.1
1EQV	SIMPLIFICATION OF A PROTEIN LOOP IN STAPHYLOCOCCAL NUCLEASE	3.1.31.1
1ER8	THE ACTIVE SITE OF ASPARTIC PROTEINASES	3.4.23.22
1ERI	X-RAY STRUCTURE OF THE DNA-ECO RI ENDONUCLEASE-DNA RECOGNITION COMPLEX: THE RECOGNITION NETWORK AND THE INTEGRATION OF RECOGNITION AND CLEAVAGE	3.1.21.4
1ERM	X-RAY CRYSTAL STRUCTURE OF TEM-1 BETA LACTAMASE IN COMPLEX WITH A DESIGNED BORONIC ACID INHIBITOR (1R)-1-ACETAMIDO-2-(3-CARBOXYPHENYL)ETHANE BORONIC ACID	3.5.2.6
1ERO	X-RAY CRYSTAL STRUCTURE OF TEM-1 BETA LACTAMASE IN COMPLEX WITH A DESIGNED BORONIC ACID INHIBITOR (1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	3.5.2.6
1ERQ	X-RAY CRYSTAL STRUCTURE OF TEM-1 BETA LACTAMASE IN COMPLEX WITH A DESIGNED BORONIC ACID INHIBITOR (1R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID	3.5.2.6
1ERZ	CRYSTAL STRUCTURE OF N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE WITH A NOVEL CATALYTIC FRAMEWORK COMMON TO AMIDOHYDROLASES	3.5.1.77
1ES2	S96A MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE	3.4.16.4
1ES3	C98A MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE	3.4.16.4
1ES4	C98N MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE	3.4.16.4
1ES5	S216A MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE	3.4.16.4
1ES8	CRYSTAL STRUCTURE OF FREE BGLII	3.1.21.4
1ES9	X-RAY CRYSTAL STRUCTURE OF R22K MUTANT OF THE MAMMALIAN BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASES (PAF-AH)	3.1.1.47
1ESA	DIRECT STRUCTURE OBSERVATION OF AN ACYL-ENZYME INTERMEDIATE IN THE HYDROLYSIS OF AN ESTER SUBSTRATE BY ELASTASE	3.4.21.36
1ESB	DIRECT STRUCTURE OBSERVATION OF AN ACYL-ENZYME INTERMEDIATE IN THE HYDROLYSIS OF AN ESTER SUBSTRATE BY ELASTASE	3.4.21.36
1ESC	THE MOLECULAR MECHANISM OF ENANTIORECOGNITION BY ESTERASES	3.1.1
1ESD	THE MOLECULAR MECHANISM OF ENANTIORECOGNITION BY ESTERASES	3.1.1
1ESE	THE MOLECULAR MECHANISM OF ENANTIORECOGNITION BY ESTERASES	3.1.1
1ESG	RESTRICTION ENDONUCLEASE BAMHI BOUND TO A NON-SPECIFIC DNA.	3.1.21.4
1ESI	R248L MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE	3.4.16.4
1ESP	NEUTRAL PROTEASE MUTANT E144S	3.4.24.28
1EST	THE ATOMIC STRUCTURE OF CRYSTALLINE PORCINE PANCREATIC ELASTASE AT 2.5 ANGSTROMS RESOLUTION. COMPARISONS WITH THE STRUCTURE OF ALPHA-CHYMOTRYPSIN	3.4.21.36
1ESU	S235A MUTANT OF TEM1 BETA-LACTAMASE	3.5.2.6
1ETH	TRIACYLGLYCEROL LIPASE/COLIPASE COMPLEX	3.1.1.3
1ETR	REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS	3.4.21.5
1ETS	REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS	3.4.21.5
1ETT	REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS	3.4.21.5
1EU5	STRUCTURE OF E. COLI DUTPASE AT 1.45 A	3.6.1.23
1EUB	SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NON-PEPTIDIC SULFONAMIDE INHIBITOR	3.4.24
1EUF	BOVINE DUODENASE(NEW SERINE PROTEASE), CRYSTAL STRUCTURE	3.4.21
1EUG	CRYSTAL STRUCTURE OF ESCHERICHIA COLI URACIL DNA GLYCOSYLASE AND ITS COMPLEXES WITH URACIL AND GLYCEROL: STRUCTURE AND GLYCOSYLASE MECHANISM REVISITED	3.2.2.3 3.2.2.27
1EUI	ESCHERICHIA COLI URACIL-DNA GLYCOSYLASE COMPLEX WITH URACIL-DNA GLYCOSYLASE INHIBITOR PROTEIN	3.2.2 3.2.2.27
1EUR	SIALIDASE	3.2.1.18
1EUS	SIALIDASE COMPLEXED WITH 2-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID	3.2.1.18
1EUT	SIALIDASE, LARGE 68KD FORM, COMPLEXED WITH GALACTOSE	3.2.1.18
1EUU	SIALIDASE OR NEURAMINIDASE, LARGE 68KD FORM	3.2.1.18
1EUV	X-RAY STRUCTURE OF THE C-TERMINAL ULP1 PROTEASE DOMAIN IN COMPLEX WITH SMT3, THE YEAST ORTHOLOG OF SUMO.	3.4.22.68
1EUW	ATOMIC RESOLUTION STRUCTURE OF E. COLI DUTPASE	3.6.1.23
1EV1	ECHOVIRUS 1	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1EV7	CRYSTAL STRUCTURE OF DNA RESTRICTION ENDONUCLEASE NAEI	3.1.21.4
1EVE	THREE DIMENSIONAL STRUCTURE OF THE ANTI-ALZHEIMER DRUG, E2020 (ARICEPT), COMPLEXED WITH ITS TARGET ACETYLCHOLINESTERASE	3.1.1.7
1EVQ	THE CRYSTAL STRUCTURE OF THE THERMOPHILIC CARBOXYLESTERASE EST2 FROM ALICYCLOBACILLUS ACIDOCALDARIUS	3.1.1.1
1EVW	L116A MUTANT OF THE HOMING ENDONUCLEASE I-PPOI COMPLEXED TO HOMING SITE DNA.	3.1
1EVX	APO CRYSTAL STRUCTURE OF THE HOMING ENDONUCLEASE, I-PPOI	3.1
1EW2	CRYSTAL STRUCTURE OF A HUMAN PHOSPHATASE	3.1.3.1
1EW8	ALKALINE PHOSPHATASE (E.C. 3.1.3.1) COMPLEX WITH PHOSPHONOACETIC ACID	3.1.3.1
1EW9	ALKALINE PHOSPHATASE (E.C. 3.1.3.1) COMPLEX WITH MERCAPTOMETHYL PHOSPHONATE	3.1.3.1
1EWL	CRYSTAL STRUCTURE OF CRUZAIN BOUND TO WRR-99	3.4.22 3.4.22.51
1EWM	THE CYSTEINE PROTEASE CRUZAIN BOUND TO WRR-112	3.4.22 3.4.22.51
1EWN	CRYSTAL STRUCTURE OF THE HUMAN AAG DNA REPAIR GLYCOSYLASE COMPLEXED WITH 1,N6-ETHENOADENINE-DNA	3.2.2.21
1EWO	THE CYSTEINE PROTEASE CRUZAIN BOUND TO WRR-204	3.4.22 3.4.22.51
1EWP	CRUZAIN BOUND TO MOR-LEU-HPQ	3.4.22 3.4.22.51
1EWZ	CRYSTAL STRUCTURE OF THE OXA-10 BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA	3.5.2.6
1EX1	BETA-D-GLUCAN EXOHYDROLASE FROM BARLEY	3.2.1.58
1EX2	CRYSTAL STRUCTURE OF BACILLUS SUBTILIS MAF PROTEIN	3.6.1.9
1EX3	CRYSTAL STRUCTURE OF BOVINE CHYMOTRYPSINOGEN A (TETRAGONAL)	3.4.21.1
1EX4	HIV-1 INTEGRASE CATALYTIC CORE AND C-TERMINAL DOMAIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EX9	CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA LIPASE COMPLEXED WITH RC-(RP,SP)-1,2-DIOCTYLCARBAMOYL-GLYCERO-3-O-OCTYLPHOSPHONATE	3.1.1.3
1EXC	CRYSTAL STRUCTURE OF B. SUBTILIS MAF PROTEIN COMPLEXED WITH D-(UTP)	3.6.1.9
1EXF	EXFOLIATIVE TOXIN A	3.4.21
1EXG	SOLUTION STRUCTURE OF A CELLULOSE BINDING DOMAIN FROM CELLULOMONAS FIMI BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY	3.2.1.91 3.2.1.8
1EXH	SOLUTION STRUCTURE OF A CELLULOSE BINDING DOMAIN FROM CELLULOMONAS FIMI BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY	3.2.1.91 3.2.1.8
1EXN	T5 5'-EXONUCLEASE	3.1.11.3 3.1.11
1EXP	BETA-1,4-GLYCANASE CEX-CD	3.2.1.91 3.2.1.8
1EXQ	CRYSTAL STRUCTURE OF THE HIV-1 INTEGRASE CATALYTIC CORE DOMAIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1EXW	CRYSTAL STRUCTURE OF PALMITOYL PROTEIN THIOESTERASE 1 COMPLEXED WITH HEXADECYLSULFONYL FLUORIDE	3.1.2.22
1EY0	STRUCTURE OF WILD-TYPE S. NUCLEASE AT 1.6 A RESOLUTION	3.1.31.1
1EY4	STRUCTURE OF S. NUCLEASE STABILIZING MUTANT S59A	3.1.31.1
1EY5	STRUCTURE OF S. NUCLEASE STABILIZING MUTANT T33V	3.1.31.1
1EY6	STRUCTURE OF S. NUCLEASE STABILIZING MUTANT T41I	3.1.31.1
1EY7	STRUCTURE OF S. NUCLEASE STABILIZING MUTANT S128A	3.1.31.1
1EY8	STRUCTURE OF S. NUCLEASE STABILIZING TRIPLE MUTANT P117G/H124L/S128A	3.1.31.1
1EY9	STRUCTURE OF S. NUCLEASE STABILIZING QUADRUPLE MUTANT T41I/P117G/H124L/S128A	3.1.31.1
1EYA	STRUCTURE OF S. NUCLEASE STABILIZING QUINTUPLE MUTANT T33V/T41I/P117G/H124L/S128A	3.1.31.1
1EYC	STRUCTURE OF S. NUCLEASE STABILIZING QUINTUPLE MUTANT T41I/S59A/P117G/H124L/S128A	3.1.31.1
1EYD	STRUCTURE OF WILD-TYPE S. NUCLEASE AT 1.7 A RESOLUTION	3.1.31.1
1EYI	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE (R-STATE)	3.1.3.11
1EYJ	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH AMP, MAGNESIUM, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE (T-STATE)	3.1.3.11
1EYK	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH AMP, ZINC, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE (T-STATE)	3.1.3.11
1EYU	HIGH RESOLUTION STRUCTURE OF THE PVUII ENDONCULEASE/COGNATE DNA COMPLEX AT PH 4.6	3.1.21.4
1EYW	THREE-DIMENSIONAL STRUCTURE OF THE ZINC-CONTAINING PHOSPHOTRIESTERASE WITH BOUND SUBSTRATE ANALOG TRIETHYLPHOSPHATE	3.1.8.1
1EZ2	THREE-DIMENSIONAL STRUCTURE OF THE ZINC-CONTAINING PHOSPHOTRIESTERASE WITH BOUND SUBSTRATE ANALOG DIISOPROPYLMETHYL PHOSPHONATE.	3.1.8.1
1EZ6	STRUCTURE OF S. NUCLEASE STABILIZING SEXTUPLE MUTANT T33V/T41I/S59A/P117G/H124L/S128A	3.1.31.1
1EZ8	STRUCTURE OF S. NUCLEASE STABILIZING MUTANT T33V	3.1.31.1
1EZM	THREE-DIMENSIONAL STRUCTURE OF THE ELASTASE OF PSEUDOMONAS AERUGINOSA AT 1.5 ANGSTROMS RESOLUTION	3.4.24.26
1EZQ	CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515	3.4.21.6
1EZR	CRYSTAL STRUCTURE OF NUCLEOSIDE HYDROLASE FROM LEISHMANIA MAJOR	3.2.2.1 3.2.2.2 3.2.2.3
1F08	CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF THE REPLICATION INITIATION PROTEIN E1 FROM PAPILLOMAVIRUS	3.6.4.12
1F0I	THE FIRST CRYSTAL STRUCTURE OF A PHOSPHOLIPASE D	3.1.4.4
1F0J	CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B	3.1.4.17 3.1.4.53
1F0O	PVUII ENDONUCLEASE/COGNATE DNA COMPLEX (GLUTARALDEHYDE-CROSSLINKED CRYSTAL) AT PH 7.5 WITH TWO CALCIUM IONS AT EACH ACTIVE SITE	3.1.21.4
1F0R	CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815	3.4.21.6
1F0S	CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707	3.4.21.6
1F0T	BOVINE TRYPSIN COMPLEXED WITH RPR131247	3.4.21.4
1F0U	BOVINE TRYPSIN COMPLEXED WITH RPR128515	3.4.21.4
1F0V	CRYSTAL STRUCTURE OF AN RNASE A DIMER DISPLAYING A NEW TYPE OF 3D DOMAIN SWAPPING	3.1.27.5 4.6.1.18
1F0W	CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 6.5	3.2.1.17
1F10	CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 6.5 AT 88% RELATIVE HUMIDITY	3.2.1.17
1F1J	CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO	3.4.22 3.4.22.60
1F21	DIVALENT METAL COFACTOR BINDING IN THE KINETIC FOLDING TRAJECTORY OF E. COLI RIBONUCLEASE HI	3.1.26.4
1F29	CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO A VINYL SULFONE DERIVED INHIBITOR (I)	3.4.22 3.4.22.51
1F2A	CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO A VINYL SULFONE DERIVED INHIBITOR (II)	3.4.22 3.4.22.51
1F2B	CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO VINYL SULFONE DERIVED INHIBITOR (III)	3.4.22 3.4.22.51
1F2C	CRYSTAL STRUCTURE ANALYSIS OF CRYZAIN BOUND TO VINYL SULFONE DERIVED INHIBITOR (IV)	3.4.22 3.4.22.51
1F2D	1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE	4.1.99.4 3.5.99.7
1F2M	SIMPLIFICATION OF A PROTEIN LOOP IN STAPHYLOCOCCAL NUCLEASE	3.1.31.1
1F2O	CRYSTAL STRUCTURE OF THE STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH L-LEUCINE	3.4.11 3.4.11.24
1F2P	CRYSTAL STRUCTURE OF THE STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH L-PHENYLALANINE	3.4.11 3.4.11.24
1F2R	NMR STRUCTURE OF THE HETERODIMERIC COMPLEX BETWEEN CAD DOMAINS OF CAD AND ICAD	3
1F2S	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY AT 1.8 A RESOLUTION	3.4.21.4
1F2Y	SIMPLIFICATION OF A PROTEIN LOOP IN STAPHYLOCOCCAL NUCLEASE	3.1.31.1
1F2Z	SIMPLIFICATION OF A PROTEIN LOOP IN STAPHYLOCOCCAL NUCLEASE	3.1.31.1
1F31	CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE	3.4.24.69
1F34	CRYSTAL STRUCTURE OF ASCARIS PEPSIN INHIBITOR-3 BOUND TO PORCINE PEPSIN	3.4.23.1
1F3U	CRYSTAL STRUCTURE OF THE RAP30/74 INTERACTION DOMAINS OF HUMAN TFIIF	3.6.4.12
1F3Y	SOLUTION STRUCTURE OF THE NUDIX ENZYME DIADENOSINE TETRAPHOSPHATE HYDROLASE FROM LUPINUS ANGUSTIFOLIUS L.	3.6.1.17
1F48	CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI ARSENITE-TRANSLOCATING ATPASE	3.6.1 7.3.2.7
1F4A	E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER-ORTHORHOMBIC)	3.2.1.23
1F4R	CRYSTAL STRUCTURE OF THE HUMAN AAG DNA REPAIR GLYCOSYLASE COMPLEXED WITH 1,N6-ETHENOADENINE-DNA	3.2.2.20 3.2.2.21
1F57	CARBOXYPEPTIDASE A COMPLEX WITH D-CYSTEINE AT 1.75 A	3.4.17.1
1F5J	CRYSTAL STRUCTURE OF XYNB, A HIGHLY THERMOSTABLE BETA-1,4-XYLANASE FROM DICTYOGLOMUS THERMOPHILUM RT46B.1, AT 1.8 A RESOLUTION	3.2.1.8
1F5K	UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-BENZAMIDINE COMPLEX	3.4.21.73
1F5L	UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-AMILORIDE COMPLEX	3.4.21.73
1F5N	HUMAN GUANYLATE BINDING PROTEIN-1 IN COMPLEX WITH THE GTP ANALOGUE, GMPPNP.	3.6.5
1F5S	CRYSTAL STRUCTURE OF PHOSPHOSERINE PHOSPHATASE FROM METHANOCOCCUS JANNASCHII	3.1.3.3
1F6O	CRYSTAL STRUCTURE OF THE HUMAN AAG DNA REPAIR GLYCOSYLASE COMPLEXED WITH DNA	3.2.2.20 3.2.2.21
1F6U	NMR STRUCTURE OF THE HIV-1 NUCLEOCAPSID PROTEIN BOUND TO STEM-LOOP SL2 OF THE PSI-RNA PACKAGING SIGNAL. IMPLICATIONS FOR GENOME RECOGNITION	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1F6V	SOLUTION STRUCTURE OF THE C TERMINAL OF MU B TRANSPOSITION PROTEIN	3.6.1
1F6W	STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN BILE SALT ACTIVATED LIPASE	3.1.1.3 3.1.1.13 3.1.1.6
1F7A	HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1F7D	CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1F7E	THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, 20 STRUCTURES	3.4.21.21
1F7K	CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1F7M	THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, MINIMIZED AVERAGE STRUCTURE	3.4.21.21
1F7N	CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1F7O	CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1F7P	CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1F7Q	CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1F7R	CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.	3.6.1.23 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1F82	BOTULINUM NEUROTOXIN TYPE B CATALYTIC DOMAIN	3.4.24.69
1F89	CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE NIT3, A MEMBER OF BRANCH 10 OF THE NITRILASE SUPERFAMILY	3.5.1.3
1F8B	NATIVE INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH NEU5AC2EN	3.2.1.18
1F8C	NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4-AMINO-2-DEOXY-2,3-DEHYDRO-N-NEURAMINIC ACID	3.2.1.18
1F8D	NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 9-AMINO-2-DEOXY-2,3-DEHYDRO-N-NEURAMINIC ACID	3.2.1.18
1F8E	NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4,9-DIAMINO-2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID	3.2.1.18
1F8Q	CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN ACETONITRILE-WATER MIXTURE	3.2.2.22
1F8V	THE STRUCTURE OF PARIACOTO VIRUS REVEALS A DODECAHEDRAL CAGE OF DUPLEX RNA	3.4.23.44
1F92	UROKINASE PLASMINOGEN ACTIVATOR B CHAIN-UKI-1D COMPLEX	3.4.21.73
1F9B	MELANIN PROTEIN INTERACTION: X-RAY STRUCTURE OF THE COMPLEX OF MARE LACTOFERRIN WITH MELANIN MONOMERS	3.4.21
1F9D	CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM IN COMPLEX WITH CELLOTETRAOSE	3.2.1.4
1F9E	CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO	3.4.22 3.4.22.61
1F9O	CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM WITH THE THIOOLIGOSACCHARIDE INHIBITOR PIPS-IG3	3.2.1.4
1FA2	CRYSTAL STRUCTURE OF BETA-AMYLASE FROM SWEET POTATO	3.2.1.2
1FAE	CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM IN COMPLEX WITH CELLOBIOSE	3.2.1.4
1FAF	NMR STRUCTURE OF THE N-TERMINAL J DOMAIN OF MURINE POLYOMAVIRUS T ANTIGENS.	3.6.4
1FAJ	INORGANIC PYROPHOSPHATASE	3.6.1.1
1FAK	HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT	3.4.21.21
1FAX	COAGULATION FACTOR XA INHIBITOR COMPLEX	3.4.21.6
1FAZ	THE CRYSTAL STRUCTURE OF PROKARYOTIC PHOSPHOLIPASE A2	3.1.1.4
1FB1	CRYSTAL STRUCTURE OF HUMAN GTP CYCLOHYDROLASE I	3.5.4.16
1FB2	STRUCTURE OF PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AT 1.95	3.1.1.4
1FB7	CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT IN COMPLEX WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OF DRUG RESISTANCE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FBC	CRYSTALLOGRAPHIC STUDIES OF THE CATALYTIC MECHANISM OF THE NEUTRAL FORM OF FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
1FBD	CRYSTALLOGRAPHIC STUDIES OF THE CATALYTIC MECHANISM OF THE NEUTRAL FORM OF FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
1FBE	CRYSTALLOGRAPHIC STUDIES OF THE CATALYTIC MECHANISM OF THE NEUTRAL FORM OF FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
1FBF	CRYSTALLOGRAPHIC STUDIES OF THE CATALYTIC MECHANISM OF THE NEUTRAL FORM OF FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
1FBG	CRYSTALLOGRAPHIC STUDIES OF THE CATALYTIC MECHANISM OF THE NEUTRAL FORM OF FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
1FBH	CRYSTALLOGRAPHIC STUDIES OF THE CATALYTIC MECHANISM OF THE NEUTRAL FORM OF FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
1FBL	STRUCTURE OF FULL-LENGTH PORCINE SYNOVIAL COLLAGENASE (MMP1) REVEALS A C-TERMINAL DOMAIN CONTAINING A CALCIUM-LINKED, FOUR-BLADED BETA-PROPELLER	3.4.24.7
1FBO	CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM IN COMPLEX WITH CELLOBIITOL	3.2.1.4
1FBP	CRYSTAL STRUCTURE OF FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH FRUCTOSE 6-PHOSPHATE, AMP, AND MAGNESIUM	3.1.3.11
1FBT	THE BISPHOSPHATASE DOMAIN OF THE BIFUNCTIONAL RAT LIVER 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE	3.1.3.46 2.7.1.105
1FBW	CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM IN COMPLEX WITH CELLOHEXAOSE	3.2.1.4
1FC6	PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE	3.4.21.102
1FC7	PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE	3.4.21.102
1FC9	PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE	3.4.21.102
1FCE	PROCESSIVE ENDOCELLULASE CELF OF CLOSTRIDIUM CELLULOLYTICUM	3.2.1.4
1FCF	PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE	3.4.21.102
1FCK	STRUCTURE OF DICERIC HUMAN LACTOFERRIN	3.4.21
1FCM	CRYSTAL STRUCTURE OF THE E.COLI AMPC BETA-LACTAMASE MUTANT Q120L/Y150E COVALENTLY ACYLATED WITH THE INHIBITORY BETA-LACTAM, CLOXACILLIN	3.5.2.6
1FCN	CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE MUTANT Q120L/Y150E COVALENTLY ACYLATED WITH THE SUBSTRATE BETA-LACTAM LORACARBEF	3.5.2.6
1FCO	CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE COVALENTLY ACYLATED WITH THE INHIBITORY BETA-LACTAM, MOXALACTAM	3.5.2.6
1FCQ	CRYSTAL STRUCTURE (MONOCLINIC) OF BEE VENOM HYALURONIDASE	3.2.1.35
1FCU	CRYSTAL STRUCTURE (TRIGONAL) OF BEE VENOM HYALURONIDASE	3.2.1.35
1FCV	CRYSTAL STRUCTURE OF BEE VENOM HYALURONIDASE IN COMPLEX WITH HYALURONIC ACID TETRAMER	3.2.1.35
1FDK	CARBOXYLIC ESTER HYDROLASE (PLA2-MJ33 INHIBITOR COMPLEX)	3.1.1.4
1FDP	PROENZYME OF HUMAN COMPLEMENT FACTOR D, RECOMBINANT PROFACTOR D	3.4.21.46
1FE5	SEQUENCE AND CRYSTAL STRUCTURE OF A BASIC PHOSPHOLIPASE A2 FROM COMMON KRAIT (BUNGARUS CAERULEUS) AT 2.4 RESOLUTION: IDENTIFICATION AND CHARACTERIZATION OF ITS PHARMACOLOGICAL SITES.	3.1.1.4
1FEJ	STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FEZ	THE CRYSTAL STRUCTURE OF BACILLUS CEREUS PHOSPHONOACETALDEHYDE HYDROLASE COMPLEXED WITH TUNGSTATE, A PRODUCT ANALOG	3.11.1.1
1FF0	STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FF7	THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES	3.4.21.21
1FFA	CONTRIBUTION OF CUTINASE SERINE 42 SIDE CHAIN TO THE STABILIZATION OF THE OXYANION TRANSITION STATE	3.1.1.3 3.1.1.74
1FFB	CONTRIBUTION OF CUTINASE SERINE 42 SIDE CHAIN TO THE STABILIZATION OF THE OXYANION TRANSITION STATE	3.1.1.3 3.1.1.74
1FFC	CONTRIBUTION OF CUTINASE SERINE 42 SIDE CHAIN TO THE STABILIZATION OF THE OXYANION TRANSITION STATE	3.1.1.3 3.1.1.74
1FFD	CONTRIBUTION OF CUTINASE SERINE 42 SIDE CHAIN TO THE STABILIZATION OF THE OXYANION TRANSITION STATE	3.1.1.3 3.1.1.74
1FFE	CONTRIBUTION OF CUTINASE SERINE 42 SIDE CHAIN TO THE STABILIZATION OF THE OXYANION TRANSITION STATE	3.1.1.3 3.1.1.74
1FFF	STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE : HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FFI	STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FFM	THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE	3.4.21.21
1FFQ	CRYSTAL STRUCTURE OF CHITINASE A COMPLEXED WITH ALLOSAMIDIN	3.2.1.14
1FFR	CRYSTAL STRUCTURE OF CHITINASE A MUTANT Y390F COMPLEXED WITH HEXA-N-ACETYLCHITOHEXAOSE (NAG)6	3.2.1.14
1FG6	STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FG8	STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FGC	STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FH0	CRYSTAL STRUCTURE OF HUMAN CATHEPSIN V COMPLEXED WITH AN IRREVERSIBLE VINYL SULFONE INHIBITOR	3.4.22 3.4.22.43
1FH7	CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED INHIBITOR DEOXYNOJIRIMYCIN	3.2.1.91 3.2.1.8
1FH8	CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED ISOFAGOMINE INHIBITOR	3.2.1.91 3.2.1.8
1FH9	CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED LACTAM OXIME INHIBITOR	3.2.1.91 3.2.1.8
1FHD	CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED IMIDAZOLE INHIBITOR	3.2.1.91 3.2.1.8
1FHI	SUBSTRATE ANALOG (IB2) COMPLEX WITH THE FRAGILE HISTIDINE TRIAD PROTEIN, FHIT	3.6.1.29
1FHL	CRYSTAL STRUCTURE OF BETA-1,4-GALACTANASE FROM ASPERGILLUS ACULEATUS AT 293K	3.2.1.89
1FI8	RAT GRANZYME B [N66Q] COMPLEXED TO ECOTIN [81-84 IEPD]	3.4.21 3.4.21.79
1FIT	FHIT (FRAGILE HISTIDINE TRIAD PROTEIN)	3.6.1.29
1FIU	TETRAMERIC RESTRICTION ENDONUCLEASE NGOMIV IN COMPLEX WITH CLEAVED DNA	3.1.21.4
1FIV	STRUCTURE OF AN INHIBITOR COMPLEX OF PROTEINASE FROM FELINE IMMUNODEFICIENCY VIRUS	3.4.23.16 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 3.6.1.23 2.7.7 3.1
1FIW	THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA	3.4.21.10
1FIZ	THREE DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM BOAR SPERMATOZOA	3.4.21.10
1FJ2	CRYSTAL STRUCTURE OF THE HUMAN ACYL PROTEIN THIOESTERASE 1 AT 1.5 A RESOLUTION	3.1.4.39 3.1.2
1FJ3	THERMOLYSIN (50% ACETONE SOAKED)	3.4.24.27
1FJ6	FRUCTOSE-1,6-BISPHOSPHATASE (MUTANT Y57W) PRODUCT/ZN COMPLEX (R-STATE)	3.1.3.11
1FJ9	FRUCTOSE-1,6-BISPHOSPHATASE (MUTANT Y57W) PRODUCTS/ZN/AMP COMPLEX (T-STATE)	3.1.3.11
1FJM	PROTEIN SERINE/THREONINE PHOSPHATASE-1 (ALPHA ISOFORM, TYPE 1) COMPLEXED WITH MICROCYSTIN-LR TOXIN	3.1.3.16
1FJO	THERMOLYSIN (60% ACETONE SOAKED CRYSTALS)	3.4.24.27
1FJQ	THERMOLYSIN (70% ACETONE SOAKED CRYSTALS)	3.4.24.27
1FJS	CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA	3.4.21.6
1FJT	THERMOLYSIN (50% ACETONITRILE SOAKED CRYSTALS)	3.4.24.27
1FJU	THERMOLYSIN (80% ACETONITRILE SOAKED CRYSTALS)	3.4.24.27
1FJV	THERMOLYSIN (60% ACETONITRILE SOAKED CRYSTALS)	3.4.24.27
1FJW	THERMOLYSIN (50 MM PHENOL SOAKED)	3.4.24.27
1FK9	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FKN	STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR	3.4.23.46
1FKO	CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FKP	CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FKW	MURINE ADENOSINE DEAMINASE (D295E)	3.5.4.4
1FKX	MURINE ADENOSINE DEAMINASE (D296A)	3.5.4.4
1FLC	X-RAY STRUCTURE OF THE HAEMAGGLUTININ-ESTERASE-FUSION GLYCOPROTEIN OF INFLUENZA C VIRUS	3.1.1.53
1FLE	CRYSTAL STRUCTURE OF ELAFIN COMPLEXED WITH PORCINE PANCREATIC ELASTASE	3.4.21.36
1FLH	CRYSTAL STRUCTURE OF HUMAN UROPEPSIN AT 2.45 A RESOLUTION	3.4.23.1
1FLQ	HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE	3.2.1.17
1FLS	SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR	3.4.24
1FLU	HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE	3.2.1.17
1FLW	HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE	3.2.1.17
1FLY	HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE	3.2.1.17
1FLZ	URACIL DNA GLYCOSYLASE WITH UAAP	3.2.2.3 3.2.2.27
1FM1	SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR	3.4.24
1FM2	THE 2 ANGSTROM CRYSTAL STRUCTURE OF CEPHALOSPORIN ACYLASE	3.5.1.93
1FMB	EIAV PROTEASE COMPLEXED WITH THE INHIBITOR HBY-793	3.4.23.16 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1
1FMG	CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.04% POLYDOCANOL	3.4.21.4
1FMI	CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA1,2-MANNOSIDASE	3.2.1.113
1FMU	STRUCTURE OF NATIVE PROTEINASE A IN P3221 SPACE GROUP.	3.4.23.25
1FMX	STRUCTURE OF NATIVE PROTEINASE A IN THE SPACE GROUP P21	3.4.23.25
1FN5	HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE	3.2.1.17
1FN6	CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.1% POLYDOCANOL	3.4.21.4
1FN7	COUPLING OF DAMAGE RECOGNITION AND CATALYSIS BY A HUMAN BASE-EXCISION DNA REPAIR PROTEIN	3.2.2 4.2.99.18
1FN8	FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION	3.4.21.4
1FNI	CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.01% POLYDOCANOL	3.4.21.4
1FNO	PEPTIDASE T (TRIPEPTIDASE)	3.4.11 3.4.11.4
1FO2	CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA1,2-MANNOSIDASE IN COMPLEX WITH 1-DEOXYMANNOJIRIMYCIN	3.2.1.24 3.2.1.113
1FO3	CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA1,2-MANNOSIDASE IN COMPLEX WITH KIFUNENSINE	3.2.1.24 3.2.1.113
1FO6	CRYSTAL STRUCTURE ANALYSIS OF N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE	3.4.22.12 3.5.1.77
1FOB	CRYSTAL STRUCTURE OF BETA-1,4-GALACTANASE FROM ASPERGILLUS ACULEATUS AT 100K	3.2.1.89
1FOF	CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10	3.5.2.6
1FOK	STRUCTURE OF RESTRICTION ENDONUCLEASE FOKI BOUND TO DNA	3.1.21.4
1FPB	CRYSTAL STRUCTURE OF THE NEUTRAL FORM OF FRUCTOSE 1,6-BISPHOSPHATASE COMPLEXED WITH REGULATORY INHIBITOR FRUCTOSE 2,6-BISPHOSPHATE AT 2.6-ANGSTROMS RESOLUTION	3.1.3.11
1FPC	ACTIVE SITE MIMETIC INHIBITION OF THROMBIN	3.4.21.5
1FPD	STRUCTURAL ASPECTS OF THE ALLOSTERIC INHIBITION OF FRUCTOSE-1,6-BISPHOSPHATASE BY AMP: THE BINDING OF BOTH THE SUBSTRATE ANALOGUE 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE AND CATALYTIC METAL IONS MONITORED BY X-RAY CRYSTALLOGRAPHY	3.1.3.11
1FPE	STRUCTURAL ASPECTS OF THE ALLOSTERIC INHIBITION OF FRUCTOSE-1,6-BISPHOSPHATASE BY AMP: THE BINDING OF BOTH THE SUBSTRATE ANALOGUE 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE AND CATALYTIC METAL IONS MONITORED BY X-RAY CRYSTALLOGRAPHY	3.1.3.11
1FPF	STRUCTURAL ASPECTS OF THE ALLOSTERIC INHIBITION OF FRUCTOSE-1,6-BISPHOSPHATASE BY AMP: THE BINDING OF BOTH THE SUBSTRATE ANALOGUE 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE AND CATALYTIC METAL IONS MONITORED BY X-RAY CRYSTALLOGRAPHY	3.1.3.11
1FPG	STRUCTURAL ASPECTS OF THE ALLOSTERIC INHIBITION OF FRUCTOSE-1,6-BISPHOSPHATASE BY AMP: THE BINDING OF BOTH THE SUBSTRATE ANALOGUE 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE AND CATALYTIC METAL IONS MONITORED BY X-RAY CRYSTALLOGRAPHY	3.1.3.11
1FPI	FRUCTOSE-1,6-BISPHOSPHATASE (D-FRUCTOSE-1,6-BISPHOSPHATE 1-PHOSPHOHYDROLASE) COMPLEXED WITH AMP, 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE AND POTASSIUM IONS (100 MM)	3.1.3.11
1FPJ	FRUCTOSE-1,6-BISPHOSPHATASE (D-FRUCTOSE-1,6-BISPHOSPHATE 1-PHOSPHOHYDROLASE) COMPLEXED WITH AMP, 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE, THALLIUM (10 MM) AND LITHIUM IONS (10 MM)	3.1.3.11
1FPK	FRUCTOSE-1,6-BISPHOSPHATASE (D-FRUCTOSE-1,6-BISPHOSPHATE 1-PHOSPHOHYDROLASE) COMPLEXED WITH THALLIUM IONS (10 MM)	3.1.3.11
1FPL	FRUCTOSE-1,6-BISPHOSPHATASE (D-FRUCTOSE-1,6-BISPHOSPHATE 1-PHOSPHOHYDROLASE) COMPLEXED WITH AMP, 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE AND THALLIUM IONS (10 MM)	3.1.3.11
1FPN	HUMAN RHINOVIRUS SEROTYPE 2 (HRV2)	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1FPR	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN THE CATALYTIC DOMAIN OF SHP-1 AND AN IN VITRO PEPTIDE SUBSTRATE PY469 DERIVED FROM SHPS-1.	3.1.3.48
1FPZ	CRYSTAL STRUCTURE ANALYSIS OF KINASE ASSOCIATED PHOSPHATASE (KAP) WITH A SUBSTITUTION OF THE CATALYTIC SITE CYSTEINE (CYS140) TO A SERINE	3.1.3.48 3.1.3.16
1FQ1	CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2	3.1.3.48 3.1.3.16
1FQ3	CRYSTAL STRUCTURE OF HUMAN GRANZYME B	3.4.21.79
1FQ4	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP-108,420 AND YEAST ASPARTIC PROTEINASE A	3.4.23.25
1FQ5	X-RAY STRUCTURE OF A CYCLIC STATINE INHIBITOR PD-129,541 BOUND TO YEAST PROTEINASE A	3.4.23.25
1FQ6	X-RAY STRUCTURE OF GLYCOL INHIBITOR PD-133,450 BOUND TO SACCHAROPEPSIN	3.4.23.25
1FQ7	X-RAY STRUCTURE OF INHIBITOR CP-72,647 BOUND TO SACCHAROPEPSIN	3.4.23.25
1FQ8	X-RAY STRUCTURE OF DIFLUOROSTATINE INHIBITOR CP81,198 BOUND TO SACCHAROPEPSIN	3.4.23.25
1FQG	MOLECULAR STRUCTURE OF THE ACYL-ENZYME INTERMEDIATE IN TEM-1 BETA-LACTAMASE	3.5.2.6
1FQO	GLUCOSAMINE 6-PHOSPHATE DEAMINASE COMPLEXED WITH THE SUBSTRATE OF THE REVERSE REACTION FRUCTOSE 6-PHOSPHATE (OPEN FORM)	3.5.99.6
1FQX	CRYSTAL STRUCTURE OF THE COMPLEX OF HIV-1 PROTEASE WITH A PEPTIDOMIMETIC INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1FR1	REFINED CRYSTAL STRUCTURE OF BETA-LACTAMASE FROM CITROBACTER FREUNDII INDICATES A MECHANISM FOR BETA-LACTAM HYDROLYSIS	3.5.2.6
1FR6	REFINED CRYSTAL STRUCTURE OF BETA-LACTAMASE FROM CITROBACTER FREUNDII INDICATES A MECHANISM FOR BETA-LACTAM HYDROLYSIS	3.5.2.6
1FRP	CRYSTAL STRUCTURE OF FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH FRUCTOSE-2,6-BISPHOSPHATE, AMP AND ZN2+ AT 2.0 ANGSTROMS RESOLUTION. ASPECTS OF SYNERGISM BETWEEN INHIBITORS	3.1.3.11
1FRZ	GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI, R CONFORMER. COMPLEXED WITH THE ALLOSTERIC ACTIVATOR N-ACETYL-GLUCOSAMINE-6-PHOSPHATE AT 2.2 A RESOLUTION	3.5.99.6
1FS3	CRYSTAL STRUCTURE OF WILD-TYPE BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1FS5	A DISCOVERY OF THREE ALTERNATE CONFORMATIONS IN THE ACTIVE SITE OF GLUCOSAMINE-6-PHOSPHATE ISOMERASE	3.5.99.6
1FS6	GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI, T CONFORMER, AT 2.2A RESOLUTION	3.5.99.6
1FSA	THE T-STATE STRUCTURE OF LYS 42 TO ALA MUTANT OF THE PIG KIDNEY FRUCTOSE 1,6-BISPHOSPHATASE EXPRESSED IN E. COLI	3.1.3.11
1FSF	GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI, T CONFORMER, AT 1.9A RESOLUTION	3.5.99.6
1FSI	CRYSTAL STRUCTURE OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE OF APPR>P FROM ARABIDOPSIS THALIANA	3.1.4
1FSJ	CRYSTAL STRUCTURE OF THE E9 DNASE DOMAIN	3.1.21.1 3.1
1FSS	ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH FASCICULIN-II	3.1.1.7
1FSU	CRYSTAL STRUCTURE OF 4-SULFATASE (HUMAN)	3.1.6.12
1FSW	AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CEPHALOTHINBORONIC ACID	3.5.2.6
1FSY	AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CLOXACILLINBORONIC ACID	3.5.2.6
1FT7	AAP COMPLEXED WITH L-LEUCINEPHOSPHONIC ACID	3.4.11.10
1FTA	FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE, 1-PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH THE ALLOSTERIC INHIBITOR AMP	3.1.3.11
1FTN	CRYSTAL STRUCTURE OF THE HUMAN RHOA/GDP COMPLEX	3.6.5.2
1FUJ	PR3 (MYELOBLASTIN)	3.4.21.76
1FUK	CRYSTAL STRUCTURE OF THE CARBOXY TERMINAL DOMAIN OF YEAST EIF4A	3.6.4.13
1FUS	CRYSTAL STRUCTURES OF RIBONUCLEASE F1 OF FUSARIUM MONILIFORME IN ITS FREE FORM AND IN COMPLEX WITH 2'GMP	3.1.27.3 4.6.1.24
1FUT	CRYSTAL STRUCTURES OF RIBONUCLEASE F1 OF FUSARIUM MONILIFORME IN ITS FREE FORM AND IN COMPLEX WITH 2'GMP	3.1.27.3 4.6.1.24
1FUU	YEAST INITIATION FACTOR 4A	3.6.4.13
1FV0	FIRST STRUCTURAL EVIDENCE OF THE INHIBITION OF PHOSPHOLIPASE A2 BY ARISTOLOCHIC ACID: CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND ARISTOLOCHIC ACID	3.1.1.4
1FV2	THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B	3.4.24.68
1FV3	THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B	3.4.24.68
1FV9	CRYSTAL STRUCTURE OF HUMAN MICROUROKINASE IN COMPLEX WITH 2-AMINO-5-HYDROXY-BENZIMIDAZOLE	3.4.21.73
1FVL	THE NUCLEAR MAGNETIC RESONANCE SOLUTION STRUCTURE OF FLAVORIDIN, AN ANTAGONIST OF THE PLATELET GP IIB-IIIA RECEPTOR	3.4.24
1FW2	OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI	3.1.1.32 3.1.1.4
1FW3	OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI	3.1.1.32 3.1.1.4
1FW7	NMR STRUCTURE OF 15N-LABELED BARNASE	3.1.27
1FWA	KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 7.5	3.5.1.5
1FWB	KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 6.5	3.5.1.5
1FWC	KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 8.5	3.5.1.5
1FWD	KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 9.4	3.5.1.5
1FWE	KLEBSIELLA AEROGENES UREASE, C319A VARIANT WITH ACETOHYDROXAMIC ACID (AHA) BOUND	3.5.1.5
1FWF	KLEBSIELLA AEROGENES UREASE, C319D VARIANT	3.5.1.5
1FWG	KLEBSIELLA AEROGENES UREASE, C319S VARIANT	3.5.1.5
1FWH	KLEBSIELLA AEROGENES UREASE, C319Y VARIANT	3.5.1.5
1FWI	KLEBSIELLA AEROGENES UREASE, H134A VARIANT	3.5.1.5
1FWJ	KLEBSIELLA AEROGENES UREASE, NATIVE	3.5.1.5
1FWO	THE SOLUTION STRUCTURE OF A 35-RESIDUE FRAGMENT FROM THE GRANULIN/EPITHELIN-LIKE SUBDOMAIN OF RICE ORYZAIN BETA (ROB 382-416 (C398S,C399S,C407S,C413S))	3.4.22
1FX9	CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + MJ33 INHIBITOR + SULPHATE IONS)	3.1.1.4
1FXF	CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + MJ33 INHIBITOR + PHOSPHATE IONS)	3.1.1.4
1FXH	MUTANT OF PENICILLIN ACYLASE IMPAIRED IN CATALYSIS WITH PHENYLACETIC ACID IN THE ACTIVE SITE	3.5.1.11
1FXV	PENICILLIN ACYLASE MUTANT IMPAIRED IN CATALYSIS WITH PENICILLIN G IN THE ACTIVE SITE	3.5.1.11
1FXW	CRYSTAL STRUCTURE OF THE RECOMBINANT ALPHA1/ALPHA2 CATALYTIC HETERODIMER OF BOVINE BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB.	3.1.1.47
1FXX	THE STRUCTURE OF EXONUCLEASE I SUGGESTS HOW PROCESSIVITY IS ACHIEVED	3.1.11.1
1FXY	COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-CHLOROMETHYLKETONE	3.4.21.4
1FY2	ASPARTYL DIPEPTIDASE	3.4 3.4.13.21
1FY4	FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION	3.4.21.4
1FY5	FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION	3.4.21.4
1FYE	ASPARTYL DIPEPTIDASE (ANISOTROPIC B-FACTOR REFINEMENT)	3.4 3.4.13.21
1FYS	RIBONUCLEASE T1 V16C MUTANT	3.1.27.3 4.6.1.24
1FYV	CRYSTAL STRUCTURE OF THE TIR DOMAIN OF HUMAN TLR1	3.2.2.6
1FYW	CRYSTAL STRUCTURE OF THE TIR DOMAIN OF HUMAN TLR2	3.2.2.6
1FYX	CRYSTAL STRUCTURE OF P681H MUTANT OF TIR DOMAIN OF HUMAN TLR2	3.2.2.6
1FZR	CRYSTAL STRUCTURE OF BACTERIOPHAGE T7 ENDONUCLEASE I	3.1.21.2
1FZU	RNASE T1 V78A MUTANT	3.1.27.3 4.6.1.24
1FZZ	THE CRYSTAL STRUCTURE OF THE COMPLEX OF NON-PEPTIDIC INHIBITOR ONO-6818 AND PORCINE PANCREATIC ELASTASE.	3.4.21.36
1G01	ALKALINE CELLULASE K CATALYTIC DOMAIN	3.2.1.4
1G02	RIBONUCLEASE T1 V16S MUTANT	3.1.27.3 4.6.1.24
1G05	HETEROCYCLE-BASED MMP INHIBITOR WITH P2'SUBSTITUENTS	3.4.24.17
1G06	CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149S	3.2.1.17
1G07	CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149C	3.2.1.17
1G0C	ALKALINE CELLULASE K CATALYTIC DOMAIN-CELLOBIOSE COMPLEX	3.2.1.4
1G0G	CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152A	3.2.1.17
1G0H	CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE-FRUCTOSE 1,6 BISPHOSPHATASE	3.1.3.25 3.1.3.11
1G0I	CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE-FRUCTOSE 1,6 BISPHOSPHATASE	3.1.3.25 3.1.3.11
1G0J	CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152S	3.2.1.17
1G0K	CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152C	3.2.1.17
1G0L	CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152V	3.2.1.17
1G0M	CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152I	3.2.1.17
1G0P	CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149G	3.2.1.17
1G0Q	CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149I	3.2.1.17
1G0S	THE CRYSTAL STRUCTURE OF THE E.COLI ADP-RIBOSE PYROPHOSPHATASE	3.6.1.13
1G0V	THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV	3.4.23.25
1G0Z	SPECIFIC MUTATIONS IN KRAIT PLA2 LEAD TO DIMERIZATION OF PROTEIN MOLECULES: CRYSTAL STRUCTURE OF KRAIT PLA2 AT 2.1 RESOLUTION	3.1.1.4
1G12	ZINC PEPTIDASE FROM GRIFOLA FRONDOSA	3.4.24.20
1G15	CO-CRYSTAL OF E. COLI RNASE HI WITH TWO MN2+ IONS BOUND IN THE THE ACTIVE SITE	3.1.26.4
1G18	RECA-ADP-ALF4 COMPLEX	3.1
1G19	STRUCTURE OF RECA PROTEIN	3.1
1G1F	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A TRI-PHOSPHORYLATED PEPTIDE (RDI(PTR)ETD(PTR)(PTR)RK) FROM THE INSULIN RECEPTOR KINASE	3.1.3.48
1G1G	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A MONO-PHOSPHORYLATED PEPTIDE (ETDY(PTR)RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE	3.1.3.48
1G1H	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A BIS-PHOSPHORYLATED PEPTIDE (ETD(PTR)(PTR)RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE	3.1.3.48
1G1V	T4 LYSOZYME MUTANT C54T/C97A/I58T	3.2.1.17
1G1W	T4 LYSOZYME MUTANT C54T/C97A/Q105M	3.2.1.17
1G1Y	CRYSTAL STRUCTURE OF ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R-47 AND BETA-CYCLODEXTRIN COMPLEX	3.2.1.135
1G27	CRYSTAL STRUCTURE OF E.COLI POLYPEPTIDE DEFORMYLASE COMPLEXED WITH THE INHIBITOR BB-3497	3.5.1.31 3.5.1.88
1G2A	THE CRYSTAL STRUCTURE OF E.COLI PEPTIDE DEFORMYLASE COMPLEXED WITH ACTINONIN	3.5.1.31 3.5.1.88
1G2I	CRYSTAL STRUCTURE OF A NOVEL INTRACELLULAR PROTEASE FROM PYROCOCCUS HORIKOSHII AT 2 A RESOLUTION	3.2 3.5.1.124 3.4.22
1G2K	HIV-1 PROTEASE WITH CYCLIC SULFAMIDE INHIBITOR, AHA047	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1G2L	FACTOR XA INHIBITOR COMPLEX	3.4.21.6
1G2M	FACTOR XA INHIBITOR COMPLEX	3.4.21.6
1G2X	SEQUENCE INDUCED TRIMERIZATION OF KRAIT PLA2: CRYSTAL STRUCTURE OF THE TRIMERIC FORM OF KRAIT PLA2	3.1.1.4
1G30	THROMBIN INHIBITOR COMPLEX	3.4.21.5
1G32	THROMBIN INHIBITOR COMPLEX	3.4.21.5
1G35	CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR, AHA024	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1G36	TRYPSIN INHIBITOR COMPLEX	3.4.21.4
1G37	CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND EXOSITE-DIRECTED PEPTIDE	3.4.21.5
1G3B	BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE MAGNESIUM(II) CHELATE	3.4.21.4
1G3C	BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF BASE IRON(III) CHELATE	3.4.21.4
1G3D	BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE COPPER (II) CHELATE	3.4.21.4
1G3E	BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF-BASE COPPER (II) CHELATE	3.4.21.4
1G3K	CRYSTAL STRUCTURE OF THE H. INFLUENZAE PROTEASE HSLV AT 1.9 A RESOLUTION	3.4.99 3.4.25.2
1G42	STRUCTURE OF 1,3,4,6-TETRACHLORO-1,4-CYCLOHEXADIENE HYDROLASE (LINB) FROM SPHINGOMONAS PAUCIMOBILIS COMPLEXED WITH 1,2-DICHLOROPROPANE	3.8.1 3.8.1.5
1G49	A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3	3.4.24.17
1G4A	CRYSTAL STRUCTURES OF THE HSLVU PEPTIDASE-ATPASE COMPLEX REVEAL AN ATP-DEPENDENT PROTEOLYSIS MECHANISM	3.4.99 3.4.25.2
1G4H	LINB COMPLEXED WITH BUTAN-1-OL	3.8.1 3.8.1.5
1G4I	CRYSTAL STRUCTURE OF THE BOVINE PANCREATIC PHOSPHOLIPASE A2 AT 0.97A	3.1.1.4
1G4K	X-RAY STRUCTURE OF A NOVEL MATRIX METALLOPROTEINASE INHIBITOR COMPLEXED TO STROMELYSIN	3.4.24.17
1G4U	CRYSTAL STRUCTURE OF THE SALMONELLA TYROSINE PHOSPHATASE AND GTPASE ACTIVATING PROTEIN SPTP BOUND TO RAC1	3.6.5.2
1G4W	CRYSTAL STRUCTURE OF THE SALMONELLA TYROSINE PHOSPHATASE AND GTPASE ACTIVATING PROTEIN SPTP	3.1.3.48
1G5B	BACTERIOPHAGE LAMBDA SER/THR PROTEIN PHOSPHATASE	3.1.3 3.1.3.16
1G5F	STRUCTURE OF LINB COMPLEXED WITH 1,2-DICHLOROETHANE	3.8.1 3.8.1.5
1G66	ACETYLXYLAN ESTERASE AT 0.90 ANGSTROM RESOLUTION	3.1.1.6 3.1.1.72
1G68	PSE-4 CARBENICILLINASE, WILD TYPE	3.5.2.6
1G6A	PSE-4 CARBENICILLINASE, R234K MUTANT	3.5.2.6
1G6I	CRYSTAL STRUCTURE OF THE YEAST ALPHA-1,2-MANNOSIDASE WITH BOUND 1-DEOXYMANNOJIRIMYCIN AT 1.59 A RESOLUTION	3.2.1.113
1G6L	1.9A CRYSTAL STRUCTURE OF TETHERED HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1G7F	HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177496	3.1.3.48
1G7G	HUMAN PTP1B CATALYTIC DOMAIN COMPLEXES WITH PNU179326	3.1.3.48
1G86	CHARCOT-LEYDEN CRYSTAL PROTEIN/N-ETHYLMALEIMIDE COMPLEX	3.1.1.5
1G87	THE CRYSTAL STRUCTURE OF ENDOGLUCANASE 9G FROM CLOSTRIDIUM CELLULOLYTICUM	3.2.1.4
1G8M	CRYSTAL STRUCTURE OF AVIAN ATIC, A BIFUNCTIONAL TRANSFORMYLASE AND CYCLOHYDROLASE ENZYME IN PURINE BIOSYNTHESIS AT 1.75 ANG. RESOLUTION	2.1.2.3 3.5.4.10
1G8T	SM ENDONUCLEASE FROM SERATIA MARCENSCENS AT 1.1 A RESOLUTION	3.1.30.2
1G94	CRYSTAL STRUCTURE ANALYSIS OF THE TERNARY COMPLEX BETWEEN PSYCHROPHILIC ALPHA AMYLASE FROM PSEUDOALTEROMONAS HALOPLANCTIS IN COMPLEX WITH A HEPTA-SACCHARIDE AND A TRIS MOLECULE	3.2.1.1
1G9A	CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3)	3.4.24.69
1G9B	CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1)	3.4.24.69
1G9C	CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4)	3.4.24.69
1G9D	CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2)	3.4.24.69
1G9G	XTAL-STRUCTURE OF THE FREE NATIVE CELLULASE CEL48F	3.2.1.4
1G9H	TERNARY COMPLEX BETWEEN PSYCHROPHILIC ALPHA-AMYLASE, COMII (PSEUDO TRI-SACCHARIDE FROM BAYER) AND TRIS (2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL)	3.2.1.1
1G9I	CRYSTAL STRUCTURE OF BETA-TRYSIN COMPLEX IN CYCLOHEXANE	3.4.21.4
1G9J	X-TAL STRUCTURE OF THE MUTANT E44Q OF THE CELLULASE CEL48F IN COMPLEX WITH A THIOOLIGOSACCHARIDE	3.2.1.4
1G9K	CRYSTAL STRUCTURE OF A PSYCHROPHILIC ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18	3.4.24.40
1G9Q	COMPLEX STRUCTURE OF THE ADPR-ASE AND ITS SUBSTRATE ADP-RIBOSE	3.6.1.13
1G9Y	HOMING ENDONUCLEASE I-CREI / DNA SUBSTRATE COMPLEX WITH CALCIUM	3.1
1G9Z	LAGLIDADG HOMING ENDONUCLEASE I-CREI / DNA PRODUCT COMPLEX WITH MAGNESIUM	3.1
1GA0	STRUCTURE OF THE E. CLOACAE GC1 BETA-LACTAMASE WITH A CEPHALOSPORIN SULFONE INHIBITOR	3.5.2.6
1GA1	CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH A FRAGMENT OF IODOTYROSTATIN (THIS ENZYME RENAMED SEDOLISIN" IN 2003)"	3.4.23.37 3.4.21.100
1GA2	THE CRYSTAL STRUCTURE OF ENDOGLUCANASE 9G FROM CLOSTRIDIUM CELLULOLYTICUM COMPLEXED WITH CELLOBIOSE	3.2.1.4
1GA4	CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH INHIBITOR PSEUDOIODOTYROSTATIN (THIS ENZYME RENAMED SEDOLISIN" IN 2003)"	3.4.23.37 3.4.21.100
1GA6	CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH A FRAGMENT OF TYROSTATIN (THIS ENZYME RENAMED SEDOLISIN" IN 2003)"	3.4.23.37 3.4.21.100
1GA7	CRYSTAL STRUCTURE OF THE ADP-RIBOSE PYROPHOSPHATASE IN COMPLEX WITH GD+3	3.6.1.13
1GA9	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH NON-BETA-LACTAMASE INHIBITOR (2, 3-(4-BENZENESULFONYL-THIOPHENE-2-SULFONYLAMINO)-PHENYLBORONIC ACID)	3.5.2.6
1GAH	GLUCOAMYLASE-471 COMPLEXED WITH ACARBOSE	3.2.1.3
1GAI	GLUCOAMYLASE-471 COMPLEXED WITH D-GLUCO-DIHYDROACARBOSE	3.2.1.3
1GAY	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GAZ	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GB0	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GB2	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GB3	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GB5	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GB6	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GB7	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GB8	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GB9	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GBA	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA	3.4.21.12
1GBB	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID	3.4.21.12
1GBC	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID	3.4.21.12
1GBD	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID	3.4.21.12
1GBE	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU	3.4.21.12
1GBF	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID	3.4.21.12
1GBG	BACILLUS LICHENIFORMIS BETA-GLUCANASE	3.2.1.73
1GBH	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID	3.4.21.12
1GBI	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID	3.4.21.12
1GBJ	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA	3.4.21.12
1GBK	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID	3.4.21.12
1GBL	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID	3.4.21.12
1GBM	ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID	3.4.21.12
1GBO	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GBS	CRYSTAL STRUCTURE OF BLACK SWAN GOOSE-TYPE LYSOZYME AT 1.8 ANGSTROMS RESOLUTION	3.2.1.17
1GBT	STRUCTURE OF AN ACYL-ENZYME INTERMEDIATE DURING CATALYSIS: (GUANIDINOBENZOYL) TRYPSIN	3.4.21.4
1GBW	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GBX	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GBY	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GBZ	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GCB	GAL6, YEAST BLEOMYCIN HYDROLASE DNA-BINDING PROTEASE (THIOL)	3.4.22.40
1GCD	REFINED CRYSTAL STRUCTURE OF AGED" AND "NON-AGED" ORGANOPHOSPHORYL CONJUGATES OF GAMMA-CHYMOTRYPSIN"	3.4.21.1
1GCE	STRUCTURE OF THE BETA-LACTAMASE OF ENTEROBACTER CLOACAE GC1	3.5.2.6
1GCI	THE 0.78 ANGSTROMS STRUCTURE OF A SERINE PROTEASE-BACILLUS LENTUS SUBTILISIN	3.4.21.62
1GCT	IS GAMMA-CHYMOTRYPSIN A TETRAPEPTIDE ACYL-ENZYME ADDUCT OF GAMMA-CHYMOTRYPSIN?	3.4.21.1
1GCY	HIGH RESOLUTION CRYSTAL STRUCTURE OF MALTOTETRAOSE-FORMING EXO-AMYLASE	3.2.1.60
1GD6	STRUCTURE OF THE BOMBYX MORI LYSOZYME	3.2.1.17
1GDN	FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION	3.4.21.4
1GDQ	FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION	3.4.21.4
1GDU	FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION	3.4.21.4
1GDW	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS	3.2.1.17
1GDX	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS	3.2.1.17
1GE0	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS	3.2.1.17
1GE1	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS	3.2.1.17
1GE2	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS	3.2.1.17
1GE3	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS	3.2.1.17
1GE4	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS	3.2.1.17
1GE5	ZINC PEPTIDASE FROM GRIFOLA FRONDOSA	3.4.24.20
1GE6	ZINC PEPTIDASE FROM GRIFOLA FRONDOSA	3.4.24.20
1GE7	ZINC PEPTIDASE FROM GRIFOLA FRONDOSA	3.4.24.20
1GEC	GLYCYL ENDOPEPTIDASE-COMPLEX WITH BENZYLOXYCARBONYL-LEUCINE-VALINE-GLYCINE-METHYLENE COVALENTLY BOUND TO CYSTEINE 25	3.4.22.25
1GEF	CRYSTAL STRUCTURE OF THE ARCHAEAL HOLLIDAY JUNCTION RESOLVASE HJC	3.1.22.4
1GEN	C-TERMINAL DOMAIN OF GELATINASE A	3.4.24.24
1GEV	BURIED POLAR MUTANT HUMAN LYSOZYME	3.2.1.17
1GEZ	BURIED POLAR MUTANT HUMAN LYSOZYME	3.2.1.17
1GF0	BURIED POLAR MUTANT HUMAN LYSOZYME	3.2.1.17
1GF3	BURIED POLAR MUTANT HUMAN LYSOZYME	3.2.1.17
1GF4	BURIED POLAR MUTANT HUMAN LYSOZYME	3.2.1.17
1GF5	BURIED POLAR MUTANT HUMAN LYSOZYME	3.2.1.17
1GF6	BURIED POLAR MUTANT HUMAN LYSOZYME	3.2.1.17
1GF7	BURIED POLAR MUTANT HUMAN LYSOZYME	3.2.1.17
1GF8	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GF9	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFA	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFE	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFG	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFH	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFJ	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFK	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFR	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFT	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFU	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFV	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1GFW	THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN OR CPP32)IN COMPLEX WITH AN ISATIN SULFONAMIDE INHIBITOR.	3.4.22.56
1GFY	RESIDUE 259 IS A KEY DETERMINANT OF SUBSTRATE SPECIFICITY OF PROTEIN-TYROSINE PHOSPHATASE 1B AND ALPHA	3.1.3.48
1GG6	CRYSTAL STRUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-PHENYLALANINE TRIFLUOROMETHYL KETONE BOUND AT THE ACTIVE SITE	3.4.21.1
1GGD	CRYSTAL STRUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-LEUCIL-PHENYLALANINE ALDEHYDE BOUND AT THE ACTIVE SITE	3.4.21.1
1GGP	CRYSTAL STRUCTURE OF TRICHOSANTHES KIRILOWII LECTIN-1 AND ITS RELATION TO THE TYPE 2 RIBOSOME INACTIVATING PROTEINS	3.2.2.22
1GGV	CRYSTAL STRUCTURE OF THE C123S MUTANT OF DIENELACTONE HYDROLASE (DLH) BOUND WITH THE PMS MOIETY OF THE PROTEASE INHIBITOR, PHENYLMETHYLSULFONYL FLUORIDE (PMSF)	3.1.1.45
1GH4	STRUCTURE OF THE TRIPLE MUTANT (K56M, K120M, K121M) OF PHOSPHOLIPASE A2	3.1.1.4
1GH6	RETINOBLASTOMA POCKET COMPLEXED WITH SV40 LARGE T ANTIGEN	3.6.4
1GHA	A SECOND ACTIVE SITE IN CHYMOTRYPSIN? THE X-RAY CRYSTAL STRUCTURE OF N-ACETYL-D-TRYPTOPHAN BOUND TO GAMMA-CHYMOTRYPSIN	3.4.21.1
1GHB	A SECOND ACTIVE SITE IN CHYMOTRYPSIN? THE X-RAY CRYSTAL STRUCTURE OF N-ACETYL-D-TRYPTOPHAN BOUND TO GAMMA-CHYMOTRYPSIN	3.4.21.1
1GHD	CRYSTAL STRUCTURE OF THE GLUTARYL-7-AMINOCEPHALOSPORANIC ACID ACYLASE BY MAD PHASING	3.5.1
1GHI	STRUCTURE OF BETA-LACTAMASE GLU166ASP:ASN170GLN MUTANT	3.5.2.6
1GHL	THE THREE-DIMENSIONAL STRUCTURE OF PHEASANT AND GUINEA-FOWL EGG LYSOZYMES	3.2.1.17
1GHM	STRUCTURES OF THE ACYL-ENZYME COMPLEX OF THE STAPHYLOCOCCUS AUREUS BETA-LACTAMASE MUTANT GLU166ASP:ASN170GLN WITH DEGRADED CEPHALORIDINE	3.5.2.6
1GHP	STRUCTURES OF THE ACYL-ENZYME COMPLEX OF THE STAPHYLOCOCCUS AUREUS BETA-LACTAMASE MUTANT GLU166ASP:ASN170GLN WITH DEGRADED BENZYLPENICILLIN	3.5.2.6
1GHR	THE THREE-DIMENSIONAL STRUCTURES OF TWO PLANT BETA-GLUCAN ENDOHYDROLASES WITH DISTINCT SUBSTRATE SPECIFICITIES	3.2.1.73
1GHS	THE THREE-DIMENSIONAL STRUCTURES OF TWO PLANT BETA-GLUCAN ENDOHYDROLASES WITH DISTINCT SUBSTRATE SPECIFICITIES	3.2.1.39
1GHV	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.5
1GHW	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.5
1GHX	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.5
1GHY	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.5
1GHZ	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.4
1GI0	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.4
1GI1	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.4
1GI2	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.4
1GI3	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.4
1GI4	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.4
1GI5	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.4
1GI6	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.4
1GI7	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.73
1GI8	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.73
1GI9	A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE	3.4.21.73
1GIK	POKEWEED ANTIVIRAL PROTEIN FROM SEEDS	3.2.2.22
1GIO	NMR SOLUTION STRUCTURE OF BOVINE ANGIOGENIN, 10 STRUCTURES	3.1.27
1GIS	A TRICHOSANTHIN(TCS) MUTANT(E85Q) COMPLEX STRUCTURE WITH 2'-DEOXY-ADENOSIN-5'-MONOPHOSPHATE	3.2.2.22
1GIU	A TRICHOSANTHIN(TCS) MUTANT(E85R) COMPLEX STRUCTURE WITH ADENINE	3.2.2.22
1GJ4	SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN	3.4.21.5
1GJ5	SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN	3.4.21.5
1GJ6	ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS	3.4.21.4
1GJ7	ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS	3.4.21.73
1GJ8	ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS	3.4.21.73
1GJ9	ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS	3.4.21.73
1GJA	ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS	3.4.21.73
1GJB	ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS	3.4.21.73
1GJC	ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS	3.4.21.73
1GJD	ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS	3.4.21.73
1GK0	STRUCTURE-BASED PREDICTION OF MODIFICATIONS IN GLUTARYLAMIDASE TO ALLOW SINGLE-STEP ENZYMATIC PRODUCTION OF 7-AMINOCEPHALOSPORANIC ACID FROM CEPHALOSPORIN C	3.5.1.11 3.5.1.93
1GK1	STRUCTURE-BASED PREDICTION OF MODIFICATIONS IN GLUTARYLAMIDASE TO ALLOW SINGLE-STEP ENZYMATIC PRODUCTION OF 7-AMINOCEPHALOSPORANIC ACID FROM CEPHALOSPORIN C	3.5.1.11 3.5.1.93
1GK9	CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM	3.5.1.11
1GKC	MMP9-INHIBITOR COMPLEX	3.4.24.35
1GKD	MMP9 ACTIVE SITE MUTANT-INHIBITOR COMPLEX	3.4.24.35
1GKF	CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM	3.5.1.11
1GKK	FERULOYL ESTERASE DOMAIN OF XYNY FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.8
1GKL	S954A MUTANT OF THE FERULOYL ESTERASE MODULE FROM CLOSTRIDIUM THERMOCELLUM COMPLEXED WITH FERULIC ACID	3.2.1.8
1GKP	D-HYDANTOINASE (DIHYDROPYRIMIDINASE) FROM THERMUS SP. IN SPACE GROUP C2221	3.5.2.2
1GKT	NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH TRANSITION STATE ANALOGUE INHIBITOR H261	3.4.23.22
1GKU	REVERSE GYRASE FROM ARCHAEOGLOBUS FULGIDUS	3.6.4.12 5.6.2.2
1GL0	STRUCTURE OF THE COMPLEX BETWEEN BOVINE ALPHA-CHYMOTRYPSIN AND PMP-D2V, AN INHIBITOR FROM THE INSECT LOCUSTA MIGRATORIA	3.4.21.1
1GL1	STRUCTURE OF THE COMPLEX BETWEEN BOVINE ALPHA-CHYMOTRYPSIN AND PMP-C, AN INHIBITOR FROM THE INSECT LOCUSTA MIGRATORIA	3.4.21.1
1GL9	ARCHAEOGLOBUS FULGIDUS REVERSE GYRASE COMPLEXED WITH ADPNP	3.6.4.12 5.6.2.2
1GLH	CATION BINDING TO A BACILLUS (1,3-1,4)-BETA-GLUCANASE. GEOMETRY, AFFINITY AND EFFECT ON PROTEIN STABILITY	3.2.1.73
1GLM	REFINED CRYSTAL STRUCTURES OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100	3.2.1.3
1GLO	CRYSTAL STRUCTURE OF CYS25SER MUTANT OF HUMAN CATHEPSIN S	3.4.22.27
1GM1	SECOND PDZ DOMAIN (PDZ2) OF PTP-BL	3.1.3.48
1GM5	STRUCTURE OF RECG BOUND TO THREE-WAY DNA JUNCTION	3.6.4.12
1GM7	CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM	3.5.1.11
1GM8	CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM	3.5.1.11
1GM9	CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM	3.5.1.11
1GMH	REFINED CRYSTAL STRUCTURE OF AGED" AND "NON-AGED" ORGANOPHOSPHORYL CONJUGATES OF GAMMA-CHYMOTRYPSIN"	3.4.21.1
1GMM	CARBOHYDRATE BINDING MODULE CBM6 FROM XYLANASE U CLOSTRIDIUM THERMOCELLUM	3.2.1.8
1GMP	COMPLEX OF RIBONUCLEASE FROM STREPTOMYCES AUREOFACIENS WITH 2'-GMP AT 1.7 ANGSTROMS RESOLUTION	3.1.27.3 4.6.1.24
1GMQ	COMPLEX OF RIBONUCLEASE FROM STREPTOMYCES AUREOFACIENS WITH 2'-GMP AT 1.7 ANGSTROMS RESOLUTION	3.1.27.3 4.6.1.24
1GMR	COMPLEX OF RIBONUCLEASE FROM STREPTOMYCES AUREOFACIENS WITH 2'-GMP AT 1.7 ANGSTROMS RESOLUTION	3.1.27.3 4.6.1.24
1GMY	CATHEPSIN B COMPLEXED WITH DIPEPTIDYL NITRILE INHIBITOR	3.4.22.1
1GMZ	CRYSTAL STRUCTURE OF THE D49 PHOSPHOLIPASE A2 PIRATOXIN III FROM BOTHROPS PIRAJAI.	3.1.1.4
1GNM	HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASP (V82D) COMPLEXED WITH U89360E (INHIBITOR)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1GNN	HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASN (V82N) COMPLEXED WITH U89360E (INHIBITOR)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1GNO	HIV-1 PROTEASE (WILD TYPE) COMPLEXED WITH U89360E (INHIBITOR)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1GNP	X-RAY CRYSTAL STRUCTURE ANALYSIS OF THE CATALYTIC DOMAIN OF THE ONCOGENE PRODUCT P21H-RAS COMPLEXED WITH CAGED GTP AND MANT DGPPNHP	3.6.5.2
1GNQ	X-RAY CRYSTAL STRUCTURE ANALYSIS OF THE CATALYTIC DOMAIN OF THE ONCOGENE PRODUCT P21H-RAS COMPLEXED WITH CAGED GTP AND MANT DGPPNHP	3.6.5.2
1GNR	X-RAY CRYSTAL STRUCTURE ANALYSIS OF THE CATALYTIC DOMAIN OF THE ONCOGENE PRODUCT P21H-RAS COMPLEXED WITH CAGED GTP AND MANT DGPPNHP	3.6.5.2
1GNS	SUBTILISIN BPN'	3.4.21.62
1GNV	CALCIUM INDEPENDENT SUBTILISIN BPN' MUTANT	3.4.21.62
1GNX	B-GLUCOSIDASE FROM STREPTOMYCES SP	3.2.1.21
1GNY	XYLAN-BINDING MODULE CBM15	3.2.1.8
1GO7	THE METZINCIN'S METHIONINE: PRTC M226C-E189K DOUBLE MUTANT	3.4.24.40
1GO8	THE METZINCIN'S METHIONINE: PRTC M226L MUTANT	3.4.24.40
1GOA	COOPERATIVE STABILIZATION OF ESCHERICHIA COLI RIBONUCLEASE HI BY INSERTION OF GLY-80B AND GLY-77-> ALA SUBSTITUTION	3.1.26.4
1GOB	COOPERATIVE STABILIZATION OF ESCHERICHIA COLI RIBONUCLEASE HI BY INSERTION OF GLY-80B AND GLY-77-> ALA SUBSTITUTION	3.1.26.4
1GOC	COOPERATIVE STABILIZATION OF ESCHERICHIA COLI RIBONUCLEASE HI BY INSERTION OF GLY-80B AND GLY-77-> ALA SUBSTITUTION	3.1.26.4
1GOD	MONOMERIC LYS-49 PHOSPHOLIPASE A2 HOMOLOGUE ISOLATED FROM THE VENOM OF CERROPHIDION (BOTHROPS) GODMANI	3.1.1.4
1GOI	CRYSTAL STRUCTURE OF THE D140N MUTANT OF CHITINASE B FROM SERRATIA MARCESCENS AT 1.45 A RESOLUTION	3.2.1.14
1GOJ	STRUCTURE OF A FAST KINESIN: IMPLICATIONS FOR ATPASE MECHANISM AND INTERACTIONS WITH MICROTUBULES	3.6.4.4
1GOK	THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS- CRYSTAL FORM II	3.2.1.8
1GOM	THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS- CRYSTAL FORM I	3.2.1.8
1GON	B-GLUCOSIDASE FROM STREPTOMYCES SP	3.2.1.21
1GOO	THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS - CRYOCOOLED GLYCEROL COMPLEX	3.2.1.8
1GOQ	THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS - ROOM TEMPERATURE XYLOBIOSE COMPLEX	3.2.1.8
1GOR	THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS - XYLOBIOSE COMPLEX AT 100 K	3.2.1.8
1GOU	RIBONUCLEASE BINASE (G SPECIFIC ENDONUCLEASE) UNLIGANDED FORM	3.1.27.3 3.1.27
1GOV	RIBONUCLEASE BI(G SPECIFIC ENDONUCLEASE) COMPLEXED WITH SULFATE IONS	3.1.27.3 3.1.27
1GOW	BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS	3.2.1.23
1GOY	HYDROLASE(ENDORIBONUCLEASE)RIBONUCLEASE BI(G SPECIFIC ENDONUCLEASE) (E.C.3.1.27.-) COMPLEXED WITH GUANOSINE-3'-PHOSPHATE (3'-GMP)	3.1.27.3 3.1.27
1GP7	ACIDIC PHOSPHOLIPASE A2 FROM VENOM OF OPHIOPHAGUS HANNAH	3.1.1.4
1GPF	CHITINASE B FROM SERRATIA MARCESCENS IN COMPLEX WITH INHIBITOR PSAMMAPLIN	3.2.1.14
1GPI	CELLOBIOHYDROLASE CEL7D (CBH 58) FROM PHANEROCHAETE CHRYSOSPORIUM. CATALYTIC MODULE AT 1.32 ANGSTROM RESOLUTION	3.2.1.91 3.2.1
1GPK	STRUCTURE OF ACETYLCHOLINESTERASE COMPLEX WITH (+)-HUPERZINE A AT 2.1A RESOLUTION	3.1.1.7
1GPL	RP2 LIPASE	3.1.1.3 3.1.1.26
1GPN	STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE B AT 2.35A RESOLUTION	3.1.1.7
1GPP	CRYSTAL STRUCTURE OF THE S.CEREVISIAE HOMING ENDONUCLEASE PI-SCEI DOMAIN I	3.6.3.14 7.1.2.2 3.1
1GPZ	THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R	3.4.21.41
1GQ6	PROCLAVAMINATE AMIDINO HYDROLASE FROM STREPTOMYCES CLAVULIGERUS	3.5.3.11 3.5.3.22
1GQ7	PROCLAVAMINATE AMIDINO HYDROLASE FROM STREPTOMYCES CLAVULIGERUS	3.5.3.11 3.5.3.22
1GQ8	PECTIN METHYLESTERASE FROM CARROT	3.1.1.11
1GQF	CRYSTAL STRUCTURE OF HUMAN PROCASPASE-7	3.4.22.60
1GQI	STRUCTURE OF PSEUDOMONAS CELLULOSA ALPHA-D-GLUCURONIDASE	3.2.1.139 3.2.1.131
1GQJ	STRUCTURE OF PSEUDOMONAS CELLULOSA ALPHA-D-GLUCURONIDASE COMPLEXED WITH XYLOBIOSE	3.2.1.139 3.2.1.131
1GQK	STRUCTURE OF PSEUDOMONAS CELLULOSA ALPHA-D-GLUCURONIDASE COMPLEXED WITH GLUCURONIC ACID	3.2.1.139 3.2.1.131
1GQL	STRUCTURE OF PSEUDOMONAS CELLULOSA ALPHA-D-GLUCURONIDASE COMPLEXED WITH GLUCURONIC ACID AND XYLOTRIOSE	3.2.1.139 3.2.1.131
1GQR	ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH RIVASTIGMINE	3.1.1.7
1GQS	ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH NAP	3.1.1.7
1GQV	ATOMIC RESOLUTION (0.98A) STRUCTURE OF EOSINOPHIL-DERIVED NEUROTOXIN	3.1.27.5 4.6.1.18
1GRN	CRYSTAL STRUCTURE OF THE CDC42/CDC42GAP/ALF3 COMPLEX.	3.6.5.2
1GSP	RIBONUCLEASE T1 COMPLEXED WITH 2',3'-CGPS, 1 DAY	3.1.27.3 4.6.1.24
1GT6	S146A MUTANT OF THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE COMPLEX WITH OLEIC ACID	3.1.1.3
1GU3	CBM4 STRUCTURE AND FUNCTION	3.2.1.4
1GUA	HUMAN RAP1A, RESIDUES 1-167, DOUBLE MUTANT (E30D,K31E) COMPLEXED WITH GPPNHP AND THE RAS-BINDING-DOMAIN OF HUMAN C-RAF1, RESIDUES 51-131	3.6.5.2
1GUV	STRUCTURE OF HUMAN CHITOTRIOSIDASE	3.2.1.14
1GV7	ARH-I, AN ANGIOGENIN/RNASE A CHIMERA	3.1.27.5 4.6.1.18
1GVL	HUMAN PROKALLIKREIN 6 (HK6)/ PROZYME/ PROPROTEASE M/ PRONEUROSIN	3.4.21
1GVM	CHOLINE BINDING DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS PNEUMONIAE	3.5.1.28
1GVT	ENDOTHIAPEPSIN COMPLEX WITH CP-80,794	3.4.23.22
1GVU	ENDOTHIAPEPSIN COMPLEX WITH H189	3.4.23.22
1GVV	FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN INHIBITOR COMPLEXES; IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM	3.4.23.22
1GVW	ENDOTHIAPEPSIN COMPLEX WITH PD-130,328	3.4.23.22
1GVX	ENDOTHIAPEPSIN COMPLEXED WITH H256	3.4.23.22
1GVY	SUBSTRATE DISTORSION BY BETA-MANNANASE FROM PSEUDOMONAS CELLULOSA	3.2.1.78
1GVZ	PROSTATE SPECIFIC ANTIGEN (PSA) FROM STALLION SEMINAL PLASMA	3.4.21.35
1GW1	SUBSTRATE DISTORTION BY BETA-MANNANASE FROM PSEUDOMONAS CELLULOSA	3.2.1.78
1GW6	STRUCTURE OF LEUKOTRIENE A4 HYDROLASE D375N MUTANT	3.3.2.6 3.4.11.4
1GWA	TRIIODIDE DERIVATIVE OF PORCINE PANCREAS ELASTASE	3.4.21.36
1GWD	TRI-IODIDE DERIVATIVE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
1GWZ	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTEIN TYROSINE PHOSPHATASE SHP-1	3.1.3.48
1GX5	HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH GTP AND MANGANESE	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
1GX6	HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH UTP AND MANGANESE	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
1GXD	PROMMP-2/TIMP-2 COMPLEX	3.4.24.24
1GXV	SOLUTION STRUCTURE OF LYSOZYME AT LOW AND HIGH PRESSURE	3.2.1.17
1GXW	THE 2.2 A RESOLUTION STRUCTURE OF THERMOLYSIN CRYSTALLIZED IN PRESENCE OF POTASSIUM THIOCYANATE	3.4.24.27
1GXX	SOLUTION STRUCTURE OF LYSOZYME AT LOW AND HIGH PRESSURE	3.2.1.17
1GXY	CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM A (P21)	2.4.2.31 3.2.2.5
1GXZ	CRYSTAL STRUCTURE OF THE EUKARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM B (P212121)	2.4.2.31 3.2.2.5
1GY0	CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM C (P3121)	2.4.2.31 3.2.2.5
1GYD	STRUCTURE OF CELLVIBRIO CELLULOSA ALPHA-L-ARABINANASE	3.2.1.99 3.2.1.55
1GYE	STRUCTURE OF CELLVIBRIO CELLULOSA ALPHA-L-ARABINANASE COMPLEXED WITH ARABINOHEXAOSE	3.2.1.99 3.2.1.55
1GYG	R32 CLOSED FORM OF ALPHA-TOXIN FROM CLOSTRIDIUM PERFRINGENS STRAIN CER89L43	3.1.4.3
1GYH	STRUCTURE OF D158A CELLVIBRIO CELLULOSA ALPHA-L-ARABINANASE MUTANT	3.2.1.99 3.2.1.55
1GYM	PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C IN COMPLEX WITH GLUCOSAMINE-(ALPHA-1-6)-MYO-INOSITOL	3.1.4.10 4.6.1.13
1GZ1	MUTANT D416A OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH METHYL-CELLOBIOSYL-4-DEOXY-4-THIO-BETA-D-CELLOBIOSIDE	3.2.1.91
1GZ7	CRYSTAL STRUCTURE OF THE CLOSED STATE OF LIPASE 2 FROM CANDIDA RUGOSA	3.1.1.3
1GZJ	STRUCTURE OF THERMOASCUS AURANTIACUS FAMILY 5 ENDOGLUCANASE	3.2.1.4
1GZS	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE GEF DOMAIN OF THE SALMONELLA TYPHIMURIUM SOPE TOXIN AND HUMAN CDC42	3.6.5.2
1H09	MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1	3.2.1.17
1H0B	ENDOGLUCANASE CEL12A FROM RHODOTHERMUS MARINUS	3.2.1.4
1H0G	COMPLEX OF A CHITINASE WITH THE NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGADIN FROM CLONOSTACHYS	3.2.1.14
1H0I	COMPLEX OF A CHITINASE WITH THE NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGIFIN FROM GLIOCLADIUM	3.2.1.14
1H11	2-DEOXY-2-FLURO-B-D-CELLOTRIOSYL/ENZYME INTERMEDIATE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHEARANS AT 1.08 ANGSTROM RESOLUTION	3.2.1.4
1H12	STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE	3.2.1.8 3.2.1.4
1H13	STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE	3.2.1.8 3.2.1.4
1H14	STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE	3.2.1.8 3.2.1.4
1H19	STRUCTURE OF [E271Q]LEUKOTRIENE A4 HYDROLASE	3.3.2.6 3.4.11.4
1H1A	THERMOPHILIC BETA-1,4-XYLANASE FROM CHAETOMIUM THERMOPHILUM	3.2.1.8
1H1B	CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE COMPLEXED WITH AN INHIBITOR (GW475151)	3.4.21.37
1H1H	CRYSTAL STRUCTURE OF EOSINOPHIL CATIONIC PROTEIN IN COMPLEX WITH 2',5'-ADP AT 2.0 A RESOLUTION REVEALS THE DETAILS OF THE RIBONUCLEOLYTIC ACTIVE SITE	3.1.27
1H1N	ATOMIC RESOLUTION STRUCTURE OF THE MAJOR ENDOGLUCANASE FROM THERMOASCUS AURANTIACUS	3.2.1.4
1H22	STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH (S,S)-(-)-BIS(10)-HUPYRIDONE AT 2.15A RESOLUTION	3.1.1.7
1H23	STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH (S,S)-(-)-BIS(12)-HUPYRIDONE AT 2.15A RESOLUTION	3.1.1.7
1H2G	ALTERED SUBSTRATE SPECIFICITY MUTANT OF PENICILLIN ACYLASE	3.5.1.11
1H2J	ENDOGLUCANASE CEL5A IN COMPLEX WITH UNHYDROLYSED AND COVALENTLY LINKED 2,4-DINITROPHENYL-2-DEOXY-2-FLUORO-CELLOBIOSIDE AT 1.15 A RESOLUTION	3.2.1.4
1H2W	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN	3.4.21.26
1H2X	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, Y473F MUTANT	3.4.21.26
1H2Y	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, Y473F MUTANT WITH COVALENTLY BOUND INHIBITOR Z-PRO-PROLINAL	3.4.21.26
1H2Z	PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND SUC-GLY-PRO	3.4.21.26
1H3G	CYCLOMALTODEXTRINASE FROM FLAVOBACTERIUM SP. NO. 92: FROM DNA SEQUENCE TO PROTEIN STRUCTURE	3.2.1.54
1H41	PSEUDOMONAS CELLULOSA E292A ALPHA-D-GLUCURONIDASE MUTANT COMPLEXED WITH ALDOTRIURONIC ACID	3.2.1.139 3.2.1.131
1H43	R210E N-TERMINAL LOBE HUMAN LACTOFERRIN	3.4.21
1H44	R210L N-TERMINAL LOBE HUMAN LACTOFERRIN	3.4.21
1H45	R210G N-TERMINAL LOBE HUMAN LACTOFERRIN	3.4.21
1H46	THE CATALYTIC MODULE OF CEL7D FROM PHANEROCHAETE CHRYSOSPORIUM AS A CHIRAL SELECTOR: STRUCTURAL STUDIES OF ITS COMPLEX WITH THE B-BLOCKER (R)-PROPRANOLOL	3.2.1.91 3.2.1
1H49	CRYSTAL STRUCTURE OF THE INACTIVE DOUBLE MUTANT OF THE MAIZE BETA-GLUCOSIDASE ZMGLU1-E191D-F198V IN COMPLEX WITH DIMBOA-GLUCOSIDE	3.2.1.21 3.2.1.182
1H4G	OLIGOSACCHARIDE-BINDING TO FAMILY 11 XYLANASES: BOTH COVALENT INTERMEDIATE AND MUTANT-PRODUCT COMPLEXES DISPLAY 2,5B CONFORMATIONS AT THE ACTIVE-CENTRE	3.2.1.8
1H4H	OLIGOSACCHARIDE-BINDING TO FAMILY 11 XYLANASES: BOTH COVALENT INTERMEDIATE AND MUTANT-PRODUCT COMPLEXES DISPLAY 2,5B CONFORMATIONS AT THE ACTIVE-CENTRE	3.2.1.8
1H4W	STRUCTURE OF HUMAN TRYPSIN IV (BRAIN TRYPSIN)	3.4.21.4
1H52	BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY	3.1.27
1H53	BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY	3.1.27
1H56	STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF A NEW MAGNESIUM ION BINDING SITE NEAR TYR94 IN THE RESTRICTION ENDONUCLEASE PVUII	3.1.21.4
1H5V	THIOPENTASACCHARIDE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHARENS AT 1.1 A RESOLUTION IN THE TETRAGONAL CRYSTAL FORM	3.2.1.4
1H5X	CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-13 COMPLEXED WITH IMIPENEM	3.5.2.6
1H65	CRYSTAL STRUCTURE OF PEA TOC34 - A NOVEL GTPASE OF THE CHLOROPLAST PROTEIN TRANSLOCON	3.6.5
1H6L	BETA-PROPELLER PHYTASE IN COMPLEX WITH PHOSPHATE AND CALCIUM IONS	3.1.3.8
1H6M	COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF HEN EGG WHITE LYSOZYME	3.2.1.17
1H6X	THE ROLE OF CONSERVED AMINO ACIDS IN THE CLEFT OF THE C-TERMINAL FAMILY 22 CARBOHYDRATE BINDING MODULE OF CLOSTRIDIUM THERMOCELLUM XYN10B IN LIGAND BINDING	3.2.1.8
1H6Y	THE ROLE OF CONSERVED AMINO ACIDS IN THE CLEFT OF THE C-TERMINAL FAMILY 22 CARBOHYDRATE BINDING MODULE OF CLOSTRIDIUM THERMOCELLUM XYN10B IN LIGAND BINDING	3.2.1.8
1H70	DDAH FROM PSEUDOMONAS AERUGINOSA. C249S MUTANT COMPLEXED WITH CITRULLINE	3.5.3.18
1H71	PSYCHROPHILIC PROTEASE FROM PSEUDOALTEROMONAS 'TAC II 18'	3.4.24.40
1H7S	N-TERMINAL 40KDA FRAGMENT OF HUMAN PMS2	3.1
1H7U	HPMS2-ATPGS	3.1
1H80	1,3-ALPHA-1,4-BETA-D-GALACTOSE-4-SULFATE- 3,6-ANHYDRO-D-GALACTOSE-2-SULFATE 4 GALACTOHYDROLASE	3.2.1.157
1H87	GADOLINIUM DERIVATIVE OF TETRAGONAL HEN EGG-WHITE LYSOZYME AT 1.7 A RESOLUTION	3.2.1.17
1H8D	X-RAY STRUCTURE OF THE HUMAN ALPHA-THROMBIN COMPLEX WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR.	3.4.21.5
1H8G	C-TERMINAL DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS PNEUMONIAE	3.5.1.28
1H8I	X-RAY CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR.	3.4.21.5
1H8L	DUCK CARBOXYPEPTIDASE D DOMAIN II IN COMPLEX WITH GEMSA	3.4.17.22
1H8T	ECHOVIRUS 11	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1H8V	THE X-RAY CRYSTAL STRUCTURE OF THE TRICHODERMA REESEI FAMILY 12 ENDOGLUCANASE 3, CEL12A, AT 1.9 A RESOLUTION	3.2.1.4
1H8X	DOMAIN-SWAPPED DIMER OF A HUMAN PANCREATIC RIBONUCLEASE VARIANT	3.1.27.5 4.6.1.18
1H8Y	CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-13 IN COMPLEX WITH MEROPENEM	3.5.2.6
1H8Z	CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-13	3.5.2.6
1H9H	COMPLEX OF EETI-II WITH PORCINE TRYPSIN	3.4.21.4
1H9I	COMPLEX OF EETI-II MUTANT WITH PORCINE TRYPSIN	3.4.21.4
1HA3	ELONGATION FACTOR TU IN COMPLEX WITH AURODOX	3.1.5.1
1HAG	THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN	3.4.21.5
1HAH	THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN	3.4.21.5
1HAI	THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN	3.4.21.5
1HAR	2.2 ANGSTROMS RESOLUTION STRUCTURE OF THE AMINO-TERMINAL HALF OF HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HAV	HEPATITIS A VIRUS 3C PROTEINASE	2.7.7.48 3.6.1.15 3.4.22.28
1HAY	SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (B) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 JUMPED TO PH 10 FOR 10 SECONDS	3.4.21.11 3.4.21.36
1HB0	SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (D) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 JUMPED TO PH 10 FOR 2 MINUTES	3.4.21.11 3.4.21.36
1HBJ	X-RAY CRYSTAL STRUCTURE OF COMPLEX BETWEEN TORPEDO CALIFORNICA ACHE AND A REVERSIBLE INHIBITOR, 4-AMINO-5-FLUORO-2-METHYL-3-(3-TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE	3.1.1.7
1HBT	HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL KETONE CONTAINING BIVALENT INHIBITOR	3.4.21.5
1HBV	A CHECK ON RATIONAL DRUG DESIGN. CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A NOVEL GAMMA-TURN MIMETIC	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HBY	BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY	3.1.27
1HC0	STRUCTURE OF LYSOZYME WITH PERIODATE	3.2.1.17
1HCG	STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 ANGSTROMS RESOLUTION	3.4.21.6
1HCU	ALPHA-1,2-MANNOSIDASE FROM TRICHODERMA REESEI	3.2.1.113 3.2.1
1HCX	CHOLINE BINDING DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS PNEUMONIAE	3.5.1.28
1HD5	ENDOGLUCANASE FROM HUMICOLA INSOLENS AT 1.7A RESOLUTION	3.2.1.4
1HD7	A SECOND DIVALENT METAL ION IN THE ACTIVE SITE OF A NEW CRYSTAL FORM OF HUMAN APURINIC/APYRIDINIMIC ENDONUCLEASE, APE1, AND ITS IMPLICATIONS FOR THE CATALYTIC MECHANISM	4.2.99.18 3.1
1HD8	CRYSTAL STRUCTURE OF A DEACYLATION-DEFECTIVE MUTANT OF PENICILLIN-BINDING PROTEIN 5 AT 2.3 A RESOLUTION	3.4.16.4 3.5.2.6
1HDE	HALOALKANE DEHALOGENASE MUTANT WITH PHE 172 REPLACED WITH TRP	3.8.1.5
1HDH	ARYLSULFATASE FROM PSEUDOMONAS AERUGINOSA	3.1.6.1
1HDK	CHARCOT-LEYDEN CRYSTAL PROTEIN - PCMBS COMPLEX	3.1.1.5
1HDQ	CRYSTAL STRUCTURE OF BOVINE PANCREATIC CARBOXYPEPTIDASE A COMPLEXED WITH D-N-HYDROXYAMINOCARBONYL PHENYLALANINE AT 2.3 A	3.4.17.1
1HDT	STRUCTURE OF A RETRO-BINDING PEPTIDE INHIBITOR COMPLEXED WITH HUMAN ALPHA-THROMBIN	3.4.21.5
1HDU	CRYSTAL STRUCTURE OF BOVINE PANCREATIC CARBOXYPEPTIDASE A COMPLEXED WITH AMINOCARBONYLPHENYLALANINE AT 1.75 A	3.4.17.1
1HEE	CRYSTAL STRUCTURE OF BOVINE PANCREATIC CARBOXYPEPTIDASE A COMPLEXED WITH L-N-HYDROXYAMINOCARBONYL PHENYLALANINE AT 2.3 A	3.4.17.1
1HEF	THE CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF HYDROXYETHYLENE-BASED INHIBITORS BOUND TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE SHOW THAT THE INHIBITORS ARE PRESENT IN TWO DISTINCT ORIENTATIONS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HEG	THE CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF HYDROXYETHYLENE-BASED INHIBITORS BOUND TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE SHOW THAT THE INHIBITORS ARE PRESENT IN TWO DISTINCT ORIENTATIONS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HEH	C-TERMINAL XYLAN BINDING DOMAIN FROM CELLULOMONAS FIMI XYLANASE 11A	3.2.1.8 3.5.1
1HEI	STRUCTURE OF THE HEPATITIS C VIRUS RNA HELICASE DOMAIN	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1HEJ	C-TERMINAL XYLAN BINDING DOMAIN FROM CELLULOMONAS FIMI XYLANASE 11A	3.2.1.8 3.5.1
1HEL	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF COMPENSATING MUTATIONS WITHIN THE CORE OF CHICKEN EGG WHITE LYSOZYME	3.2.1.17
1HEM	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF COMPENSATING MUTATIONS WITHIN THE CORE OF CHICKEN EGG WHITE LYSOZYME	3.2.1.17
1HEN	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF COMPENSATING MUTATIONS WITHIN THE CORE OF CHICKEN EGG WHITE LYSOZYME	3.2.1.17
1HEO	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF COMPENSATING MUTATIONS WITHIN THE CORE OF CHICKEN EGG WHITE LYSOZYME	3.2.1.17
1HEP	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF COMPENSATING MUTATIONS WITHIN THE CORE OF CHICKEN EGG WHITE LYSOZYME	3.2.1.17
1HEQ	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF COMPENSATING MUTATIONS WITHIN THE CORE OF CHICKEN EGG WHITE LYSOZYME	3.2.1.17
1HER	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF COMPENSATING MUTATIONS WITHIN THE CORE OF CHICKEN EGG WHITE LYSOZYME	3.2.1.17
1HEW	REFINEMENT OF AN ENZYME COMPLEX WITH INHIBITOR BOUND AT PARTIAL OCCUPANCY. HEN EGG-WHITE LYSOZYME AND TRI-N-ACETYLCHITOTRIOSE AT 1.75 ANGSTROMS RESOLUTION	3.2.1.17
1HF4	STRUCTURAL EFFECTS OF MONOVALENT ANIONS ON POLYMORPHIC LYSOZYME CRYSTALS	3.2.1.17
1HF6	ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE ORTHORHOMBIC CRYSTAL FORM IN COMPLEX WITH CELLOTRIOSE	3.2.1.4
1HFC	1.56 ANGSTROM STRUCTURE OF MATURE TRUNCATED HUMAN FIBROBLAST COLLAGENASE	3.4.24.7
1HFD	HUMAN COMPLEMENT FACTOR D IN A P21 CRYSTAL FORM	3.4.21.46
1HFJ	ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH SULFATE	3.5.1.1
1HFK	ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH WEAK SULFATE	3.5.1.1
1HFS	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-764,004	3.4.24.17
1HFW	X-RAY STRUCTURE OF THE COMPLEX BETWEEN ERWINIA CHRYSANTHEMI L-ASPARAGINASE AND L-GLUTAMATE	3.5.1.1
1HG0	X-RAY STRUCTURE OF THE COMPLEX BETWEEN ERWINIA CHRYSANTHEMI L-ASPARAGINASE AND SUCCINIC ACID	3.5.1.1
1HG1	X-RAY STRUCTURE OF THE COMPLEX BETWEEN ERWINIA CHRYSANTHEMI L-ASPARAGINASE AND D-ASPARTATE	3.5.1.1
1HG8	ENDOPOLYGALACTURONASE FROM THE PHYTOPATHOGENIC FUNGUS FUSARIUM MONILIFORME	3.2.1.15
1HGT	STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN	3.4.21.5
1HGW	CEL6A D175A MUTANT	3.2.1.91
1HGY	CEL6A D221A MUTANT	3.2.1.91
1HH1	THE STRUCTURE OF HJC, A HOLLIDAY JUNCTION RESOLVING ENZYME FROM SULFOLOBUS SOLFATARICUS	3.1.22.4
1HH4	RAC1-RHOGDI COMPLEX INVOLVED IN NADPH OXIDASE ACTIVATION	3.6.5.2
1HHL	THE THREE-DIMENSIONAL STRUCTURE OF PHEASANT AND GUINEA-FOWL EGG LYSOZYMES	3.2.1.17
1HHP	THE THREE-DIMENSIONAL STRUCTURE OF THE ASPARTYL PROTEASE FROM THE HIV-1 ISOLATE BRU	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HI2	EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - SULPHATE COMPLEX	3.1.27.5 4.6.1.18
1HI3	EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE 2'-5'-DIPHOSPHATE COMPLEX	3.1.27.5 4.6.1.18
1HI4	EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSIEN-3'-5'-DIPHOSPHATE COMPLEX	3.1.27.5 4.6.1.18
1HI5	EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE-5'-DIPHOSPHATE COMPLEX	3.1.27.5 4.6.1.18
1HI9	ZN-DEPENDENT D-AMINOPEPTIDASE DPPA FROM BACILLUS SUBTILIS, A SELF-COMPARTMENTALIZING PROTEASE.	3.4.11
1HIA	KALLIKREIN COMPLEXED WITH HIRUSTASIN	3.4.21.35
1HIH	COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR	3.4.23 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HII	COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR	3.4.23 3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HIV	CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A DIHYDROETHYLENE-CONTAINING INHIBITOR: COMPARISONS WITH MOLECULAR MODELING	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HIW	TRIMERIC HIV-1 MATRIX PROTEIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HIX	CRYSTALLOGRAPHIC ANALYSES OF FAMILY 11 ENDO-BETA-1,4-XYLANASE XYL1 FROM STREPTOMYCES SP. S38	3.2.1.8
1HIZ	XYLANASE T6 (XT6) FROM BACILLUS STEAROTHERMOPHILUS	3.2.1.8
1HJ8	1.00 AA TRYPSIN FROM ATLANTIC SALMON	3.4.21.4
1HJ9	ATOMIC RESOLUTION STRUCTURES OF TRYPSIN PROVIDE INSIGHT INTO STRUCTURAL RADIATION DAMAGE	3.4.21.4
1HJA	LYS 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH ALPHA-CHYMOTRYPSIN	3.4.21.1
1HJK	ALKALINE PHOSPHATASE MUTANT H331Q	3.1.3.1
1HJO	ATPASE DOMAIN OF HUMAN HEAT SHOCK 70KDA PROTEIN 1	3.6.1.3
1HJP	HOLLIDAY JUNCTION BINDING PROTEIN RUVA FROM E. COLI	3.6.4.12
1HJQ	STRUCTURE OF TWO FUNGAL BETA-1,4-GALACTANASES: SEARCHING FOR THE BASIS FOR TEMPERATURE AND PH OPTIMUM.	3.2.1.89
1HJR	ATOMIC STRUCTURE OF THE RUVC RESOLVASE: A HOLLIDAY JUNCTION-SPECIFIC ENDONUCLEASE FROM E. COLI	3.1.22.4
1HJS	STRUCTURE OF TWO FUNGAL BETA-1,4-GALACTANASES: SEARCHING FOR THE BASIS FOR TEMPERATURE AND PH OPTIMUM.	3.2.1.89
1HJU	STRUCTURE OF TWO FUNGAL BETA-1,4-GALACTANASES: SEARCHING FOR THE BASIS FOR TEMPERATURE AND PH OPTIMUM.	3.2.1.89
1HJZ	CRYSTAL STRUCTURE OF AF1521 PROTEIN CONTAINING A MACROH2A DOMAIN	3.2.2
1HKI	CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH GLUCOALLOSAMIDIN B	3.2.1.14
1HKJ	CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH METHYLALLOSAMIDIN	3.2.1.14
1HKK	HIGH RESOULTION CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH ALLOSAMIDIN	3.2.1.14
1HKM	HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH DEMETHYLALLOSAMIDIN	3.2.1.14
1HL8	CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA ALPHA-FUCOSIDASE	3.2.1.51
1HL9	CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA ALPHA-FUCOSIDASE IN COMPLEX WITH A MECHANISM BASED INHIBITOR	3.2.1.51
1HLG	CRYSTAL STRUCTURE OF HUMAN GASTRIC LIPASE	3.1.1.3
1HLK	METALLO-BETA-LACTAMASE FROM BACTEROIDES FRAGILIS IN COMPLEX WITH A TRICYCLIC INHIBITOR	3.5.2.6
1HLT	THE STRUCTURE OF A NONADECAPEPTIDE OF THE FIFTH EGF DOMAIN OF THROMBOMODULIN COMPLEXED WITH THROMBIN	3.4.21.5
1HN4	PROPHOSPHOLIPASE A2 DIMER COMPLEXED WITH MJ33, SULFATE, AND CALCIUM	3.1.1.4
1HNE	STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A PEPTIDE CHLOROMETHYL KETONE INHIBITOR AT 1.84-ANGSTROMS RESOLUTION	3.4.21.37
1HNI	STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HNL	CRYSTAL STRUCTURE OF A GLUTATHIONYLATED HUMAN LYSOZYME: A FOLDING INTERMEDIATE MIMIC IN THE FORMATION OF A DISULFIDE BOND	3.2.1.17
1HNV	STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HNY	THE STRUCTURE OF HUMAN PANCREATIC ALPHA-AMYLASE AT 1.8 ANGSTROMS RESOLUTION AND COMPARISONS WITH RELATED ENZYMES	3.2.1.1
1HO3	CRYSTAL STRUCTURE ANALYSIS OF E. COLI L-ASPARAGINASE II (Y25F MUTANT)	3.5.1.1
1HO5	5'-NUCLEOTIDASE (E. COLI) IN COMPLEX WITH ADENOSINE AND PHOSPHATE	3.1.3.5 3.6.1.45
1HOR	STRUCTURE AND CATALYTIC MECHANISM OF GLUCOSAMINE 6-PHOSPHATE DEAMINASE FROM ESCHERICHIA COLI AT 2.1 ANGSTROMS RESOLUTION	3.5.99.6
1HOS	INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C2-SYMMETRIC PHOSPHINATE SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HOT	GLUCOSAMINE 6-PHOSPHATE DEAMINASE COMPLEXED WITH THE ALLOSTERIC ACTIVATOR N-ACETYL-GLUCOSAMINE-6-PHOSPHATE	3.5.99.6
1HOV	SOLUTION STRUCTURE OF A CATALYTIC DOMAIN OF MMP-2 COMPLEXED WITH SC-74020	3.4.24.24
1HOZ	CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX	3.2.2.1
1HP0	CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX IN COMPLEX WITH THE SUBSTRATE ANALOGUE 3-DEAZA-ADENOSINE	3.2.2.1
1HP1	5'-NUCLEOTIDASE (OPEN FORM) COMPLEX WITH ATP	3.1.3.5 3.6.1.45
1HP4	CRYSTAL STRUCTURE OF STREPTOMYCES PLICATUS BETA-N-ACETYLHEXOSAMINIDASE	3.2.1.52
1HP5	STREPTOMYCES PLICATUS BETA-N-ACETYLHEXOSAMINIDASE COMPLEXED WITH INTERMEDIATE ANALOUGE NAG-THIAZOLINE	3.2.1.52
1HPG	A GLUTAMIC ACID SPECIFIC SERINE PROTEASE UTILIZES A NOVEL HISTIDINE TRIAD IN SUBSTRATE BINDING	3.4.21.82
1HPJ	SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC ACID AT PH 5.3, 310K, DERIVED FROM RANDOMLY GENERATED STRUCTURES USING SIMULATED ANNEALING, 12 STRUCTURES	3.4.21.7
1HPK	SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC ACID AT PH 5.3, 310K, DERIVED FROM RANDOMLY GENERATED STRUCTURES USING SIMULATED ANNEALING, MINIMIZED AVERAGE STRUCTURE	3.4.21.7
1HPL	HORSE PANCREATIC LIPASE. THE CRYSTAL STRUCTURE AT 2.3 ANGSTROMS RESOLUTION	3.1.1.3
1HPM	HOW POTASSIUM AFFECTS THE ACTIVITY OF THE MOLECULAR CHAPERONE HSC70. II. POTASSIUM BINDS SPECIFICALLY IN THE ATPASE ACTIVE SITE	3.6.1.3
1HPO	HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HPS	RATIONAL DESIGN, SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS OF A HYDROXYETHYLENE-BASED HIV-1 PROTEASE INHIBITOR CONTAINING A HETEROCYCLIC P1'-P2' AMIDE BOND ISOSTERE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HPU	5'-NUCLEOTIDASE (CLOSED FORM), COMPLEX WITH AMPCP	3.1.3.5 3.6.1.45
1HPV	CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH VX-478, A POTENT AND ORALLY BIOAVAILABLE INHIBITOR OF THE ENZYME	3.4.23 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HPX	HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR KNI-272	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HPZ	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HQ5	CRYSTAL STRUCTURE OF THE BINUCLEAR MANGANESE METALLOENZYME ARGINASE COMPLEXED WITH S-(2-BORONOETHYL)-L-CYSTEINE, AN L-ARGININE ANALOGUE	3.5.3.1
1HQA	ALKALINE PHOSPHATASE (H412Q)	3.1.3.1
1HQC	STRUCTURE OF RUVB FROM THERMUS THERMOPHILUS HB8	3.6.1.3 3.6.4.12
1HQD	PSEUDOMONAS CEPACIA LIPASE COMPLEXED WITH TRANSITION STATE ANALOGUE OF 1-PHENOXY-2-ACETOXY BUTANE	3.1.1.3
1HQE	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HQF	CRYSTAL STRUCTURE OF THE BINUCLEAR MANGANESE METALLOENZYME ARGINASE COMPLEXED WITH N-HYDROXY-L-ARGININE	3.5.3.1
1HQG	CRYSTAL STRUCTURE OF THE H141C ARGINASE VARIANT COMPLEXED WITH PRODUCTS ORNITHINE AND UREA	3.5.3.1
1HQH	CRYSTAL STRUCTURE OF THE BINUCLEAR MANGANESE METALLOENZYME ARGINASE COMPLEXED WITH NOR-N-HYDROXY-L-ARGININE	3.5.3.1
1HQU	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HQX	R308K ARGINASE VARIANT	3.5.3.1
1HQY	NUCLEOTIDE-DEPENDENT CONFORMATIONAL CHANGES IN A PROTEASE-ASSOCIATED ATPASE HSLU	3.4.25.2
1HRH	CRYSTAL STRUCTURE OF THE RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HRI	STRUCTURE DETERMINATION OF ANTIVIRAL COMPOUND SCH 38057 COMPLEXED WITH HUMAN RHINOVIRUS 14	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1HRN	HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE INHIBITORS	3.4.23.15
1HRT	THE STRUCTURE OF A COMPLEX OF BOVINE ALPHA-THROMBIN AND RECOMBINANT HIRUDIN AT 2.8 ANGSTROMS RESOLUTION	3.4.21.5
1HRV	HRV14/SDZ 35-682 COMPLEX	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1HS6	STRUCTURE OF LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH BESTATIN.	3.3.2.6 3.4.11.4
1HSE	H253M N TERMINAL LOBE OF HUMAN LACTOFERRIN	3.4.21
1HSG	CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES	3.4.23 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HSH	CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES	3.4.23 3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HSI	CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES	3.4.23 3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HSQ	SOLUTION STRUCTURE OF THE SH3 DOMAIN OF PHOSPHOLIPASE CGAMMA	3.1.4.11
1HSW	LYSOZYME (MUCOPEPTIDE N-ACETYLMURAMYL HYDROLASE)	3.2.1.17
1HSX	LYSOZYME GROWN AT BASIC PH AND ITS LOW HUMIDITY VARIANT	3.2.1.17
1HT3	MERCURY INDUCED MODIFICATIONS IN THE STEREOCHEMISTRY OF THE ACTIVE SITE THROUGH CYS-73 IN A SERINE PROTEASE: CRYSTAL STRUCTURE OF THE COMPLEX OF A PARTIALLY MODIFIED PROTEINASE K WITH MERCURY AT 1.8 A RESOLUTION	3.4.21.64
1HT6	CRYSTAL STRUCTURE AT 1.5A RESOLUTION OF THE BARLEY ALPHA-AMYLASE ISOZYME 1	3.2.1.1
1HTD	STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE, ATROLYSIN C (HT-D)	3.4.24.42
1HTE	X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HTF	X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HTG	X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HTR	CRYSTAL AND MOLECULAR STRUCTURES OF HUMAN PROGASTRICSIN AT 1.62 ANGSTROMS RESOLUTION	3.4.23.3
1HTY	GOLGI ALPHA-MANNOSIDASE II	3.2.1.114
1HTZ	CRYSTAL STRUCTURE OF TEM52 BETA-LACTAMASE	3.5.2.6
1HU0	CRYSTAL STRUCTURE OF AN HOGG1-DNA BOROHYDRIDE TRAPPED INTERMEDIATE COMPLEX	3.2.2 4.2.99.18
1HUC	THE REFINED 2.15 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF HUMAN LIVER CATHEPSIN B: THE STRUCTURAL BASIS FOR ITS SPECIFICITY	3.4.22.1
1HUF	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE TYROSINE PHOSPHATASE YOPH FROM YERSINIA PESTIS.	3.1.3.48
1HUJ	REFINED STRUCTURE OF YEAST INORGANIC PYROPHOSPHATASE AND ITS K61R MUTANT	3.6.1.1
1HUK	REFINED STRUCTURE OF YEAST INORGANIC PYROPHOSPHATASE AND ITS K61R MUTANT	3.6.1.1
1HUX	CRYSTAL STRUCTURE OF THE ACIDAMINOCOCCUS FERMENTANS (R)-2-HYDROXYGLUTARYL-COA DEHYDRATASE COMPONENT A	3.6.1
1HV0	DISSECTING ELECTROSTATIC INTERACTIONS AND THE PH-DEPENDENT ACTIVITY OF A FAMILY 11 GLYCOSIDASE	3.2.1.8
1HV1	DISSECTING ELECTROSTATIC INTERACTIONS AND THE PH-DEPENDENT ACTIVITY OF A FAMILY 11 GLYCOSIDASE	3.2.1.8
1HV5	CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR	3.4.24
1HV7	PORCINE PANCREATIC ELASTASE COMPLEXED WITH GW311616A	3.4.21.36
1HV8	CRYSTAL STRUCTURE OF A DEAD BOX PROTEIN FROM THE HYPERTHERMOPHILE METHANOCOCCUS JANNASCHII	3.6.4.13
1HVB	CRYSTAL STRUCTURE OF STREPTOMYCES R61 DD-PEPTIDASE COMPLEXED WITH A NOVEL CEPHALOSPORIN ANALOG OF CELL WALL PEPTIDOGLYCAN	3.4.16.4
1HVH	NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HVJ	INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HVK	INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HVL	INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HVQ	CRYSTAL STRUCTURES OF HEVAMINE, A PLANT DEFENCE PROTEIN WITH CHITINASE AND LYSOZYME ACTIVITY, AND ITS COMPLEX WITH AN INHIBITOR	3.2.1.14 3.2.1.17
1HVR	RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HVS	STRUCTURAL BASIS OF DRUG RESISTANCE FOR THE V82A MUTANT OF HIV-1 PROTEASE: BACKBONE FLEXIBILITY AND SUBSITE REPACKING	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HVX	BACILLUS STEAROTHERMOPHILUS ALPHA-AMYLASE	3.2.1.1
1HWM	EBULIN,ORTHORHOMBIC CRYSTAL FORM MODEL	3.2.2.22
1HWN	EBULIN COMPLEXED WITH GALACTOSE, TRIGONAL CRYSTAL FORM	3.2.2.22
1HWO	EBULIN COMPLEXED WITH LACTOSE, TRIGONAL CRYSTAL FORM	3.2.2.22
1HWP	EBULIN COMPLEXED WITH PTEROIC ACID, TRIGONAL CRYSTAL FORM	3.2.2.22
1HWR	MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HWW	GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH SWAINSONINE	3.2.1.114
1HX0	STRUCTURE OF PIG PANCREATIC ALPHA-AMYLASE COMPLEXED WITH THE TRUNCATE" ACARBOSE MOLECULE (PSEUDOTRISACCHARIDE)"	3.2.1.1
1HXB	HIV-1 PROTEINASE COMPLEXED WITH RO 31-8959	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HXE	SERINE PROTEASE	3.4.21.5
1HXF	HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT	3.4.21.5
1HXJ	CRYSTAL STRUCTURE OF THE MAIZE ZM-P60.1 BETA-GLUCOSIDASE	3.2.1.21 3.2.1.182
1HXK	GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH DEOXYMANNOJIRIMICIN	3.2.1.114
1HXS	CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1HXW	HIV-1 PROTEASE DIMER COMPLEXED WITH A-84538	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HY7	A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3	3.4.24.17
1HYF	RIBONUCLEASE T1 V16A MUTANT IN COMPLEX WITH SR2+	3.1.27.3 4.6.1.24
1HYL	THE 1.8 A STRUCTURE OF COLLAGENASE FROM HYPODERMA LINEATUM	3.4.21 3.4.21.49
1HYO	CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH 4-(HYDROXYMETHYLPHOSPHINOYL)-3-OXO-BUTANOIC ACID	3.7.1.2
1HYS	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HYT	RE-DETERMINATION AND REFINEMENT OF THE COMPLEX OF BENZYLSUCCINIC ACID WITH THERMOLYSIN AND ITS RELATION TO THE COMPLEX WITH CARBOXYPEPTIDASE A	3.4.24.27
1HYV	HIV INTEGRASE CORE DOMAIN COMPLEXED WITH TETRAPHENYL ARSONIUM	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HYZ	HIV INTEGRASE CORE DOMAIN COMPLEXED WITH A DERIVATIVE OF TETRAPHENYL ARSONIUM.	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1HZ1	RIBONUCLEASE T1 V16A MUTANT IN COMPLEX WITH MG2+	3.1.27.3 4.6.1.24
1HZF	C4ADG FRAGMENT OF HUMAN COMPLEMENT FACTOR C4A	3.4.21.43
1HZM	STRUCTURE OF ERK2 BINDING DOMAIN OF MAPK PHOSPHATASE MKP-3: STRUCTURAL INSIGHTS INTO MKP-3 ACTIVATION BY ERK2	3.1.3.48 3.1.3.16
1HZO	STRUCTURE OF CLASS A CEPHALOSPORINASE FROM PROTEUS VULGARIS K1	3.5.2.6
1HZY	HIGH RESOLUTION STRUCTURE OF THE ZINC-CONTAINING PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA	3.1.8.1
1I0B	HIGH RESOLUTION STRUCTURE OF THE MANGANESE-CONTAINING PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA	3.1.8.1
1I0D	HIGH RESOLUTION STRUCTURE OF THE ZINC/CADMIUM-CONTAINING PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA	3.1.8.1
1I0V	RIBONUCLEASE T1 IN COMPLEX WITH 2'GMP (FORM I CRYSTAL)	3.1.27.3 4.6.1.24
1I0X	RIBONUCLEASE T1 IN COMPLEX WITH 2'GMP (FORM II CRYSTAL)	3.1.27.3 4.6.1.24
1I1E	CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN	3.4.24.69
1I1I	NEUROLYSIN (ENDOPEPTIDASE 24.16) CRYSTAL STRUCTURE	3.4.24.16
1I1W	0.89A ULTRA HIGH RESOLUTION STRUCTURE OF A THERMOSTABLE XYLANASE FROM THERMOASCUS AURANTIACUS	3.2.1.8
1I1X	1.11 A ATOMIC RESOLUTION STRUCTURE OF A THERMOSTABLE XYLANASE FROM THERMOASCUS AURANTIACUS	3.2.1.8
1I1Z	MUTANT HUMAN LYSOZYME (Q86D)	3.2.2.17 3.2.1.17
1I20	MUTANT HUMAN LYSOZYME (A92D)	3.2.2.17 3.2.1.17
1I22	MUTANT HUMAN LYSOZYME (A83K/Q86D/A92D)	3.2.1.17
1I2E	RIBONUCLEASE T1 V16A MUTANT, FORM I	3.1.27.3 4.6.1.24
1I2F	RIBONUCLEASE T1 V16A MUTANT, FORM II	3.1.27.3 4.6.1.24
1I2G	RIBONUCLEASE T1 V16T MUTANT	3.1.27.3 4.6.1.24
1I2S	BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS BS3	3.5.2.6
1I2W	BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS BS3 COMPLEXED WITH CEFOXITIN	3.5.2.6
1I39	RNASE HII FROM ARCHAEOGLOBUS FULGIDUS	3.1.26.4
1I3A	RNASE HII FROM ARCHAEOGLOBUS FULGIDUS WITH COBALT HEXAMMINE CHLORIDE	3.1.26.4
1I3F	RIBONUCLEASE T1 V89S MUTANT	3.1.27.3 4.6.1.24
1I3I	RIBONUCLEASE T1 V78T MUTANT	3.1.27.3 4.6.1.24
1I3J	CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF INTRON ENDONUCLEASE I-TEVI WITH ITS SUBSTRATE	3.1
1I3O	CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3	3.4.22 3.4.22.56
1I40	STRUCTURE OF INORGANIC PYROPHOSPHATASE	3.6.1.1
1I4O	CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX	3.4.22 3.4.22.60
1I4S	CRYSTAL STRUCTURE OF RNASE III ENDONUCLEASE DOMAIN FROM AQUIFEX AEOLICUS AT 2.15 ANGSTROM RESOLUTION	3.1.26.3
1I4V	SOLUTION STRUCTURE OF THE UMUD' HOMODIMER	3.4.21
1I51	CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP	3.4.22 3.4.22.60
1I56	SOLUTION STRUCTURE OF CA2+-BOUND STATE OF CANINE MILK LYSOZYME	3.2.1.17
1I57	CRYSTAL STRUCTURE OF APO HUMAN PTP1B (C215S) MUTANT	3.1.3.48
1I5K	STRUCTURE AND BINDING DETERMINANTS OF THE RECOMBINANT KRINGLE-2 DOMAIN OF HUMAN PLASMINOGEN TO AN INTERNAL PEPTIDE FROM A GROUP A STREPTOCOCCAL SURFACE PROTEIN	3.4.21.7
1I5Q	CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE MUTANT N152A COVALENTLY ACYLATED WITH THE INHIBITORY BETA-LACTAM, MOXALACTAM	3.5.2.6
1I6B	STRUCTURE OF EQUINE APOLACTOFERRIN AT 3.2 A RESOLUTION USING CRYSTALS GROWN AT 303K	3.4.21
1I6J	CRYSTAL STRUCTURE OF A PSEUDO-16-MER DNA WITH STACKED GUANINES AND TWO G-A MISPAIRS COMPLEXED WITH THE N-TERMINAL FRAGMENT OF MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
1I6Q	FORMATION OF A PROTEIN INTERMEDIATE AND ITS TRAPPING BY THE SIMULTANEOUS CRYSTALLIZATION PROCESS: CRYSTAL STRUCTURE OF AN IRON-SATURATED INTERMEDIATE IN THE FE3+ BINDING PATHWAY OF CAMEL LACTOFERRIN AT 2.7 RESOLUTION	3.4.21
1I6S	T4 LYSOZYME MUTANT C54T/C97A/N101A	3.2.1.17
1I6T	STRUCTURE OF INORGANIC PYROPHOSPHATASE	3.6.1.1
1I6W	THE CRYSTAL STRUCTURE OF BACILLUS SUBTILIS LIPASE: A MINIMAL ALPHA/BETA HYDROLASE ENZYME	3.1.1.3
1I70	CRYSTAL STRUCTURE OF RNASE SA Y86F MUTANT	3.1.27.3 4.6.1.24
1I71	HIGH RESOLUTION CRYSTAL STRUCTURE OF APOLIPOPROTEIN(A) KRINGLE IV TYPE 7: INSIGHTS INTO LIGAND BINDING	3.4.21
1I73	COMPLEX OF PRO-LEU-L-TRP PHOSPHONATE WITH THE CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)	3.4.24.34
1I74	STREPTOCOCCUS MUTANS INORGANIC PYROPHOSPHATASE	3.6.1.1
1I76	COMPLEX OF 2-(BIPHENYL-4-SULFONYL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID (D-TIC DERIVATIVE) WITH T CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)	3.4.24.34
1I78	CRYSTAL STRUCTURE OF OUTER MEMBRANE PROTEASE OMPT FROM ESCHERICHIA COLI	3.4.21.87 3.4.23.49
1I82	FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A WITH CELLOBIOSE	3.2.1.8
1I8A	FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A WITH GLUCOSE	3.2.1.8
1I8G	SOLUTION STRUCTURE OF PIN1 WW DOMAIN COMPLEXED WITH CDC25 PHOSPHOTHREONINE PEPTIDE	3.1.3.48
1I8U	FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A	3.2.1.8
1I8V	CRYSTAL STRUCTURE OF RNASE SA Y80F MUTANT	3.1.27.3 4.6.1.24
1I9S	CRYSTAL STRUCTURE OF THE RNA TRIPHOSPHATASE DOMAIN OF MOUSE MRNA CAPPING ENZYME	3.1.3.33 2.7.7.50
1I9T	CRYSTAL STRUCTURE OF THE OXIDIZED RNA TRIPHOSPHATASE DOMAIN OF MOUSE MRNA CAPPING ENZYME	3.1.3.33 2.7.7.50
1I9Y	CRYSTAL STRUCTURE OF INOSITOL POLYPHOSPHATE 5-PHOSPHATASE DOMAIN (IPP5C) OF SPSYNAPTOJANIN	3.1.3.36
1I9Z	CRYSTAL STRUCTURE OF INOSITOL POLYPHOSPHATE 5-PHOSPHATASE DOMAIN (IPP5C) OF SPSYNAPTOJANIN IN COMPLEX WITH INOSITOL (1,4)-BISPHOSPHATE AND CALCIUM ION	3.1.3.36
1IA5	POLYGALACTURONASE FROM ASPERGILLUS ACULEATUS	3.2.1.15
1IA6	CRYSTAL STRUCTURE OF THE CELLULASE CEL9M OF C. CELLULOLYTICUM	3.2.1.4 3.2.1
1IA7	CRYSTAL STRUCTURE OF THE CELLULASE CEL9M OF C. CELLULOLYTICIUM IN COMPLEX WITH CELLOBIOSE	3.2.1.4 3.2.1
1IAA	CRYSTAL STRUCTURES, SPECTROSCOPIC FEATURES, AND CATALYTIC PROPERTIES OF COBALT(II), COPPER(II), NICKEL(II), AND MERCURY(II) DERIVATIVES OF THE ZINC ENDOPEPTIDASE ASTACIN. A CORRELATION OF STRUCTURE AND PROTEOLYTIC ACTIVITY	3.4.24.21
1IAB	CRYSTAL STRUCTURES, SPECTROSCOPIC FEATURES, AND CATALYTIC PROPERTIES OF COBALT(II), COPPER(II), NICKEL(II), AND MERCURY(II) DERIVATIVES OF THE ZINC ENDOPEPTIDASE ASTACIN. A CORRELATION OF STRUCTURE AND PROTEOLYTIC ACTIVITY	3.4.24.21
1IAC	REFINED 1.8 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF ASTACIN, A ZINC-ENDOPEPTIDASE FROM THE CRAYFISH ASTACUS ASTACUS L. STRUCTURE DETERMINATION, REFINEMENT, MOLECULAR STRUCTURE AND COMPARISON WITH THERMOLYSIN	3.4.24.21
1IAD	REFINED 1.8 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF ASTACIN, A ZINC-ENDOPEPTIDASE FROM THE CRAYFISH ASTACUS ASTACUS L. STRUCTURE DETERMINATION, REFINEMENT, MOLECULAR STRUCTURE AND COMPARISON TO THERMOLYSIN	3.4.24.21
1IAE	CRYSTAL STRUCTURES, SPECTROSCOPIC FEATURES, AND CATALYTIC PROPERTIES OF COBALT(II), COPPER(II), NICKEL(II), AND MERCURY(II) DERIVATIVES OF THE ZINC ENDOPEPTIDASE ASTACIN. A CORRELATION OF STRUCTURE AND PROTEOLYTIC ACTIVITY	3.4.24.21
1IAG	FIRST STRUCTURE OF A SNAKE VENOM METALLOPROTEINASE: A PROTOTYPE FOR MATRIX METALLOPROTEINASES(SLASH)COLLAGENASES	3.4.24.46
1IAQ	C-H-RAS P21 PROTEIN MUTANT WITH THR 35 REPLACED BY SER (T35S) COMPLEXED WITH GUANOSINE-5'-[B,G-IMIDO] TRIPHOSPHATE	3.6.5.2
1IAU	HUMAN GRANZYME B IN COMPLEX WITH AC-IEPD-CHO	3.4.21.79
1IAV	STRUCTURE ON NATIVE (ASN 87) SUBTILISIN FROM BACILLUS LENTUS	3.4.21.62
1IAW	CRYSTAL STRUCTURE OF NAEI COMPLEXED WITH 17MER DNA	3.1.21.4
1IB4	CRYSTAL STRUCTURE OF POLYGALACTURONASE FROM ASPERGILLUS ACULEATUS AT PH4.5	3.2.1.15
1IBC	CRYSTAL STRUCTURE OF INHIBITED INTERLEUKIN-1BETA CONVERTING ENZYME	3.4.22.36
1IBQ	ASPERGILLOPEPSIN FROM ASPERGILLUS PHOENICIS	3.4.23.18
1IBX	NMR STRUCTURE OF DFF40 AND DFF45 N-TERMINAL DOMAIN COMPLEX	3
1IC6	STRUCTURE OF A SERINE PROTEASE PROTEINASE K FROM TRITIRACHIUM ALBUM LIMBER AT 0.98 A RESOLUTION	3.4.21.64
1ICE	STRUCTURE AND MECHANISM OF INTERLEUKIN-1BETA CONVERTING ENZYME	3.4.22.36
1ICF	CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L	3.4.22.15
1ICJ	PDF PROTEIN IS CRYSTALLIZED AS NI2+ CONTAINING FORM, COCRYSTALLIZED WITH INHIBITOR POLYETHYLENE GLYCOL (PEG)	3.5.1.31 3.5.1.88
1ICX	CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR10.1A FROM YELLOW LUPINE	3.1.27
1ID0	CRYSTAL STRUCTURE OF THE NUCLEOTIDE BOND CONFORMATION OF PHOQ KINASE DOMAIN	2.7.1.37 2.7.13.3 3.1.3
1ID4	CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT (H157Q) OF THE HUMAN CYTOMEGALOVIRUS PROTEASE	3.4.21.97
1ID5	CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEX WITH PROTEASE INHIBITOR ECOTIN	3.4.21.5
1IDA	CRYSTAL STRUCTURES OF HIV-2 PROTEASE IN COMPLEX WITH INHIBITORS CONTAINING THE HYDROXYETHYLAMINE DIPEPTIDE ISOSTERE	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IDB	CRYSTAL STRUCTURES OF HIV-2 PROTEASE IN COMPLEX WITH INHIBITORS CONTAINING THE HYDROXYETHYLAMINE DIPEPTIDE ISOSTERE	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IE7	PHOSPHATE INHIBITED BACILLUS PASTEURII UREASE CRYSTAL STRUCTURE	3.5.1.5
1IEC	CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT (H157A) OF THE HUMAN CYTOMEGALOVIRUS PROTEASE	3.4.21.97
1IED	CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT (H157E) OF THE HUMAN CYTOMEGALOVIRUS PROTEASE	3.4.21.97
1IEE	STRUCTURE OF TETRAGONAL HEN EGG WHITE LYSOZYME AT 0.94 A FROM CRYSTALS GROWN BY THE COUNTER-DIFFUSION METHOD	3.2.1.17
1IEF	CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT S134A OF THE HUMAN CYTOMEGALOVIRUS PROTEASE	3.4.21.97
1IEG	CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT S134A/H157A OF THE HUMAN CYTOMEGALOVIRUS PROTEASE	3.4.21.97
1IEL	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH CEFTAZIDIME	3.5.2.6
1IEM	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH A BORONIC ACID INHIBITOR (1, CEFB4)	3.5.2.6
1IEQ	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1	3.2.1.58
1IEV	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH CYCLOHEXITOL	3.2.1.58
1IEW	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 2-DEOXY-2-FLUORO-ALPHA-D-GLUCOSIDE	3.2.1.58
1IEX	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4I,4III,4V-S-TRITHIOCELLOHEXAOSE	3.2.1.58
1IFS	RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH ADENOSINE (ADENOSINE BECOMES ADENINE IN THE COMPLEX)	3.2.2.22
1IFT	RICIN A-CHAIN (RECOMBINANT)	3.2.2.22
1IFU	RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH FORMYCIN	3.2.2.22
1IFV	CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR10.1B FROM YELLOW LUPINE	3.1.27
1IG9	STRUCTURE OF THE REPLICATING COMPLEX OF A POL ALPHA FAMILY DNA POLYMERASE	2.7.7.7 3.1.11
1IGB	AEROMONAS PROTEOLYTICA AMINOPEPTIDASE COMPLEXED WITH THE INHIBITOR PARA-IODO-D-PHENYLALANINE HYDROXAMATE	3.4.11.10
1IGO	FAMILY 11 XYLANASE	3.2.1.8
1IGP	X-RAY CRYSTALLOGRAPHIC STUDIES OF RECOMBINANT INORGANIC PYROPHOSPHATASE FROM ESCHERICHIA COLI	3.6.1.1
1IH7	HIGH-RESOLUTION STRUCTURE OF APO RB69 DNA POLYMERASE	2.7.7.7 3.1.11
1IHD	CRYSTAL STRUCTURE OF TRIGONAL FORM OF D90E MUTANT OF ESCHERICHIA COLI ASPARAGINASE II	3.5.1.1
1IHP	STRUCTURE OF PHOSPHOMONOESTERASE	3.1.3.8
1IHS	CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ALPHA-THROMBIN AND NON-HYDROLYZABLE BIFUNCTIONAL INHIBITORS, HIRUTONIN-2 AND HIRUTONIN-6	3.4.21.5
1IHT	CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ALPHA-THROMBIN AND NON-HYDROLYZABLE BIFUNCTIONAL INHIBITORS, HIRUTONIN-2 AND HIRUTONIN-6	3.4.21.5
1IHU	CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI ARSENITE-TRANSLOCATING ATPASE IN COMPLEX WITH MG-ADP-ALF3	3.6.3.16 7.3.2.7
1IHV	SOLUTION STRUCTURE OF THE DNA BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, MINIMIZED AVERAGE STRUCTURE	2.7.7 3.1
1IHW	SOLUTION STRUCTURE OF THE DNA BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 40 STRUCTURES	2.7.7 3.1
1IHZ	STRUCTURE OF S. NUCLEASE MUTANT QUINTUPLE MUTANT V23L/V66L/I72L/I92L/V99L	3.1.31.1
1II0	CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI ARSENITE-TRANSLOCATING ATPASE	3.6.3.16 7.3.2.7
1II3	STRUCTURE OF S. NUCLEASE QUINTUPLE MUTANT V23I/V66L/I72L/I92L/V99L	3.1.31.1
1II7	CRYSTAL STRUCTURE OF P. FURIOSUS MRE11 WITH MANGANESE AND DAMP	3.1
1II9	CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI ARSENITE-TRANSLOCATING ATPASE IN COMPLEX WITH AMP-PNP	3.6.3.16 7.3.2.7
1IIQ	CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IIZ	CRYSTAL STRUCTURE OF THE INDUCED ANTIBACTERIAL PROTEIN FROM TASAR SILKWORM, ANTHERAEA MYLITTA	3.2.1.17
1IJL	CRYSTAL STRUCTURE OF ACIDIC PHOSPHOLIPASE A2 FROM DEINAGKISTRODON ACUTUS	3.1.1.4
1IKG	MICHAELIS COMPLEX OF STREPTOMYCES R61 DD-PEPTIDASE WITH A SPECIFIC PEPTIDOGLYCAN SUBSTRATE FRAGMENT	3.4.16.4
1IKI	COMPLEX OF STREPTOMYCES R61 DD-PEPTIDASE WITH THE PRODUCTS OF A SPECIFIC PEPTIDOGLYCAN SUBSTRATE FRAGMENT	3.4.16.4
1IKV	K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IKW	WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IKX	K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IKY	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IL3	STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 7-DEAZAGUANINE	3.2.2.22
1IL4	STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 9-DEAZAGUANINE	3.2.2.22
1IL5	STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 2,5-DIAMINO-4,6-DIHYDROXYPYRIMIDINE (DDP)	3.2.2.22
1IL9	STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 8-METHYL-9-OXOGUANINE	3.2.2.22
1ILD	OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT PH 4.6	3.1.1.32 3.1.1.4
1ILV	CRYSTAL STRUCTURE ANALYSIS OF THE TM107	3.1.3.5
1ILW	CRYSTAL STRUCTURE OF PYRAZINAMIDASE/NICOTINAMIDASE OF PYROCOCCUS HORIKOSHII	3.5.1.19
1ILZ	OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT PH 6.1	3.1.1.32 3.1.1.4
1IM0	OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT PH 8.3	3.1.1.32 3.1.1.4
1IM5	CRYSTAL STRUCTURE OF PYRAZINAMIDASE OF PYROCOCCUS HORIKOSHII IN COMPLEX WITH ZINC	3.5.1.19
1IMA	STRUCTURAL ANALYSIS OF INOSITOL MONOPHOSPHATASE COMPLEXES WITH SUBSTRATES	3.1.3.25 3.1.3.94
1IMB	STRUCTURAL ANALYSIS OF INOSITOL MONOPHOSPHATASE COMPLEXES WITH SUBSTRATES	3.1.3.25 3.1.3.94
1IMC	STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS	3.1.3.25 3.1.3.94
1IMD	STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS	3.1.3.25 3.1.3.94
1IME	STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS	3.1.3.25 3.1.3.94
1IMF	STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS	3.1.3.25 3.1.3.94
1IMJ	CRYSTAL STRUCTURE OF THE HUMAN CCG1/TAFII250-INTERACTING FACTOR B (CIB)	3
1IN4	THERMOTOGA MARITIMA RUVB HOLLIDAY JUNCTION BRANCH MIGRATION MOTOR	3.6.4.12
1IN5	THERMOGOTA MARITIMA RUVB A156S MUTANT	3.6.4.12
1IN6	THERMOTOGA MARITIMA RUVB K64R MUTANT	3.6.4.12
1IN7	THERMOTOGA MARITIMA RUVB R170A	3.6.4.12
1IN8	THERMOTOGA MARITIMA RUVB T158V	3.6.4.12
1INC	CRYSTAL STRUCTURES OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE WITH TWO VALINE-DERIVED BENZOXAZINONE INHIBITORS	3.4.21.36
1INF	INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE COMPLEXED WITH BANA113 INHIBITOR	3.2.1.18
1ING	INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR	3.2.1.18
1INH	INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR	3.2.1.18
1INO	RECOMBINANT INORGANIC PYROPHOSPHATASE FROM ESCHERICHIA COLI	3.6.1.1
1INP	CRYSTAL STRUCTURE OF INOSITOL POLYPHOSPHATE 1-PHOSPHATASE AT 2.3 ANGSTROMS RESOLUTION	3.1.3.57
1INU	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS	3.2.1.17
1INV	A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES	3.2.1.18
1INW	A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES	3.2.1.18
1INX	A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES	3.2.1.18
1INY	A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES	3.2.1.18
1IO2	CRYSTAL STRUCTURE OF TYPE 2 RIBONUCLEASE H FROM HYPERTHERMOPHILIC ARCHAEON, THERMOCOCCUS KODAKARAENSIS KOD1	3.1.26.4
1IO5	HYDROGEN AND HYDRATION OF HEN EGG-WHITE LYSOZYME DETERMINED BY NEUTRON DIFFRACTION	3.2.1.17
1IOC	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME, EAEA-I56T	3.2.1.17
1IOE	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55532	3.4.21.6
1IOF	X-RAY CRYSTALLINE STRUCTURES OF PYRROLIDONE CARBOXYL PEPTIDASE FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS, AND ITS CYS-FREE MUTANT	3.4.19.3
1IOI	X-RAY CRYSTALLINE STRUCTURES OF PYRROLIDONE CARBOXYL PEPTIDASE FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS, AND ITS CYS-FREE MUTANT	3.4.19.3
1IOQ	STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLING MUTATION	3.2.1.17
1IOR	STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLING MUTATION	3.2.1.17
1IOS	STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLING MUTATION	3.2.1.17
1IOT	STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLING MUTATION	3.2.1.17
1IOZ	CRYSTAL STRUCTURE OF THE C-HA-RAS PROTEIN PREPARED BY THE CELL-FREE SYNTHESIS	3.6.5.2
1IP1	G37A HUMAN LYSOZYME	3.2.1.17
1IP2	G48A HUMAN LYSOZYME	3.2.1.17
1IP3	G68A HUMAN LYSOZYME	3.2.1.17
1IP4	G72A HUMAN LYSOZYME	3.2.1.17
1IP5	G105A HUMAN LYSOZYME	3.2.1.17
1IP6	G127A HUMAN LYSOZYME	3.2.1.17
1IP7	G129A HUMAN LYSOZYME	3.2.1.17
1IPI	CRYSTAL STRUCTURE OF THE ARCHAEAL HOLLIDAY JUNCTION RESOLVASE HJC FROM PYROCOCCUS FURIOSUS FORM II	3.1.22.4
1IPP	HOMING ENDONUCLEASE/DNA COMPLEX	3.1
1IPW	INORGANIC PYROPHOSPHATASE FROM ESCHERICHIA COLI WITH THREE MAGNESIUM IONS	3.6.1.1
1IQB	CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ ISOLECTIN I	3.2.1.14
1IQE	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55590	3.4.21.6
1IQF	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55165	3.4.21.6
1IQG	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55159	3.4.21.6
1IQH	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55143	3.4.21.6
1IQI	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55125	3.4.21.6
1IQJ	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55124	3.4.21.6
1IQK	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55113	3.4.21.6
1IQL	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54476	3.4.21.6
1IQM	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54471	3.4.21.6
1IQN	HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55192	3.4.21.6
1IQQ	CRYSTAL STRUCTURE OF JAPANESE PEAR S3-RNASE	3.1.27.1 4.6.1.19
1IR6	CRYSTAL STRUCTURE OF EXONUCLEASE RECJ BOUND TO MANGANESE	3.1
1IR7	IM MUTANT OF LYSOZYME	3.2.1.17
1IR8	IM MUTANT OF LYSOZYME	3.2.1.17
1IR9	IM MUTANT OF LYSOZYME	3.2.1.17
1IRB	CARBOXYLIC ESTER HYDROLASE	3.1.1.4
1IRY	SOLUTION STRUCTURE OF THE HMTH1, A NUCLEOTIDE POOL SANITIZATION ENZYME	3.1.6 3.6.1.55 3.6.1.56
1IS7	CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX	3.5.4.16
1IS8	CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN	3.5.4.16
1IS9	ENDOGLUCANASE A FROM CLOSTRIDIUM THERMOCELLUM AT ATOMIC RESOLUTION	3.2.1.4
1ISF	CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157	3.2.2.5 3.2.2.6
1ISG	CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 WITH ATPGAMMAS	3.2.2.5 3.2.2.6
1ISH	CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 COMPLEXED WITH ETHENONADP	3.2.2.5 3.2.2.6
1ISI	CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 COMPLEXED WITH ETHENONAD	3.2.2.5 3.2.2.6
1ISJ	CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 COMPLEXED WITH NMN	3.2.2.5 3.2.2.6
1ISM	CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 COMPLEXED WITH NICOTINAMIDE	3.2.2.5 3.2.2.6
1ISP	CRYSTAL STRUCTURE OF BACILLUS SUBTILIS LIPASE AT 1.3A RESOLUTION	3.1.1.3
1ISV	CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOSE	3.2.1.8
1ISW	CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOBIOSE	3.2.1.8
1ISX	CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOTRIOSE	3.2.1.8
1ISY	CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GLUCOSE	3.2.1.8
1ISZ	CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GALACTOSE	3.2.1.8
1IT0	CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH LACTOSE	3.2.1.8
1IT4	SOLUTION STRUCTURE OF THE PROKARYOTIC PHOSPHOLIPASE A2 FROM STREPTOMYCES VIOLACEORUBER	3.1.1.4
1IT5	SOLUTION STRUCTURE OF APO-TYPE PLA2 FROM STREPTOMYCES VIOLACERUBER A-2688.	3.1.1.4
1IT6	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CALYCULIN A AND THE CATALYTIC SUBUNIT OF PROTEIN PHOSPHATASE 1	3.1.3.16
1ITC	BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES COMPLEXED WITH MALTOPENTAOSE	3.2.1.2
1ITG	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HIV-1 INTEGRASE: SIMILARITY TO OTHER POLYNUCLEOTIDYL TRANSFERASES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1ITO	CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B-E64C COMPLEX	3.4.22.1
1ITQ	HUMAN RENAL DIPEPTIDASE	3.4.13.19 3.5.2.6
1ITU	HUMAN RENAL DIPEPTIDASE COMPLEXED WITH CILASTATIN	3.4.13.19 3.5.2.6
1ITV	DIMERIC FORM OF THE HAEMOPEXIN DOMAIN OF MMP9	3.4.24.35
1ITX	CATALYTIC DOMAIN OF CHITINASE A1 FROM BACILLUS CIRCULANS WL-12	3.2.1.14
1IU8	THE X-RAY CRYSTAL STRUCTURE OF PYRROLIDONE-CARBOXYLATE PEPTIDASE FROM HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS HORIKOSHII	3.4.19.3
1IUH	CRYSTAL STRUCTURE OF TT0787 OF THERMUS THERMOPHILUS HB8	3.1.4.58
1IUN	META-CLEAVAGE PRODUCT HYDROLASE FROM PSEUDOMONAS FLUORESCENS IP01 (CUMD) S103A MUTANT HEXAGONAL	3.7.1.9
1IUO	META-CLEAVAGE PRODUCT HYDROLASE FROM PSEUDOMONAS FLUORESCENS IP01 (CUMD) S103A MUTANT COMPLEXED WITH ACETATES	3.7.1.9
1IUP	META-CLEAVAGE PRODUCT HYDROLASE FROM PSEUDOMONAS FLUORESCENS IP01 (CUMD) S103A MUTANT COMPLEXED WITH ISOBUTYRATES	3.7.1.9
1IV0	SOLUTION STRUCTURE OF THE YQGF-FAMILY PROTEIN (N-TERMINAL FRAGMENT)	3.1
1IVB	STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
1IVC	STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
1IVD	STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
1IVE	STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
1IVF	STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
1IVG	STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
1IVM	SOLUTION STRUCTURE OF MOUSE LYSOZYME M	3.2.1.17
1IVN	E.COLI THIOESTERASE I/PROTEASE I/LYSOPHOSPHOLIASE L1	3.1.1.5 3.1.2 3.1.2.2 3.1.1.2 3.1.2.14 3.4.21
1IVP	THE CRYSTALLOGRAPHIC STRUCTURE OF THE PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 WITH TWO SYNTHETIC PEPTIDIC TRANSITION STATE ANALOG INHIBITORS	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IVQ	THE CRYSTALLOGRAPHIC STRUCTURE OF THE PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 WITH TWO SYNTHETIC PEPTIDIC TRANSITION STATE ANALOG INHIBITORS	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IVY	PHYSIOLOGICAL DIMER HPP PRECURSOR	3.4.16.5
1IW8	CRYSTAL STRUCTURE OF A MUTANT OF ACID PHOSPHATASE FROM ESCHERICHIA BLATTAE (G74D/I153T)	3.1.3.2
1IWC	TFE-INDUDED STRUCTURE OF THE N-TERMINAL DOMAIN OF PIG GASTRIC H/K-ATPASE	3.6.3.10
1IWD	PROPOSED AMINO ACID SEQUENCE AND THE 1.63 ANGSTROM X-RAY CRYSTAL STRUCTURE OF A PLANT CYSTEINE PROTEASE ERVATAMIN B: INSIGHT INTO THE STRUCTURAL BASIS OF ITS STABILITY AND SUBSTRATE SPECIFICITY.	3.4.22
1IWF	SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF PIG GASTRIC H/K-ATPASE	3.6.3.10
1IWT	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 113K.	3.2.1.17
1IWU	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 127K.	3.2.1.17
1IWV	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 147K.	3.2.1.17
1IWW	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 152K.	3.2.1.17
1IWX	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 161K.	3.2.1.17
1IWY	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 170K.	3.2.1.17
1IWZ	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 178K.	3.2.1.17
1IX0	I59A-3SS HUMAN LYSOZYME	3.2.1.17
1IX1	CRYSTAL STRUCTURE OF P.AERUGINOSA PEPTIDE DEFORMYLASE COMPLEXED WITH ANTIBIOTIC ACTINONIN	3.5.1.88
1IXA	THE THREE-DIMENSIONAL STRUCTURE OF THE FIRST EGF-LIKE MODULE OF HUMAN FACTOR IX: COMPARISON WITH EGF AND TGF-A	3.4.21.22
1IXD	SOLUTION STRUCTURE OF THE CAP-GLY DOMAIN FROM HUMAN CYLINDROMATOSIS TOMOUR-SUPPRESSOR CYLD	3.1.2.15 3.4.19.12
1IXR	RUVA-RUVB COMPLEX	3.6.4.12
1IXS	STRUCTURE OF RUVB COMPLEXED WITH RUVA DOMAIN III	3.6.4.12
1IXZ	CRYSTAL STRUCTURE OF THE FTSH ATPASE DOMAIN FROM THERMUS THERMOPHILUS	3.4.24
1IY0	CRYSTAL STRUCTURE OF THE FTSH ATPASE DOMAIN WITH AMP-PNP FROM THERMUS THERMOPHILUS	3.4.24
1IY1	CRYSTAL STRUCTURE OF THE FTSH ATPASE DOMAIN WITH ADP FROM THERMUS THERMOPHILUS	3.4.24
1IY2	CRYSTAL STRUCTURE OF THE FTSH ATPASE DOMAIN FROM THERMUS THERMOPHILUS	3.4.24
1IY3	SOLUTION STRUCTURE OF THE HUMAN LYSOZYME AT 4 DEGREE C	3.2.1.17
1IY4	SOLUTION STRUCTURE OF THE HUMAN LYSOZYME AT 35 DEGREE C	3.2.1.17
1IY7	CRYSTAL STRUCTURE OF CPA AND SULFAMIDE-BASED INHIBITOR COMPLEX	3.4.17.1
1IYB	CRYSTAL STRUCTURE OF THE NICOTIANA GLUTINOSA RIBONUCLEASE NW	3.1
1IYO	TOHO-1 BETA-LACTAMASE IN COMPLEX WITH CEFOTAXIME	3.5.2.6
1IYP	TOHO-1 BETA-LACTAMASE IN COMPLEX WITH CEPHALOTHIN	3.5.2.6
1IYQ	TOHO-1 BETA-LACTAMASE IN COMPLEX WITH BENZYLPENICILLIN	3.5.2.6
1IYS	CRYSTAL STRUCTURE OF CLASS A BETA-LACTAMASE TOHO-1	3.5.2.6
1IYY	NMR STRUCTURE OF GLN25-RIBONUCLEASE T1, 24 STRUCTURES	3.1.27.3 4.6.1.24
1IZ7	RE-REFINEMENT OF THE STRUCTURE OF HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 AT 1.6 A RESOLUTION	3.8.1 3.8.1.5
1IZ8	RE-REFINEMENT OF THE STRUCTURE OF HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 WITH 1,3-PROPANEDIOL, A PRODUCT OF DEBROMIDATION OF DIBROMPROPANE, AT 2.0A RESOLUTION	3.8.1 3.8.1.5
1IZD	CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE	3.4.23.18
1IZE	CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN	3.4.23.18
1IZH	INHIBITOR OF HIV PROTEASE WITH UNUSUAL BINDING MODE POTENTLY INHIBITING MULTI-RESISTANT PROTEASE MUTANTS	3.4.23.16
1IZI	INHIBITOR OF HIV PROTEASE WITH UNUSUAL BINDING MODE POTENTLY INHIBITING MULTI-RESISTANT PROTEASE MUTANTS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1IZJ	THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 MUTANT ENZYME F313A	3.2.1.1 3.2.1.135
1IZK	THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 MUTANT ENZYME W398V	3.2.1.1 3.2.1.135
1IZP	F46L MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1IZQ	F46V MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1IZR	F46A MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A	3.1.27.5 4.6.1.18
1IZY	CRYSTAL STRUCTURE OF HSP31	3.1.2 3.5.1 3.5.1.124 4.2.1.130
1IZZ	CRYSTAL STRUCTURE OF HSP31	3.1.2 3.5.1 3.5.1.124 4.2.1.130
1J00	E. COLI THIOESTERASE I/PROTEASE I/LYSOPHOSPHOLIPASE L1 IN COMPLEXED WITH DIETHYL PHOSPHONO MOIETY	3.1.2 3.1.1.5 3.1.2.2 3.1.1.2 3.1.2.14 3.4.21
1J01	CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED INHIBITOR ISOFAGOMINE LACTAM	3.2.1.91 3.2.1.8
1J06	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE IN THE APO FORM	3.1.1.7
1J07	CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-DECIDIUM COMPLEX	3.1.1.7
1J0A	CRYSTAL STRUCTURE ANALYSIS OF THE ACC DEAMINASE HOMOLOGUE	4.1.99.4 3.5.99.7
1J0C	ACC DEAMINASE MUTATED TO CATALYTIC RESIDUE	4.1.99.4 3.5.99.7
1J0D	ACC DEAMINASE MUTANT COMPLEXED WITH ACC	4.1.99.4 3.5.99.7
1J0E	ACC DEAMINASE MUTANT REACTON INTERMEDIATE	4.1.99.4 3.5.99.7
1J0H	CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS NEOPULLULANASE	3.2.1.135
1J0I	CRYSTAL STRUCTURE OF NEOPULLULANASE COMPLEX WITH PANOSE	3.2.1.135
1J0J	CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH MALTOTETRAOSE	3.2.1.135
1J0K	CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH ISOPANOSE	3.2.1.135
1J0Y	BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH GLUCOSE	3.2.1.2
1J0Z	BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH MALTOSE	3.2.1.2
1J10	BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH GGX	3.2.1.2
1J11	BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH ALPHA-EPG	3.2.1.2
1J12	BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH ALPHA-EBG	3.2.1.2
1J14	BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99RT	3.4.21.4
1J15	BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT	3.4.21.4
1J16	BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT	3.4.21.4
1J17	FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT	3.4.21.4
1J18	CRYSTAL STRUCTURE OF A BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES COCRYSTALLIZED WITH MALTOSE	3.2.1.2
1J1A	PANCREATIC SECRETORY PHOSPHOLIPASE A2 (IIA) WITH ANTI-INFLAMMATORY ACTIVITY	3.1.1.4
1J1F	CRYSTAL STRUCTURE OF THE RNASE MC1 MUTANT N71T IN COMPLEX WITH 5'-GMP	3.1.27.1 4.6.1.19
1J1G	CRYSTAL STRUCTURE OF THE RNASE MC1 MUTANT N71S IN COMPLEX WITH 5'-GMP	3.1.27.1 4.6.1.19
1J1I	CRYSTAL STRUCTURE OF A HIS-TAGGED SERINE HYDROLASE INVOLVED IN THE CARBAZOLE DEGRADATION (CARC ENZYME)	3.7.1.8
1J1J	CRYSTAL STRUCTURE OF HUMAN TRANSLIN	3.1
1J1M	RICIN A-CHAIN (RECOMBINANT) AT 100K	3.2.2.22
1J1Q	STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN FROM SEEDS (PAP-S1)	3.2.2.22
1J1R	STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN FROM SEEDS (PAP-S1) COMPLEXED WITH ADENINE	3.2.2.22
1J1S	POKEWEED ANTIVIRAL PROTEIN FROM SEEDS (PAP-S1) COMPLEXED WITH FORMYCIN	3.2.2.22
1J26	SOLUTION STRUCTURE OF A PUTATIVE PEPTIDYL-TRNA HYDROLASE DOMAIN IN A MOUSE HYPOTHETICAL PROTEIN	3.1.1.29
1J2E	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV	3.4.14.5
1J2P	ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS	3.4.25.1
1J2R	CRYSTAL STRUCTURE OF ESCHERICHIA COLI GENE PRODUCT YECD AT 1.3 A RESOLUTION	3
1J2T	CREATININASE MN	3.5.2.10
1J2U	CREATININASE ZN	3.5.2.10
1J36	CRYSTAL STRUCTURE OF DROSOPHILA ANCE	3.4.15.1
1J37	CRYSTAL STRUCTURE OF DROSOPHILA ANCE	3.4.15.1
1J38	CRYSTAL STRUCTURE OF DROSOPHILA ANCE	3.4.15.1
1J3G	SOLUTION STRUCTURE OF CITROBACTER FREUNDII AMPD	3.5.1.28
1J42	CRYSTAL STRUCTURE OF HUMAN DJ-1	3.1.2 3.5.1 3.5.1.124
1J4G	CRYSTAL STRUCTURE ANALYSIS OF THE TRICHOSANTHIN DELTA C7	3.2.2.22
1J4X	HUMAN VH1-RELATED DUAL-SPECIFICITY PHOSPHATASE C124S MUTANT-PEPTIDE COMPLEX	3.1.3.48 3.1.3.16
1J5O	CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1J5X	CRYSTAL STRUCTURE OF GLUCOSAMINE-6-PHOSPHATE DEAMINASE (TM0813) FROM THERMOTOGA MARITIMA AT 1.8 A RESOLUTION	3.5.99.6
1J6O	CRYSTAL STRUCTURE OF TATD-RELATED DEOXYRIBONUCLEASE (TM0667) FROM THERMOTOGA MARITIMA AT 1.8 A RESOLUTION	3.1.21
1J6P	CRYSTAL STRUCTURE OF METAL-DEPENDENT HYDROLASE OF CYTOSINEDEMANIASE/CHLOROHYDROLASE FAMILY (TM0936) FROM THERMOTOGA MARITIMA AT 1.9 A RESOLUTION	3.5.4.28 3.5.4.31
1J71	STRUCTURE OF THE EXTRACELLULAR ASPARTIC PROTEINASE FROM CANDIDA TROPICALIS YEAST.	3.4.23.24
1J79	MOLECULAR STRUCTURE OF DIHYDROOROTASE: A PARADIGM FOR CATALYSIS THROUGH THE USE OF A BINUCLEAR METAL CENTER	3.5.2.3
1J7G	STRUCTURE OF YIHZ FROM HAEMOPHILUS INFLUENZAE (HI0670), A D-TYR-TRNA(TYR) DEACYLASE	3.1 3.1.1.96
1J7K	THERMOTOGA MARITIMA RUVB P216G MUTANT	3.6.4.12
1J7M	THE THIRD FIBRONECTIN TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2	3.4.24.24
1J7N	ANTHRAX TOXIN LETHAL FACTOR	3.4.24.83
1J7Z	OSMOLYTE STABILIZATION OF RIBONUCLEASE	3.1.27.5
1J80	OSMOLYTE STABILIZATION OF RNASE	3.1.27.5
1J81	OSMOLYTE STABILIZATION OF RNASE	3.1.27.5
1J82	OSMOLYTE STABILIZATION OF RNASE	3.1.27.5
1J83	STRUCTURE OF FAM17 CARBOHYDRATE BINDING MODULE FROM CLOSTRIDIUM CELLULOVORANS	3.2.1.4
1J84	STRUCTURE OF FAM17 CARBOHYDRATE BINDING MODULE FROM CLOSTRIDIUM CELLULOVORANS WITH BOUND CELLOTETRAOSE	3.2.1.4
1J8A	CRYSTAL STRUCTURE OF BENZAMIDINE INHIBITED BOVINE PANCREATIC TRYPSIN AT 105K TO 1.21A RESOLUTION FROM LABORATORY SOURCE WITH HIGH NUMBER OF WATERS MODELLED	3.4.21.4
1J8D	STRUCTURE OF THE METAL-FREE FORM OF THE DEOXY-D-MANNOSE-OCTULOSONATE 8-PHOSPHATE PHOSPHATASE (YRBI) FROM HAEMOPHILUS INFLUENZAE (HI1679)	3.1.3 3.1.3.45
1J8V	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4'-NITROPHENYL 3I-THIOLAMINARITRIOSIDE	3.2.1.58
1J97	PHOSPHO-ASPARTYL INTERMEDIATE ANALOGUE OF PHOSPHOSERINE PHOSPHATASE	3.1.3.3
1J9A	OLIGORIBONUCLEASE	3.1
1J9C	CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX	3.4.21.21
1J9I	STRUCTURE OF THE DNA BINDING DOMAIN OF THE GPNU1 SUBUNIT OF LAMBDA TERMINASE	3.6.4
1J9J	CRYSTAL STRUCTURE ANALYSIS OF SURE PROTEIN FROM T.MARITIMA	3.1.3.5
1J9K	CRYSTAL STRUCTURE OF SURE PROTEIN FROM T.MARITIMA IN COMPLEX WITH TUNGSTATE	3.1.3.5
1J9L	CRYSTAL STRUCTURE OF SURE PROTEIN FROM T.MARITIMA IN COMPLEX WITH VANADATE	3.1.3.5
1J9M	K38H MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE	3.4.16.4
1J9Y	CRYSTAL STRUCTURE OF MANNANASE 26A FROM PSEUDOMONAS CELLULOSA	3.2.1.78
1JA2	BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: A POWDER DIFFRACTION STUDY	3.2.1.17
1JA4	BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: A POWDER DIFFRACTION STUDY	3.2.1.17
1JA6	BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: A POWDER DIFFRACTION STUDY	3.2.1.17
1JA7	BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: A POWDER DIFFRACTION STUDY	3.2.1.17
1JAD	C-TERMINAL DOMAIN OF TURKEY PLC-BETA	3.1.4.11
1JAE	STRUCTURE OF TENEBRIO MOLITOR LARVAL ALPHA-AMYLASE	3.2.1.1
1JAH	H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITH GUANOSINE-5'-[BETA,GAMMA-METHYLENE] TRIPHOSPHATE AND MAGNESIUM	3.6.5.2
1JAI	H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITH GUANOSINE-5'-[BETA,GAMMA-METHYLENE] TRIPHOSPHATE AND MANGANESE	3.6.5.2
1JAK	STREPTOMYCES PLICATUS BETA-N-ACETYLHEXOSAMINIDASE IN COMPLEX WITH (2R,3R,4S,5R)-2-ACETAMIDO-3,4-DIHYDROXY-5-HYDROXYMETHYL-PIPERIDINIUM CHLORIDE (IFG)	3.2.1.52
1JAN	COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (PHE79 FORM)	3.4.24.34
1JAO	COMPLEX OF 3-MERCAPTO-2-BENZYLPROPANOYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)	3.4.24.34
1JAP	COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)	3.4.24.34
1JAQ	COMPLEX OF 1-HYDROXYLAMINE-2-ISOBUTYLMALONYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)	3.4.24.34
1JAW	AMINOPEPTIDASE P FROM E. COLI LOW PH FORM	3.4.11.9
1JAZ	CRYSTAL STRUCTURE OF MONOCLINIC FORM OF D90E MUTANT OF ESCHERICHIA COLI ASPARAGINASE II	3.5.1.1
1JB1	LACTOBACILLUS CASEI HPRK/P BOUND TO PHOSPHATE	2.7.1 3.1.3 2.7.11 2.7.4
1JBR	CRYSTAL STRUCTURE OF THE RIBOTOXIN RESTRICTOCIN AND A 31-MER SRD RNA INHIBITOR	3.1.27
1JBS	CRYSTAL STRUCTURE OF RIBOTOXIN RESTRICTOCIN AND A 29-MER SRD RNA ANALOG	3.1.27
1JBT	CRYSTAL STRUCTURE OF RIBOTOXIN RESTRICTOCIN COMPLEXED WITH A 29-MER SARCIN/RICIN DOMAIN RNA ANALOG	3.1.27
1JBU	COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEX WITH INHIBITORY EXOSITE PEPTIDE A-183	3.4.21.21
1JCH	CRYSTAL STRUCTURE OF COLICIN E3 IN COMPLEX WITH ITS IMMUNITY PROTEIN	3.1.21 3.1
1JD7	CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT K300R OF PSEUDOALTEROMONAS HALOPLANCTIS ALPHA-AMYLASE	3.2.1.1
1JD9	CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT K300Q OF PSEUDOALTEROMONAS HALOPLANCTIS ALPHA-AMYLASE	3.2.1.1
1JDA	MALTOTETRAOSE-FORMING EXO-AMYLASE	3.2.1.60
1JDC	MUTANT (E219Q) MALTOTETRAOSE-FORMING EXO-AMYLASE COCRYSTALLIZED WITH MALTOTETRAOSE (CRYSTAL TYPE 1)	3.2.1.60
1JDD	MUTANT (E219Q) MALTOTETRAOSE-FORMING EXO-AMYLASE COCRYSTALLIZED WITH MALTOTETRAOSE (CRYSTAL TYPE 2)	3.2.1.60
1JEA	ALTERED TOPOLOGY AND FLEXIBILITY IN ENGINEERED SUBTILISIN	3.4.21.62
1JEF	TURKEY LYSOZYME COMPLEX WITH (GLCNAC)3	3.2.1.17
1JEQ	CRYSTAL STRUCTURE OF THE KU HETERODIMER	3.6.4 4.2.99
1JEW	CRYO-EM STRUCTURE OF COXSACKIEVIRUS B3(M STRAIN) WITH ITS CELLULAR RECEPTOR, COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR (CAR).	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1JEY	CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA	3.6.4 4.2.99
1JF5	CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 MUTANT F286A	3.2.1.135
1JF6	CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE MUTANT F286Y	3.2.1.135
1JF7	HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177836	3.1.3.48
1JFD	STRUCTURE OF INORGANIC PYROPHOSPHATASE	3.6.1.1
1JFH	STRUCTURE OF A PANCREATIC ALPHA-AMYLASE BOUND TO A SUBSTRATE ANALOGUE AT 2.03 ANGSTROM RESOLUTION	3.2.1.1
1JFN	SOLUTION STRUCTURE OF HUMAN APOLIPOPROTEIN(A) KRINGLE IV TYPE 6	3.4.21
1JFX	CRYSTAL STRUCTURE OF THE BACTERIAL LYSOZYME FROM STREPTOMYCES COELICOLOR AT 1.65 A RESOLUTION	3.2.1.17
1JFZ	CRYSTAL STRUCTURE OF MN(II)-COMPLEX OF RNASE III ENDONUCLEASE DOMAIN FROM AQUIFEX AEOLICUS AT 2.10 ANGSTROM RESOLUTION	3.1.26.3
1JGM	HIGH RESOLUTION STRUCTURE OF THE CADMIUM-CONTAINING PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA	3.1.8.1
1JH1	CRYSTAL STRUCTURE OF MMP-8 COMPLEXED WITH A 6H-1,3,4-THIADIAZINE DERIVED INHIBITOR	3.4.24.34
1JH6	SEMI-REDUCED CYCLIC NUCLEOTIDE PHOSPHODIESTERASE FROM ARABIDOPSIS THALIANA	3.1.4
1JH7	SEMI-REDUCED INHIBITOR-BOUND CYCLIC NUCLEOTIDE PHOSPHODIESTERASE FROM ARABIDOPSIS THALIANA	3.1.4
1JHC	LEXA S119A C-TERMINAL TRYPTIC FRAGMENT	3.4.21.88
1JHE	LEXA L89P Q92W E152A K156A MUTANT	3.4.21.88
1JHF	LEXA G85D MUTANT	3.4.21.88
1JHH	LEXA S119A MUTANT	3.4.21.88
1JHL	THREE-DIMENSIONAL STRUCTURE OF A HETEROCLITIC ANTIGEN-ANTIBODY CROSS-REACTION COMPLEX	3.2.1.17
1JI1	CRYSTAL STRUCTURE ANALYSIS OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1	3.2.1.1 3.2.1.135
1JI2	IMPROVED X-RAY STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2	3.2.1.135
1JI3	CRYSTAL STRUCTURE OF THE FIRST THERMOSTABLE BACTERIAL LIPASE FROM BACILLUS STEAROTHERMOPHILUS	3.1.1.3
1JIA	STRUCTURE OF A BASIC PHOSPHOLIPASE A2 FROM AGKISTRODON HALYS PALLAS AT 2.13A RESOLUTION	3.1.1.4
1JIB	COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH MALTOTETRAOSE BASED ON A CRYSTAL SOAKED WITH MALTOHEXAOSE.	3.2.1.135
1JIC	SOLUTION NMR STRUCTURE OF RECOMBINANT SSO7D WITH RNASE ACTIVITY, MINIMIZED AVERAGE STRUCTURE	3.1.27
1JIM	STEREOSPECIFIC REACTION OF 3-METHOXY-4-CHLORO-7-AMINOISOCOUMARIN WITH CRYSTALLINE PORCINE PANCREATIC ELASTASE	3.4.21.36
1JIR	CRYSTAL STRUCTURE OF TRYPSIN COMPLEX WITH AMYLAMINE IN CYCLOHEXANE	3.4.21.4
1JIS	CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN AT PH 4.6	3.2.1.17
1JIT	CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN IN PRESENCE 30% TREHALOSE	3.2.1.17
1JIY	CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN IN PRESENCE 20% SORBITOL	3.2.1.17
1JIZ	CRYSTAL STRUCTURE ANALYSIS OF HUMAN MACROPHAGE ELASTASE MMP-12	3.4.24.65
1JJ0	CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN IN PRESENCE OF 30% SUCROSE	3.2.1.17
1JJ1	CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 4.6 IN PRESENCE OF 5% SORBITOL	3.2.1.17
1JJ3	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN AT PH 4.6	3.2.1.17
1JJ9	CRYSTAL STRUCTURE OF MMP8-BARBITURATE COMPLEX REVEALS MECHANISM FOR COLLAGEN SUBSTRATE RECOGNITION	3.4.24.34
1JJA	CRYSTAL STRUCTURE OF ORTHORHOMBIC FORM OF D90E MUTANT OF ESCHERICHIA COLI L-ASPARAGINASE II	3.5.1.1
1JJB	A NEUTRAL MOLECULE IN CATION-BINDING SITE: SPECIFIC BINDING OF PEG-SH TO ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA	3.1.1.7
1JJE	IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INHIBITOR (11)	3.5.2.6
1JJF	STRUCTURAL BASIS FOR THE SUBSTRATE SPECIFICITY OF THE FERULOYL ESTERASE DOMAIN OF THE CELLULOSOMAL XYLANASE Z OF CLOSTRIDIUM THERMOCELLUM	3.2.1.8
1JJI	THE CRYSTAL STRUCTURE OF A HYPER-THERMOPHILIC CARBOXYLESTERASE FROM THE ARCHAEON ARCHAEOGLOBUS FULGIDUS	3.1.1.1
1JJR	THE THREE-DIMENSIONAL STRUCTURE OF THE C-TERMINAL DNA BINDING DOMAIN OF HUMAN KU70	3.6.4 4.2.99
1JJT	IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INHIBITOR (1)	3.5.2.6
1JJW	STRUCTURE OF HAEMOPHILUS INFLUENZAE HSLV PROTEIN AT 1.9 A RESOLUTION	3.4.99 3.4.25.2
1JK3	CRYSTAL STRUCTURE OF HUMAN MMP-12 (MACROPHAGE ELASTASE) AT TRUE ATOMIC RESOLUTION	3.4.24.65
1JK7	CRYSTAL STRUCTURE OF THE TUMOR-PROMOTER OKADAIC ACID BOUND TO PROTEIN PHOSPHATASE-1	3.1.3.16
1JKA	HUMAN LYSOZYME MUTANT WITH GLU 35 REPLACED BY ASP	3.2.1.17
1JKB	HUMAN LYSOZYME MUTANT WITH GLU 35 REPLACED BY ALA	3.2.1.17
1JKC	HUMAN LYSOZYME MUTANT WITH TRP 109 REPLACED BY PHE	3.2.1.17
1JKD	HUMAN LYSOZYME MUTANT WITH TRP 109 REPLACED BY ALA	3.2.1.17
1JKE	D-TYR TRNATYR DEACYLASE FROM ESCHERICHIA COLI	3.1.1.96
1JKH	CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1JKN	SOLUTION STRUCTURE OF THE NUDIX ENZYME DIADENOSINE TETRAPHOSPHATE HYDROLASE FROM LUPINUS ANGUSTIFOLIUS COMPLEXED WITH ATP	3.6.1.17
1JKY	CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR (LF): WILD-TYPE LF COMPLEXED WITH THE N-TERMINAL SEQUENCE OF MAPKK2	3.4.24.83
1JL1	D10A E. COLI RIBONUCLEASE HI	3.1.26.4
1JL2	CRYSTAL STRUCTURE OF TCEO RNASE H-A CHIMERA COMBINING THE FOLDING CORE FROM T. THERMOPHILUS RNASE H AND THE REMAINING REGION OF E. COLI RNASE H	3.1.26.4
1JL8	COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH BETA-CYCLODEXTRIN BASED ON A CO-CRYSTALLIZATION WITH METHYL BETA-CYCLODEXTRIN	3.2.1.135
1JLA	CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1JLB	CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1JLC	CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1JLD	POTENT HIV PROTEASE INHIBITORS CONTAINING A NOVEL (HYDROXYETHYL)AMIDE ISOSTERE	3.4.23.16 3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1JLE	CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1JLF	CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1JLG	CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1JLN	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE PTP-SL/BR7	3.1.3.48
1JLQ	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1JMS	CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF MURINE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE	2.7.7.31 3.1.11
1JMY	TRUNCATED RECOMBINANT HUMAN BILE SALT STIMULATED LIPASE	3.1.1.3 3.1.1.13 3.1.1.6
1JN4	THE CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 2'-DEOXYURIDINE 3'-PYROPHOSPHATE (P'-5') ADENOSINE	3.1.27.5 4.6.1.18
1JN9	STRUCTURE OF PUTATIVE ASPARAGINASE ENCODED BY ESCHERICHIA COLI YBIK GENE	3.5.1.1 3.4.19.5
1JOK	AVERAGED STRUCTURE FOR STAPHYLOCOCCAL NUCLEASE-H124L IN TERNARY COMPLEX WITH CA2+ AND THYMIDINE-3',5'-BISPHOSPHATE	3.1.31.1
1JOO	AVERAGED STRUCTURE FOR UNLIGATED STAPHYLOCOCCAL NUCLEASE-H124L	3.1.31.1
1JOQ	ENSEMBLE STRUCTURES FOR STAPHYLOCOCCAL NUCLEASE-H124L IN TERNARY COMPLEX WITH CA2+ AND THYMIDINE-3',5'-BISPHOSPHATE	3.1.31.1
1JOR	ENSEMBLE STRUCTURES FOR UNLIGATED STAPHYLOCOCCAL NUCLEASE-H124L	3.1.31.1
1JOU	CRYSTAL STRUCTURE OF NATIVE S195A THROMBIN WITH AN UNOCCUPIED ACTIVE SITE	3.4.21.5
1JP4	CRYSTAL STRUCTURE OF AN ENZYME DISPLAYING BOTH INOSITOL-POLYPHOSPHATE 1-PHOSPHATASE AND 3'-PHOSPHOADENOSINE-5'-PHOSPHATE PHOSPHATASE ACTIVITIES	3.1.3.7 3.1.3.57
1JPO	LOW TEMPERATURE ORTHORHOMBIC LYSOZYME	3.2.1.17
1JQ6	HUMAN CYTOMEGALOVIRUS PROTEASE DIMER-INTERFACE MUTANT, S225Y	3.4.21.97
1JQ7	HCMV PROTEASE DIMER-INTERFACE MUTANT, S225Y COMPLEXED TO INHIBITOR BILC 408	3.4.21.97
1JQ8	DESIGN OF SPECIFIC INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AND A DESIGNED PENTAPEPTIDE LEU-ALA-ILE-TYR-SER AT 2.0 RESOLUTION	3.1.1.4
1JQ9	CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AND A DESIGNED PENTAPEPTIDE PHE-LEU-SER-TYR-LYS AT 1.8 RESOLUTION	3.1.1.4
1JQG	CRYSTAL STRUCTURE OF THE CARBOXYPEPTIDASE A FROM HELICOVERPA ARMIGERA	3.4.17.1
1JQP	DIPEPTIDYL PEPTIDASE I (CATHEPSIN C), A TETRAMERIC CYSTEINE PROTEASE OF THE PAPAIN FAMILY	3.4.14.1
1JQU	ARE CARBOXY TERMINII OF HELICES CODED BY THE LOCAL SEQUENCE OR BY TERTIARY STRUCTURE CONTACTS	3.2.1.17
1JR6	SOLUTION STRUCTURE OF AN ENGINEERED ARGININE-RICH SUBDOMAIN 2 OF THE HEPATITIS C VIRUS NS3 RNA HELICASE	3.4.21.98 3.4.22 3.6.1.15 3.6.4.13 2.7.7.48
1JRL	CRYSTAL STRUCTURE OF E. COLI LYSOPHOSPHOLIASE L1/ACYL-COA THIOESTERASE I/PROTEASE I L109P MUTANT	3.1.2 3.1.1.5 3.1.2.2 3.1.1.2 3.1.2.14 3.4.21
1JRS	HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN	3.4.21.4
1JRT	HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN	3.4.21.4
1JS0	CRYSTAL STRUCTURE OF 3D DOMAIN-SWAPPED RNASE A MINOR TRIMER	3.1.27.5 4.6.1.18
1JS4	ENDO/EXOCELLULASE:CELLOBIOSE FROM THERMOMONOSPORA	3.2.1.4
1JSE	FULL-MATRIX LEAST-SQUARES REFINEMENT OF TURKEY LYSOZYME	3.2.1.17
1JSF	FULL-MATRIX LEAST-SQUARES REFINEMENT OF HUMAN LYSOZYME	3.2.1.17
1JSL	CRYSTAL STRUCTURE OF ERWINIA CHRYSANTHEMI L-ASPARAGINASE COMPLEXED WITH 6-HYDROXY-D-NORLEUCINE	3.5.1.1
1JSR	CRYSTAL STRUCTURE OF ERWINIA CHRYSANTHEMI L-ASPARAGINASE COMPLEXED WITH 6-HYDROXY-L-NORLEUCINE	3.5.1.1
1JT1	FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII MODELLED WITH D-CAPTOPRIL	3.5.2.6
1JT2	STRUCTURAL BASIS FOR THE SUBSTRATE SPECIFICITY OF THE FERUL DOMAIN OF THE CELLULOSOMAL XYLANASE Z FROM C. THERMOCELLUM	3.2.1.8
1JT9	STRUCTURE OF THE MUTANT F174A T FORM OF THE GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI	3.5.99.6
1JTD	CRYSTAL STRUCTURE OF BETA-LACTAMASE INHIBITOR PROTEIN-II IN COMPLEX WITH TEM-1 BETA-LACTAMASE	3.5.2.6
1JTG	CRYSTAL STRUCTURE OF TEM-1 BETA-LACTAMASE / BETA-LACTAMASE INHIBITOR PROTEIN COMPLEX	3.5.2.6
1JTK	CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE FROM BACILLUS SUBTILIS IN COMPLEX WITH THE INHIBITOR TETRAHYDRODEOXYURIDINE	3.5.4.5
1JTM	ALTERNATIVE STRUCTURES OF A SEQUENCE EXTENDED T4 LYSOZYME SHOW THAT THE HIGHLY CONSERVED BETA-SHEET HAS WEAK INTRINSIC FOLDING PROPENSITY	3.2.1.17
1JTN	ALTERNATIVE STRUCTURES OF A SEQUENCE EXTENDED T4 LYSOZYME SHOW THAT THE HIGHLY CONSERVED BETA-SHEET REGION HAS WEAK INTRINSIC FOLDING PROPENSITY	3.2.1.17
1JU3	BACTERIAL COCAINE ESTERASE COMPLEX WITH TRANSITION STATE ANALOG	3.1.1.84
1JU4	BACTERIAL COCAINE ESTERASE COMPLEX WITH PRODUCT	3.1.1.84
1JUD	L-2-HALOACID DEHALOGENASE	3.8.1.2
1JUG	LYSOZYME FROM ECHIDNA MILK (TACHYGLOSSUS ACULEATUS)	3.2.1.17
1JVA	CRYSTAL STRUCTURE OF THE VMA1-DERIVED ENDONUCLEASE BEARING THE N AND C EXTEIN PROPEPTIDES	7.1.2.2 3.1
1JVJ	CRYSTAL STRUCTURE OF N132A MUTANT OF TEM-1 BETA-LACTAMASE IN COMPLEX WITH A N-FORMIMIDOYL-THIENAMYCINE	3.5.2.6
1JVN	CRYSTAL STRUCTURE OF IMIDAZOLE GLYCEROL PHOSPHATE SYNTHASE: A TUNNEL THROUGH A (BETA/ALPHA)8 BARREL JOINS TWO ACTIVE SITES	2.4.2 4.3.2.10 3.5.1.2
1JVR	STRUCTURE OF THE HTLV-II MATRIX PROTEIN, NMR, 20 STRUCTURES	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
1JVT	CRYSTAL STRUCTURE OF RIBONUCLEASE A (LIGAND-FREE FORM)	3.1.27.5 4.6.1.18
1JVU	CRYSTAL STRUCTURE OF RIBONUCLEASE A (COMPLEXED FORM)	3.1.27.5 4.6.1.18
1JVV	CRYSTAL STRUCTURE OF RIBONUCLEASE A (RETRO-SOAKED FORM)	3.1.27.5 4.6.1.18
1JVZ	STRUCTURE OF CEPHALOSPORIN ACYLASE IN COMPLEX WITH GLUTARYL-7-AMINOCEPHALOSPORANIC ACID	3.5.1.93
1JW0	STRUCTURE OF CEPHALOSPORIN ACYLASE IN COMPLEX WITH GLUTARATE	3.5.1.93
1JW1	CRYSTALLIZATION AND STRUCTURE DETERMINATION OF GOAT LACTOFERRIN AT 4.0 RESOLUTION: A NEW FORM OF PACKING IN LACTOFERRINS WITH A HIGH SOLVENT CONTENT IN CRYSTALS	3.4.21
1JWE	NMR STRUCTURE OF THE N-TERMINAL DOMAIN OF E. COLI DNAB HELICASE	3.6.1 3.6.4.12
1JWP	STRUCTURE OF M182T MUTANT OF TEM-1 BETA-LACTAMASE	3.5.2.6
1JWQ	STRUCTURE OF THE CATALYTIC DOMAIN OF CWLV, N-ACETYLMURAMOYL-L-ALANINE AMIDASE FROM BACILLUS(PAENIBACILLUS) POLYMYXA VAR.COLISTINUS	3.5.1.28
1JWR	CRYSTAL STRUCTURE OF HUMAN LYSOZYME AT 100 K	3.2.1.17
1JWT	CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH A NOVEL BICYCLIC LACTAM INHIBITOR	3.4.21.5
1JWV	CRYSTAL STRUCTURE OF G238A MUTANT OF TEM-1 BETA-LACTAMASE IN COMPLEX WITH A BORONIC ACID INHIBITOR (SEFB4)	3.5.2.6
1JWW	NMR CHARACTERIZATION OF THE N-TERMINAL DOMAIN OF A POTENTIAL COPPER-TRANSLOCATING P-TYPE ATPASE FROM BACILLUS SUBTILIS	3.6.3.4 7.2.2.8
1JWZ	CRYSTAL STRUCTURE OF TEM-64 BETA-LACTAMASE IN COMPLEX WITH A BORONIC ACID INHIBITOR (105)	3.5.2.6
1JX9	PENICILLIN ACYLASE, MUTANT	3.5.1.11
1JXB	I53A, A POINT MUTANT OF THE CYSTEINE-FREE VARIANT OF E. COLI RNASE HI	3.1.26.4
1JXJ	ROLE OF MOBILE LOOP IN THE MECHANISM OF HUMAN SALIVARY AMYLASE	3.2.1.1
1JXK	ROLE OF ETHE MOBILE LOOP IN THE MEHANISM OF HUMAN SALIVARY AMYLASE	3.2.1.1
1JXP	BK STRAIN HEPATITIS C VIRUS (HCV) NS3-NS4A	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1JXQ	STRUCTURE OF CLEAVED, CARD DOMAIN DELETED CASPASE-9	3.4.22 3.4.22.62
1JXZ	STRUCTURE OF THE H90Q MUTANT OF 4-CHLOROBENZOYL-COENZYME A DEHALOGENASE COMPLEXED WITH 4-HYDROXYBENZOYL-COENZYME A (PRODUCT)	3.8.1.6 3.8.1.7
1JY1	CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE (TDP1)	3.1.4
1JYM	CRYSTALS OF PEPTIDE DEFORMYLASE FROM PLASMODIUM FALCIPARUM WITH TEN SUBUNITS PER ASYMMETRIC UNIT REVEAL CRITICAL CHARACTERISTICS OF THE ACTIVE SITE FOR DRUG DESIGN	3.5.1.31 3.5.1.88
1JYS	CRYSTAL STRUCTURE OF E. COLI MTA/ADOHCY NUCLEOSIDASE	3.2.2.9
1JZ3	E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY-GALACTOSYL ENZYME INTERMEDIATE	3.2.1.23
1JZ6	E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO-TETRAZOLE	3.2.1.23
1K07	NATIVE FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII	3.5.2.6
1K0Z	CRYSTAL STRUCTURE OF THE PVUII ENDONUCLEASE WITH PR3+ AND SO4 IONS BOUND IN THE ACTIVE SITE AT 2.05A.	3.1.21.4
1K1E	STRUCTURE OF THE COBALT-BOUND FORM OF THE DEOXY-D-MANNOSE-OCTULOSONATE 8-PHOSPHATE PHOSPHATASE (YRBI) FROM HAEMOPHILUS INFLUENZAE (HI1679)	3.1.3 3.1.3.45
1K1I	BOVINE TRYPSIN-INHIBITOR COMPLEX	3.4.21.4
1K1J	BOVINE TRYPSIN-INHIBITOR COMPLEX	3.4.21.4
1K1L	BOVINE TRYPSIN-INHIBITOR COMPLEX	3.4.21.4
1K1M	BOVINE TRYPSIN-INHIBITOR COMPLEX	3.4.21.4
1K1N	BOVINE TRYPSIN-INHIBITOR COMPLEX	3.4.21.4
1K1O	BOVINE TRYPSIN-INHIBITOR COMPLEX	3.4.21.4
1K1P	BOVINE TRYPSIN-INHIBITOR COMPLEX	3.4.21.4
1K1T	COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1K1U	COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1K20	INORGANIC PYROPHOSPHATASE (FAMILY II) FROM STREPTOCOCCUS GORDONII AT 1.5 A RESOLUTION	3.6.1.1
1K21	HUMAN THROMBIN-INHIBITOR COMPLEX	3.4.21.5
1K22	HUMAN THROMBIN-INHIBITOR COMPLEX	3.4.21.5
1K23	INORGANIC PYROPHOSPHATASE (FAMILY II) FROM BACILLUS SUBTILIS	3.6.1.1
1K28	THE STRUCTURE OF THE BACTERIOPHAGE T4 CELL-PUNCTURING DEVICE	3.2.1.17
1K2A	MODIFIED FORM OF EOSINOPHIL-DERIVED NEUROTOXIN	3.1.27.5 4.6.1.18
1K2B	COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1K2C	COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1K2I	CRYSTAL STRUCTURE OF GAMMA-CHYMOTRYPSIN IN COMPLEX WITH 7-HYDROXYCOUMARIN	3.4.21.1
1K2X	CRYSTAL STRUCTURE OF PUTATIVE ASPARAGINASE ENCODED BY ESCHERICHIA COLI YBIK GENE	3.5.1.1 3.4.19.5
1K38	CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-2	3.5.2.6
1K3B	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C): EXCLUSION DOMAIN ADDED TO AN ENDOPEPTIDASE FRAMEWORK CREATES THE MACHINE FOR ACTIVATION OF GRANULAR SERINE PROTEASES	3.4.14.1
1K42	THE SOLUTION STRUCTURE OF THE CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE.	3.2.1.8
1K45	THE SOLUTION STRUCTURE OF THE CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE.	3.2.1.8
1K46	CRYSTAL STRUCTURE OF THE TYPE III SECRETORY DOMAIN OF YERSINIA YOPH REVEALS A DOMAIN-SWAPPED DIMER	3.1.3.48
1K4E	CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASES OXA-10 DETERMINED BY MAD PHASING WITH SELENOMETHIONINE	3.5.2.6
1K4F	CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 AT 1.6 A RESOLUTION	3.5.2.6
1K4R	STRUCTURE OF DENGUE VIRUS	3.4.21.91 3.6.1.15 3.6.4.13
1K4Y	CRYSTAL STRUCTURE OF RABBIT LIVER CARBOXYLESTERASE IN COMPLEX WITH 4-PIPERIDINO-PIPERIDINE	3.1.1.1
1K54	OXA-10 CLASS D BETA-LACTAMASE PARTIALLY ACYLATED WITH REACTED 6BETA-(1-HYDROXY-1-METHYLETHYL) PENICILLANIC ACID	3.5.2.6
1K55	OXA 10 CLASS D BETA-LACTAMASE AT PH 7.5	3.5.2.6
1K56	OXA 10 CLASS D BETA-LACTAMASE AT PH 6.5	3.5.2.6
1K57	OXA 10 CLASS D BETA-LACTAMASE AT PH 6.0	3.5.2.6
1K58	CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT D116H	3.1.27
1K59	CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT Q117G	3.1.27
1K5A	CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN DOUBLE VARIANT I119A/F120A	3.1.27
1K5B	CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT DES(121-123)	3.1.27
1K5C	ENDOPOLYGALACTURONASE I FROM STEREUM PURPUREUM AT 0.96 A RESOLUTION	3.2.1.15
1K5M	CRYSTAL STRUCTURE OF A HUMAN RHINOVIRUS TYPE 14:HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 V3 LOOP CHIMERIC VIRUS MN-III-2	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1K5P	HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 AT 1.8A RESOLUTION	3.8.1.5
1K5Q	PENICILLIN ACYLASE, MUTANT COMPLEXED WITH PAA	3.5.1.11
1K5S	PENICILLIN ACYLASE, MUTANT COMPLEXED WITH PPA	3.5.1.11
1K63	COMPLEX OF HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS WITH UT26 2-BROMO-2-PROPENE-1-OL AT 1.8A RESOLUTION	3.8.1.5
1K6A	STRUCTURAL STUDIES ON THE MOBILITY IN THE ACTIVE SITE OF THE THERMOASCUS AURANTIACUS XYLANASE I	3.2.1.8
1K6C	LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1K6E	COMPLEX OF HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 WITH 1,2-PROPANEDIOL (PRODUCT OF DEHALOGENATION OF 1,2-DIBROMOPROPANE) AT 1.85A	3.8.1.5
1K6M	CRYSTAL STRUCTURE OF HUMAN LIVER 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE	2.7.1.105 3.1.3.46
1K6P	LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1K6R	STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 IN COMPLEX WITH MOXALACTAM	3.5.2.6
1K6S	STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 IN COMPLEX WITH A PHENYLBORONIC ACID	3.5.2.6
1K6T	LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1K6V	LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1K6W	THE STRUCTURE OF ESCHERICHIA COLI CYTOSINE DEAMINASE	3.5.4.1 3.5.4
1K6Y	CRYSTAL STRUCTURE OF A TWO-DOMAIN FRAGMENT OF HIV-1 INTEGRASE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1K70	THE STRUCTURE OF ESCHERICHIA COLI CYTOSINE DEAMINASE BOUND TO 4-HYDROXY-3,4-DIHYDRO-1H-PYRIMIDIN-2-ONE	3.5.4.1 3.5.4
1K72	THE X-RAY CRYSTAL STRUCTURE OF CEL9G COMPLEXED WITH CELLOTRIOSE	3.2.1.4
1K7C	RHAMNOGALACTURONAN ACETYLESTERASE WITH SEVEN N-LINKED CARBOHYDRATE RESIDUES DISTRIBUTED AT TWO N-GLYCOSYLATION SITES REFINED AT 1.12 A RESOLUTION	3.1.1.86
1K7D	PENICILLIN ACYLASE WITH PHENYL PROPRIONIC ACID	3.5.1.11
1K7G	PRTC FROM ERWINIA CHRYSANTHEMI	3.4.24 3.4.24.40
1K7H	CRYSTAL STRUCTURE OF SHRIMP ALKALINE PHOSPHATASE	3.1.3.1
1K7I	PRTC FROM ERWINIA CHRYSANTHEMI: Y228F MUTANT	3.4.24 3.4.24.40
1K7K	CRYSTAL STRUCTURE OF RDGB- INOSINE TRIPHOSPHATE PYROPHOSPHATASE FROM E. COLI	3.6.1.66
1K7Q	PRTC FROM ERWINIA CHRYSANTHEMI: E189A MUTANT	3.4.24 3.4.24.40
1K82	CRYSTAL STRUCTURE OF E.COLI FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE (FPG) COVALENTLY TRAPPED WITH DNA	3.2.2.23 4.2.99.18
1K85	SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE III DOMAIN FROM BACILLUS CIRCULANS WL-12 CHITINASE A1.	3.2.1.14
1K86	CRYSTAL STRUCTURE OF CASPASE-7	3.4.22 3.4.22.60
1K88	CRYSTAL STRUCTURE OF PROCASPASE-7	3.4.22 3.4.22.60
1K8Q	CRYSTAL STRUCTURE OF DOG GASTRIC LIPASE IN COMPLEX WITH A PHOSPHONATE INHIBITOR	3.1.1.3
1K8R	CRYSTAL STRUCTURE OF RAS-BRY2RBD COMPLEX	3.6.5.2
1K9D	THE 1.7 A CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE, A FAMILY-67 GLYCOSIDE HYDROLASE FROM BACILLUS STEAROTHERMOPHILUS T-1	3.2.1.139 3.2.1.131
1K9E	CRYSTAL STRUCTURE OF A MUTATED FAMILY-67 ALPHA-D-GLUCURONIDASE (E285N) FROM BACILLUS STEAROTHERMOPHILUS T-6, COMPLEXED WITH 4-O-METHYL-GLUCURONIC ACID	3.2.1.139 3.2.1.131
1K9F	CRYSTAL STRUCTURE OF A MUTATED FAMILY-67 ALPHA-D-GLUCURONIDASE (E285N) FROM BACILLUS STEAROTHERMOPHILUS T-6, COMPLEXED WITH ALDOTETRAOURONIC ACID	3.2.1.139 3.2.1.131
1K9O	CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX	3.4.21.4
1K9T	CHITINASE A COMPLEXED WITH TETRA-N-ACETYLCHITOTRIOSE	3.2.1.14
1K9V	STRUCTURAL EVIDENCE FOR AMMONIA TUNELLING ACROSS THE (BETA-ALPHA)8-BARREL OF THE IMIDAZOLE GLYCEROL PHOSPHATE SYNTHASE BIENZYME COMPLEX	2.4.2 4.3.2.10 3.5.1.2
1K9X	STRUCTURE OF PYROCOCCUS FURIOSUS CARBOXYPEPTIDASE APO-YB	3.4.17.19
1K9Y	THE PAPASE HAL2P COMPLEXED WITH MAGNESIUM IONS AND REACTION PRODUCTS: AMP AND INORGANIC PHOSPHATE	3.1.3.7
1K9Z	THE PAPASE HAL2P COMPLEXED WITH ZINC IONS	3.1.3.7
1KA0	THE PAPASE HAL2P COMPLEXED WITH A SODIUM ION AND THE REACTION PRODUCT AMP	3.1.3.7
1KA1	THE PAPASE HAL2P COMPLEXED WITH CALCIUM AND MAGNESIUM IONS AND REACTION SUBSTRATE: PAP	3.1.3.7
1KA8	CRYSTAL STRUCTURE OF THE PHAGE P4 ORIGIN-BINDING DOMAIN	2.7.7 3.6.4.12
1KAA	STRESS AND STRAIN IN STAPHYLOCOCCAL NUCLEASE	3.1.31.1
1KAB	STRESS AND STRAIN IN STAPHYLOCOCCAL NUCLEASE	3.1.31.1
1KAK	HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR	3.1.3.48
1KAO	CRYSTAL STRUCTURE OF THE SMALL G PROTEIN RAP2A WITH GDP	3.6.5.2
1KAV	HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR	3.1.3.48
1KAX	70KD HEAT SHOCK COGNATE PROTEIN ATPASE DOMAIN, K71M MUTANT	3.6.1.3
1KAY	70KD HEAT SHOCK COGNATE PROTEIN ATPASE DOMAIN, K71A MUTANT	3.6.1.3
1KAZ	70KD HEAT SHOCK COGNATE PROTEIN ATPASE DOMAIN, K71E MUTANT	3.6.1.3
1KB3	THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R195A VARIANT OF HUMAN PANCREATIC ALPHA AMYLASE	3.2.1.1
1KBB	MECHANISTIC ANALYSES OF CATALYSIS IN HUMAN PANCREATIC ALPHA-AMYLASE: DETAILED KINETIC AND STRUCTURAL STUDIES OF MUTANTS OF THREE CONSERVED CARBOXYLIC ACIDS	3.2.1.1
1KBC	PROCARBOXYPEPTIDASE TERNARY COMPLEX	3.4.24.34
1KBK	MECHANISTIC ANALYSES OF CATALYSIS IN HUMAN PANCREATIC ALPHA-AMYLASE: DETAILED KINETIC AND STRUCTURAL STUDIES OF MUTANTS OF THREE CONSERVED CARBOXYLIC ACIDS	3.2.1.1
1KBP	KIDNEY BEAN PURPLE ACID PHOSPHATASE	3.1.3.2
1KC6	HINCII BOUND TO COGNATE DNA	3.1.21.4
1KCC	ENDOPOLYGALACTURONASE I FROM STEREUM PURPUREUM COMPLEXED WITH A GALACTURONATE AT 1.00 A RESOLUTION.	3.2.1.15
1KCD	ENDOPOLYGALACTURONASE I FROM STEREUM PURPUREUM COMPLEXED WITH TWO GALACTURONATE AT 1.15 A RESOLUTION.	3.2.1.15
1KCF	CRYSTAL STRUCTURE OF THE YEAST MITOCHONDRIAL HOLLIDAY JUNCTION RESOLVASE, YDC2	3.1 3.1.22.4
1KDA	STABILIZATION OF A STRAINED PROTEIN LOOP CONFORMATION THROUGH PROTEIN ENGINEERING	3.1.31.1
1KDB	STABILIZATION OF A STRAINED PROTEIN LOOP CONFORMATION THROUGH PROTEIN ENGINEERING	3.1.31.1
1KDC	STABILIZATION OF A STRAINED PROTEIN LOOP CONFORMATION THROUGH PROTEIN ENGINEERING	3.1.31.1
1KDH	BINARY COMPLEX OF MURINE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE WITH A PRIMER SINGLE STRANDED DNA	2.7.7.31 3.1.11
1KDQ	CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT S189D RAT CHYMOTRYPSIN	3.4.21.1
1KDS	X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 3-NITROPHENYLBORONIC ACID	3.5.2.6
1KDU	SEQUENTIAL 1H NMR ASSIGNMENTS AND SECONDARY STRUCTURE OF THE KRINGLE DOMAIN FROM UROKINASE	3.4.21.73
1KDW	X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 4-CARBOXYPHENYLBORONIC ACID	3.5.2.6
1KE0	X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 4-(CARBOXYVIN-2-YL)PHENYLBORONIC ACID	3.5.2.6
1KE3	X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 4,4'-BIPHENYLDIBORONIC ACID	3.5.2.6
1KE4	X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI	3.5.2.6
1KEA	STRUCTURE OF A THERMOSTABLE THYMINE-DNA GLYCOSYLASE	3.2.2 3.2.2.29
1KEC	PENICILLIN ACYLASE MUTANT WITH PHENYL PROPRIONIC ACID	3.5.1.11
1KEH	PRECURSOR STRUCTURE OF CEPHALOSPORIN ACYLASE	3.5.1 3.5.1.93
1KEI	THERMOLYSIN (SUBSTRATE-FREE)	3.4.24.27
1KEJ	CRYSTAL STRUCTURE OF MURINE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE COMPLEXED WITH DDATP	2.7.7.31 3.1.11
1KEY	CRYSTAL STRUCTURE OF MOUSE TESTIS/BRAIN RNA-BINDING PROTEIN (TB-RBP)	3.1
1KF2	ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 5.2	3.1.27.5 4.6.1.18
1KF3	ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 5.9	3.1.27.5 4.6.1.18
1KF4	ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 6.3	3.1.27.5 4.6.1.18
1KF5	ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 7.1	3.1.27.5 4.6.1.18
1KF7	ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 8.0	3.1.27.5 4.6.1.18
1KF8	ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 8.8	3.1.27.5 4.6.1.18
1KFG	THE X-RAY CRYSTAL STRUCTURE OF CEL9G FROM CLOSTRIDIUM CELLULOLYTICUM COMPLEXED WITH A THIO-OLIGOSACCHARIDE INHIBITOR	3.2.1.4
1KFU	CRYSTAL STRUCTURE OF HUMAN M-CALPAIN FORM II	3.4.22.53
1KFV	CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS FORMAMIDO-PYRIMIDINE DNA GLYCOSYLASE (ALIAS FPG OR MUTM) NON COVALENTLY BOUND TO AN AP SITE CONTAINING DNA.	3.2.2.23 4.2.99.18
1KFW	STRUCTURE OF CATALYTIC DOMAIN OF PSYCHROPHILIC CHITINASE B FROM ARTHROBACTER TAD20	3.2.1.14
1KFX	CRYSTAL STRUCTURE OF HUMAN M-CALPAIN FORM I	3.4.22.53
1KG2	CRYSTAL STRUCTURE OF THE CORE FRAGMENT OF MUTY FROM E.COLI AT 1.2A RESOLUTION	3.2.2 3.2.2.31
1KG3	CRYSTAL STRUCTURE OF THE CORE FRAGMENT OF MUTY FROM E.COLI AT 1.55A RESOLUTION	3.2.2 3.2.2.31
1KG4	CRYSTAL STRUCTURE OF THE K142A MUTANT OF E. COLI MUTY (CORE FRAGMENT)	3.2.2 3.2.2.31
1KG5	CRYSTAL STRUCTURE OF THE K142Q MUTANT OF E.COLI MUTY (CORE FRAGMENT)	3.2.2 3.2.2.31
1KG6	CRYSTAL STRUCTURE OF THE K142R MUTANT OF E.COLI MUTY (CORE FRAGMENT)	3.2.2 3.2.2.31
1KG7	CRYSTAL STRUCTURE OF THE E161A MUTANT OF E.COLI MUTY (CORE FRAGMENT)	3.2.2 3.2.2.31
1KGE	STRUCTURE OF BETA-LACTAMASE ASN 170 MET MUTANT	3.5.2.6
1KGF	STRUCTURE OF BETA-LACTAMASE ASN 170 GLN MUTANT	3.5.2.6
1KGG	STRUCTURE OF BETA-LACTAMASE GLU166GLN:ASN170ASP MUTANT	3.5.2.6
1KGU	THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337A VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE	3.2.1.1
1KGW	THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337Q VARIANT OF HUMAN PANCREATIC ALPHA-MYLASE	3.2.1.1
1KGX	THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R195Q VARIANT OF HUMAN PANCREATIC ALPHA AMYLASE	3.2.1.1
1KH4	E. COLI ALKALINE PHOSPHATASE MUTANT (D330N) IN COMPLEX WITH PHOSPHATE	3.1.3.1
1KH5	E. COLI ALKALINE PHOSPHATASE MUTANT (D330N) MIMIC OF THE TRANSITION STATES WITH ALUMINIUM FLUORIDE	3.1.3.1
1KH7	E. COLI ALKALINE PHOSPHATASE MUTANT (D153GD330N)	3.1.3.1
1KH8	STRUCTURE OF A CIS-PROLINE (P114) TO GLYCINE VARIANT OF RIBONUCLEASE A	3.1.27.5 4.6.1.18
1KH9	E. COLI ALKALINE PHOSPHATASE MUTANT (D153GD330N) COMPLEX WITH PHOSPHATE	3.1.3.1
1KHJ	E. COLI ALKALINE PHOSPHATASE MUTANT (D153HD330N) MIMIC OF THE TRANSITION STATES WITH ALUMINIUM FLUORIDE	3.1.3.1
1KHK	E. COLI ALKALINE PHOSPHATASE MUTANT (D153HD330N)	3.1.3.1
1KHL	E. COLI ALKALINE PHOSPHATASE MUTANT (D153HD330N) COMPLEX WITH PHOSPHATE	3.1.3.1
1KHN	E. COLI ALKALINE PHOSPHATASE MUTANT (D153HD330N) ZINC FORM	3.1.3.1
1KHO	CRYSTAL STRUCTURE ANALYSIS OF CLOSTRIDIUM PERFRINGENS ALPHA-TOXIN ISOLATED FROM AVIAN STRAIN SWCP	3.1.4.3
1KHP	MONOCLINIC FORM OF PAPAIN/ZLFG-DAM COVALENT COMPLEX	3.4.22.2
1KHQ	ORTHORHOMBIC FORM OF PAPAIN/ZLFG-DAM COVALENT COMPLEX	3.4.22.2
1KHV	CRYSTAL STRUCTURE OF RABBIT HEMORRHAGIC DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE COMPLEXED WITH LU3+	2.7.7.48 3.6.1.15 3.4.22.66
1KHW	CRYSTAL STRUCTURE OF RABBIT HEMORRHAGIC DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE COMPLEXED WITH MN2+	2.7.7.48 3.6.1.15 3.4.22.66
1KHZ	STRUCTURE OF THE ADPR-ASE IN COMPLEX WITH AMPCPR AND MG	3.6.1.13
1KI0	THE X-RAY STRUCTURE OF HUMAN ANGIOSTATIN	3.4.21.7
1KI1	GUANINE NUCLEOTIDE EXCHANGE REGION OF INTERSECTIN IN COMPLEX WITH CDC42	3.6.5.2
1KIC	INOSINE-ADENOSINE-GUANOSINE PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX: ASP10ALA MUTANT IN COMPLEX WITH INOSINE	3.2.2.1
1KIE	INOSINE-ADENOSINE-GUANOSINE PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX: ASP10ALA MUTANT IN COMPLEX WITH 3-DEAZA-ADENOSINE	3.2.2.1
1KIG	BOVINE FACTOR XA	3.4.21.6
1KIT	VIBRIO CHOLERAE NEURAMINIDASE	3.2.1.18
1KIV	RECOMBINANT KRINGLE IV-10/M66 VARIANT OF HUMAN APOLIPOPROTEIN(A)	3.4.21
1KJ4	SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1KJ7	SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1KJF	SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1KJG	SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1KJH	SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1KJK	SOLUTION STRUCTURE OF THE LAMBDA INTEGRASE AMINO-TERMINAL DOMAIN	2.7.7 3.1
1KJO	THERMOLYSIN COMPLEXED WITH Z-L-THREONINE (BENZYLOXYCARBONYL-L-THREONINE)	3.4.24.27
1KJP	THERMOLYSIN COMPLEXED WITH Z-L-GLUTAMIC ACID (BENZYLOXYCARBONYL-L-GLUTAMIC ACID)	3.4.24.27
1KJU	CA2+-ATPASE IN THE E2 STATE	3.6.3.8 7.2.2.10
1KJZ	STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI-G235D MUTANT	3.6.5.3
1KK0	STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI	3.6.5.3
1KK1	STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI-G235D MUTANT COMPLEXED WITH GDPNP-MG2+	3.6.5.3
1KK2	STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI-G235D MUTANT COMPLEXED WITH GDP-MG2+	3.6.5.3
1KK3	STRUCTURE OF THE WILD-TYPE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI COMPLEXED WITH GDP-MG2+	3.6.5.3
1KKK	THERMOLYSIN COMPLEXED WITH Z-L-ASPARTIC ACID (BENZYLOXYCARBONYL-L-ASPARTIC ACID)	3.4.24.27
1KKL	L.CASEI HPRK/P IN COMPLEX WITH B.SUBTILIS HPR	2.7.1 3.1.3 2.7.11 2.7.4
1KKM	L.CASEI HPRK/P IN COMPLEX WITH B.SUBTILIS P-SER-HPR	2.7.1 3.1.3 2.7.11 2.7.4
1KKT	STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES	3.2.1.113
1KL6	THERMOLYSIN COMPLEXED WITH Z-L-ALANINE (BENZYLOXYCARBONYL-L-ALANINE)	3.4.24.27
1KLI	COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA	3.4.21.21
1KLJ	CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA	3.4.21.21
1KLM	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1KLT	CRYSTAL STRUCTURE OF PMSF-TREATED HUMAN CHYMASE AT 1.9 ANGSTROMS RESOLUTION	3.4.21.39
1KLX	HELICOBACTER PYLORI CYSTEINE RICH PROTEIN B (HCPB)	3.5.2.6
1KM8	THE STRUCTURE OF A CYTOTOXIC RIBONUCLEASE FROM THE OOCYTE OF RANA CATESBEIANA (BULLFROG)	3.1.27.5 3.1.27
1KM9	THE STRUCTURE OF A CYTOTOXIC RIBONUCLEASE FROM THE OOCYTE OF RANA CATESBEIANA (BULLFROG)	3.1.27.5 3.1.27
1KMC	CRYSTAL STRUCTURE OF THE CASPASE-7 / XIAP-BIR2 COMPLEX	3.4.22 3.4.22.60
1KMQ	CRYSTAL STRUCTURE OF A CONSTITUTIVELY ACTIVATED RHOA MUTANT (Q63L)	3.6.5.2
1KN6	SOLUTION STRUCTURE OF THE MOUSE PROHORMONE CONVERTASE 1 PRO-DOMAIN	3.4.21.93
1KN9	CRYSTAL STRUCTURE OF A BACTERIAL SIGNAL PEPTIDASE APO-ENZYME, IMPLICATIONS FOR SIGNAL PEPTIDE BINDING AND THE SER-LYS DYAD MECHANISM.	3.4.21.89
1KNI	STABILIZING DISULFIDE BRIDGE MUTANT OF T4 LYSOZYME	3.2.1.17
1KNL	STREPTOMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13	3.2.1.8
1KNM	STREPTOMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13 IN COMPLEX WITH LACTOSE	3.2.1.8
1KNV	BSE634I RESTRICTION ENDONUCLEASE	3.1.21.4
1KNX	HPR KINASE/PHOSPHATASE FROM MYCOPLASMA PNEUMONIAE	2.7.1 3.1.3 2.7.11 2.7.4
1KO2	VIM-2, A ZN-BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA WITH AN OXIDIZED CYS (CYSTEINESULFONIC)	3.5.2.6
1KO3	VIM-2, A ZN-BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA WITH CYS221 REDUCED	3.5.2.6
1KO6	CRYSTAL STRUCTURE OF C-TERMINAL AUTOPROTEOLYTIC DOMAIN OF NUCLEOPORIN NUP98	3.4.21
1KO7	X-RAY STRUCTURE OF THE HPR KINASE/PHOSPHATASE FROM STAPHYLOCOCCUS XYLOSUS AT 1.95 A RESOLUTION	2.7.1 3.1.3 2.7.11 2.7.4
1KO9	NATIVE STRUCTURE OF THE HUMAN 8-OXOGUANINE DNA GLYCOSYLASE HOGG1	3.2.2 4.2.99.18
1KP0	THE CRYSTAL STRUCTURE ANALYSIS OF CREATINE AMIDINOHYDROLASE FROM ACTINOBACILLUS	3.5.3.3
1KP4	CALCIUM-BOUND FORM OF PROKARYOTIC PHOSPHOLIPASE A2	3.1.1.4
1KPA	PKCI-1-ZINC	3
1KPB	PKCI-1-APO	3
1KPC	PKCI-1-APO+ZINC	3
1KPE	PKCI-TRANSITION STATE ANALOG	3
1KPF	PKCI-SUBSTRATE ANALOG	3
1KPM	FIRST STRUCTURAL EVIDENCE OF A SPECIFIC INHIBITION OF PHOSPHOLIPASE A2 BY VITAMIN E AND ITS IMPLICATIONS IN INFLAMMATION: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND VITAMIN E AT 1.8 A RESOLUTION.	3.1.1.4
1KQ0	HUMAN METHIONINE AMINOPEPTIDASE TYPE II IN COMPLEX WITH D-METHIONINE	3.4.11.18
1KQ9	HUMAN METHIONINE AMINOPEPTIDASE TYPE II IN COMPLEX WITH L-METHIONINE	3.4.11.18
1KQJ	CRYSTAL STRUCTURE OF A MUTANT OF MUTY CATALYTIC DOMAIN	3.2.2 3.2.2.31
1KQK	SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF A POTENTIAL COPPER-TRANSLOCATING P-TYPE ATPASE FROM BACILLUS SUBTILIS IN THE CU(I)LOADED STATE	3.6.3.4 7.2.2.8
1KQU	HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A SUBSTRATE ANOLOGUE	3.1.1.4
1KQY	HEVAMINE MUTANT D125A/E127A/Y183F IN COMPLEX WITH PENTA-NAG	3.2.1.14 3.2.1.17
1KQZ	HEVAMINE MUTANT D125A/E127A/Y183F IN COMPLEX WITH TETRA-NAG	3.2.1.14 3.2.1.17
1KR0	HEVAMINE MUTANT D125A/Y183F IN COMPLEX WITH TETRA-NAG	3.2.1.14 3.2.1.17
1KR1	HEVAMINE MUTANT D125A/E127A IN COMPLEX WITH TETRA-NAG	3.2.1.14 3.2.1.17
1KR3	CRYSTAL STRUCTURE OF THE METALLO BETA-LACTAMASE FROM BACTEROIDES FRAGILIS (CFIA) IN COMPLEX WITH THE TRICYCLIC INHIBITOR SB-236050.	3.5.2.6
1KR6	THERMOLYSIN COMPLEXED WITH Z-D-GLUTAMIC ACID (BENZYLOXYCARBONYL-D-GLUTAMIC ACID)	3.4.24.27
1KRA	CRYSTAL STRUCTURE OF KLEBSIELLA AEROGENES UREASE, ITS APOENZYME AND TWO ACTIVE SITE MUTANTS	3.5.1.5
1KRB	CRYSTAL STRUCTURE OF KLEBSIELLA AEROGENES UREASE, ITS APOENZYME AND TWO ACTIVE SITE MUTANTS	3.5.1.5
1KRC	CRYSTAL STRUCTURE OF KLEBSIELLA AEROGENES UREASE, ITS APOENZYME AND TWO ACTIVE SITE MUTANTS	3.5.1.5
1KRE	STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES	3.2.1.113
1KRF	STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES	3.2.1.113
1KRM	CRYSTAL STRUCTURE OF BOVINE ADENOSINE DEAMINASE COMPLEXED WITH 6-HYDROXYL-1,6-DIHYDROPURINE RIBOSIDE	3.5.4.4
1KRN	STRUCTURE OF KRINGLE 4 AT 4C TEMPERATURE AND 1.67 ANGSTROMS RESOLUTION	3.4.21.7
1KRO	THERMOLYSIN COMPLEXED WITH Z-D-THREONINE (BENZYLOXYCARBONYL-D-THREONINE)	3.4.24.27
1KS0	THE FIRST FIBRONECTIN TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2	3.4.24.24
1KS3	METHIONINE CORE MUTANT OF T4 LYSOZYME	3.2.1.17
1KS4	THE STRUCTURE OF ASPERGILLUS NIGER ENDOGLUCANASE-PALLADIUM COMPLEX	3.2.1.4
1KS5	STRUCTURE OF ASPERGILLUS NIGER ENDOGLUCANASE	3.2.1.4
1KS7	THERMOLYSIN COMPLEXED WITH Z-D-ASPARTIC ACID (BENZYLOXYCARBONYL-D-ASPARTIC ACID)	3.4.24.27
1KS8	THE STRUCTURE OF ENDOGLUCANASE FROM TERMITE, NASUTITERMES TAKASAGOENSIS, AT PH 2.5.	3.2.1.4
1KSC	THE STRUCTURE OF ENDOGLUCANASE FROM TERMITE, NASUTITERMES TAKASAGOENSIS, AT PH 5.6.	3.2.1.4
1KSD	THE STRUCTURE OF ENDOGLUCANASE FROM TERMITE, NASUTITERMES TAKASAGOENSIS, AT PH 6.5.	3.2.1.4
1KSN	CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH FXV673	3.4.21.6
1KSX	CRYSTAL STRUCTURES OF TWO INTERMEDIATES IN THE ASSEMBLY OF THE PAPILLOMAVIRUS REPLICATION INITIATION COMPLEX	3.6.4.12
1KSY	CRYSTAL STRUCTURES OF TWO INTERMEDIATES IN THE ASSEMBLY OF THE PAPILLOMAVIRUS REPLICATION INITIATION COMPLEX	3.6.4.12
1KT9	CRYSTAL STRUCTURE OF C. ELEGANS AP4A HYDROLASE	3.6.1.17 3.6.1
1KTB	THE STRUCTURE OF ALPHA-N-ACETYLGALACTOSAMINIDASE	3.2.1.49
1KTC	THE STRUCTURE OF ALPHA-N-ACETYLGALACTOSAMINIDASE	3.2.1.49
1KTG	CRYSTAL STRUCTURE OF A C. ELEGANS AP4A HYDROLASE BINARY COMPLEX	3.6.1.17 3.6.1
1KTO	THERMOLYSIN COMPLEXED WITH Z-D-ALANINE (BENZYLOXYCARBONYL-D-ALANINE)	3.4.24.27
1KTS	THROMBIN INHIBITOR COMPLEX	3.4.21.5
1KTT	THROMBIN INHIBITOR COMPLEX	3.4.21.5
1KTW	IOTA-CARRAGEENASE COMPLEXED TO IOTA-CARRAGEENAN FRAGMENTS	3.2.1.157
1KU0	STRUCTURE OF THE BACILLUS STEAROTHERMOPHILUS L1 LIPASE	3.1.1.3
1KU6	FASCICULIN 2-MOUSE ACETYLCHOLINESTERASE COMPLEX	3.1.1.7
1KUF	HIGH-RESOLUTION CRYSTAL STRUCTURE OF A SNAKE VENOM METALLOPROTEINASE FROM TAIWAN HABU	3.4.24.44 3.4.24
1KUG	CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH ITS ENDOGENOUS INHIBITOR PENW	3.4.24.44 3.4.24
1KUH	ZINC PROTEASE FROM STREPTOMYCES CAESPITOSUS	3.4.24.77
1KUI	CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEQW.	3.4.24.44 3.4.24
1KUK	CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEKW.	3.4.24.44 3.4.24
1KUL	GLUCOAMYLASE, GRANULAR STARCH-BINDING DOMAIN, NMR, 5 STRUCTURES	3.2.1.3
1KUM	GLUCOAMYLASE, GRANULAR STARCH-BINDING DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE	3.2.1.3
1KUU	CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM CONSERVED PROTEIN MTH1020 REVEALS AN NTN-HYDROLASE FOLD	3.5.4.10
1KVA	E. COLI RIBONUCLEASE HI D134A MUTANT	3.1.26.4
1KVB	E. COLI RIBONUCLEASE HI D134H MUTANT	3.1.26.4
1KVC	E. COLI RIBONUCLEASE HI D134N MUTANT	3.1.26.4
1KVI	SOLUTION STRUCTURE OF THE REDUCED FORM OF THE FIRST HEAVY METAL BINDING MOTIF OF THE MENKES PROTEIN	3.6.3.4 7.2.2.8
1KVJ	SOLUTION STRUCTURE OF THE CU(I) BOUND FORM OF THE FIRST HEAVY METAL BINDING MOTIF OF THE MENKES PROTEIN	3.6.3.4 7.2.2.8
1KVL	X-RAY CRYSTAL STRUCTURE OF AMPC S64G MUTANT BETA-LACTAMASE IN COMPLEX WITH SUBSTRATE AND PRODUCT FORMS OF CEPHALOTHIN	3.5.2.6
1KVM	X-RAY CRYSTAL STRUCTURE OF AMPC WT BETA-LACTAMASE IN COMPLEX WITH COVALENTLY BOUND CEPHALOTHIN	3.5.2.6
1KVO	HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE	3.1.1.4
1KVW	CARBOXYLIC ESTER HYDROLASE, SINGLE MUTANT H48Q OF BOVINE PANCREATIC PLA2 ENZYME	3.1.1.4
1KVX	CARBOXYLIC ESTER HYDROLASE, SINGLE MUTANT D99A OF BOVINE PANCREATIC PLA2, 1.9 A ORTHORHOMBIC FORM	3.1.1.4
1KVY	CARBOXYLIC ESTER HYDROLASE, SINGLE MUTANT D49E COORDINATED TO CALCIUM	3.1.1.4
1KW5	METHIONINE CORE MUTANT OF T4 LYSOZYME	3.2.1.17
1KW7	METHIONINE CORE MUTANT OF T4 LYSOZYME	3.2.1.17
1KWF	ATOMIC RESOLUTION STRUCTURE OF AN INVERTING GLYCOSIDASE IN COMPLEX WITH SUBSTRATE	3.2.1.4
1KWG	CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS A4 BETA-GALACTOSIDASE	3.2.1.23
1KWK	CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS A4 BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE	3.2.1.23
1KWM	HUMAN PROCARBOXYPEPTIDASE B: THREE-DIMENSIONAL STRUCTURE AND IMPLICATIONS FOR THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI)	3.4.17.2
1KXA	SINDBIS VIRUS CAPSID, (WILD-TYPE) RESIDUES 106-264, TETRAGONAL CRYSTAL FORM	3.4.21 3.4.21.90
1KXB	SINDBIS VIRUS CAPSID (S215A MUTANT), TETRAGONAL CRYSTAL FORM	3.4.21 3.4.21.90
1KXC	SINDBIS VIRUS CAPSID (N190K MUTANT), TETRAGONAL CRYSTAL FORM	3.4.21 3.4.21.90
1KXD	SINDBIS VIRUS CAPSID (N222L MUTANT), TETRAGONAL CRYSTAL FORM	3.4.21 3.4.21.90
1KXE	SINDBIS VIRUS CAPSID (Y180S, E183G DOUBLE MUTANT), TETRAGONAL CRYSTAL FORM	3.4.21 3.4.21.90
1KXF	SINDBIS VIRUS CAPSID, (WILD-TYPE) RESIDUES 1-264, TETRAGONAL CRYSTAL FORM (FORM II)	3.4.21 3.4.21.90
1KXH	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AN INACTIVE MUTANT OF PSYCHROPHILIC ALPHA-AMYLASE (D174N) AND ACARBOSE	3.2.1.1
1KXJ	THE CRYSTAL STRUCTURE OF GLUTAMINE AMIDOTRANSFERASE FROM THERMOTOGA MARITIMA	2.4.2 4.3.2.10 3.5.1.2
1KXQ	CAMELID VHH DOMAIN IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE	3.2.1.1
1KXR	CRYSTAL STRUCTURE OF CALCIUM-BOUND PROTEASE CORE OF CALPAIN I	3.4.22.17 3.4.22.52
1KXT	CAMELID VHH DOMAINS IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE	3.2.1.1
1KXV	CAMELID VHH DOMAINS IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE	3.2.1.1
1KXW	ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS	3.2.1.17
1KXX	ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS	3.2.1.17
1KXY	ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS	3.2.1.17
1KY0	METHIONINE CORE MUTANT OF T4 LYSOZYME	3.2.1.17
1KY1	METHIONINE CORE MUTANT OF T4 LYSOZYME	3.2.1.17
1KY4	S-ADENOSYLHOMOCYSTEINE HYDROLASE REFINED WITH NONCRYSTALLOGRAPHIC RESTRAINTS	3.3.1.1
1KY5	D244E MUTANT S-ADENOSYLHOMOCYSTEINE HYDROLASE REFINED WITH NONCRYSTALLOGRAPHIC RESTRAINTS	3.3.1.1
1KY9	CRYSTAL STRUCTURE OF DEGP (HTRA)	3.4.21 3.4.21.107
1KYN	CATHEPSIN-G	3.4.21.20
1KYT	CRYSTAL STRUCTURE OF THERMOPLASMA ACIDOPHILUM 0175 (APC014)	3.1.3.18
1KZ8	CRYSTAL STRUCTURE OF PORCINE FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH A NOVEL ALLOSTERIC-SITE INHIBITOR	3.1.3.11
1KZK	JE-2147-HIV PROTEASE COMPLEX	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1L00	PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTURE, STABILITY, SOLVATION, AND SPECTROSCOPIC PROPERTIES	3.2.1.17
1L01	STRUCTURAL STUDIES OF MUTANTS OF THE LYSOZYME OF BACTERIOPHAGE T4. THE TEMPERATURE-SENSITIVE MUTANT PROTEIN THR157 (RIGHT ARROW) ILE	3.2.1.17
1L02	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L03	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L04	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L05	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L06	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L07	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L08	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L09	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L0D	X-RAY CRYSTAL STRUCTURE OF AMPC S64D MUTANT BETA-LACTAMASE	3.5.2.6
1L0E	X-RAY CRYSTAL STRUCTURE OF AMPC K67Q MUTANT BETA-LACTAMASE	3.5.2.6
1L0F	X-RAY CRYSTAL STRUCTURE OF AMPC N152H MUTANT BETA-LACTAMASE	3.5.2.6
1L0G	X-RAY CRYSTAL STRUCTURE OF AMPC S64G MUTANT BETA-LACTAMASE	3.5.2.6
1L0J	METHIONINE CORE MUTANT OF T4 LYSOZYME	3.2.1.17
1L0K	METHIONINE CORE MUTANT OF T4 LYSOZYME	3.2.1.17
1L0P	CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX BETWEEN PSYCHROPHILIC ALPHA AMYLASE FROM PSEUDOALTEROMONAS HALOPLANCTIS AND NITRATE	3.2.1.1
1L0Z	THE STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH XENON AND BROMIDE, CRYOPROTECTED WITH DRY PARAFFIN OIL	3.4.21.36
1L10	STRUCTURAL STUDIES OF MUTANTS OF THE LYSOZYME OF BACTERIOPHAGE T4. THE TEMPERATURE-SENSITIVE MUTANT PROTEIN THR157 (RIGHT ARROW) ILE	3.2.1.17
1L11	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L12	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L13	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L14	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L15	CONTRIBUTIONS OF HYDROGEN BONDS OF THR 157 TO THE THERMODYNAMIC STABILITY OF PHAGE T4 LYSOZYME	3.2.1.17
1L16	STRUCTURAL ANALYSIS OF THE TEMPERATURE-SENSITIVE MUTANT OF BACTERIOPHAGE T4 LYSOZYME, GLYCINE 156 (RIGHT ARROW) ASPARTIC ACID	3.2.1.17
1L17	HYDROPHOBIC STABILIZATION IN T4 LYSOZYME DETERMINED DIRECTLY BY MULTIPLE SUBSTITUTIONS OF ILE 3	3.2.1.17
1L18	HYDROPHOBIC STABILIZATION IN T4 LYSOZYME DETERMINED DIRECTLY BY MULTIPLE SUBSTITUTIONS OF ILE 3	3.2.1.17
1L19	ENHANCED PROTEIN THERMOSTABILITY FROM DESIGNED MUTATIONS THAT INTERACT WITH ALPHA-HELIX DIPOLES	3.2.1.17
1L1G	THE STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH XENON AND BROMIDE, CRYOPROTECTED WITH GLYCEROL	3.4.21.36
1L1J	CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF AN ATP-INDEPENDENT HEAT SHOCK PROTEASE HTRA	3.4.21
1L1N	POLIOVIRUS 3C PROTEINASE	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
1L1T	MUTM (FPG) BOUND TO ABASIC-SITE CONTAINING DNA	3.2.2.23 4.2.99.18
1L1Z	MUTM (FPG) COVALENT-DNA INTERMEDIATE	3.2.2.23 4.2.99.18
1L20	ENHANCED PROTEIN THERMOSTABILITY FROM DESIGNED MUTATIONS THAT INTERACT WITH ALPHA-HELIX DIPOLES	3.2.1.17
1L21	CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L22	CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L23	ENHANCED PROTEIN THERMOSTABILITY FROM SITE-DIRECTED MUTATIONS THAT DECREASE THE ENTROPY OF UNFOLDING	3.2.1.17
1L24	ENHANCED PROTEIN THERMOSTABILITY FROM SITE-DIRECTED MUTATIONS THAT DECREASE THE ENTROPY OF UNFOLDING	3.2.1.17
1L25	REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY	3.2.1.17
1L26	REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY	3.2.1.17
1L27	REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY	3.2.1.17
1L28	REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY	3.2.1.17
1L29	REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY	3.2.1.17
1L2B	MUTM (FPG) DNA END-PRODUCT STRUCTURE	3.2.2.23 4.2.99.18
1L2C	MUTM (FPG)-DNA ESTRANGED THYMINE MISMATCH RECOGNITION COMPLEX	3.2.2.23 4.2.99.18
1L2E	HUMAN KALLIKREIN 6 (HK6) ACTIVE FORM WITH BENZAMIDINE INHIBITOR	3.4.21
1L2M	MINIMIZED AVERAGE STRUCTURE OF THE N-TERMINAL, DNA-BINDING DOMAIN OF THE REPLICATION INITIATION PROTEIN FROM A GEMINIVIRUS (TOMATO YELLOW LEAF CURL VIRUS-SARDINIA)	2.7.7 3.1.21
1L2P	ATP SYNTHASE B SUBUNIT DIMERIZATION DOMAIN	3.6.3.34
1L2S	X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH A DOCK-PREDICTED NON-COVALENT INHIBITOR	3.5.2.6
1L30	REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY	3.2.1.17
1L31	REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY	3.2.1.17
1L32	REPLACEMENTS OF PRO86 IN PHAGE T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY	3.2.1.17
1L33	CONTRIBUTIONS OF LEFT-HANDED HELICAL RESIDUES TO THE STRUCTURE AND STABILITY OF BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L34	HIGH-RESOLUTION STRUCTURE OF THE TEMPERATURE-SENSITIVE MUTANT OF PHAGE LYSOZYME, ARG 96 (RIGHT ARROW) HIS	3.2.1.17
1L35	STRUCTURE OF A THERMOSTABLE DISULFIDE-BRIDGE MUTANT OF PHAGE T4 LYSOZYME SHOWS THAT AN ENGINEERED CROSSLINK IN A FLEXIBLE REGION DOES NOT INCREASE THE RIGIDITY OF THE FOLDED PROTEIN	3.2.1.17
1L36	TOWARD A SIMPLIFICATION OF THE PROTEIN FOLDING PROBLEM: A STABILIZING POLYALANINE ALPHA-HELIX ENGINEERED IN T4 LYSOZYME	3.2.1.17
1L37	CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS	3.2.1.17
1L38	CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS	3.2.1.17
1L39	CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS	3.2.1.17
1L3F	THERMOLYSIN IN THE ABSENCE OF SUBSTRATE HAS AN OPEN CONFORMATION	3.4.24.27
1L3X	SOLUTION STRUCTURE OF NOVEL DISINTEGRIN SALMOSIN	3.4.24
1L40	CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS	3.2.1.17
1L41	CONTRIBUTIONS OF ENGINEERED SURFACE SALT BRIDGES TO THE STABILITY OF T4 LYSOZYME DETERMINED BY DIRECTED MUTAGENESIS	3.2.1.17
1L42	CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY	3.2.1.17
1L43	CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY	3.2.1.17
1L44	CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY	3.2.1.17
1L45	CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY	3.2.1.17
1L46	CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY	3.2.1.17
1L47	CUMULATIVE SITE-DIRECTED CHARGE-CHANGE REPLACEMENTS IN BACTERIOPHAGE T4 LYSOZYME SUGGEST THAT LONG-RANGE ELECTROSTATIC INTERACTIONS CONTRIBUTE LITTLE TO PROTEIN STABILITY	3.2.1.17
1L48	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L49	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L4D	CRYSTAL STRUCTURE OF MICROPLASMINOGEN-STREPTOKINASE ALPHA DOMAIN COMPLEX	3.4.21.7
1L4Z	X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF MICROPLASMINOGEN WITH ALPHA DOMAIN OF STREPTOKINASE IN THE PRESENCE CADMIUM IONS	3.4.21.7
1L50	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L51	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L52	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L53	STRUCTURAL AND THERMODYNAMIC ANALYSIS OF THE PACKING OF TWO ALPHA-HELICES IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L54	THE STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF BURYING A CHARGED RESIDUE WITHIN THE HYDROPHOBIC CORE OF T4 LYSOZYME	3.2.1.17
1L55	ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME	3.2.1.17
1L56	ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME	3.2.1.17
1L57	ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME	3.2.1.17
1L58	ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME	3.2.1.17
1L59	ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME	3.2.1.17
1L5I	30-CONFORMER NMR ENSEMBLE OF THE N-TERMINAL, DNA-BINDING DOMAIN OF THE REPLICATION INITIATION PROTEIN FROM A GEMINIVIRUS (TOMATO YELLOW LEAF CURL VIRUS-SARDINIA)	2.7.7 3.1.21
1L5T	CRYSTAL STRUCTURE OF A DOMAIN-OPENED MUTANT (R121D) OF THE HUMAN LACTOFERRIN N-LOBE REFINED FROM A MEROHEDRALLY-TWINNED CRYSTAL FORM.	1.16.1.2 3.4.21
1L5X	THE 2.0-ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF A SURVIVAL PROTEIN E (SURE) HOMOLOG FROM PYROBACULUM AEROPHILUM	3.1.3.5
1L60	ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME	3.2.1.17
1L61	ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME	3.2.1.17
1L62	ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME	3.2.1.17
1L63	ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME	3.2.1.17
1L64	TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES	3.2.1.17
1L65	TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES	3.2.1.17
1L66	TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES	3.2.1.17
1L67	TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES	3.2.1.17
1L68	TOLERANCE OF T4 LYSOZYME TO MULTIPLE XAA (RIGHT ARROW) ALA SUBSTITUTIONS: A POLYALANINE ALPHA-HELIX CONTAINING TEN CONSECUTIVE ALANINES	3.2.1.17
1L69	MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY	3.2.1.17
1L6J	CRYSTAL STRUCTURE OF HUMAN MATRIX METALLOPROTEINASE MMP9 (GELATINASE B).	3.4.24.35
1L6R	CRYSTAL STRUCTURE OF THERMOPLASMA ACIDOPHILUM 0175 (APC0014)	3.1.3.18
1L6T	STRUCTURE OF ALA24/ASP61 TO ASP24/ASN61 SUBSTITUTED SUBUNIT C OF ESCHERICHIA COLI ATP SYNTHASE	3.6.3.34
1L70	MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY	3.2.1.17
1L71	MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY	3.2.1.17
1L72	MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY	3.2.1.17
1L73	MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY	3.2.1.17
1L74	MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY	3.2.1.17
1L75	MULTIPLE STABILIZING ALANINE REPLACEMENTS WITHIN ALPHA-HELIX 126-134 OF T4 LYSOZYME HAVE INDEPENDENT, ADDITIVE EFFECTS ON BOTH STRUCTURE AND STABILITY	3.2.1.17
1L76	TOLERANCE OF T4 LYSOZYME TO PROLINE SUBSTITUTIONS WITHIN THE LONG INTERDOMAIN ALPHA-HELIX ILLUSTRATES THE ADAPTABILITY OF PROTEINS TO POTENTIALLY DESTABILIZING LESIONS	3.2.1.17
1L77	DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L79	DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L7A	STRUCTURAL GENOMICS, CRYSTAL STRUCTURE OF CEPHALOSPORIN C DEACETYLASE	3.1.1.41 3.1.1.72
1L7F	CRYSTAL STRUCTURE OF INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812	3.2.1.18
1L7G	CRYSTAL STRUCTURE OF E119G MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812	3.2.1.18
1L7H	CRYSTAL STRUCTURE OF R292K MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812	3.2.1.18
1L7M	HIGH RESOLUTION LIGANDED STRUCTURE OF PHOSPHOSERINE PHOSPHATASE (PI COMPLEX)	3.1.3.3
1L7N	TRANSITION STATE ANALOGUE OF PHOSPHOSERINE PHOSPHATASE (ALUMINUM FLUORIDE COMPLEX)	3.1.3.3
1L7O	CRYSTAL STRUCTURE OF PHOSPHOSERINE PHOSPHATASE IN APO FORM	3.1.3.3
1L7P	SUBSTRATE BOUND PHOSPHOSERINE PHOSPHATASE COMPLEX STRUCTURE	3.1.3.3
1L7Q	SER117ALA MUTANT OF BACTERIAL COCAINE ESTERASE COCE	3.1.1.1 3.1.1.84
1L7R	TYR44PHE MUTANT OF BACTERIAL COCAINE ESTERASE COCE	3.1.1.1 3.1.1.84
1L80	DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L81	DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L82	DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
1L83	A CAVITY-CONTAINING MUTANT OF T4 LYSOZYME IS STABILIZED BY BURIED BENZENE	3.2.1.17
1L84	A CAVITY-CONTAINING MUTANT OF T4 LYSOZYME IS STABILIZED BY BURIED BENZENE	3.2.1.17
1L85	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L86	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L87	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L88	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L89	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L8F	STRUCTURE OF 20K-ENDOGLUCANASE FROM MELANOCARPUS ALBOMYCES AT 1.8 A	3.2.1.4
1L8G	CRYSTAL STRUCTURE OF PTP1B COMPLEXED WITH 7-(1,1-DIOXO-1H-BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID	3.1.3.48
1L8K	T CELL PROTEIN-TYROSINE PHOSPHATASE STRUCTURE	3.1.3.48
1L8L	MOLECULAR BASIS FOR THE LOCAL CONFOMATIONAL REARRANGEMENT OF HUMAN PHOSPHOSERINE PHOSPHATASE	3.1.3.3
1L8N	THE 1.5A CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE FROM BACILLUS STEAROTHERMOPHILUS T-1, COMPLEXED WITH 4-O-METHYL-GLUCURONIC ACID AND XYLOTRIOSE	3.2.1.139 3.2.1.131
1L8O	MOLECULAR BASIS FOR THE LOCAL CONFORMATIONAL REARRANGEMENT OF HUMAN PHOSPHOSERINE PHOSPHATASE	3.1.3.3
1L8S	CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + LPC-ETHER + ACETATE + PHOSPHATE IONS)	3.1.1.4
1L90	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L91	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L92	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L93	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L94	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L95	SIMILAR HYDROPHOBIC REPLACEMENTS OF LEU 99 AND PHE 153 WITHIN THE CORE OF T4 LYSOZYME HAVE DIFFERENT STRUCTURAL AND THERMODYNAMIC CONSEQUENCES	3.2.1.17
1L96	STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO	3.2.1.17
1L97	STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO	3.2.1.17
1L98	PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTURE, STABILITY, SOLVATION, AND SPECTROSCOPIC PROPERTIES	3.2.1.17
1L99	PERTURBATION OF TRP 138 IN T4 LYSOZYME BY MUTATIONS AT GLN 105 USED TO CORRELATE CHANGES IN STRUCTURE, STABILITY, SOLVATION, AND SPECTROSCOPIC PROPERTIES	3.2.1.17
1L9G	CRYSTAL STRUCTURE OF URACIL-DNA GLYCOSYLASE FROM T. MARITIMA	3.2.2.27
1L9K	DENGUE METHYLTRANSFERASE	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
1L9V	NON STRUCTURAL PROTEIN ENCODED BY GENE SEGMENT 8 OF ROTAVIRUS (NSP2), AN NTPASE, SSRNA BINDING AND NUCLEIC ACID HELIX-DESTABILIZING PROTEIN	3.6.4
1L9X	STRUCTURE OF GAMMA-GLUTAMYL HYDROLASE	3.4.19.9
1L9Y	FEZ-1-Y228A, A MUTANT OF THE METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII	3.5.2.6
1LAA	X-RAY STRUCTURE OF GLU 53 HUMAN LYSOZYME	3.2.1.17
1LAM	LEUCINE AMINOPEPTIDASE (UNLIGATED)	3.4.11.1 3.4.13.23 3.4.11.5
1LAN	LEUCINE AMINOPEPTIDASE COMPLEX WITH L-LEUCINAL	3.4.11.1 3.4.13.23 3.4.11.5
1LAP	MOLECULAR STRUCTURE OF LEUCINE AMINOPEPTIDASE AT 2.7-ANGSTROMS RESOLUTION	3.4.11.1 3.4.13.23 3.4.11.5
1LAR	CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR	3.1.3.48
1LAV	STABILIZATION OF ESCHERICHIA COLI RIBONUCLEASE HI BY CAVITY-FILLING MUTATIONS WITHIN A HYDROPHOBIC CORE	3.1.26.4
1LAW	STABILIZATION OF ESCHERICHIA COLI RIBONUCLEASE HI BY CAVITY-FILLING MUTATIONS WITHIN A HYDROPHOBIC CORE	3.1.26.4
1LAY	CRYSTAL STRUCTURE OF CYTOMEGALOVIRUS PROTEASE	3.4.21 3.4.21.97
1LBA	THE STRUCTURE OF BACTERIOPHAGE T7 LYSOZYME, A ZINC AMIDASE AND AN INHIBITOR OF T7 RNA POLYMERASE	3.5.1.28
1LBE	APLYSIA ADP RIBOSYL CYCLASE	3.2.2.5 3.2.2.6 2.4.99.20
1LBS	LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROL HYDROLASE)	3.1.1.3
1LBT	LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROL HYDROLASE)	3.1.1.3
1LBU	HYDROLASE METALLO (ZN) DD-PEPTIDASE	3.4.17.8 3.4.17.14
1LBV	CRYSTAL STRUCTURE OF APO-FORM (P21) OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS	3.1.3.11 3.1.3.25
1LBW	CRYSTAL STRUCTURE OF APO-FORM (P32) OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS	3.1.3.11 3.1.3.25
1LBX	CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS WITH CALCIUM IONS AND D-MYO-INOSITOL-1-PHOSPHATE	3.1.3.11 3.1.3.25
1LBY	CRYSTAL STRUCTURE OF A COMPLEX (P32 CRYSTAL FORM) OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS WITH 3 MANGANESE IONS, FRUCTOSE-6-PHOSPHATE, AND PHOSPHATE ION	3.1.3.11 3.1.3.25
1LBZ	CRYSTAL STRUCTURE OF A COMPLEX (P32 CRYSTAL FORM) OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS WITH 3 CALCIUM IONS AND FRUCTOSE-1,6 BISPHOSPHATE	3.1.3.11 3.1.3.25
1LCF	CRYSTAL STRUCTURE OF COPPER-AND OXALATE-SUBSTITUTED HUMAN LACTOFERRIN AT 2.0 ANGSTROMS RESOLUTION	3.4.21
1LCL	CHARCOT-LEYDEN CRYSTAL PROTEIN	3.1.1.5
1LCN	MONOCLINIC HEN EGG WHITE LYSOZYME, THIOCYANATE COMPLEX	3.2.1.17
1LCP	BOVINE LENS LEUCINE AMINOPEPTIDASE COMPLEXED WITH L-LEUCINE PHOSPHONIC ACID	3.4.11.1 3.4.13.23 3.4.11.5
1LCT	STRUCTURE OF THE RECOMBINANT N-TERMINAL LOBE OF HUMAN LACTOFERRIN AT 2.0 ANGSTROMS RESOLUTION	3.4.21
1LCY	CRYSTAL STRUCTURE OF THE MITOCHONDRIAL SERINE PROTEASE HTRA2	3.4.21 3.4.21.108
1LD4	PLACEMENT OF THE STRUCTURAL PROTEINS IN SINDBIS VIRUS	3.4.21 3.4.21.90
1LE6	CARBOXYLIC ESTER HYDROLASE, P 1 21 1 SPACE GROUP	3.1.1.4
1LE7	CARBOXYLIC ESTER HYDROLASE, C 2 2 21 SPACE GROUP	3.1.1.4
1LEA	SOLUTION STRUCTURE OF THE LEXA REPRESSOR DNA BINDING DETERMINED BY 1H NMR SPECTROSCOPY	3.4.21.88
1LEB	SOLUTION STRUCTURE OF THE LEXA REPRESSOR DNA BINDING DETERMINED BY 1H NMR SPECTROSCOPY	3.4.21.88
1LEE	CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH INHIBITOR RS367	3.4.23.39
1LEV	PORCINE KIDNEY FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH AN AMP-SITE INHIBITOR	3.1.3.11
1LF0	CRYSTAL STRUCTURE OF RASA59G IN THE GTP-BOUND FORM	3.6.5.2
1LF1	CRYSTAL STRUCTURE OF CEL5 FROM ALKALOPHILIC BACILLUS SP.	3.2.1.4
1LF2	CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR RS370	3.4.23.39
1LF3	CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR EH58	3.4.23.39
1LF4	STRUCTURE OF PLASMEPSIN II	3.4.23.39
1LF5	CRYSTAL STRUCTURE OF RASA59G IN THE GDP-BOUND FORM	3.6.5.2
1LF6	CRYSTAL STRUCTURE OF BACTERIAL GLUCOAMYLASE	3.2.1.3
1LF9	CRYSTAL STRUCTURE OF BACTERIAL GLUCOAMYLASE COMPLEXED WITH ACARBOSE	3.2.1.3
1LFC	BOVINE LACTOFERRICIN (LFCINB), NMR, 20 STRUCTURES	3.4.21
1LFG	STRUCTURE OF DIFERRIC HUMAN LACTOFERRIN	3.4.21
1LFH	MOLECULAR REPLACEMENT SOLUTION OF THE STRUCTURE OF APOLACTOFERRIN, A PROTEIN DISPLAYING LARGE-SCALE CONFORMATIONAL CHANGE	3.4.21
1LFI	METAL SUBSTITUTION IN TRANSFERRINS: THE CRYSTAL STRUCTURE OF HUMAN COPPER-LACTOFERRIN AT 2.1 ANGSTROMS RESOLUTION	3.4.21
1LFW	CRYSTAL STRUCTURE OF PEPV	3.4.13.3 3.4.13
1LG1	CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE IN COMPLEX WITH CHITOBIOSE	3.2.1.14
1LG2	CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE IN COMPLEX WITH ETHYLENE GLYCOL	3.2.1.14
1LGU	T4 LYSOZYME MUTANT L99A/M102Q	3.2.1.17
1LGW	T4 LYSOZYME MUTANT L99A/M102Q BOUND BY 2-FLUOROANILINE	3.2.1.17
1LGX	T4 LYSOZYME MUTANT L99A/M102Q BOUND BY 3,5-DIFLUOROANILINE	3.2.1.17
1LGY	LIPASE II FROM RHIZOPUS NIVEUS	3.1.1.3
1LHC	HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROARG-OH	3.4.21.5
1LHD	HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROLYS-OH	3.4.21.5
1LHE	HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO-N-BUTYL-AMIDINO-GLYCINE-OH	3.4.21.5
1LHF	HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO-HOMOLYS-OH	3.4.21.5
1LHG	HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROORNITHINE-OH	3.4.21.5
1LHH	ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS	3.2.1.17
1LHI	ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS	3.2.1.17
1LHJ	ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS	3.2.1.17
1LHK	ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS	3.2.1.17
1LHL	ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS	3.2.1.17
1LHM	THE CRYSTAL STRUCTURE OF A MUTANT LYSOZYME C77(SLASH)95A WITH INCREASED SECRETION EFFICIENCY IN YEAST	3.2.1.17
1LHY	CRYSTAL STRUCTURE OF TEM-30 BETA-LACTAMASE AT 2.0 ANGSTROM	3.5.2.6
1LI0	CRYSTAL STRUCTURE OF TEM-32 BETA-LACTAMASE AT 1.6 ANGSTROM	3.5.2.6
1LI2	T4 LYSOZYME MUTANT L99A/M102Q BOUND BY PHENOL	3.2.1.17
1LI3	T4 LYSOZYME MUTANT L99A/M102Q BOUND BY 3-CHLOROPHENOL	3.2.1.17
1LI4	HUMAN S-ADENOSYLHOMOCYSTEINE HYDROLASE COMPLEXED WITH NEPLANOCIN	3.3.1.1
1LI6	T4 LYSOZYME MUTANT L99A/M102Q BOUND BY 5-METHYLPYRROLE	3.2.1.17
1LI9	CRYSTAL STRUCTURE OF TEM-34 BETA-LACTAMASE AT 1.5 ANGSTROM	3.5.2.6
1LJ3	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN AT PH 4.6	3.2.1.17
1LJ4	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN AT PH 4.6	3.2.1.17
1LJE	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 10% SUCROSE	3.2.1.17
1LJF	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 10% SUCROSE	3.2.1.17
1LJG	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 5% GLYCEROL	3.2.1.17
1LJH	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 5% GLYCEROL	3.2.1.17
1LJI	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE 10% SORBITOL	3.2.1.17
1LJJ	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 10% TREHALOSE	3.2.1.17
1LJK	CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 15% TREHALOSE	3.2.1.17
1LJN	CRYSTAL STRUCTURE OF TUEKEY EGG LYSOZYME COMPLEX WITH DI-N-ACETYLCHITOBIOSE AT 1.19A RESOLUTION	3.2.1.17
1LKA	PORCINE PANCREATIC ELASTASE/CA-COMPLEX	3.4.21.36
1LKB	PORCINE PANCREATIC ELASTASE/NA-COMPLEX	3.4.21.36
1LKR	MONOCLINIC HEN EGG WHITE LYSOZYME IODIDE	3.2.1.17
1LKS	HEN EGG WHITE LYSOZYME NITRATE	3.2.1.17
1LKT	CRYSTAL STRUCTURE OF THE HEAD-BINDING DOMAIN OF PHAGE P22 TAILSPIKE PROTEIN	3.2.1
1LL5	X-RAY CRYSTAL STRUCTURE OF AMPC WT BETA-LACTAMASE IN COMPLEX WITH COVALENTLY BOUND IMIPENEM	3.5.2.6
1LL6	STRUCTURE OF THE D169N MUTANT OF C. IMMITIS CHITINASE 1	3.2.1.14
1LL7	STRUCTURE OF THE E171Q MUTANT OF C. IMMITIS CHITINASE 1	3.2.1.14
1LL9	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH AMOXICILLIN	3.5.2.6
1LLB	CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH ATMO-PENICILLIN	3.5.2.6
1LLF	CHOLESTEROL ESTERASE (CANDIDA CYLINDRACEA) CRYSTAL STRUCTURE AT 1.4A RESOLUTION	3.1.1.3
1LLH	ARE CARBOXY TERMINII OF HELICES CODED BY THE LOCAL SEQUENCE OR BY TERTIARY STRUCTURE CONTACTS	3.2.1.17
1LLN	1.6A CRYSTAL STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN-III (PAP-III) WITH METHYLATED LYSINES	3.2.2.22
1LLO	HEVAMINE A (A PLANT ENDOCHITINASE/LYSOZYME) COMPLEXED WITH ALLOSAMIDIN	3.2.1.14 3.2.1.17
1LM4	STRUCTURE OF PEPTIDE DEFORMYLASE FROM STAPHYLOCOCCUS AUREUS AT 1.45 A	3.5.1.88
1LM6	CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM STREPTOCOCCUS PNEUMONIAE	3.5.1.88
1LMA	PROTEIN HYDRATION AND WATER STRUCTURE: X-RAY ANALYSIS OF A CLOSELY PACKED PROTEIN CRYSTAL WITH VERY LOW SOLVENT CONTENT	3.2.1.17
1LMC	THE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN BULGECIN, A BACTERIAL METABOLITE, AND LYSOZYME FROM THE RAINBOW TROUT	3.2.1.17
1LME	CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM THERMOTOGA MARITIMA	3.5.1.88
1LMH	CRYSTAL STRUCTURE OF S. AUREUS PEPTIDE DEFORMYLASE	3.5.1.27 3.5.1.88
1LML	LEISHMANOLYSIN	3.4.24.36
1LMN	THE REFINED CRYSTAL STRUCTURE OF LYSOZYME FROM THE RAINBOW TROUT (ONCORHYNCHUS MYKISS)	3.2.1.17
1LMO	THE CRYSTAL STRUCTURES OF THREE COMPLEXES BETWEEN CHITOOLIGOSACCHARIDES AND LYSOZYME FROM THE RAINBOW TROUT	3.2.1.17
1LMP	THE CRYSTAL STRUCTURES OF THREE COMPLEXES BETWEEN CHITOOLIGOSACCHARIDES AND LYSOZYME FROM THE RAINBOW TROUT	3.2.1.17
1LMQ	THE CRYSTAL STRUCTURES OF THREE COMPLEXES BETWEEN CHITOOLIGOSACCHARIDES AND LYSOZYME FROM THE RAINBOW TROUT	3.2.1.17
1LMT	STRUCTURE OF A CONFORMATIONALLY CONSTRAINED ARG-GLY-ASP SEQUENCE INSERTED INTO HUMAN LYSOZYME	3.2.1.17
1LMW	LMW U-PA STRUCTURE COMPLEXED WITH EGRCMK (GLU-GLY-ARG CHLOROMETHYL KETONE)	3.4.21.73
1LMZ	SOLUTION STRUCTURE OF 3-METHYLADENINE DNA GLYCOSYLASE I (TAG)	3.2.2.20
1LN0	STRUCTURE OF THE CATALYTIC DOMAIN OF HOMING ENDONUCLEASE I-TEVI	3.1
1LN8	CRYSTAL STRUCTURE OF A NEW ISOFORM OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 1.6 A RESOLUTION	3.1.1.4
1LNA	A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN	3.4.24.27
1LNB	A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN	3.4.24.27
1LNC	A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN	3.4.24.27
1LND	A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN	3.4.24.27
1LNE	A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN	3.4.24.27
1LNF	A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN	3.4.24.27
1LNI	CRYSTAL STRUCTURE ANALYSIS OF A RIBONUCLEASE FROM STREPTOMYCES AUREOFACIENS AT ATOMIC RESOLUTION (1.0 A)	3.1.27.3 4.6.1.24
1LNS	CRYSTAL STRUCTURE ANALYSIS OF THE X-PROLYL DIPEPTIDYL AMINOPEPTIDASE FROM LACTOCOCCUS LACTIS	3.4.14.11
1LNZ	STRUCTURE OF THE OBG GTP-BINDING PROTEIN	3.6.5
1LO6	HUMAN KALLIKREIN 6 (HK6) ACTIVE FORM WITH BENZAMIDINE INHIBITOR AT 1.56 A RESOLUTION	3.4.21
1LO7	X-RAY STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE COMPLEXED WITH 4-HYDROXYPHENACYL COA	3.1.2.23
1LO8	X-RAY CRYSTAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE COMPLEXED WITH 4-HYDROXYBENZYL COA	3.1.2.23
1LO9	X-RAY CRYSTAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT D17N COMPLEXED WITH 4-HYDROXYBENZOYL COA	3.1.2.23
1LOI	N-TERMINAL SPLICE REGION OF RAT C-AMP PHOSPHODIESTERASE, NMR, 7 STRUCTURES	3.1.4.17 3.1.4.53
1LOK	THE 1.20 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE AMINOPEPTIDASE FROM AEROMONAS PROTEOLYTICA COMPLEXED WITH TRIS: A TALE OF BUFFER INHIBITION	3.4.11.10
1LOV	X-RAY STRUCTURE OF THE E58A MUTANT OF RIBONUCLEASE T1 COMPLEXED WITH 3'-GUANOSINE MONOPHOSPHATE	3.1.27.3 4.6.1.24
1LOW	X-RAY STRUCTURE OF THE H40A MUTANT OF RIBONUCLEASE T1 COMPLEXED WITH 3'-GUANOSINE MONOPHOSPHATE	3.1.27.3 4.6.1.24
1LOY	X-RAY STRUCTURE OF THE H40A/E58A MUTANT OF RIBONUCLEASE T1 COMPLEXED WITH 3'-GUANOSINE MONOPHOSPHATE	3.1.27.3 4.6.1.24
1LOZ	AMYLOIDOGENIC VARIANT (I56T) VARIANT OF HUMAN LYSOZYME	3.2.1.17
1LP8	HIGH RESOLUTION STRUCTURE OF RECOMBINANT DIANTHIN ANTIVIRAL PROTEIN-POTENT ANTI-HIV AGENT	3.2.2.22
1LPC	HIGH RESOLUTION STRUCTURE OF RECOMBINANT DIANTHIN ANTIVIRAL PROTEIN-POTENT ANTI-HIV AGENT (COMPLEX WITH CYCLIC AMP)	3.2.2.22
1LPD	HIGH RESOLUTION STRUCTURE OF RECOMBINANT DIANTHIN ANTIVIRAL PROTEIN-POTENT ANTI-HIV AGENT (COMPLEX WITH ADENINE)	3.2.2.22
1LPG	CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.	3.4.21.6
1LPI	HEW LYSOZYME: TRP...NA CATION-PI INTERACTION	3.2.1.17
1LPK	CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.	3.4.21.6
1LPM	A STRUCTURAL BASIS FOR THE CHIRAL PREFERENCES OF LIPASES	3.1.1.3
1LPN	ANALOGS OF REACTION INTERMEDIATES IDENTIFY A UNIQUE SUBSTRATE BINDING SITE IN CANDIDA RUGOSA LIPASE	3.1.1.3
1LPO	ANALOGS OF REACTION INTERMEDIATES IDENTIFY A UNIQUE SUBSTRATE BINDING SITE IN CANDIDA RUGOSA LIPASE	3.1.1.3
1LPP	ANALOGS OF REACTION INTERMEDIATES IDENTIFY A UNIQUE SUBSTRATE BINDING SITE IN CANDIDA RUGOSA LIPASE	3.1.1.3
1LPS	A STRUCTURAL BASIS FOR THE CHIRAL PREFERENCES OF LIPASES	3.1.1.3
1LPY	MULTIPLE METHIONINE SUBSTITUTIONS IN T4 LYSOZYME	3.2.1.17
1LPZ	CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.	3.4.21.6
1LQ0	CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE AT 2.2 ANGSTROM RESOLUTION	3.2.1.14
1LQ2	CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE	3.2.1.58
1LQD	CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.	3.4.21.6
1LQE	CRYSTAL STRUCTURE OF TRYPSIN IN COMPLEX WITH 79.	3.4.21.4
1LQF	STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR	3.1.3.48
1LQG	ESCHERICHIA COLI URACIL-DNA GLYCOSYLASE COMPLEX WITH URACIL-DNA GLYCOSYLASE INHIBITOR PROTEIN	3.2.2 3.2.2.27
1LQJ	ESCHERICHIA COLI URACIL-DNA GLYCOSYLASE	3.2.2 3.2.2.27
1LQM	ESCHERICHIA COLI URACIL-DNA GLYCOSYLASE COMPLEX WITH URACIL-DNA GLYCOSYLASE INHIBITOR PROTEIN	3.2.2 3.2.2.27
1LQW	CRYSTAL STRUCTURE OF S.AUREUS PEPTIDE DEFORMYLASE	3.5.1.88
1LQY	CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS PEPTIDE DEFORMYLASE COMPLEXED WITH ANTIBIOTIC ACTINONIN	3.5.1.88
1LRA	CRYSTALLOGRAPHIC STUDY OF GLU 58 ALA RNASE T1(ASTERISK)2'-GUANOSINE MONOPHOSPHATE AT 1.9 ANGSTROMS RESOLUTION	3.1.27.3 4.6.1.24
1LRU	CRYSTAL STRUCTURE OF E.COLI PEPTIDE DEFORMYLASE COMPLEXED WITH ANTIBIOTIC ACTINONIN	3.5.1.88
1LRY	CRYSTAL STRUCTURE OF P. AERUGINOSA PEPTIDE DEFORMYLASE COMPLEXED WITH ANTIBIOTIC ACTINONIN	3.5.1.88
1LS5	CRYSTAL STRUCTURE OF PLASMEPSIN IV FROM P. FALCIPARUM IN COMPLEX WITH PEPSTATIN A	3.4.23
1LSA	THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS. STRUCTURE AND DYNAMICS OF PROTEIN AND WATER	3.2.1.17
1LSB	THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS. STRUCTURE AND DYNAMICS OF PROTEIN AND WATER	3.2.1.17
1LSC	THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS. STRUCTURE AND DYNAMICS OF PROTEIN AND WATER	3.2.1.17
1LSD	THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS. STRUCTURE AND DYNAMICS OF PROTEIN AND WATER	3.2.1.17
1LSE	THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS. STRUCTURE AND DYNAMICS OF PROTEIN AND WATER	3.2.1.17
1LSF	THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS. STRUCTURE AND DYNAMICS OF PROTEIN AND WATER	3.2.1.17
1LSG	THREE-DIMENSIONAL STRUCTURE OF THE PLATELET INTEGRIN RECOGNITION SEGMENT OF THE FIBRINOGEN GAMMA CHAIN OBTAINED BY CARRIER PROTEIN-DRIVEN CRYSTALLIZATION	3.2.1.17
1LSM	THERMAL STABILITY DETERMINANTS OF CHICKEN EGG-WHITE LYSOZYME CORE MUTANTS: HYDROPHOBICITY, PACKING VOLUME AND CONSERVED BURIED WATER MOLECULES	3.2.1.17
1LSN	THERMAL STABILITY DETERMINANTS OF CHICKEN EGG-WHITE LYSOZYME CORE MUTANTS: HYDROPHOBICITY, PACKING VOLUME AND CONSERVED BURIED WATER MOLECULES	3.2.1.17
1LSP	THE CRYSTAL STRUCTURE OF A BULGECIN-INHIBITED G-TYPE LYSOZYME FROM THE EGG-WHITE OF THE AUSTRALIAN BLACK SWAN. A COMPARISON OF THE BINDING OF BULGECIN TO THREE MURAMIDASES	3.2.1.17
1LSQ	RIBONUCLEASE A WITH ASN 67 REPLACED BY A BETA-ASPARTYL RESIDUE	3.1.27.5 4.6.1.18
1LSY	CRYSTAL STRUCTURE OF THE MUTANT D52S HEN EGG WHITE LYSOZYME WITH AN OLIGOSACCHARIDE PRODUCT	3.2.1.17
1LSZ	CRYSTAL STRUCTURE OF THE MUTANT D52S HEN EGG WHITE LYSOZYME WITH AN OLIGOSACCHARIDE PRODUCT	3.2.1.17
1LTL	THE DODECAMER STRUCTURE OF MCM FROM ARCHAEAL M. THERMOAUTOTROPHICUM	3.6.4.12
1LTM	ACCELERATED X-RAY STRUCTURE ELUCIDATION OF A 36 KDA MURAMIDASE/TRANSGLYCOSYLASE USING WARP	3.2.1 4.2.2
1LTO	HUMAN ALPHA1-TRYPTASE	3.4.21.59
1LTQ	CRYSTAL STRUCTURE OF T4 POLYNUCLEOTIDE KINASE	2.7.1.78 3.1.3.34
1LV1	CRYSTAL STRUCTURE ANALYSIS OF THE NON-ACTIVE SITE MUTANT OF TETHERED HIV-1 PROTEASE TO 2.1A RESOLUTION	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1LV7	CRYSTAL STRUCTURE OF THE AAA DOMAIN OF FTSH	3.4.24
1LVB	CATALYTICALLY INACTIVE TOBACCO ETCH VIRUS PROTEASE COMPLEXED WITH SUBSTRATE	3.4 3.4.22.45 3.6.4 3.4.22.44 2.7.7.48
1LVM	CATALYTICALLY ACTIVE TOBACCO ETCH VIRUS PROTEASE COMPLEXED WITH PRODUCT	3.4 3.4.22.45 3.6.4 3.4.22.44 2.7.7.48
1LVO	STRUCTURE OF CORONAVIRUS MAIN PROTEINASE REVEALS COMBINATION OF A CHYMOTRYPSIN FOLD WITH AN EXTRA ALPHA-HELICAL DOMAIN	3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1
1LVY	PORCINE ELASTASE	3.4.21.36
1LW0	CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1LW2	CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1LW3	CRYSTAL STRUCTURE OF MYOTUBULARIN-RELATED PROTEIN 2 COMPLEXED WITH PHOSPHATE	3.1.3.64 3.1.3.95
1LW6	CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 AT 1.5 ANGSTROM RESOLUTION	3.4.21.62
1LW9	MULTIPLE METHIONINE SUBSTITUTIONS ARE TOLERATED IN T4 LYSOZYME AND HAVE COUPLED EFFECTS ON FOLDING AND STABILITY	3.2.1.17
1LWB	CRYSTAL STRUCTURE OF PROKARYOTIC PHOSPHOLIPASE A2 AT ATOMIC RESOLUTION	3.1.1.4
1LWC	CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1LWE	CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1LWF	CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1LWG	MULTIPLE METHIONINE SUBSTITUTIONS ARE TOLERATED IN T4 LYSOZYME AND HAVE COUPLED EFFECTS ON FOLDING AND STABILITY	3.2.1.17
1LWK	MULTIPLE METHIONINE SUBSTITUTIONS ARE TOLERATED IN T4 LYSOZYME AND HAVE COUPLED EFFECTS ON FOLDING AND STABILITY	3.2.1.17
1LWS	CRYSTAL STRUCTURE OF THE INTEIN HOMING ENDONUCLEASE PI-SCEI BOUND TO ITS RECOGNITION SEQUENCE	3.1 7.1.2.2
1LWT	CRYSTAL STRUCTURE OF THE INTEIN HOMING ENDONUCLEASE PI-SCEI BOUND TO ITS SUBSTRATE DNA (CA2+ FREE)	3.1 7.1.2.2
1LWV	BOROHYDRIDE-TRAPPED HOGG1 INTERMEDIATE STRUCTURE CO-CRYSTALLIZED WITH 8-AMINOGUANINE	3.2.2 4.2.99.18
1LWW	BOROHYDRIDE-TRAPPED HOGG1 INTERMEDIATE STRUCTURE CO-CRYSTALLIZED WITH 8-BROMOGUANINE	3.2.2 4.2.99.18
1LWY	HOGG1 BOROHYDRIDE-TRAPPED INTERMEDIATE WITHOUT 8-OXOGUANINE	3.2.2 4.2.99.18
1LXY	CRYSTAL STRUCTURE OF ARGININE DEIMINASE COVALENTLY LINKED WITH L-CITRULLINE	3.5.3.6
1LY1	STRUCTURE AND MECHANISM OF T4 POLYNUCLEOTIDE KINASE	2.7.1.78 3.1.3.34
1LYA	CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN	3.4.23.5
1LYB	CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN	3.4.23.5
1LYD	CRYSTAL STRUCTURE OF T4-LYSOZYME GENERATED FROM SYNTHETIC CODING DNA EXPRESSED IN ESCHERICHIA COLI	3.2.1.17
1LYE	DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59	3.2.1.17
1LYF	DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59	3.2.1.17
1LYG	DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59	3.2.1.17
1LYH	DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59	3.2.1.17
1LYI	DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59	3.2.1.17
1LYJ	DISSECTION OF HELIX CAPPING IN T4 LYSOZYME BY STRUCTURAL AND THERMODYNAMIC ANALYSIS OF SIX AMINO ACID SUBSTITUTIONS AT THR 59	3.2.1.17
1LYO	CROSS-LINKED LYSOZYME CRYSTAL IN NEAT WATER	3.2.1.17
1LYS	X-RAY STRUCTURE OF A MONOCLINIC FORM OF HEN EGG-WHITE LYSOZYME CRYSTALLIZED AT 313K. COMPARISON OF TWO INDEPENDENT MOLECULES	3.2.1.17
1LYV	HIGH-RESOLUTION STRUCTURE OF THE CATALYTICALLY INACTIVE YERSINIA TYROSINE PHOSPHATASE C403A MUTANT IN COMPLEX WITH PHOSPHATE.	3.1.3.48
1LYW	CATHEPSIN D AT PH 7.5	3.4.23.5
1LYY	AMYLOIDOGENIC VARIANT (ASP67HIS) OF HUMAN LYSOZYME	3.2.1.17
1LYZ	REAL-SPACE REFINEMENT OF THE STRUCTURE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
1LZ1	REFINEMENT OF HUMAN LYSOZYME AT 1.5 ANGSTROMS RESOLUTION. ANALYSIS OF NON-BONDED AND HYDROGEN-BOND INTERACTIONS	3.2.1.17
1LZ2	CRYSTALLOGRAPHIC STUDY OF TURKEY EGG-WHITE LYSOZYME AND ITS COMPLEX WITH A DISACCHARIDE	3.2.1.17
1LZ4	ENTHALPIC DESTABILIZATION OF A MUTANT HUMAN LYSOZYME LACKING A DISULFIDE BRIDGE BETWEEN CYSTEINE-77 AND CYSTEINE-95	3.2.1.17
1LZ5	STRUCTURAL AND FUNCTIONAL ANALYSES OF THE ARG-GLY-ASP SEQUENCE INTRODUCED INTO HUMAN LYSOZYME	3.2.1.17
1LZ6	STRUCTURAL AND FUNCTIONAL ANALYSES OF THE ARG-GLY-ASP SEQUENCE INTRODUCED INTO HUMAN LYSOZYME	3.2.1.17
1LZ8	LYSOZYME PHASED ON ANOMALOUS SIGNAL OF SULFURS AND CHLORINES	3.2.1.17
1LZ9	ANOMALOUS SIGNAL OF SOLVENT BROMINES USED FOR PHASING OF LYSOZYME	3.2.1.17
1LZA	DISSECTION OF PROTEIN-CARBOHYDRATE INTERACTIONS IN MUTANT HEN EGG-WHITE LYSOZYME COMPLEXES AND THEIR HYDROLYTIC ACTIVITY	3.2.1.17
1LZB	DISSECTION OF PROTEIN-CARBOHYDRATE INTERACTIONS IN MUTANT HEN EGG-WHITE LYSOZYME COMPLEXES AND THEIR HYDROLYTIC ACTIVITY	3.2.1.17
1LZC	DISSECTION OF PROTEIN-CARBOHYDRATE INTERACTIONS IN MUTANT HEN EGG-WHITE LYSOZYME COMPLEXES AND THEIR HYDROLYTIC ACTIVITY	3.2.1.17
1LZD	DISSECTION OF PROTEIN-CARBOHYDRATE INTERACTIONS IN MUTANT HEN EGG-WHITE LYSOZYME COMPLEXES AND THEIR HYDROLYTIC ACTIVITY	3.2.1.17
1LZE	DISSECTION OF PROTEIN-CARBOHYDRATE INTERACTIONS IN MUTANT HEN EGG-WHITE LYSOZYME COMPLEXES AND THEIR HYDROLYTIC ACTIVITY	3.2.1.17
1LZG	DISSECTION OF PROTEIN-CARBOHYDRATE INTERACTIONS IN MUTANT HEN EGG-WHITE LYSOZYME COMPLEXES AND THEIR HYDROLYTIC ACTIVITY	3.2.1.17
1LZN	NEUTRON STRUCTURE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
1LZQ	CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH AN ETHYLENAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[CH2CH2NH]-PHE-GLU-PHE-NH2	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1LZR	STRUCTURAL CHANGES OF THE ACTIVE SITE CLEFT AND DIFFERENT SACCHARIDE BINDING MODES IN HUMAN LYSOZYME CO-CRYSTALLIZED WITH HEXA-N-ACETYL-CHITOHEXAOSE AT PH 4.0	3.2.1.17
1LZS	STRUCTURAL CHANGES OF THE ACTIVE SITE CLEFT AND DIFFERENT SACCHARIDE BINDING MODES IN HUMAN LYSOZYME CO-CRYSTALLIZED WITH HEXA-N-ACETYL-CHITOHEXAOSE AT PH 4.0	3.2.1.17
1LZT	REFINEMENT OF TRICLINIC LYSOZYME	3.2.1.17
1LZY	X-RAY STRUCTURE OF TURKEY EGG LYSOZYME COMPLEX WITH DI-N-ACETYLCHITOBIOSE. RECOGNITION AND BINDING OF ALPHA-ANOMERIC FORM	3.2.1.17
1M01	WILDTYPE STREPTOMYCES PLICATUS BETA-HEXOSAMINIDASE IN COMPLEX WITH PRODUCT (GLCNAC)	3.2.1.52
1M03	MUTANT STREPTOMYCES PLICATUS BETA-HEXOSAMINIDASE (D313A) IN COMPLEX WITH PRODUCT (GLCNAC)	3.2.1.52
1M04	MUTANT STREPTOMYCES PLICATUS BETA-HEXOSAMINIDASE (D313N) IN COMPLEX WITH PRODUCT (GLCNAC)	3.2.1.52
1M07	RESIDUES INVOLVED IN THE CATALYSIS AND BASE SPECIFICITY OF CYTOTOXIC RIBONUCLEASE FROM BULLFROG (RANA CATESBEIANA)	3.1.27.5 3.1.27
1M08	CRYSTAL STRUCTURE OF THE UNBOUND NUCLEASE DOMAIN OF COLE7	3.1
1M0B	HIV-1 PROTEASE IN COMPLEX WITH AN ETHYLENEAMINE INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1M0D	CRYSTAL STRUCTURE OF BACTERIOPHAGE T7 ENDONUCLEASE I WITH A WILD-TYPE ACTIVE SITE AND BOUND MANGANESE IONS	3.1.21.2
1M0I	CRYSTAL STRUCTURE OF BACTERIOPHAGE T7 ENDONUCLEASE I WITH A WILD-TYPE ACTIVE SITE	3.1.21.2
1M0V	NMR STRUCTURE OF THE TYPE III SECRETORY DOMAIN OF YERSINIA YOPH COMPLEXED WITH THE SKAP-HOM PHOSPHO-PEPTIDE N-ACETYL-DEPYDDPF-NH2	3.1.3.48
1M11	STRUCTURAL MODEL OF HUMAN DECAY-ACCELERATING FACTOR BOUND TO ECHOVIRUS 7 FROM CRYO-ELECTRON MICROSCOPY	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1M1F	KID TOXIN PROTEIN FROM E.COLI PLASMID R1	3.1
1M21	CRYSTAL STRUCTURE ANALYSIS OF THE PEPTIDE AMIDASE PAM IN COMPLEX WITH THE COMPETITIVE INHIBITOR CHYMOSTATIN	3.5.1
1M22	X-RAY STRUCTURE OF NATIVE PEPTIDE AMIDASE FROM STENOTROPHOMONAS MALTOPHILIA AT 1.4 A	3.5.1
1M2T	MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH ADENINE MONOPHOSPHATE. CRYSTAL STRUCTURE AT 1.9 A RESOLUTION	3.2.2.22
1M2X	CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BLAB OF CHRYSEOBACTERIUM MENINGOSEPTICUM IN COMPLEX WITH THE INHIBITOR D-CAPTOPRIL	3.5.2.6
1M33	CRYSTAL STRUCTURE OF BIOH AT 1.7 A	3.1.1.85
1M35	AMINOPEPTIDASE P FROM ESCHERICHIA COLI	3.4.11.9
1M38	STRUCTURE OF INORGANIC PYROPHOSPHATASE	3.6.1.1
1M3G	SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF MAPK PHOSPHATASE PAC-1: INSIGHTS INTO SUBSTRATE-INDUCED ENZYMATIC ACTIVATION	3.1.3.48 3.1.3.16
1M3H	CRYSTAL STRUCTURE OF HOGG1 D268E MUTANT WITH PRODUCT OLIGONUCLEOTIDE	3.2.2 4.2.99.18
1M3Q	CRYSTAL STRUCTURE OF HOGG1 D268E MUTANT WITH BASE-EXCISED DNA AND 8-AMINOGUANINE	3.2.2 4.2.99.18
1M40	ULTRA HIGH RESOLUTION CRYSTAL STRUCTURE OF TEM-1	3.5.2.6
1M43	CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH PEPSTATIN A TO 2.4 A	3.4.23.39
1M4H	CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR OM00-3	3.4.23 3.4.23.46
1M4L	STRUCTURE OF NATIVE CARBOXYPEPTIDASE A AT 1.25 RESOLUTION	3.4.17.1
1M4W	THERMOPHILIC B-1,4-XYLANASE FROM NONOMURAEA FLEXUOSA	3.2.1.8
1M4Y	CRYSTAL STRUCTURE OF HSLV FROM THERMOTOGA MARITIMA	3.4.25 3.4.25.2
1M63	CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN SHOWS COMMON BUT DISTINCT RECOGNITION OF IMMUNOPHILIN-DRUG COMPLEXES	3.1.3.16
1M65	YCDX PROTEIN	3.1.3
1M68	YCDX PROTEIN, TRINUCLEAR ZINC SITE	3.1.3
1M6D	CRYSTAL STRUCTURE OF HUMAN CATHEPSIN F	3.4.22.41
1M6K	STRUCTURE OF THE OXA-1 CLASS D BETA-LACTAMASE	3.5.2.6
1M72	CRYSTAL STRUCTURE OF CASPASE-1 FROM SPODOPTERA FRUGIPERDA	3.4.22.36 3.4.22
1M7J	CRYSTAL STRUCTURE OF D-AMINOACYLASE DEFINES A NOVEL SUBSET OF AMIDOHYDROLASES	3.5.1.81
1M7R	CRYSTAL STRUCTURE OF MYOTUBULARIN-RELATED PROTEIN-2 (MTMR2) COMPLEXED WITH PHOSPHATE	3.1.3.64 3.1.3.95
1M8R	CRYSTAL STRUCTURES OF CADMIUM-BINDING ACIDIC PHOSPHOLIPASE A2 FROM THE VENOM OF AGKISTRODON HALYS PALLAS AT 1.9 RESOLUTION (CRYSTAL GROWN AT PH 7.4)	3.1.1.4
1M8S	CRYSTAL STRUCTURES OF CADMIUM-BINDING ACIDIC PHOSPHOLIPASE A2 FROM THE VENOM OF AGKISTRODON HALYS PALLAS AT 1.9 RESOLUTION (CRYSTAL GROWN AT PH 5.9)	3.1.1.4
1M8T	STRUCTURE OF AN ACIDIC PHOSPHOLIPASE A2 FROM THE VENOM OF OPHIOPHAGUS HANNAH AT 2.1 RESOLUTION FROM A HEMIHEDRALLY TWINNED CRYSTAL FORM	3.1.1.4
1M9N	CRYSTAL STRUCTURE OF THE HOMODIMERIC BIFUNCTIONAL TRANSFORMYLASE AND CYCLOHYDROLASE ENZYME AVIAN ATIC IN COMPLEX WITH AICAR AND XMP AT 1.93 ANGSTROMS.	2.1.2.3 3.5.4.10
1M9U	CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT A FROM EISENIA FETIDA	3.4.21
1MAA	MOUSE ACETYLCHOLINESTERASE CATALYTIC DOMAIN, GLYCOSYLATED PROTEIN	3.1.1.7
1MAC	CRYSTAL STRUCTURE AND SITE-DIRECTED MUTAGENESIS OF BACILLUS MACERANS ENDO-1,3-1,4-BETA-GLUCANASE	3.2.1.73
1MAH	FASCICULIN2-MOUSE ACETYLCHOLINESTERASE COMPLEX	3.1.1.7
1MAI	STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM PHOSPHOLIPASE C DELTA IN COMPLEX WITH INOSITOL TRISPHOSPHATE	3.1.4.11
1MAS	PURINE NUCLEOSIDE HYDROLASE	3.2.2.1 3.2.2.2 3.2.2.3
1MAT	STRUCTURE OF THE COBALT-DEPENDENT METHIONINE AMINOPEPTIDASE FROM ESCHERICHIA COLI: A NEW TYPE OF PROTEOLYTIC ENZYME	3.4.11.18
1MAX	BETA-TRYPSIN PHOSPHONATE INHIBITED	3.4.21.4
1MAY	BETA-TRYPSIN PHOSPHONATE INHIBITED	3.4.21.4
1MBL	A CATALYTICALLY-IMPAIRED CLASS A BETA-LACTAMASE: 2 ANGSTROMS CRYSTAL STRUCTURE AND KINETICS OF THE BACILLUS LICHENIFORMIS E166A MUTANT	3.5.2.6
1MBM	NSP4 PROTEINASE FROM EQUINE ARTERITIS VIRUS	3.4.21 3.4.22 3.4.19.12 2.7.7.48 3.6.4.12 3.6.4.13
1MBQ	ANIONIC TRYPSIN FROM PACIFIC CHUM SALMON	3.4.21.4
1MC0	REGULATORY SEGMENT OF MOUSE 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 2A, CONTAINING THE GAF A AND GAF B DOMAINS	3.1.4.35 3.1.4.17
1MC8	CRYSTAL STRUCTURE OF FLAP ENDONUCLEASE-1 R42E MUTANT FROM PYROCOCCUS HORIKOSHII	3.1
1MC9	STREPROMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13 IN COMPLEX WITH XYLOPENTAOSE	3.2.1.8
1MCT	THE REFINED 1.6 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PORCINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY	3.4.21.4
1MCV	CRYSTAL STRUCTURE ANALYSIS OF A HYBRID SQUASH INHIBITOR IN COMPLEX WITH PORCINE PANCREATIC ELASTASE	3.4.21.36
1MD7	MONOMERIC STRUCTURE OF THE ZYMOGEN OF COMPLEMENT PROTEASE C1R	3.4.21.41
1MD8	MONOMERIC STRUCTURE OF THE ACTIVE CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R	3.4.21.41
1MDW	CRYSTAL STRUCTURE OF CALCIUM-BOUND PROTEASE CORE OF CALPAIN II REVEALS THE BASIS FOR INTRINSIC INACTIVATION	3.4.22.17 3.4.22.53
1ME3	HIGH RESOLUTION CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN NON-COVALENTLY BOUND TO A HYDROXYMETHYL KETONE INHIBITOR (II)	3.4.22 3.4.22.51
1ME4	HIGH RESOLUTION CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN NON-COVALENTLY BOUND TO A HYDROXYMETHYL KETONE INHIBITOR (I)	3.4.22 3.4.22.51
1ME6	CRYSTAL STRUCTURE OF PLASMEPSIN II, AN ASPARTYL PROTEASE FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH A STATINE-BASED INHIBITOR	3.4.23.39
1MEC	CONFORMATIONAL VARIABILITY OF A PICORNAVIRUS CAPSID: PH-DEPENDENT STRUCTURAL CHANGES OF MENGO VIRUS RELATED TO ITS HOST RECEPTOR ATTACHMENT SITE AND DISASSEMBLY	3.6.4.13 3.4.22.28 2.7.7.48
1MEE	THE COMPLEX BETWEEN THE SUBTILISIN FROM A MESOPHILIC BACTERIUM AND THE LEECH INHIBITOR EGLIN-C	3.4.21.14 3.4.21.62
1MEG	CRYSTAL STRUCTURE OF A CARICAIN D158E MUTANT IN COMPLEX WITH E-64	3.4.22.30
1MEM	CRYSTAL STRUCTURE OF CATHEPSIN K COMPLEXED WITH A POTENT VINYL SULFONE INHIBITOR	3.4.22.38
1MER	HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MES	HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MET	HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MEU	HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MF4	STRUCTURE-BASED DESIGN OF POTENT AND SELECTIVE INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AND A DESIGNED PEPTIDE INHIBITOR AT 1.9 A RESOLUTION	3.1.1.4
1MF8	CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH CYCLOSPORIN A AND HUMAN CYCLOPHILIN	3.1.3.16
1MFS	DYNAMICAL BEHAVIOR OF THE HIV-1 NUCLEOCAPSID PROTEIN; NMR, 30 STRUCTURES	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MFU	PROBING THE ROLE OF A MOBILE LOOP IN HUMAN SALIVARY AMYLASE: STRUCTURAL STUDIES ON THE LOOP-DELETED MUTANT	3.2.1.1
1MFV	PROBING THE ROLE OF A MOBILE LOOP IN HUMAN SLAIVARY AMYLASE: STRUCTURAL STUDIES ON THE LOOP-DELETED ENZYME	3.2.1.1
1MG6	THE CRYSTAL STRUCTURE OF A K49 PLA2 FROM THE SNAKE VENOM OF AGKISTRODON ACUTUS	3.1.1.4
1MGR	CRYSTAL STRUCTURE OF RNASE SA3,CYTOTOXIC MICROBIAL RIBONUCLEASE	3.1.27.3 4.6.1.24
1MGW	CRYSTAL STRUCTURE OF RNASE SA3, CYTOTOXIC MICROBIAL RIBONUCLEASE	3.1.27.3 4.6.1.24
1MH0	CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN	3.4.21.5
1MH1	SMALL G-PROTEIN	3.6.5.2
1MH2	CRYSTAL STRUCTURE OF A ZINC CONTAINING DIMER OF PHOSPHOLIPASE A2 FROM THE VENOM OF INDIAN COBRA (NAJA NAJA SAGITTIFERA)	3.1.1.4
1MH7	CRYSTAL STRUCTURE OF A CALCIUM-FREE ISOFORM OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 2.0 A RESOLUTION	3.1.1.4
1MH8	CRYSTAL STRUCTURE OF A PHOPHOLIPASE A2 MONOMER WITH ISOLEUCINE AT SECOND POSITION	3.1.1.4
1MH9	CRYSTAL STRUCTURE ANALYSIS OF DEOXYRIBONUCLEOTIDASE	3.1.3.5 3.1.3
1MHS	MODEL OF NEUROSPORA CRASSA PROTON ATPASE	3.6.3.6 7.1.2.1
1MHW	DESIGN OF NON-COVALENT INHIBITORS OF HUMAN CATHEPSIN L. FROM THE 96-RESIDUE PROREGION TO OPTIMIZED TRIPEPTIDES	3.4.22.15
1MI8	2.0 ANGSTROM CRYSTAL STRUCTURE OF A DNAB INTEIN FROM SYNECHOCYSTIS SP. PCC 6803	3.6.1 3.6.4.12
1MII	SOLUTION STRUCTURE OF ALPHA-CONOTOXIN MII	3.2.1.17
1MIR	RAT PROCATHEPSIN B	3.4.22.1
1MJ5	LINB (HALOALKANE DEHALOGENASE) FROM SPHINGOMONAS PAUCIMOBILIS UT26 AT ATOMIC RESOLUTION	3.8.1.5
1MJW	STRUCTURE OF INORGANIC PYROPHOSPHATASE MUTANT D42N	3.6.1.1
1MJX	STRUCTURE OF INORGANIC PYROPHOSPHATASE MUTANT D65N	3.6.1.1
1MJY	STRUCTURE OF INORGANIC PYROPHOSPHATASE MUTANT D70N	3.6.1.1
1MJZ	STRUCTURE OF INORGANIC PYROPHOSPHATASE MUTANT D97N	3.6.1.1
1MK0	CATALYTIC DOMAIN OF INTRON ENDONUCLEASE I-TEVI, E75A MUTANT	3.1
1MK1	STRUCTURE OF THE MT-ADPRASE IN COMPLEX WITH ADPR, A NUDIX ENZYME	3.6.1.13
1MKI	CRYSTAL STRUCTURE OF BACILLUS SUBTILIS PROBABLE GLUTAMINASE, APC1040	3.5.1.2
1MKP	CRYSTAL STRUCTURE OF PYST1 (MKP3)	3.1.3.48 3.1.3.16
1MKS	CARBOXYLIC ESTER HYDROLASE, TRIGONAL FORM OF THE TRIPLE MUTANT	3.1.1.4
1MKT	CARBOXYLIC ESTER HYDROLASE, 1.72 ANGSTROM TRIGONAL FORM OF THE BOVINE RECOMBINANT PLA2 ENZYME	3.1.1.4
1MKU	CARBOXYLIC ESTER HYDROLASE, ORTHORHOMBIC FORM OF THE TRIPLE MUTANT	3.1.1.4
1MKV	CARBOXYLIC ESTER HYDROLASE COMPLEX (PLA2 + TRANSITION STATE ANALOG COMPLEX)	3.1.1.4
1MKW	THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA-THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING	3.4.21.5
1MKX	THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA-THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING	3.4.21.5
1MM2	SOLUTION STRUCTURE OF THE 2ND PHD DOMAIN FROM MI2B	3.6.4.12
1MM3	SOLUTION STRUCTURE OF THE 2ND PHD DOMAIN FROM MI2B WITH C-TERMINAL LOOP REPLACED BY CORRESPONDING LOOP FROM WSTF	3.6.4.12
1MM8	CRYSTAL STRUCTURE OF TN5 TRANSPOSASE COMPLEXED WITH ME DNA	3.1
1MMB	COMPLEX OF BB94 WITH THE CATALYTIC DOMAIN OF MATRIX METALLOPROTEINASE-8	3.4.24.34
1MMJ	PORCINE PANCREATIC ELASTASE COMPLEXED WITH A POTENT PEPTIDYL INHIBITOR, FR136706	3.4.21.36
1MML	MECHANISTIC IMPLICATIONS FROM THE STRUCTURE OF A CATALYTIC FRAGMENT OF MMLV REVERSE TRANSCRIPTASE	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
1MMP	MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR	3.4.24.23
1MMQ	MATRILYSIN COMPLEXED WITH HYDROXAMATE INHIBITOR	3.4.24.23
1MMR	MATRILYSIN COMPLEXED WITH SULFODIIMINE INHIBITOR	3.4.24.23
1MNC	STRUCTURE OF HUMAN NEUTROPHIL COLLAGENASE REVEALS LARGE S1' SPECIFICITY POCKET	3.4.24.7 3.4.24.34
1MO3	RECA-ADP COMPLEX	3.4.99.37 3.1
1MO4	RECA-ATP-GAMMA-S COMPLEX	3.4.99.37 3.1
1MO5	RECA-ATP-GAMMA-S-MG COMPLEX	3.4.99.37 3.1
1MO6	RECA-DATP-MG COMPLEX	3.4.99.37 3.1
1MO7	ATPASE	3.6.3.9 7.2.2.13
1MO8	ATPASE	3.6.3.9 7.2.2.13
1MOM	CRYSTAL STRUCTURE OF MOMORDIN, A TYPE I RIBOSOME INACTIVATING PROTEIN FROM THE SEEDS OF MOMORDICA CHARANTIA	3.2.2.22
1MOW	E-DREI	3.1
1MP2	STRUCTURE OF MT-ADPRASE (APOENZYME), A NUDIX HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS	3.6.1.13
1MPG	3-METHYLADENINE DNA GLYCOSYLASE II FROM ESCHERICHIA COLI	3.2.2.21
1MPL	CRYSTAL STRUCTURE OF PHOSPHONATE-INHIBITED D-ALA-D-ALA PEPTIDASE REVEALS AN ANALOG OF A TETRAHEDRAL TRANSITION STATE	3.4.16.4
1MPP	X-RAY ANALYSES OF ASPARTIC PROTEINASES. V. STRUCTURE AND REFINEMENT AT 2.0 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM MUCOR PUSILLUS	3.4.23.23
1MPT	CRYSTAL STRUCTURE OF A NEW ALKALINE SERINE PROTEASE (M-PROTEASE) FROM BACILLUS SP. KSM-K16	3.4.21.62 3.4.21
1MPX	ALPHA-AMINO ACID ESTER HYDROLASE LABELED WITH SELENOMETHIONINE	3.1.1.43
1MQ0	CRYSTAL STRUCTURE OF HUMAN CYTIDINE DEAMINASE	3.5.4.5
1MQ5	CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA	3.4.21.6
1MQ6	CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA	3.4.21.6
1MQ7	CRYSTAL STRUCTURE OF DUTPASE FROM MYCOBACTERIUM TUBERCULOSIS (RV2697C)	3.6.1.23
1MQE	STRUCTURE OF THE MT-ADPRASE IN COMPLEX WITH GADOLIDIUM AND ADP-RIBOSE, A NUDIX ENZYME	3.6.1.13
1MQO	METALLO-BETA-LACTAMASE BCII CD SUBSTITUTED FROM BACILLUS CEREUS AT 1.35 ANGSTROMS RESOLUTION	3.5.2.6
1MQP	THE CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE FROM BACILLUS STEAROTHERMOPHILUS T-6	3.2.1.139 3.2.1.131
1MQQ	THE CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE FROM BACILLUS STEAROTHERMOPHILUS T-1 COMPLEXED WITH GLUCURONIC ACID	3.2.1.139 3.2.1.131
1MQR	THE CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE (E386Q) FROM BACILLUS STEAROTHERMOPHILUS T-6	3.2.1.139 3.2.1.131
1MQW	STRUCTURE OF THE MT-ADPRASE IN COMPLEX WITH THREE MN2+ IONS AND AMPCPR, A NUDIX ENZYME	3.6.1.13
1MR2	STRUCTURE OF THE MT-ADPRASE IN COMPLEX WITH 1 MN2+ ION AND AMP-CP (A INHIBITOR), A NUDIX ENZYME	3.6.1.13
1MR5	ORTHORHOMBIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE	3.2.1.18
1MRG	STUDIES ON CRYSTAL STRUCTURES ACTIVE CENTER GEOMETRY AND DEPURINE MECHANISM OF TWO RIBOSOME-INACTIVATING PROTEINS	3.2.2.22
1MRH	STUDIES ON CRYSTAL STRUCTURES ACTIVE CENTER GEOMETRY AND DEPURINE MECHANISM OF TWO RIBOSOME-INACTIVATING PROTEINS	3.2.2.22
1MRI	STUDIES ON CRYSTAL STRUCTURES ACTIVE CENTER GEOMETRY AND DEPURINE MECHANISM OF TWO RIBOSOME-INACTIVATING PROTEINS	3.2.2.22
1MRJ	STUDIES ON CRYSTAL STRUCTURES ACTIVE CENTER GEOMETRY AND DEPURINE MECHANISM OF TWO RIBOSOME-INACTIVATING PROTEINS	3.2.2.22
1MRK	STUDIES ON CRYSTAL STRUCTURES ACTIVE CENTER GEOMETRY AND DEPURINE MECHANISM OF TWO RIBOSOME-INACTIVATING PROTEINS	3.2.2.22
1MRW	STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI-577	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MRX	STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I V82F I84V ) COMPLEXED WITH KNI-577	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MS0	MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, IN COMPLEX WITH 3-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)AND LACTOSE	3.2.1.18
1MS1	MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, IN COMPLEX WITH 3-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)	3.2.1.18
1MS3	MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE	3.2.1.18
1MS4	TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE	3.2.1.18
1MS5	TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, SOAKED WITH N-ACETYLNEURAMINYL-A-2,3-THIO-GALACTOSIDE (NA-S-GAL)	3.2.1.18
1MS6	DIPEPTIDE NITRILE INHIBITOR BOUND TO CATHEPSIN S.	3.4.22.27
1MS8	TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, IN COMPLEX WITH 3-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)	3.2.1.18
1MS9	TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, IN COMPLEX WITH LACTOSE	3.2.1.18
1MSM	THE HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI-764 (AN INHIBITOR)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MSN	THE HIV PROTEASE (MUTANT Q7K L33I L63I V82F I84V) COMPLEXED WITH KNI-764 (AN INHIBITOR)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MSZ	SOLUTION STRUCTURE OF THE R3H DOMAIN FROM HUMAN SMUBP-2	3.6.4.12 3.6.4.13
1MT3	CRYSTAL STRUCTURE OF THE TRICORN INTERACTING FACTOR SELENOMETHIONINE-F1	3.4.11.5
1MT7	VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MT8	VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MT9	VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MTB	VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MTL	NON-PRODUCTIVE MUG-DNA COMPLEX	3.2.2 3.2.2.28
1MTN	BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION	3.4.21.1
1MTR	HIV-1 PROTEASE COMPLEXED WITH A CYCLIC PHE-ILE-VAL PEPTIDOMIMETIC INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MTS	FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN	3.4.21.4
1MTU	FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN	3.4.21.4
1MTV	FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN	3.4.21.4
1MTW	FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN	3.4.21.4
1MTZ	CRYSTAL STRUCTURE OF THE TRICORN INTERACTING FACTOR F1	3.4.11.5
1MU0	CRYSTAL STRUCTURE OF THE TRICORN INTERACTING FACTOR F1 COMPLEX WITH PCK	3.4.11.5
1MU2	CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE	2.7.7.49 3.4.23.47 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1MU6	CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622	3.4.21.5
1MU7	CRYSTAL STRUCTURE OF A HUMAN TYROSYL-DNA PHOSPHODIESTERASE (TDP1)-TUNGSTATE COMPLEX	3.1.4
1MU8	THROMBIN-HIRUGEN_L-378,650	3.4.21.5
1MU9	CRYSTAL STRUCTURE OF A HUMAN TYROSYL-DNA PHOSPHODIESTERASE (TDP1)-VANADATE COMPLEX	3.1.4
1MUD	CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI, D138N MUTANT COMPLEXED TO ADENINE	3.2.2.31
1MUE	THROMBIN-HIRUGEN-L405,426	3.4.21.5
1MUG	G:T/U MISMATCH-SPECIFIC DNA GLYCOSYLASE FROM E.COLI	3.2.2 3.2.2.28
1MUH	CRYSTAL STRUCTURE OF TN5 TRANSPOSASE COMPLEXED WITH TRANSPOSON END DNA	3.1
1MUI	CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LOPINAVIR.	3.4.23.16
1MUN	CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI D138N MUTANT	3.2.2 3.2.2.31
1MUS	CRYSTAL STRUCTURE OF TN5 TRANSPOSASE COMPLEXED WITH RESOLVED OUTSIDE END DNA	3.1
1MUT	NMR STUDY OF MUTT ENZYME, A NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE	3.6.1 3.6.1.55
1MUY	CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI	3.2.2 3.2.2.31
1MVE	CRYSTAL STRUCTURE OF A NATURAL CIRCULARLY-PERMUTATED JELLYROLL PROTEIN: 1,3-1,4-BETA-D-GLUCANASE FROM FIBROBACTER SUCCINOGENES	3.2.1.73
1MVP	STRUCTURAL STUDIES OF THE RETROVIRAL PROTEINASE FROM AVIAN MYELOBLASTOSIS ASSOCIATED VIRUS	3.4.23
1MWE	THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH SIALIC ACID AT 4 DEGREES C REVEALING A SECOND SIALIC ACID BINDING SITE	3.2.1.18
1MWI	CRYSTAL STRUCTURE OF A MUG-DNA PRODUCT COMPLEX	3.2.2 3.2.2.28
1MWJ	CRYSTAL STRUCTURE OF A MUG-DNA PSEUDO SUBSTRATE COMPLEX	3.2.2 3.2.2.28
1MWO	CRYSTAL STRUCTURE ANALYSIS OF THE HYPERTHERMOSTABLE PYROCOOCUS WOESEI ALPHA-AMYLASE	3.2.1.1
1MWT	STRUCTURE OF PENICILLIN G ACYL-PENICILLIN BINDING PROTEIN 2A FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS STRAIN 27R AT 2.45 A RESOLUTION.	3.4.16.4 2.4.1.129
1MWY	SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF ZNTA IN THE APO-FORM	3.6.3.3 3.6.3.5 7.2.2 7.2.2.12 7.2.2.21
1MWZ	SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF ZNTA IN THE ZN(II)-FORM	3.6.3.3 3.6.3.5 7.2.2 7.2.2.12 7.2.2.21
1MXD	STRUCTURE OF A (CA,ZN)-DEPENDENT ALPHA-AMYLASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS WOESEI	3.2.1.1
1MXG	CRYSTAL STRUCTURE OF A (CA,ZN)-DEPENDENT ALPHA-AMYLASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS WOESEI IN COMPLEX WITH ACARBOSE	3.2.1.1
1MXO	AMPC BETA-LACTAMASE IN COMPLEX WITH AN M.CARBOXYPHENYLGLYCYLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN	3.5.2.6
1MY8	AMPC BETA-LACTAMASE IN COMPLEX WITH AN M.CARBOXYPHENYLGLYCYLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN	3.5.2.6
1MYR	MYROSINASE FROM SINAPIS ALBA	3.2.3.1 3.2.1.147
1MZ5	TRYPANOSOMA RANGELI SIALIDASE	3.2.1.18
1MZ6	TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH THE INHIBITOR DANA	3.2.1.18
1MZA	CRYSTAL STRUCTURE OF HUMAN PRO-GRANZYME K	3.4.21
1MZD	CRYSTAL STRUCTURE OF HUMAN PRO-GRANZYME K	3.4.21
1MZK	NMR STRUCTURE OF KINASE-INTERACTING FHA DOMAIN OF KINASE ASSOCIATED PROTEIN PHOSPHATASE, KAPP IN ARABIDOPSIS	3.1.3.16
1N1L	CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND INHIBITOR (GW472467X)	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1N1M	HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH AN INHIBITOR	3.4.14.5
1N1S	TRYPANOSOMA RANGELI SIALIDASE	3.2.1.18
1N1T	TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH DANA AT 1.6 A	3.2.1.18
1N1V	TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH DANA	3.2.1.18
1N1X	CRYSTAL STRUCTURE ANALYSIS OF THE MONOMERIC [S-CARBOXYAMIDOMETHYL-CYS31, S-CARBOXYAMIDOMETHYL-CYS32] BOVINE SEMINAL RIBONUCLEASE	3.1.27.5 4.6.1.18
1N1Y	TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH SIALIC ACID	3.2.1.18
1N25	CRYSTAL STRUCTURE OF THE SV40 LARGE T ANTIGEN HELICASE DOMAIN	3.6.4
1N28	CRYSTAL STRUCTURE OF THE H48Q MUTANT OF HUMAN GROUP IIA PHOSPHOLIPASE A2	3.1.1.4
1N29	CRYSTAL STRUCTURE OF THE N1A MUTANT OF HUMAN GROUP IIA PHOSPHOLIPASE A2	3.1.1.4
1N2K	CRYSTAL STRUCTURE OF A COVALENT INTERMEDIATE OF ENDOGENOUS HUMAN ARYLSULFATASE A	3.1.6.8
1N2L	CRYSTAL STRUCTURE OF A COVALENT INTERMEDIATE OF ENDOGENOUS HUMAN ARYLSULFATASE A	3.1.6.8
1N39	STRUCTURAL AND BIOCHEMICAL EXPLORATION OF A CRITICAL AMINO ACID IN HUMAN 8-OXOGUANINE GLYCOSYLASE	3.2.2 4.2.99.18
1N3A	STRUCTURAL AND BIOCHEMICAL EXPLORATION OF A CRITICAL AMINO ACID IN HUMAN 8-OXOGUANINE GLYCOSYLASE	3.2.2 4.2.99.18
1N3C	STRUCTURAL AND BIOCHEMICAL EXPLORATION OF A CRITICAL AMINO ACID IN HUMAN 8-OXOGUANINE GLYCOSYLASE	3.2.2 4.2.99.18
1N3E	CRYSTAL STRUCTURE OF I-CREI BOUND TO A PALINDROMIC DNA SEQUENCE I (PALINDROME OF LEFT SIDE OF WILDTYPE DNA TARGET SEQUENCE)	3.1
1N3F	CRYSTAL STRUCTURE OF I-CREI BOUND TO A PALINDROMIC DNA SEQUENCE II (PALINDROME OF RIGHT SIDE OF WILDTYPE DNA TARGET SEQUENCE)	3.1
1N3S	BIOSYNTHESIS OF PTERIDINS. REACTION MECHANISM OF GTP CYCLOHYDROLASE I	3.5.4.16
1N3Z	CRYSTAL STRUCTURE OF THE [S-CARBOXYAMIDOMETHYL-CYS31, S-CARBOXYAMIDOMETHYL-CYS32] MONOMERIC DERIVATIVE OF THE BOVINE SEMINAL RIBONUCLEASE IN THE LIGANDED STATE	3.1.27.5 4.6.1.18
1N49	VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE VARIANT: STRUCTURAL INSIGHTS FOR BETTER ANTI-VIRAL THERAPY	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1N4C	NMR STRUCTURE OF THE J-DOMAIN AND CLATHRIN SUBSTRATE BINDING DOMAIN OF BOVINE AUXILIN	3.1.3.48
1N4F	PARA-ARSANILATE DERIVATIVE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
1N4L	A DNA ANALOGUE OF THE POLYPURINE TRACT OF HIV-1	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
1N4O	CRYSTAL STRUCTURE OF THE CLASS A BETA-LACTAMASE L2 FROM STENOTROPHOMONAS MALTOPHILIA	3.5.2.6
1N4Y	REFINED STRUCTURE OF KISTRIN	3.4.24
1N51	AMINOPEPTIDASE P IN COMPLEX WITH THE INHIBITOR APSTATIN	3.4.11.9
1N57	CRYSTAL STRUCTURE OF CHAPERONE HSP31	3.1.2 3.5.1 3.5.1.124 4.2.1.130
1N5M	CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-GALLAMINE COMPLEX	3.1.1.7
1N5N	CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM PSEUDOMONAS AERUGINOSA	3.5.1.88
1N5R	CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-PROPIDIUM COMPLEX	3.1.1.7
1N5Y	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1N6G	THE STRUCTURE OF IMMATURE DENGUE-2 PRM PARTICLES	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
1N6H	CRYSTAL STRUCTURE OF HUMAN RAB5A	3.6.5.2
1N6I	CRYSTAL STRUCTURE OF HUMAN RAB5A A30P MUTANT COMPLEX WITH GDP	3.6.5.2
1N6K	CRYSTAL STRUCTURE OF HUMAN RAB5A A30P MUTANT COMPLEX WITH GDP AND ALUMINUM FLUORIDE	3.6.5.2
1N6L	CRYSTAL STRUCTURE OF HUMAN RAB5A A30P MUTANT COMPLEX WITH GTP	3.6.5.2
1N6N	CRYSTAL STRUCTURE OF HUMAN RAB5A A30R MUTANT COMPLEX WITH GPPNHP	3.6.5.2
1N6O	CRYSTAL STRUCTURE OF HUMAN RAB5A A30K MUTANT COMPLEX WITH GPPNHP	3.6.5.2
1N6P	CRYSTAL STRUCTURE OF HUMAN RAB5A A30E MUTANT COMPLEX WITH GPPNHP	3.6.5.2
1N6Q	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1N6R	CRYSTAL STRUCTURE OF HUMAN RAB5A A30L MUTANT COMPLEX WITH GPPNHP	3.6.5.2
1N6X	RIP-PHASING ON BOVINE TRYPSIN	3.4.21.4
1N6Y	RIP-PHASING ON BOVINE TRYPSIN	3.4.21.4
1N76	CRYSTAL STRUCTURE OF HUMAN SEMINAL LACTOFERRIN AT 3.4 A RESOLUTION	3.4.21
1N8N	CRYSTAL STRUCTURE OF THE AU3+ COMPLEX OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE FROM E. COLI AT 1.69 A RESOLUTION	3.1.3.2
1N8O	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN BOVINE CHYMOTRYPSIN AND ECOTIN	3.4.21.1
1N8S	STRUCTURE OF THE PANCREATIC LIPASE-COLIPASE COMPLEX	3.1.1.3
1N9B	ULTRAHIGH RESOLUTION STRUCTURE OF A CLASS A BETA-LACTAMASE: ON THE MECHANISM AND SPECIFICITY OF THE EXTENDED-SPECTRUM SHV-2 ENZYME	3.5.2.6
1N9K	CRYSTAL STRUCTURE OF THE BROMIDE ADDUCT OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE FROM E. COLI AT 2.2 A RESOLUTION	3.1.3.2
1NA1	THE STRUCTURE OF HRV14 WHEN COMPLEXED WITH PLECONARIL	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1NA6	CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE ECORII MUTANT R88A	3.1.21.4
1NAE	STRUCTURE OF CSCBM6-3 FROM CLOSTRIDIUM STERCORARIUM IN COMPLEX WITH XYLOTRIOSE	3.2.1.8
1NB3	CRYSTAL STRUCTURE OF STEFIN A IN COMPLEX WITH CATHEPSIN H: N-TERMINAL RESIDUES OF INHIBITORS CAN ADAPT TO THE ACTIVE SITES OF ENDO-AND EXOPEPTIDASES	3.4.22.16
1NB4	HC-J4 RNA POLYMERASE APO-FORM	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
1NB5	CRYSTAL STRUCTURE OF STEFIN A IN COMPLEX WITH CATHEPSIN H	3.4.22.16
1NB6	HC-J4 RNA POLYMERASE COMPLEXED WITH UTP	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
1NB7	HC-J4 RNA POLYMERASE COMPLEXED WITH SHORT RNA TEMPLATE STRAND	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
1NB8	STRUCTURE OF THE CATALYTIC DOMAIN OF USP7 (HAUSP)	3.1.2.15 3.4.19.12
1NBA	CRYSTAL STRUCTURE ANALYSIS, REFINEMENT AND ENZYMATIC REACTION MECHANISM OF N-CARBAMOYLSARCOSINE AMIDOHYDROLASE FROM ARTHROBACTER SP. AT 2.0 ANGSTROMS RESOLUTION	3.5.1.59
1NBF	CRYSTAL STRUCTURE OF A UBP-FAMILY DEUBIQUITINATING ENZYME IN ISOLATION AND IN COMPLEX WITH UBIQUITIN ALDEHYDE	3.1.2.15 3.4.19.12
1NC1	CRYSTAL STRUCTURE OF E. COLI MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH 5'-METHYLTHIOTUBERCIDIN (MTH)	3.2.2.9 3.2.2.16
1NC3	CRYSTAL STRUCTURE OF E. COLI MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH FORMYCIN A (FMA)	3.2.2.9
1NC5	STRUCTURE OF PROTEIN OF UNKNOWN FUNCTION OF YTER FROM BACILLUS SUBTILIS	3.2.1.172
1NC6	POTENT, SMALL MOLECULE INHIBITORS OF HUMAN MAST CELL TRYPTASE. ANTI-ASTHMATIC ACTION OF A DIPEPTIDE-BASED TRANSITION STATE ANALOGUE CONTAINING BENZOTHIAZOLE KETONE	3.4.21.4
1NC8	HIGH-RESOLUTION SOLUTION NMR STRUCTURE OF THE MINIMAL ACTIVE DOMAIN OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 NUCLEOCAPSID PROTEIN, 15 STRUCTURES	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1NCP	STRUCTURAL CHARACTERIZATION OF A 39 RESIDUE SYNTHETIC PEPTIDE CONTAINING THE TWO ZINC BINDING DOMAINS FROM THE HIV-1 P7 NUCLEOCAPSID PROTEIN BY CD AND NMR SPECTROSCOPY	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1NCQ	THE STRUCTURE OF HRV14 WHEN COMPLEXED WITH PLECONARIL, AN ANTIVIRAL COMPOUND	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1NCR	THE STRUCTURE OF RHINOVIRUS 16 WHEN COMPLEXED WITH PLECONARIL, AN ANTIVIRAL COMPOUND	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1ND1	AMINO ACID SEQUENCE AND CRYSTAL STRUCTURE OF BAP1, A METALLOPROTEINASE FROM BOTHROPS ASPER SNAKE VENOM THAT EXERTS MULTIPLE TISSUE-DAMAGING ACTIVITIES.	3.4.24
1ND2	THE STRUCTURE OF RHINOVIRUS 16	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1ND3	THE STRUCTURE OF HRV16, WHEN COMPLEXED WITH PLECONARIL, AN ANTIVIRAL COMPOUND	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1ND5	CRYSTAL STRUCTURES OF HUMAN PROSTATIC ACID PHOSPHATASE IN COMPLEX WITH A PHOSPHATE ION AND ALPHA-BENZYLAMINOBENZYLPHOSPHONIC ACID UPDATE THE MECHANISTIC PICTURE AND OFFER NEW INSIGHTS INTO INHIBITOR DESIGN	3.1.3.2 3.1.3.5
1ND6	CRYSTAL STRUCTURES OF HUMAN PROSTATIC ACID PHOSPHATASE IN COMPLEX WITH A PHOSPHATE ION AND ALPHA-BENZYLAMINOBENZYLPHOSPHONIC ACID UPDATE THE MECHANISTIC PICTURE AND OFFER NEW INSIGHTS INTO INHIBITOR DESIGN	3.1.3.2 3.1.3.5
1NDQ	BACILLUS LENTUS SUBTILISIN	3.4.21.62
1NDU	BACILLUS LENTUS SUBTILISIN VARIANT S101G/V104N	3.4.21.62
1NDV	CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR117016	3.5.4.4
1NDW	CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR221647	3.5.4.4
1NDY	CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR230513	3.5.4.4
1NDZ	CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR235999	3.5.4.4
1NE7	HUMAN GLUCOSAMINE-6-PHOSPHATE DEAMINASE ISOMERASE AT 1.75 A RESOLUTION COMPLEXED WITH N-ACETYL-GLUCOSAMINE-6-PHOSPHATE AND 2-DEOXY-2-AMINO-GLUCITOL-6-PHOSPHATE	3.5.99.6
1NE8	YDCE PROTEIN FROM BACILLUS SUBTILIS	3.1.27
1NED	CRYSTAL STRUCTURE OF HSLV (CLPQ) AT 3.8 ANGSTROMS RESOLUTION	3.4.99 3.4.25.2
1NES	STRUCTURE OF THE PRODUCT COMPLEX OF ACETYL-ALA-PRO-ALA WITH PORCINE PANCREATIC ELASTASE AT 1.65 ANGSTROMS RESOLUTION	3.4.21.36
1NF3	STRUCTURE OF CDC42 IN A COMPLEX WITH THE GTPASE-BINDING DOMAIN OF THE CELL POLARITY PROTEIN, PAR6	3.6.5.2
1NF8	CRYSTAL STRUCTURE OF PHZD PROTEIN ACTIVE SITE MUTANT WITH SUBSTRATE	3.3.2.1 3.3.2.15
1NF9	CRYSTAL STRUCTURE OF PHZD PROTEIN FROM PSEUDOMONAS AERUGINOSA	3.3.2.1 3.3.2.15
1NFG	STRUCTURE OF D-HYDANTOINASE	3.5.2.2 3.5.2
1NFU	CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747	3.4.21.6
1NFW	CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685	3.4.21.6
1NFX	CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944	3.4.21.6
1NFY	CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095	3.4.21.6
1NG7	THE SOLUTION STRUCTURE OF THE SOLUBLE DOMAIN OF POLIOVIRUS 3A PROTEIN	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1NGA	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGB	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGC	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGD	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGE	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGF	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGG	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGH	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGI	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGJ	STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT	3.6.1.3
1NGN	MISMATCH REPAIR IN METHYLATED DNA. STRUCTURE OF THE MISMATCH-SPECIFIC THYMINE GLYCOSYLASE DOMAIN OF METHYL-CPG-BINDING PROTEIN MBD4	3.2.2
1NH0	1.03 A STRUCTURE OF HIV-1 PROTEASE: INHIBITOR BINDING INSIDE AND OUTSIDE THE ACTIVE SITE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1NH6	STRUCTURE OF S. MARCESCENS CHITINASE A, E315L, COMPLEX WITH HEXASACCHARIDE	3.2.1.14
1NHB	SPECIFICITY OF LIGAND BINDING IN A BURIED NON-POLAR CAVITY OF T4 LYSOZYME: LINKAGE OF DYNAMICS AND STRUCTURAL PLASTICITY	3.2.1.17
1NHC	STRUCTURAL INSIGHTS INTO THE PROCESSIVITY OF ENDOPOLYGALACTURONASE I FROM ASPERGILLUS NIGER	3.2.1.15
1NHU	HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE ANALOGUE INHIBITOR	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
1NHV	HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE ANALOGUE INHIBITOR	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
1NI0	STRUCTURE OF THE Y94F MUTANT OF THE RESTRICTION ENDONUCLEASE PVUII	3.1.21.4
1NI9	2.0 A STRUCTURE OF GLYCEROL METABOLISM PROTEIN FROM E. COLI	3.1.3.11
1NIJ	YJIA PROTEIN	3.6
1NIO	CRYSTAL STRUCTURE OF BETA-LUFFIN, A RIBOSOME INACTIVATING PROTEIN AT 2.0A RESOLUTION	3.2.2.22
1NJ4	CRYSTAL STRUCTURE OF A DEACYLATION-DEFECTIVE MUTANT OF PENICILLIN-BINDING PROTEIN 5 AT 1.9 A RESOLUTION	3.4.16.4 3.5.2.6
1NJK	CRYSTAL STRUCTURE OF YBAW PROBABLE THIOESTERASE FROM ESCHERICHIA COLI	3.1.2
1NJR	CRYSTAL STRUCTURE OF YEAST YMX7, AN ADP-RIBOSE-1''-MONOPHOSPHATASE	3.1.3.84
1NJT	COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR	3.4.21.97
1NJU	COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR	3.4.21.97
1NKK	COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR	3.4.21.97
1NKM	COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR	3.4.21.97
1NKQ	CRYSTAL STRUCTURE OF YEAST YNQ8, A FUMARYLACETOACETATE HYDROLASE FAMILY PROTEIN	3
1NKU	NMR SOLUTION STRUCTURE OF ZINC-BINDING PROTEIN 3-METHYLADENINE DNA GLYCOSYLASE I (TAG)	3.2.2.20
1NKX	CRYSTAL STRUCTURE OF A PROTEOLYTICALLY GENERATED FUNCTIONAL MONOFERRIC C-LOBE OF BOVINE LACTOFERRIN AT 1.9A RESOLUTION	3.4.21
1NL1	BOVINE PROTHROMBIN FRAGMENT 1 IN COMPLEX WITH CALCIUM ION	3.4.21.5
1NL2	BOVINE PROTHROMBIN FRAGMENT 1 IN COMPLEX WITH CALCIUM AND LYSOPHOSPHOTIDYLSERINE	3.4.21.5
1NL6	CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR	3.4.22.38
1NL9	POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 12 USING A LINKED-FRAGMENT STRATEGY	3.1.3.48
1NLI	COMPLEX OF [E160A-E189A] TRICHOSANTHIN AND ADENINE	3.2.2.22
1NLJ	CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR	3.4.22.38
1NLN	CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEINASE WITH ITS 11 AMINO ACID COFACTOR AT 1.6 ANGSTROM RESOLUTION	3.4.22.39
1NLR	ENDO-1,4-BETA-GLUCANASE CELB2, CELLULASE, NATIVE STRUCTURE	3.2.1.4
1NLU	PSEUDOMONAS SEDOLISIN (SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH TWO MOLECULES OF PSEUDO-IODOTYROSTATIN	3.4.21.100
1NM6	THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR AT 1.8A	3.4.21.5
1NM9	CRYSTAL STRUCTURE OF RECOMBINANT HUMAN SALIVARY AMYLASE MUTANT W58A	3.2.1.1
1NMC	COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
1NME	STRUCTURE OF CASP-3 WITH TETHERED SALICYLATE	3.4.22 3.4.22.56
1NMN	STRUCTURE OF YQGF FROM ESCHERICHIA COLI, A HYPOTHETICAL PROTEIN	3.1
1NMQ	EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS	3.4.22 3.4.22.56
1NMS	CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR	3.4.22 3.4.22.56
1NN2	THREE-DIMENSIONAL STRUCTURE OF THE NEURAMINIDASE OF INFLUENZA VIRUS A(SLASH)TOKYO(SLASH)3(SLASH)67 AT 2.2 ANGSTROMS RESOLUTION	3.2.1.18
1NN6	HUMAN PRO-CHYMASE	3.4.21.39
1NN8	CRYOEM STRUCTURE OF POLIOVIRUS RECEPTOR BOUND TO POLIOVIRUS	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
1NNA	THREE-DIMENSIONAL STRUCTURE OF INFLUENZA A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 2,3-DEHYDRO-N-ACETYL NEURAMINIC ACID	3.2.1.18
1NNB	THREE-DIMENSIONAL STRUCTURE OF INFLUENZA A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 2,3-DEHYDRO-N-ACETYL NEURAMINIC ACID	3.2.1.18
1NNC	INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 4-GUANIDINO-NEU5AC2EN INHIBITOR	3.2.1.18
1NND	ARGININE 116 IS ESSENTIAL FOR NUCLEIC ACID RECOGNITION BY THE FINGERS DOMAIN OF MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
1NNJ	CRYSTAL STRUCTURE COMPLEX BETWEEN THE LACTOCOCCUS LACTIS FPG AND AN ABASIC SITE CONTAINING DNA	3.2.2.23 4.2.99.18
1NNL	CRYSTAL STRUCTURE OF HUMAN PHOSPHOSERINE PHOSPHATASE	3.1.3.3
1NNS	L-ASPARAGINASE OF E. COLI IN C2 SPACE GROUP AND 1.95 A RESOLUTION	3.5.1.1
1NNY	POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 23 USING A LINKED-FRAGMENT STRATEGY	3.1.3.48
1NO6	POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 5 USING A LINKED-FRAGMENT STRATEGY	3.1.3.48
1NO9	DESIGN OF WEAKLY BASIC THROMBIN INHIBITORS INCORPORATING NOVEL P1 BINDING FUNCTIONS: MOLECULAR AND X-RAY CRYSTALLOGRAPHIC STUDIES.	3.4.21.5
1NOF	THE FIRST CRYSTALLOGRAPHIC STRUCTURE OF A XYLANASE FROM GLYCOSYL HYDROLASE FAMILY 5: IMPLICATIONS FOR CATALYSIS	3.2.1.8
1NOP	CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE (TDP1) IN COMPLEX WITH VANADATE, DNA AND A HUMAN TOPOISOMERASE I-DERIVED PEPTIDE	3.1.4
1NOU	NATIVE HUMAN LYSOSOMAL BETA-HEXOSAMINIDASE ISOFORM B	3.2.1.52
1NOV	NODAMURA VIRUS	3.4.23.44
1NOW	HUMAN LYSOSOMAL BETA-HEXOSAMINIDASE ISOFORM B IN COMPLEX WITH (2R,3R,4S,5R)-2-ACETAMIDO-3,4-DIHYDROXY-5-HYDROXYMETHYL-PIPERIDINIUM CHLORIDE (GALNAC-ISOFAGOMINE)	3.2.1.52
1NOY	DNA POLYMERASE (E.C.2.7.7.7)/DNA COMPLEX	2.7.7.7 3.1.11
1NOZ	T4 DNA POLYMERASE FRAGMENT (RESIDUES 1-388) AT 110K	2.7.7.7 3.1.11
1NP0	HUMAN LYSOSOMAL BETA-HEXOSAMINIDASE ISOFORM B IN COMPLEX WITH INTERMEDIATE ANALOGUE NAG-THIAZOLINE	3.2.1.52
1NP2	CRYSTAL STRUCTURE OF THERMOSTABLE BETA-GLYCOSIDASE FROM THERMOPHILIC EUBACTERIUM THERMUS NONPROTEOLYTICUS HG102	3.2.1.21
1NPA	CRYSTAL STRUCTURE OF HIV-1 PROTEASE-HUP	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1NPC	THE STRUCTURE OF NEUTRAL PROTEASE FROM BACILLUS CEREUS AT 0.2-NM RESOLUTION	3.4.24.27 3.4.24.28
1NPM	NEUROPSIN, A SERINE PROTEASE EXPRESSED IN THE LIMBIC SYSTEM OF MOUSE BRAIN	3.4.21.118
1NPV	CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LDC271	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1NPW	CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH LGZ479	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1NPZ	CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES	3.4.22.27
1NQ3	CRYSTAL STRUCTURE OF THE MAMMALIAN TUMOR ASSOCIATED ANTIGEN UK114	3.5.99.10 3.1
1NQ6	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF XYLANASE A FROM STREPTOMYCES HALSTEDII JM8	3.2.1.8
1NQC	CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES	3.4.22.27
1NQD	CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE COLLAGEN-BINDING DOMAIN 3B AT 1.65 ANGSTROM RESOLUTION IN PRESENCE OF CALCIUM	3.4.24.3
1NQJ	CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE COLLAGEN-BINDING DOMAIN 3B AT 1.0 ANGSTROM RESOLUTION IN ABSENCE OF CALCIUM	3.4.24.3
1NQY	THE STRUCTURE OF A COA PYROPHOSPHATASE FROM D. RADIODURANS	3.6.1.9
1NQZ	THE STRUCTURE OF A COA PYROPHOSPHATASE FROM D. RADIODURANS COMPLEXED WITH A MAGNESIUM ION	3.6.1.9
1NRN	CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES	3.4.21.5
1NRO	CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES	3.4.21.5
1NRP	CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES	3.4.21.5
1NRQ	CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES	3.4.21.5
1NRR	CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES	3.4.21.5
1NRS	CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES	3.4.21.5
1NRW	THE STRUCTURE OF A HALOACID DEHALOGENASE-LIKE HYDROLASE FROM B. SUBTILIS	3.1.3
1NS3	STRUCTURE OF HCV PROTEASE (BK STRAIN)	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
1NSA	THREE-DIMENSIONAL STRUCTURE OF PORCINE PROCARBOXYPEPTIDASE B: A STRUCTURAL BASIS OF ITS INACTIVITY	3.4.17.2
1NSB	THE 2.2 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF INFLUENZA B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC ACID	3.2.1.18
1NSC	INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR	3.2.1.18
1NSD	INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR	3.2.1.18
1NSF	D2 HEXAMERIZATION DOMAIN OF N-ETHYLMALEIMIDE SENSITIVE FACTOR (NSF)	3.6.4.6
1NSO	FOLDED MONOMER OF PROTEASE FROM MASON-PFIZER MONKEY VIRUS	3.4.23 3.6.1.23
1NST	THE SULFOTRANSFERASE DOMAIN OF HUMAN HAPARIN SULFATE N-DEACETYLASE/N-SULFOTRANSFERASE	2.8.2 2.8.2.8 3
1NT0	CRYSTAL STRUCTURE OF THE CUB1-EGF-CUB2 REGION OF MASP2	3.4.21.104
1NT1	THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR	3.4.21.5
1NT4	CRYSTAL STRUCTURE OF ESCHERICHIA COLI PERIPLASMIC GLUCOSE-1-PHOSPHATASE H18A MUTANT COMPLEXED WITH GLUCOSE-1-PHOSPHATE	3.1.3.10
1NTP	USE OF THE NEUTRON DIFFRACTION H/D EXCHANGE TECHNIQUE TO DETERMINE THE CONFORMATIONAL DYNAMICS OF TRYPSIN	3.4.21.4
1NU0	STRUCTURE OF THE DOUBLE MUTANT (L6M; F134M, SEMET FORM) OF YQGF FROM ESCHERICHIA COLI, A HYPOTHETICAL PROTEIN	3.1
1NU3	LIMONENE-1,2-EPOXIDE HYDROLASE IN COMPLEX WITH VALPROMIDE	3.3.2.8
1NU6	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP-IV)	3.4.14.5
1NU7	STAPHYLOCOAGULASE-THROMBIN COMPLEX	3.4.21.5
1NU8	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP-IV) IN COMPLEX WITH DIPROTIN A (IPI)	3.4.14.5
1NU9	STAPHYLOCOAGULASE-PRETHROMBIN-2 COMPLEX	3.4.21.5
1NUC	STAPHYLOCOCCAL NUCLEASE, V23C VARIANT	3.1.31.1
1NUI	CRYSTAL STRUCTURE OF THE PRIMASE FRAGMENT OF BACTERIOPHAGE T7 PRIMASE-HELICASE PROTEIN	2.7.7 3.6.4.12
1NUW	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE AT PH 9.6	3.1.3.11
1NUX	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND INHIBITORY CONCENTRATIONS OF POTASSIUM (200MM)	3.1.3.11
1NUY	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, AND PHOSPHATE	3.1.3.11
1NUZ	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE	3.1.3.11
1NV0	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND 1 MM THALLIUM	3.1.3.11
1NV1	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND THALLIUM (5 MM)	3.1.3.11
1NV2	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND THALLIUM (20 MM)	3.1.3.11
1NV3	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND THALLIUM (100 MM)	3.1.3.11
1NV4	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE, EDTA AND THALLIUM (1 MM)	3.1.3.11
1NV5	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE, EDTA AND THALLIUM (5 MM)	3.1.3.11
1NV6	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE, EDTA AND THALLIUM (20 MM)	3.1.3.11
1NV7	FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH AMP, MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND THALLIUM (20 MM)	3.1.3.11
1NVU	STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OF THE RAS-SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS	3.6.5.2
1NVV	STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OF THE RAS-SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS	3.6.5.2
1NVW	STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OF THE RAS-SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS	3.6.5.2
1NVX	STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OF THE RAS-SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS	3.6.5.2
1NWE	PTP1B R47C MODIFIED AT C47 WITH N-[4-(2-{2-[3-(2-BROMO-ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]-OXALAMIC ACID	3.1.3.48
1NWL	CRYSTAL STRUCTURE OF THE PTP1B COMPLEXED WITH SP7343-SP7964, A PTYR MIMETIC	3.1.3.48
1NWW	LIMONENE-1,2-EPOXIDE HYDROLASE	3.3.2.8
1NX9	ACETOBACTER TURBIDANS ALPHA-AMINO ACID ESTER HYDROLASE S205A MUTANT COMPLEXED WITH AMPICILLIN	3.1.1.43
1NXC	STRUCTURE OF MOUSE GOLGI ALPHA-1,2-MANNOSIDASE IA REVEALS THE MOLECULAR BASIS FOR SUBSTRATE SPECIFICITY AMONG CLASS I ENZYMES (FAMILY 47 GLYCOSIDASES)	3.2.1.113
1NXY	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN M182T MUTANT OF TEM-1 AND A BORONIC ACID INHIBITOR (SM2)	3.5.2.6
1NY0	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN M182T MUTANT OF TEM-1 AND A BORONIC ACID INHIBITOR (NBF)	3.5.2.6
1NY1	CRYSTAL STRUCTURE OF B. SUBTILIS POLYSACCHARIDE DEACETYLASE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR127.	3.5.1
1NY2	HUMAN ALPHA THROMBIN INHIBITED BY RPPGF AND HIRUGEN	3.4.21.5
1NYM	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN M182T MUTANT OF TEM-1 AND A BORONIC ACID INHIBITOR (CXB)	3.5.2.6
1NYY	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN M182T MUTANT OF TEM-1 AND A BORONIC ACID INHIBITOR (105)	3.5.2.6
1NZ0	RNASE P PROTEIN FROM THERMOTOGA MARITIMA	3.1.26.5
1NZ6	CRYSTAL STRUCTURE OF AUXILIN J-DOMAIN	3.1.3.48
1NZ7	POTENT, SELECTIVE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B USING A SECOND PHOSPHOTYROSINE BINDING SITE, COMPLEXED WITH COMPOUND 19.	3.1.3.48
1NZI	CRYSTAL STRUCTURE OF THE CUB1-EGF INTERACTION DOMAIN OF COMPLEMENT PROTEASE C1S	3.4.21.42
1NZO	THE CRYSTAL STRUCTURE OF WILD TYPE PENICILLIN-BINDING PROTEIN 5 FROM E. COLI	3.4.16.4 3.5.2.6
1NZU	WILD-TYPE PENICILLIN-BINDING PROTEIN 5 FROM E. COLI MODIFIED BY BETA-MERCAPTOETHANOL	3.4.16.4 3.5.2.6
1NZY	4-CHLOROBENZOYL COENZYME A DEHALOGENASE FROM PSEUDOMONAS SP. STRAIN CBS-3	3.8.1.6 3.8.1.7
1O07	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN Q120L/Y150E MUTANT OF AMPC AND A BETA-LACTAM INHIBITOR (MXG)	3.5.2.6
1O0E	1.9 ANGSTROM CRYSTAL STRUCTURE OF A PLANT CYSTEINE PROTEASE ERVATAMIN C	3.4.22
1O0F	RNASE A IN COMPLEX WITH 3',5'-ADP	3.1.27.5 4.6.1.18
1O0H	RIBONUCLEASE A IN COMPLEX WITH 5'-ADP	3.1.27.5 4.6.1.18
1O0M	RIBONUCLEASE A IN COMPLEX WITH URIDINE-2'-PHOSPHATE	3.1.27.5 4.6.1.18
1O0N	RIBONUCLEASE A IN COMPLEX WITH URIDINE-3'-PHOSPHATE	3.1.27.5 4.6.1.18
1O0O	RIBONUCLEASE A IN COMPLEX WITH ADENOSINE-2',5'-DIPHOSPHATE	3.1.27.5 4.6.1.18
1O0Q	CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 1 MM EDTA	3.4.24.40
1O0T	CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 5 MM EDTA (5 DAYS)	3.4.24.40
1O0W	CRYSTAL STRUCTURE OF RIBONUCLEASE III (TM1102) FROM THERMOTOGA MARITIMA AT 2.0 A RESOLUTION	3.1.26.3
1O0X	CRYSTAL STRUCTURE OF METHIONINE AMINOPEPTIDASE (TM1478) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION	3.4.11.18
1O12	CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE (TM0814) FROM THERMOTOGA MARITIMA AT 2.5 A RESOLUTION	3.5.1.25
1O1W	SOLUTION STRUCTURE OF THE RNASE H DOMAIN OF THE HIV-1 REVERSE TRANSCRIPTASE IN THE PRESENCE OF MAGNESIUM	3.1.26.4 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
1O1Z	CRYSTAL STRUCTURE OF GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE (GDPD) (TM1621) FROM THERMOTOGA MARITIMA AT 1.60 A RESOLUTION	3.1.4.46
1O2E	STRUCTURE OF THE TRIPLE MUTANT (K53,56,120M) + ANISIC ACID COMPLEX OF PHOSPHOLIPASE A2	3.1.1.4
1O2G	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.5
1O2H	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2I	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2J	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2K	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2L	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2M	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2N	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2O	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2P	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2Q	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2R	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2S	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4
1O2T	ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS	3.4.21.4